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ABSTRACT 
The yeast U6 snRNA is the most highly conserved of the snRNAs involved in 
nuclear pre-mRNA splicing. U6 snRNA is a very important and dynamic molecule, 
undergoing several conformational changes during spliceosome assembly. In snRNP 
particles and in the spliceosome, U6 snRNA is involved in numerous well characterised 
RNA-RNA interactions. In contrast, there have been few studies of the U6 snRNA-
protein interactions. With the exception of the Prp24p splicing factor, no direct U6 
snRNA-protein binding has been reported to date. 
An experimental procedure was developed to detect proteins associated with the U6 
snRNA: In a yeast nuclear extract, functional U6 snRNP particles were reconstituted 
with a radiolabelled U6 snRNA produced by transcription in vitro. The extract was UV-
irradiated to covalently crosslink proteins that are in close proximity to the U6 snRNA. 
Proteins were subsequently immunoprecipitated, either directly or via snRNP particles. 
After separation on SDS-PAGE, proteins UV-crosslinked to radiolabelled U6 snRNA 
were detected by autoradiography. Using this procedure, the splicing factor Prp24p, and 
the U6 snRNP-associated proteins Ussi, Uss4 and Uss5 were found to be in contact 
with the U6 snRNA in the U6 snRNP, the U4/1J6.U5 tri-snRNP and probably in the 
U4/U6 snRNP. Other (uncharacterized) proteins were also UV-crosslinked to the U6 
snRNA in these particles. The U5 snRNP specific Prp8 protein interacts with the U6 
snRNA in the tri-snRNP. The evidence that Prp8p contacts the U6 snRNA in this 
particle is in keeping with the proposed role for Prp8p stabilising the U4/U6 snRNA 
interaction in the tri-snIRNP. Further investigations showed that the U6 snRNP-specific 
protein Spb8 binds the U6 snRNA in an unspecific manner while Uss6p and Uss3p 
interact weakly with this RNA molecule. No UV-crosslinking was detected between 
Uss2p or Uss7p and the U6 snRNA. 
Analysis of protein-U6 snRNA contacts occuring in the spliceosome indicates that two 
unidentified polypeptides of 30 kD and 40 kD are in close proximity to the U6 snRNA, 
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at least before the first step of the splicing reaction. No contact between p2LAT mutant 
protein and U6 snRNA could be detected in spliceosomes. 
The effect of U6 snRNA mutations on these RNA-protein interactions was also 
investigated. The most significant effects were obtained for the C48A and G60C 
mutations and for a FokI truncation (lacking the last 18 nucleotides of U6 snRNA) 
which have differential effects on the crosslinking of Prp24p, Prp8p and Ussip to U6 
snRNA. The implication of the FokI truncation on protein interactions (in particular 
Prp24p and Usslp contacts) is discussed. The UV-crosslinking data suggest that the last 
18 nucleotides of the U6 snRNA may be a binding site for Prp24p and Uss ip and/or it 
may promote the binding of these proteins elsewhere in this snRNA. 
U6 snRNP particles were also reconstituted with U6 snRNA uniquely radiolabelled at 
position U54 . UV-crosslinking experiments demonstrated that Prp8p binds strongly to 
U6 snRNA at this important position. In comparison, Ussip interacts much less 
strongly, suggesting that U 54 is not the main contact point of this protein. 
The results presented here form an initial characterisation of the protein contacts made 
with the U6 snRNA in snRNP complexes. Interestingly, the binding of the U6 snRNP-
specific proteins Uss 1, Uss4 and Uss5 to the U6 snRNA in the U6, U4/1J6 snRNPs and 
in the tri-snRNP suggests that these polypeptides may have an important role to play. 
These polypeptides share significant homology with the Sm proteins and, by analogy, it 
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U6 RNA: U6 sriRNA produced by transcription in vitro with the T7 RNA polymerase 
(section 2.4.4.1). 
U6 RNA (32P-(xATP): U6 snRNA radiolabelled with 32P-aATP. This RNA was 
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U6 RNA (32P-(xUTP): U6 snRNA radiolabelled with 32P-aUTP. This RNA was 
produced by transcription in vitro using the PUC6 DNA template amplified by PCR 
reaction with oligodeoxyribonucleotides Loryl and S5761 (Table 8) as primers. 
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By the late 1970s, the physical structure of genes was firmly established from 
work in bacteria; the sequences of the gene, the RNA and the protein were colinearly 
organised and expressed. Since the science of genetics suggested that genes in 
eukaryotic organisms behaved similarly to these of prokaryotic organisms, it was then 
assumed that the bacterial gene structure was universal. However, further analyses of 
the genetic material in eukaryotic cells, indicated that the genes were physically 
separated by the nucleus' membrane from the messenger RNAs translated in the 
cytoplasm. This observation suggested that the molecular biology of gene expression in 
eukaryotes was not as straightforward as that in bacteria. In 1977, the study of the 
adenovirus expression led to the discovery of split genes and precursor-mRNA splicing 
(Berget et al., 1977; Chow et al., 1977). Shortly afterwards a number of cellular genes 
were shown to be interrupted by intervening sequences or introns. Amongst the first 
intron-containing genes discovered, the globin gene (Jeffreys and Flavell, 1977; 
Tilghman et al., 1978) and the ovalbumin gene (Breathnach et al., 1977) were shown to 
contain respectively two and eight introns. Further studies indicated that most 
eukaryotic genes harboured introns. In 1981, Breathnach and Chambon demonstrated 
that these introns possessed limited conserved sequences at their boundaries. 
Interestingly, these conserved sequences were common to plant, yeast and vertebrate 
cells (Padgett et al., 1986), suggesting that the splicing process was evolutionarily 
conserved. Since then, the splicing mechanism has been widely studied in various 
organisms highlighting the complexity of this process. 
Introns have been classified according to their conserved sequences, structures and 
mechanism of splicing. Six major groups of introns were distinguished: group I; group 
II; group III; tRNA introns; nuclear introns removed by the U2-type spliceosome and 
nuclear introns excised by the b12-type  spliceo some. The removal of these different 
introns involves different mechanisms which share several similarities, supporting the 
idea of evolutionary conservation (for review see Lambowitz and Belfort, 1993). 
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A brief presentation of the group I, II and III introns and their splicing mechanisms will 
be related in this chapter, highlighting the similarities of their structures and splicing 
processes. A more detailed description of the nuclear introns removed by the U2-type 
spliceosome and their splicing mechanism will be given. This will be followed by a 
short description of the U12-type splicing machinery. 
As nuclear introns are distributed in a wide range of organisms, their characterisation 
will be limited to that of introns located in the nuclear pre-niRNAs in mammals and in 
the yeast Saccharomyces cerevisiae. 
1.1 	Group I Introns 
Group I introns possess the widest phylogenetic distribution and are found in 
both eubacteria and eukaryotes (although not in vertebrates). They interrupt genes 
coding for proteins, rRNAs and tRNAs located in mitochondria, chloroplast and nuclear 
genomes. Group I introns are sporadically distributed, and can be present in one strain 
or species but absent in another of the same genus. Their discovery in bacteriophage T4 
marked the first time that RNA splicing was found in prokaryotes (Chu et al., 1986; 
Gott etal., 1986). 
Common features: different group I introns have limited sequence homology but share 
conserved secondary and tertiary structures. The secondary structure of group I introns 
is shown in Figure 1A, and consists of a combination of short- and long- range pairings 
denoted P1 through PlO, with elements Pl-P8 forming the catalytic core. Most group I 
introns include an "internal guide sequence" (IGS) which is shown in Figure lB. This 
structure holds the exons together and ensures that exon ligation occurs. The presence 
of a divalent metal ion is critical for group I intron structure and function. Mg 2+  or Mn 2+ 
are required for intron' activity while Ca2, Sr 2+ and Ba2 can mediate the correct 
overall folding of the RNA but cannot confer catalytic activity. This suggests that two 
classes of metal ion-binding sites (structural and catalytic) must be occupied (Cech, 
3 
Figure 1. Group I introns 
Secondary structure of the group I intron of Tetrahymena precursor rRNA (Michel 
etal., 1990). This diagram shows the conserved nucleotides and the secondary structure 
of the group I intron. The paired structures are shown (P1 -P9). Two arrows indicate the 
conserved residues located at the 3' end of the exon and the 3' end of the intron. An 
opened arrow indicates a G residue within an AGA motif of the intron (residue G264 of 
the P7 domain of the Tetrahymenaintron) (Michel et al., 1989). This guanosine (G264) 
binds to a free guanosine in the first step of splicing (see Figure IQ), and also serves to 
recognize the 3' terminal guanosine of the intron during the second step of splicing 
(Been et al., 1991). The most conserved nucleotides contained within four short 
sequences are annoted as P, Q, R and S. The distance between these sequence elements 
can vary from —P20 nt to many hundreds. 
Diagrammatic representation of the secondary structure of a group I intron. This 
scheme was adapted from Davies et al. (1982). The paired structures and the conserved 
sequences (P, Q, R, S) are shown. On this particular diagram, the "internal guide 
sequence" is indicated by a wavy lane. This sequence pairs at the end of the upstream 
exon (P1) and at the beginning of the downstream exon (P 10) acting as an adaptor 
molecule that brings the two splice sites tightly together. 
Schematic representation of the group I intron splicing reaction. Almost invariantly 
the conserved residues at the 3' end of the exon and at the 3' end of the intron are 
respectively U and G. The first step of splicing requires the specific binding of a free 
guanosine. The 3' OH group of this free guanosine attacks (nucleophilic attack) the 3' 
phosphodiester bond of the 5' exon-intron junction. Thus after cleavage of the 5' exon-
intron junction, the free G becomes covalently attached to the 5' end of the intron. In 
the second step of the reaction, the terminal G residue of the intron is attacked by the 
terminal 3' OH of the 5' exon leading to exon ligation. With some group I introns, 
cyclisation occurs, coupled to cleavage and release of a short 5' oligonucleotide 
harboring the G residue at the 5'-terminal. 
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1993). Group I introns have only a single catalytic centre and undergo splicing by a 
two-step trans-esterification mechanism which is shown in Figure 1C. Although some 
group I introns self-splice in vitro, many require proteins for efficient splicing in vivo 
(Lazowska et al., 1989). Group I introns vary in size from 200 nt to 3000 nt, depending 
on the length of the peripheral sequences and whether or not they contain an open 
reading frame (ORF). Some of these ORFs encode essential cellular proteins (e.g. 
mitochondrial ribosomal protein S-5, which is encoded within the Neurospora 
mitochondrial large rRNA intron; Burke and RajBhandary, 1982), the majority of them 
function as maturases associated with a larger family of site-specific endonucleases. 
These endonucleases target intronless alleles of the intron-containing genes, mediating 
intron mobility. 
Similarities with other groups of introns: in Tetrahymena, mutations in the invariant 
AG2MA motif of group I introns have similar effects on the second step of splicing, to 
comparable mutations in the invariant AGA motif of the U2 snRNA in S. cerevisiae 
(McPheeters and Abelson, 1992). Moreover, these two motifs are located in similar 
structural environments. In group I introns, the AGA sequence lies within the P7 helix 
of the catalytic core structure. In the U2 snRNA this motif lies within helix I, 
constituted by U2 snRNA and U6 snRNA base-pairing and located in the catalytic 
centre of the spliceo some. 
1.2 Group II Introns 
Group II introns exist in relatively small number in fungal mitochondrial 
genomes. They are predominant in plant mitochondria and chloroplasts, are present in 
algae and overwhelmingly frequent in Euglena gracilis chloroplasts. 
Common features: group II introns are multidomain RNAs endowed with catalytic 
(ribozyme) activity by which they direct and catalyse the splicing of neighbouring exon 
sequences. Group II introns that can direct a complete self-splicing reaction in the 
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absence of protein do so only under non-physiological conditions, and depend on 
proteins for in vivo activity. Only a minority of group II introns are proven ribozymes. 
A number of group II introns encode proteins of the reverse transcriptase family 
(maturases), which enable them to change genomic location. Such introns are 
bifunctional and considered as active participants of the splicing reaction, as well as 
mobile genetic elements. The secondary structure of group II introns is shown in Figure 
2A. It comprises a central wheel from which radiate six spokes that define the six major 
double-helical domains (I to VI). Two major subdivisions (hA and IIB) of group II 
introns are distinguished, based on subtle structural and sequence differences (Michel et 
al., 1989b). Splicing of group II introns proceeds via a two-step trans-esterification 
mechanism which is shown in Figure 2B. This mechanism is essentially identical to 
that involved in nuclear pre-mRNA splicing (see section for description) (Lambowitz 
and Belfort, 1993). The splicing of group II introns involves a single active site which 
rearranges its components to allow the second step to occur (Chanfreau et al., 1996). In 
particular, structural elements located in peripheral structures of domains II and VI are 
required for the conformational changes happening between the two catalytic steps 
(Chanfreau et al., 1996). 
Similarities with other groups of introns: several analogies between group II introns 
and nuclear pre-mRNA introns exist. The hairpin VI of group II introns is similar to a 
double-stranded structure located in the yeast spliceosome and constituted by the base-
pairing between the pre-mRNA branchsite sequence UACUAAC and the U2 snRNA. 
Also, in both structures the branchpoint adenosine is bulged out from the intron. The - 
8' interaction in group II introns is similar to that between the 5' splice site of the 
nuclear pre-mRNA introns and the U6 snRNA (Jacquier and Jacquesson-Breuleux, 
1991). The group II intron catalytic domain V is similar to the U2 snRNA-U6 snRNA 
interaction in the spliceosome (Jarrell et al., 1988). The terminal loop of group II intron 
domain I (subdomain 1D3) contains the exon binding site 1 (EBS1) which is 
complementary to the 3' end of the 5' exon (the intron binding site 1, IBS1). In many 
group II introns, this subdomain 1D3 can pair with bases at the 5' end of the 3' exon, 
contributing to the 3' splice site selection and activation (Jacquier and Jacquesson- 
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Figure 2. Group II introns. 
Secondary structure of intron ai5y from the S. cerevisiae mitochondrial genome 
(Michel et al., 1995). The intron is indicated by the plain line and the exons by the 
rectangles. Tertiary interactions are indicated by dashed lines, curved arrows, and/or 
greek lettering. The consensus sequence of the 5' splice site is GUGYG; the 
branchpoint is A; the 3' splice site is AY. Most group II introns have a bulging A 
(branchpoint, indicated on this diagram with an asterisk) on the 3' side of the basal 
helix of domain VI at either seven or eight nucleotides from the 3' splice site. 
Ribozyme domain I includes sequences called the exon-binding sites (EBS1 and EBS2) 
and base-pairs to the 5' exon sequences called intron-binding sites (lBS 1 and IBS2 
respectively). Integrity of the EBS1-IBS1 pairing is essential both for lariat formation 
and stability of the intermediate complex. Also EBS-IBS interactions are involved in 
aligning the splice sites. Domain V is the most highly conserved and is believed to 
interact with domain I to form the catalytic core (Koch et al. 1992). All of the group II 
intron ORFs are inserted in intron domain IV. Domain IV is highly variable and often 
quite short. Relatively little is known of the exact role of the remaining domains II and 
III. They are presumed to contribute to the folding of the ribozyme or to protein 
binding. Y: pyrimidine; 1D3: internal domain 3. 
Schematic representation of the group II intron splicing pathway. The first step 
involves the formation of a intron-lariat-exon 2 intermediate in which the nucleotide at 
the 5' end of the intron is covalently linked (via a 2'-5' phosphodiester bond) to a 
nucleotide (generally an A-residue) located at the branchpoint site. The second step is 
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Breuleux, 1991; Sontheimer and Steitz, 1993). This subdomain functionally resembles 
the conserved single-stranded loop of the U5 snRNA which interacts with exon 
sequences at both the 5' and the 3' splice sites (Newman and Norman, 1992; Steitz, 
1992). In nearly all group II introns, contacts between IBS and EBS are established as 
Watson-Crick base-pairing interactions (Michel et al., 1989b), whereas the highly 
conserved loop I of the U5 snRNA does not display significant exon sequence 
specificity and can be promiscuous in its base-pairing with exon sequences (Newman 
and Norman, 1992). Indeed, the U5 snRNA can bind to different exon sequences even 
with drastically altered loop I sequences (O'Keefe et al., 1996, 1998). Hetzer et al. 
(1997) have trans-activated the autocatalytic group II intron bli (yeast mitochondria 
group II intron) lacking the subdomain 1D3 with the US snRNA loop I, suggesting that 
1D3 and the US snRNA conserved loop are functional counterparts. Some authors have 
proposed that these numerous resemblances between group II introns and nuclear pre-
mRNA introns reflect a common origin. According to an evolutionary hypothesis, RNA 
domains or subdomains of self-splicing group II introns would have been successively 
detached from the catalytic core to become separately encoded (Cech, 1990; Michel, 
1989; Nilsen, 1994). Despite these similarities, the spliceosomal U4 and Ui snRNAs 
are left with no plausible counterparts. The last nucleotide of group II intron forms a 
classical base-pairing with one of the residues in the segment connecting domains II 
and III (the y-y' pairing, Figure 2A). No such interaction has been uncovered in 
spliceosomal introns, whose last intron nucleotide instead seems to interact with the 
first by nonclassical base-pairing during the second step of splicing (Parker and 
Siliciano, 1993). Also, group II introns have 5' and 3' consensus sequences (GUGYG 
and AY, respectively) which resemble those found in nuclear pre-mRNA introns, but 
unlike them, they have a complex conserved structure required for splicing. These 
differences between nuclear pre-mRNA and group II introns are often interpreted as 
evidence that the two systems have diverged to such an extent that tertiary structure 
became somehow altered. 
1.3 	Group III Introns 
In 1989, Christopher and Hallick discovered the first group III intron in the 
Euglena gracilis chloroplast operon encoding for ribosomal protein L5. Since then, 
several group III introns have been discovered in the Euglena gracilis genome and in 
the plastid of the heterotrophic flagellate Astasia longa (Siemeister et al., 1990). 
Common features: group III introns are small and uniform in size (100 nt), except for 
the 1503 nt long internal group III intron of psbC twintron. Group III introns are 
abbreviated group II introns. They lack domains II-IV, but have retained group II-like 
5' and 3' boundary sequences, and at their 3' end a domain VI-like structure with a 
bulged A used during lariat formation. Some group III introns also contain the 
subdomain 1D3 (Copertino and Hallick, 1993). The mechanism of splicing of group III 
introns resembles that of group II; both splice via a lariat intermediate containing an 
internal 2'-5' phosphodiester bond (Parker et al., 1987; Jacquier, 1990; Copertino et al., 
1992). 
Similarities with other groups of introns: the U residue in the second position and the 
G residue in the fifth position of the 5' splice site boundaries of group III introns (5'-
NUNNG), group II introns (5'-GUGYG) and nuclear pre-mRNA introns (5'-GIJNNG) 
are conserved (N being any nucleotide). Based on the striking similarities between 
group II and group III introns, some authors have proposed that many of the cis 
elements necessary for group II intron excision, and lacking in group III introns, are 
supplied in trans. For example, the group III intron of the psaA mRNA of the 
chlamydomonas chloroplast can be activated when a domain V from a group II intron is 
supplied in trans (Goldschmidt-Clermont, 1991). This suggests an evolutionary 
relationship between group II and group III introns (Jarrell et al., 1988; Goldschmidt-
Clermont, 1991; Hong and Hallick, 1994). Also the requirement for trans-acting RNAs 
for group III intron splicing would be an obvious parallel to the role of snRNAs in 
nuclear pre-mRNA splicing. 
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1.4 Nuclear Pre-mRNA Introns and Their Splicing Mechanism 
In the nucleus of higher eukaryotic cells, many protein-encoding genes are 
interrupted by at least one or more (up to 65) introns of the major class. Many human 
diseases are caused by mutations that interfere with nuclear pre-rnRNA splicing. Thus, 
conserving information for accurate splicing is a constraint on genetic systems. On the 
other hand, the presence of multiple introns allows the choice of several combinations 
of exons by alternative splicing, producing from an identical pre-mRNA different 
mature RNAs which extends the genome information capacity. 
The yeast Saccharomyces cerevisiae (referred to yeast in this work), differs from higher 
eukaryotes in that split genes seem to be an exception. Only -3% of the yeast nuclear 
genes contain an intron, whereas in the fission yeast Schizosaccharomyces pombe at 
least half of the genes are interrupted. In the former, most of the intron-containing 
genes possess one intervening sequence, with the expection of the MA Ta] and the 
RPL8A genes which contain two small introns. In S. cerevisiae, nuclear introns are 
generally small, the largest being 1001 bases long in the DBP2 gene (Iggo et al., 1991). 
1.4.1 	Description of the nuclear pre-mRNA introns excised by the U2-type 
spliceosome 
Introns are defined by the 5' and 3' splice sites and the branchpoint sequence 
elements which are shown in Figure 3. 
The importance of the consensus elements has been demonstrated in vitro and in vivo 
through site-directed mutagenesis and by analysing the effects of naturally occurring 
mutations. Mutations within the 5' splice site generally abolish splicing in yeast 
(Vijayraghavan et al., 1986; Fouser and Friesen, 1986), or lead to the use of proximal 
(cryptic) sites in mammalian systems (Aebi, 1986, 1987). In yeast mutations within the 
branchpoint sequence generally abolish splicing, however some mutations allow the 
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Figure 3. Schematic representation of a nuclear pre-.mRNA intron indicating the 
positions and the sequence of the three conserved elements. 
5' splice site (5' ss), branchpoint where A is the site of branch formation and 3' 
splice site (3' ss) are indicated on this diagram. The distance between the 5' splice site 
and the branchpoint varies. However, splicing efficiency is affected if this distance is 
shorter than 45 nucleotides or greater than 700-1000 nucleotides. 
Splice site consensus sequences for yeast and higher eukaryotes introns are 
indicated. In higher eukaryotes, two subclasses (GT-AG and AT-AC) of nuclear pre-
mRNA introns are excised by the U2-spliceosome, however the GT-AG introns are the 
most frequently found in the genome (for review see Sharp and Burge, 1997). 
R: purine; Y: pyrimidine, I: splice site. 
	
5' ss 	 Branchpoint 	 3' ss 
Exon I GU 	 UACUAAC 	 AG/I Exon II I 
Variable distance 	 20-50 nucleotides 
F,] 
F,] 
Organisms 5' ss consensus sequence 3' ss consensus sequence 
Yeast /GUAUGU 
Mammals AG/GURAGU YAQ/G 
Plants, Drosophila and ARG/AjJAAGU YA/ 
vertebrates 
first step to occur but block the second step of splicing (Fouser and Friesen, 1986; 
Jacquier and Rosbach, 1986). 
Additional cis-acting elements that influence splicing include exon sequences flanking 
the intron (Newman and Norman, 1991, 1992). In yeast a polypyimidine tract located 
between the branchpoint and the 3' splice site, though not strictly requisite, greatly 
enhances the efficient usage of an adjacent AG dinucleotide in alternative 3' splice site 
competition assays (Patterson and Guthrie, 1991). 
Unlike yeast, mammalian introns have defined but less well conserved elements. These 
differences are more likely to reflect the differences between the splicing machineries. 
Indeed, transcripts of genes from other organisms are generally not accurately spliced in 
S. cerevisiae because the intron sequences are not appropriate (Beggs et al., 1980), 
whereas yeast transcripts are spliced in vitro in mammalian systems although 
alternative branchpoint sequences are used. 
1.4.2 The basic nuclear pre-mRNA splicing reaction 
This reaction is shown in Figure 4. It involves two trans-esterification steps with 
the formation of a lariat-intermediate (reviewed in Moore et al., 1993). Although these 
reactions do not themselves seem to need any exogenous source of energy, ATP 
hydrolysis is required for nuclear pre-mRNA splicing. Spliceosome formation and/or 
some spliceosome rearrangements are more likely to be responsible for this ATP-
dependency. GTP-hydrolysis is required for the function of the U5 snRNP specific 
protein U5-116 kD/Snull4p indicating that GTP may be needed for splicing (Fabrizio 
et al., 1997). 
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I Exonl 	Exon2 I 
	C+ 	 AG-OH 
Figure 4. Nuclear pre-mRNA splicing reaction. 
Exon sequences (rectangles), intron sequences (lines) and conserved nucleotides and 
the branchpoint as well as reactive phosphates and hydroxyl groups are indicated. In 
step 1, the 5' splice site phosphodiester bond is cleaved by nucleophilic attack of the 2' 
hydroxyl group of the branchpoint A residue on the phosphate bond at the 5' splice site. 
This yields a 5' exon intermediate with a free 3'-OH terminus (Exon 1-OH). 
Concurrently, the 5' end of the intron is covalently linked via a 2'-5' phosphodiester 
bond to the bulged adenosine of the branchpoint sequence, this forms the so-called 
lariat-intron-exon 2 intermediate. In step 2, cleavage at the 3' splice site occurs as a 
result of a second nucleophilic attack of the free hydroxyl of exoni on the 
phosphodiester bond. Consequently, the intron-exon 2 lariat-intermediate is resolved 
and the exons ligated together through a 3'-5' phosphodiester bond. This yields two 
products: the spliced exons (or mature RNA) and an excised lariat-intron product that is 
rapidly degraded in vivo. 
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1.4.3 	Small nuclear ribonucleoprotein particles of the U2-type splicing 
machinery 
Unlike group I and group II introns, conserved sequences within the nuclear 
pre-mRNA are not sufficient to catalyse the accurate and specific removal of introns. 
The paucity of highly conserved structural elements in nuclear introns appears to be 
compensated by the involvement of a large number of trans-acting factors. These 
factors interact in a highly ordered fashion with each other and/or on the nuclear pre-
mRNA intron to form a large ribonucleoprotein complex called the spliceosome. The 
spliceosome is constituted by a set number of small nuclear ribonucleoprotein (snRNP) 
particles and associated splicing factors (proteins which interact transiently or stably 
with the spliceosome). SnRNP particles are constituted by one or two small nuclear 
RNA (snRNA) that are associated with proteins. 
1.4.3.1 The snRNAs involved in nuclear pre-mRNA splicing 
Description of the snRNAs 
Five spliceosomal snRNAs named Ui, U2, U4, U5 and U6 snRNAs, are 
involved in the splicing of the major class of introns. These are the most abundant of 
the snRNAs. Although their primary sequence varies between species, secondary 
structures are highly conserved. The secondary structure of the mammalian and yeast 
snRNAs are shown in Figures 5 and 6 respectively. 
With the exception of U4 and U6 snRNAs which are associated by extensive base 
pairing interactions and packaged into a single particle (the U4/1J6 snRNP), only one 
snIRNA molecule is present per snRNP. 
The Ui, U2, U4 and U5 snRNAs are transcribed by the RNA polymerase II and they 
possess at their 5' end a trimethylated cap structure (2, 2, 7-trimethylguanosine; Reddy 






















A U C 
U' U_U 
C 	A 
• 	 CA o C. 
u0 cy 
A 	C 
- U  
U-A 
• 	 C-C 
• C-C 	• 
U- A 








UC C-C 	 U 	C 
- C-C 
G-C 
AA 	 A -U -a 	? 	C-C CG cC 	 . 	 CA 	CC 
C 
U- 	 C 	C 
GCAA 	 CG:C* ACACCAACAGC UWGG,U 


















C S CC 




C' A C 
C. 
CG 	C- C 	 A 	U C_U G Uu.G U No 
	
_AA_ •0 0 0 
110- 	A 	 C % AU 
C 	U 	 C-C C 	A 
CA C-O U C 
U4 A 









C A- 20  
C 	 U 
• C G 
A 
A 	C 
u  u  
"DUO 












































era-a 	c 	A 	 C LA aM 
CANAl CAAILW OLAl ALMS MS MW (CS*CAAC 
Un 	 CLAM 	 iXU CAL NASA iaoaan 	£ £ 	 0C C 	 n 	u 0 
3. 	 S 
AC C 
;C U  
a U 
IC c-c 	 CC U%iniaa3uaoa.i AA ;c 	O U 
Ili 	
CAOCAS an AlMS a 
AC 
ICCO 	 Ui 
ulma 
: 















	u c 	U *AU - 







A - U UU 
U - A 
C-a 




UCA'A0uaUA0uAu'cuouuCuuuU'cAo ' - AAUACCAUUUUUUpUD 
lead 	
aU 
• 	U U OUUUUAAAGUUA AGAC 
Sm bflQ 1151 	
CArl. 	04 
uCAhh1 AGU UCU 	UGCUCOC 










o 	C C-G ot shown 
loG-C 	c-c 
U80 
























-0 05C 0 
Sc 
U-A 	30 	 30 	 I 	 50 
- CAOJS0000UCAAUUUQLAACAAUACAGA A U5  U IIAl 
A 
U 	 aD5 50 
taUO.0 C ,G 	UO 
WmI 	UcJ 	
U4 













A 	G s 








_C - 	U 	- 
CU 
transcribed by the RNA polymerase III and consequently lacks the trimethylated cap 
structure. Instead, it possesses at its 5' end a y-methyl phosphate cap. 
The U] snRNA. It is characterised by a 5' single-stranded region containing a 
sequence complementary to the 5' splice site of consensus sequence pre-mRNAs. This 
region is followed by a long-range interaction of 4-5 base-pairs that closes off a central 
domain comprising three contiguous stem-loop structures designated I, II and III 
(Guthrie and Patterson, 1988). The 3' terminal domain consists of the single-stranded 
Sm binding site (see this section for definition), followed by a terminal stem-loop 
structure, designated IV. The length of each domain is generally conserved between 
organisms, the total size of Ui snRNA varying only between 165 nt (mouse) and 147 nt 
(Schizosaccharomyces pombe). The yeast Ui snRNA is slightly different since it is 568 
nt in length and lacks the 3' terminal stem-loop element. 
The U2 snRNA. Its size greatly varies among the different organisms studied 
and ranges from 148 nt (trypanosomes) to 1175 nt (S. cerevisiae) (Guthrie and 
Patterson, 1988). The U2 snRNA can be divided into four stem-loop domains (MV), 
with single-stranded regions separating stem I from stem II and stem II from stem III. 
While the third stem-loop is highly conserved in length (-10 base-pairs) and loop 
sequence (CUUG), it is completely missing in yeast where it is replaced by an insertion 
of —1 kb (Shuster and Guthrie, 1988). Surprisingly, this insertion can be deleted without 
any impact on yeast viability. Despite the large size of the yeast U2 snRNA, it can be 
folded into a structure that resembles the structure originally proposed for the metazoan 
U2 snRNA by Keller and Noon (1985). The branchpoint recognition sequence 
identified by Parker et al. (1987) is located in the single-stranded region immediately 
downstream of stem-loop I. Within this single-stranded region, nucleotides 28-47 are 
absolutely conserved (Guthrie and Patterson, 1988). The Sin binding site is located 
downstream from stem-loop II. 
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The U6 snRNA. It is the most highly conserved of the spliceosomal snRNAs, 
and has been postulated to have a fundamental role in nuclear pre-mRNA splicing (Das 
et al., 1987; Brow and Guthrie, 1988). The 5' terminal domain (nucleotides 1-27) 
contains a hairpin structure highly variable in length among species, which is 
responsible for essentially all the differences in size of the U6 snRNAs. The contiguous 
stretch of conserved sequences (nucleotides 55-80) in U6 snRNA has been proposed to 
base-pair with the U4 snRNA to form two contiguous stems (Bringmann et al., 1984; 
Hashimoto and Steitz, 1984; Rinke etal., 1985; Das et al., 1987; Siliciano et al., 1987; 
Kiss et al., 1988). The 3' terminal domain (nucleotides 81-112) is divergent in 
sequence but constant in length. The sequencing of the U6 snRNA revealed that the 3' 
end was heterogeneous and contains 4, 5, 6, or 7 contiguous U residues (Brow and 
Guthrie, 1988). In yeast, point mutations (Fabrizio and Abelson, 1990; Madhani et al., 
1990, Madhani and Guthrie, 1992) or thiophosphate substitutions (Fabrizio and 
Abelson, 1992) in the two invariant sequences (-A 47CAGAGA53- and -A59GC61 -) block 
either the first or the second step of the splicing reaction. The same effect was observed 
for mutations in the corresponding sequences in Xenopus U6 snRNA (Vankan et al., 
1992). These two sequences were less sensitive to mutation in human cells, reflecting 
differences in the requirement of U6 snRNA sequences between human and yeast 
despite their overall similarity (Datta and Weiner, 1993). 
The U41U6 snRNAs. The U4 snRNA molecule has been proposed to contain 
six domains: stem II, 5' stem-loop, stem I, central region, 3' stem-loop and 3' terminal 
region. The 3' terminal domain of the U4 snRNA contains the Sm binding site, which 
is followed in all organisms except in S. cerevisiae and K lactis by a 3' terminal stem. 
The most remarkable aspect of the U4 snRNAJtJ6 snRNA is the interaction domain 
called domain Y (Brow and Guthrie, 1988; Guthrie and Patterson, 1988). Analysis of 
RNA content in yeast cells has shown that U6 snRNA is present at four- to five-fold 
molar excess relative to U4 snRNA (Li and Brow, 1993), while, 95% of the U4 snRNA 
is complexed to U6 snRNA (Fortner et al., 1994). The U6 snRNA sequence bound to 
the U4 snRNA shows higher conservation than does the comparable sequence of the U4 
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snRNA. U4 snRNA probably sequesters a catalytically active domain of U6 snRNA 
until other conditions of spliceosome assembly have been satisfied. The U4 snRNA 
could function as a negative effector (Yean and Lin, 1991; Moore et al., 1993). It has 
been suggested that the region of U6 snRNA interacting with the U4 snRNA may be 
involved in catalysis (Brow and Guthrie, 1988). This hypothesis was supported by 
mutagenesis studies and the discovery of an intron within the gene encoding for the U6 
snRNA in the fission yeast Schizosaccharomycespombe. This intron was located in the 
middle of the most highly conserved region of U6 5nRNA (Tani et Ohshima, 1989), 
which might reflect the proximity of that region to the catalytic centre of the 
spliceosome. 
The U5 snRNA. It varies in size over a two-fold range (from 107 nt in 
dinoflagellates to 214 nt in S. cerevisiae). The U5 snRNA appears to be the most highly 
structured of the spliceosomal snRNAs. The molecule appears to be organised into two 
domains: a 5' terminal compound helix and a 3' terminal domain containing a single-
stranded region which includes the Sin binding site and a stem-loop. The long helical 
element located at the 5' extremity is designated stem I. This stem is divided into 
several substructures with the maximum conservation found in the top portion of the 
terminal loop I (among the 11 nt constituting this loop, 9 are invariant in sequence). 
The 3' terminal stem-loop of US snIRNA varies considerably in size and sequence in 
different organisms. In yeast, half of the U5 snRNA transcripts terminate just prior to 
the 3' terminal stem-loop producing two forms of U5 snRNA which are called U5 S (for 
short) and U51, (for long) (Patterson and Guthrie, 1987; Frank et al., 1994). Both forms 
are incorporated into snRNP particles (Madhani et al., 1990), yet the U51, is 
dispensable in vivo (Haltiner-Jones and Guthrie, 1990; Frank et al., 1994). Mammalian 
US snRNA is extremely resistant to microccocal nuclease and RNase H cleavage, 
suggesting that even the single-stranded RNA sequences are largely inaccessible. 
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Processing of the snRNAs 
During snRNP biogenesis, snRNAs undergo several changes which include: 
transcription as precursor snRNAs containing at their 3' end an extension of 1-16 nt 
(Kjeinschmidt and Pederson, 1987; Madore et al., 1984a, 1984b), assembly with the 
common proteins, trimming at the 3' end of the snRNA; extensive internal 
modifications; 5' end capping (Dahlberg et al., 1988; Mattaj, 1988). The processing of 
snRNAs is very complex and involves several enzymatic activities which are not yet 
fully understood. Only a brief overview of these processing steps is given in this 
section. 
Formation of pseudouridine. SnRNAs are highly modified post-
transcriptionally (methylation of bases, formation of pseudouridine). Pseudouridine (P) 
formation represents by far the most abundant of these modifications. In HeLa cell 
extracts, the formation of P involves multiple P synthase activities that specifically 
recognise the Ui, U2, and the U5 snRNAs (Patton, 1991, 1993, 1994). Efficient P 
formation in US snRNA requires the binding of the Sin proteins (Patton, 1991), 
whereas Sm proteins are not needed for the formation of P in U2 snRNA 
(Kleinschmidt et al., 1989; Patton et al., 1994). U4 and U6 snRNAs are also modified. 
Intriguingly, the formation of P in the U6 snRNA depends upon its interaction with the 
U4 snRNA (Zerby and Patton, 1996). The function of P in spliceosomal snRNAs is 
unknown, however it is noteworthy that P are found in regions of snRNAs known to be 
necessary for the function of snRNPs in splicing (Steitz et al., 1988; Guthrie and 
Patterson, 1988). The requirement for P modification for the in vitro function of the 
snRNA varies. In HeLa cell extracts, modifications are required for the activity of the 
U2 snRNA while they are dispensable for the activity of the U5 snRNA (Ségault et al., 
1995). This difference in the requirement of P may be due to the fact that U2 snRNA 
contains a larger percentage of P; therefore the absence of P might have a greater 
impact on its function (Segault et al., 1995). 
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Trimming of the 3' end. Transcription of snRNAs produces precursor 
molecules which contain at their 3' end an extension of 1-16 nts (Kleinschmidt and 
Pederson, 1987; Madore et al., 1984a, 1984b). These longer forms are shortened by 
mechanism(s) yet unknown. Most of this extension is removed in the cytoplasm where 
Sm protein binding and cap hypermethylation of the snRNAs occur concomitantly 
(Madore et al., 1984a; Kleinschmidt and Pederson, 1987; Neuman de Vegvar and 
Dahlberg, 1990). In vertebrates, proper snRNA 3' end formation requires transcription 
from snRNA promoters only, since the transcription of snRNAs from a mRNA 
promoter results in aberrant processing of the transcript. Thus the production of a 
precursor snRNA with an extended 3' tail seems linked to transcription (Ciliberto et al., 
1986; Hernandez and Weiner, 1986; Neuman de Vegvar et al., 1986). Also, the 3' end 
maturation of snRNAs in metazoans is constrained to occur within a short distance 
from the promoter (Ramamurthy et al., 1996). In contrast, in yeast the 3' end 
shortening is not affected by substitution of the snIRNA promoter with elements of 
mRNA promoters. Also, there is no restriction in the distance between the promoter and 
the 3' end of the snRNA. These differences probably reflect the different 3' end snRNA 
processing pathway(s) in metazoans and in yeast. The study of the 3' end processing of 
the yeast U5 snRNA indicates that the formation of the U5S and U51, involves two 
distinct pathways with the RNase III being required for the production of the 
intermediates (Chanfreau et al., 1997). The complete mechanisms involved in the 
generation of U51, and U5S has not yet been deciphered. Only an exonuclease is 
suspected to be needed for the generation of U5L (Chanfreau et al., 1997). 
The Sm site and the association of the Sm proteins. Ui, U2, U4 and U5 
snRNAs share a common structural motif called the Sm site. This motif serves as the 
primary binding site for the common (also called Sm or common or core) snRNP 
proteins (see section 5.3.2 for description; for review see Mattaj, 1985, 1988; Hamm et 
al., 1990). This site has been identified as a single-stranded U-rich sequence (RAU 3 
6GR; R: purine base) which is most often flanked by two hairpin structures (Branlant et 
al., 1982). Saturation mutagenesis demonstrates that only three of the ten consensus 
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nucleotides of the Sm binding site are critical (UAUUUTJIJLJGG; crucial nucleotides 
are underlined), and their mutation is associated with a conditional or lethal phenotype 
(Jones et al., 1990; Hu et al., 1995). The nucleotides bordering the critical residues are 
relatively insensitive to site-specific mutation, whereas multiple mutations are 
associated with severe growth defects. Complete deletion or substitution of the yeast 
U4 or U5 snRNA Sm site is lethal, confirming the functional importance of this 
sequence. However, unexpectedly, the deletion of the Sm site in U4 snRNA from HeLa 
cells has little effect on in vitro splicing or spliceosome assembly, but abolishes Sm 
protein binding (Wersig et al., 1992). 
The association of the common snRNP proteins depends on this Sm site and the 
presence of only one flanking stem-loop (which may be positioned either on the 5' or 3' 
side of the Sm site). The requirement of only one hairpin structure is illustrated by the 
fact that one of the forms of the yeast U5 snRNA (1J5 S) terminates shortly after the Sm 
site and thus lacks a 3' flanking hairpin (Guthrie et al., 1988). Although these structures 
are identical, they are not interchangeable among snRNAs. They might finely tune 
protein-protein interactions between the Sm proteins themselves (Jarmolowski et al., 
1993). The binding of the Sm proteins to the snRNAs is required for the 
hypermethylation of the 5'-5' 7-methylguano sine (7-mG) cap structure of the snRNAs, 
producing a hypermethylated 2,2,7-trimethylguanosine cap. The core proteins probably 
provide a binding site for the trans-active snRNA-(guanosine-N2)-methyltransferase 
(Plessel et al., 1994). 
Proper Sm protein assembly, cap hypermethylation and 3' end processing are important 
for subsequent nuclear import of the particles (reviewed by Mattaj, 1988; Zieve and 
Sauterer, 1990; Izaurralde and Adam, 1998). Just before and/or after nuclear import, 
5nRNP-specific proteins associate with the individual snRNP precursors to complete 
biogenesis. Whether the Sm proteins have a function in nuclear pre-mRNA splicing is 
still unknown. 
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Very little is known about the biogenesis of the U6 snRNP particle and the processing 
of the U6 snRNA. In HeLa cells and in Xenopus oocytes the U6 snRNA does not leave 
the nucleus(Boelens etal., 1995; Pante eta!, 1997), whereas in L929 mouse fibroblasts 
where it has been detected in the cytoplasm as well as in the nucleus (Zieve et al., 1988; 
Fury and Zieve, 1996). Canonical Sm proteins do not bind to free U6 snRNA 
(Liihrmann et al., 1990). However U6 snRNP-specific proteins (see section 5.3.2) 
which share homology with the Sin motif of the core proteins have been identified and 
some have been characterised (Cooper et al., 1995; Séraphin, 1995; Racine-Fromont et 
al., 1997). 
1.4.3.2 The protein composition of the snRNPs involved in nuclear pre-mRNA 
splicing 
Two types of proteins associated with the spliceosomal snRNAs are 
distinguished: the common (also called the core or Sm proteins) found in all snRNP 
particles (with the exception of the U6 snRNP), and the snRNP particle-specific 
proteins which are exclusively associated with a particular snRNA or a complex of 
snRNAs. 
The Sm proteins 
They are referred to as Sm proteins because they possess an antigenic 
determinant recognised by auto-antibodies isolated from patients (so-called anti-Sm 
sera after the patient Smith) suffering from the autoimmune disease systemic lupus 
erythematosus. Anti-Sm sera immunoprecipitate also yeast Sm proteins showing that 
immunological determinants of the core proteins are conserved (Siliciano et al., 1987; 
Tollervey et al., 1987). The reconstitution in vitro of mammalian snRNP particles with 
purified Sin proteins shows that they are essential for splicing. Also, Sm proteins from 
the U2 snRNP or the Ui snRNP particle can reconstitute a functional US snRNP 
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lacking its own Sm proteins, demonstrating that common proteins are functionally 
interchangeable (Ségault et al., 1995). 
A list of all the mammalian and yeast Sm proteins is presented in Table 1. 
Table 1. List of the mammalian and yeast Sm (common/core) proteins. 
Common SnRNP Particle Proteins 










Size 	 Size - other name(s) 
29 kD 
28kD ----------------- 22kD-YERO29 
l6kD ----------------- l6kD-YGRO74 
15.5 kD---------------12 kD - YLR275 
18.5kD --------------- llkD-YLR147 
l2kD ----------------- lOkD-Y0R159 
11 kD------------------9.7 kD - YPR1 82-SMX3 
9 kD------------------8.5 kD - YFLO18-SNP2-SMX2 
The different names given for the yeast proteins are indicated. The corresponding 
human and yeast homologues are indicated by a dashed line. 
Two sequence motifs, denoted Sm motif 1 and 2, are found in all of the known Sm 
proteins from organisms as diverse as yeast, nematodes, insects, plants and higher 
vertebrates (Cooper et al., 1995; Hermann et al., 1995; Séraphin, 1995). These Sm 
motifs are important for Sm protein-protein interactions (Hermann et al., 1995). 
The mammalian Sm proteins. With the exception of F (p1: 4.6), all the core 
proteins are basic with a p1 value between 8 and 10. B and B' are encoded by the same 
gene (Van Dam, 1989; Chu and Elkon, 1991; for review see Will et al., 1993). Another 
polypeptide named N, is also shared by the snRNP particles but expressed specifically 
in neural tissues (McAllister et al., 1989). 
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Sm proteins bind to the Sm site of the Ui, U2, U4 and U5 snRNAs, and to one another, 
to form a highly stable snRNP core structure. In the snRNP particles, the core proteins 
protect a 15-25 nt long region of the Sm site against hydrolysis by micrococcal 
nuclease (Liautard et al., 1982). To date the only known direct interaction between a 
core protein and a snRNA is that demonstrated by UV-crosslinking analysis between 
the human Ui snRNA Sm site (more precisely the AAU sequence of the 
AAUTJUGUGG Sm motif) and the 5mG protein (Heinrichs et al., 1992). Protein-
protein, rather than protein-RNA interactions appear to dominate in determining the 
structure of the snRNP core. 
Some Sm proteins are able to interact together in the absence of snRNA: Dl .D2 
(Lehmeier et al., 1994); B.D3 and B'.D3 (Hermann et al., 1995); E.F, E.G, E.F.G and 
D1.D2.E.F.G (Fisher et al., 1985; Sauterer et al., 1990; Raker et al., 1996; Plessel et 
al., 1997). The assembly of the Sm proteins to form the core structure has been well 
studied in mammalian in vitro systems (Fisher et al., 1985; Sauterer et al., 1990; Raker 
et al., 1996; Plessel et al., 1997). The core proteins E, F, G interact together to form a 
(E.F.G) complex. Given the sedimentation coefficient and observation of the core 
structure by electron microscopy, it is more likely that two (E.F.G) complexes are 
present per snRNP particle (Raker et al., 1996; Plessel et al., 1997). This multimer 
probably provides a structural platform for snRNP core assembly. The ultrastructural 
similarity of Ui, U2, U4 and US snRNP cores indicates the presence of the (E.F.G) 
dimer in each of these particles (Plessel et al., 1997). Dl and D2 interact together and 
bind to the hexamer (E.F.G)2. This heteromeric complex can associate with a 
monomethylated Ui snRNA forming the subcore snRNP. The subcore formation is not 
restricted to the U 1 snRNA, and is detected with U2, U4 and U5 snRNAs (Raker et al., 
1996). Then B, B' and D3 associate with the subcore to form the core particle 
corresponding to the U snRNA and the eight common proteins (Hermann et al., 1995). 
It is not known if both B and B'or only one of these proteins assemble in vivo into the 
subcore particle. B, B' and D3 are required for the conversion of the Ui snRNA's m 7  G 
cap to its hypermethylated m 3G form. The stochiometry of DIM and B/B' .D3 in the 
snRNP particles remains unknown. 
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The yeast Sm proteins. The much lower abundance of snRNP particles in yeast 
compared to metazoans has made biochemical purification of yeast core proteins a 
difficult task. Also, their identification has been largely refractive to the screens of 
temperature-sensitive mutants that have been employed for the isolation of the majority 
of the yeast splicing factors (for review see 1-lieter et al., 1989). 
The first gene, SMDJ, encoding for a yeast Sm protein was discovered fortuitously near 
the PRP38 gene (Rymond, 1993). The corresponding protein possesses 40% identity to 
the human Dl core protein. In vivo the lack of the yeast Dl is associated with a growth 
arrest and a splicing inhibition. Also, a decrease in the abundance of Ui, U2, U4 and 
U5 snRNAs and a lack of cap modification is noticed, whereas U6 snRNA remains 
unaffected. The human Dl protein can rescue the lethal phenotype associated with the 
lack of the yeast Dl, which confirms the homology between these proteins (Rymond et 
al., 1993). In 1994, Fabrizio et al., purified by immunoaffinity chromatography six 
potential yeast Sm proteins. These proteins possessed apparent molecular weights of 
10, 11, 11.5, 12, 15 and 17 kD, however further identification has not been reported by 
these authors. 
The yeast protein D3 was found by sequence similarity with the human SmD3 (Roy et 
al., 1995). The yeast D3 possesses 51% identity to the human D3. It is essential for cell 
viability and splicing, and for the 5' cap modification of the Ui, U2, U4, US snRNAs 
which become unstable in the cell when the production of D3 is shut down. The 
overproduction of D3 cannot compensate for the loss of Dl, indicating that these 
proteins are functionally different (Roy et al., 1995). 
In an exhaustive two-hybrid screen using SmD3 as a bait, a protein named YER029cor 
5mB, which shares homology with the human B core protein, has been isolated and 
might interact with SmD3 (Fromont-Racine et al., 1997). 
Two additional potential yeast Sm proteins have been identified by computer sequence 
analysis (Séraphin, 1995). These proteins were named SmX2 and SmX3, and share 
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homology with the human SmG and F respectively (Séraphin, 1995). Both SmX2 and 
SmX3 are associated with the spliceosomal snRNAs. 
The gene SME], encoding for the yeast homologue of the human SmE protein, has been 
sequenced and characterised by Bordonné and Tarassov (1996). The corresponding 
protein is essential for cell viability and for Ui, U2, U4 and U5 snRNAs stability. The 
human SME gene can complement a lethal phenotype associated with the disruption of 
the yeast SMEJ, which confirms the homology between the human and the yeast 
proteins. 
The yeast homologue of the human SmD2 has been isolated during the purification of 
the U  and the U2 snRNP particles (Neubauer et al., 1997; Gottschalk et al., 1998). 
The investigation of Sm protein-protein interactions by directed two-hybrid tests and 
immunoprecipitation show that SmD3-B, E-G and F-E are in contact together 
(Camasses et al., 1998). 
The Sm-like proteins of the U6 snRNP particle. A list of U6 snRNP proteins 
so far identified is presented in Table 2B. The U6 snRNP particle does not share the 
common proteins with the other snRNPs. However this particle possesses a set of 
proteins which share homology with the Sm motif (reviewed in Fromont-Racine et al., 
1997; Mayes et al., 1998). These proteins are classified as Sm-like polypeptides 
because they share homology with the Sm motifs, but unlike the core proteins, they are 
associated only with the U6 snRNA. 
One of the U6 snRNP Sm-like protein, USS 1 (also named SDB23), was initially 
isolated as a weak suppresser of a mutation affecting the function of a protein kinase 
involved in the yeast cell cycle (Parkes and Johnston, 1992). Further analyses revealed 
that USS 1 was essential for cell viability and required for the U6 snRNA stability 
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(Cooper et al., 1995 and 1995b). Sequence analysis indicated that USS1 shares 
significant homology with the human D proteins, in particular with D3. 
A second gene named SMX4 or USS2, has been identified by computer sequence 
analysis (Séraphin, 1995). The corresponding protein shares significant homology with 
the human SmD2 protein (Séraphin, 1995). 
Computer analyses identified a set of putative Sm-like U6 snRNP proteins homologous 
to the yeast SmB, Dl, E, F and G proteins (Fromont-Racine et al., 1997). The ORFs 
encoding these proteins are named YJL124c, YBL026w, YER146w, YDR378c and 
YNL147w respectively. The corresponding proteins and also another one, Yjr022p, 
which contains an Sm site but does not share much homology with the cannonical Sm 
proteins, are associated with the U6 snRNA (Mayes etal., 1998). 
The snRNP specific proteins 
Unlike the core proteins, snRNP specific proteins are not required for the 
nuclear localisation of the snRNP particles. They are transported into the nucleus 
independently of any U snRNA through nuclear localisation signal sequences encoded 
within the proteins (Kambac etal., 1992; Romac et al., 1994). 
Tables 2A and 2B show an exhaustive list of the human and yeast protein composition 
of the snRNP particles. 
The mammalian U] snRNP specflc proteins. To date, three proteins have 
been isolated which belong to the human Ui snRNP particle. They are called Ui-A, 
U1-70K and Ui-C. 
U 1-A and U  -70K are members of a large family of RNA binding proteins that contain 
a conserved RNA recognition domain (RBD or RRM) (for description see section 
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Table 2A: List of the U! and U2 snRNP specific proteins in human and 
yeast. 
The size and the name(s) (when available) of these polypeptides are indicated. 
The corresponding human and yeast homologues are indicated by a dashed 
line. 
SnRNP Specific Proteins 
Human Yeast 
Ui snRNP 	70 kD-70K ---------------------------- 34 kD- SNP 1 
34 kD-A 	----------------------------- 34 kD-M1JD1 
22 kD-C 	----------------------------- 27 kD-YIJ1C-YLR298 
56 kD-SNU56-MTJD1O 
57kD-NAM8-MUD15 




Human 	 Yeast 
U2 snRNP 	12S 	17S 
33 kD-A' 33 kD-A' 
28.5 kD-B" 	28.5 kD-B" ---------------------------- 12.8 kD-YU2B" 
160 kD-SF3b160-SAP155 
150 kD-SF3b15O-SAp145 ----------------- SOkD-CUS1 
120 kD-SF3b120-SAP13O 
110kD-SF3a120-SAP114 ----------------- 33kD-PRP21-SPp91 
92 kD 
66 kD-SF3a66-SAP62 -------------------- 30 kD-PRP1 1 
60 kD-SF3a6O-SAP61 -------------------- 63 kD-PRP9 
53 kD-SF3b53-SAP49 -------------------- 24 kD-HSH49 
35 kD-SAP33 
Table 213: List of the U5, U6, U4/U6 snRNP and U4/U6.U5 tri-snRNP 
specific proteins in human and yeast. 
The size and the name(s) (when available) of these polypeptides are indicated. 
The names given by Mayes et al. (1998) are indicated by the symbol (0).  No 
human U6 snRNP proteins have been isolated to date. The yeast U6 snRNP 
proteins have been separated from the other snRNP proteins since to date, it is 
not known if some (or all) of them remain associated with the U6 snRNA in 
the U4/U6 snRNP and in the U41U6.U5 tri-snRNP particles. Only Prp24p has 
been shown to promote U4/U6 snRNAs annealing and to interact transiently 
with the U4/U6 snRNP (Shannon and Guthrie, 1991; Jandrositz and Guthrie, 
1995; Ghetti et al., 1995). U6 snRNP proteins sharing homology with the Sm 
motif of the core proteins are indicated with the symbol (p). 
Prp28p* is not stably associated with the tri-snRNP and is therefore not 
considered as a snRNP specific protein (Strauss and Guthrie, 1991). 
Yj1124p* interacts loosely with the U6 snRNP (Mayes et al., 1998). 
SnRNP Specific Proteins 
U4/U6.U5 tri-snRNP 
Human 	 Yeast 











220 kD ---------------------280 kD-PRP8 
200 kD ---------------------246 kD-SNU246-BRR2-SLj22 
116 k ---------------------- ll4kD-SNU114 
110 kD 
102 kD 





U4/U6 snRNP 60 kD-SAP60 	 60 kD-SAP60 -------------52 kD-PRP4 








Most similar to Sm proteins 
Yeast U6 snRNP 	50 kD-PRP24 
20 kD-SPB80-YJL124' *______________________ 
SmB 
11 kD-USS60-YBL026-SMX5-SNp3 SmD1 
10 kD-USS2-SMX4 SmD2 
21 kD-USS1-YERI 12 SmD3 
10.4 kD-USS70-YER146' SmE 
14 kD-USS4 0-YDR378' SmF 
12 kD-USS5 0-YNL147' SmG 
° 14.5 kD-USS3-YJR022' 
1.4.7; for review see Birney et al., 1993). They bind directly to the Ui snRNA stem-
loop II and stem-loop I respectively (Scherly et al., 1989; Query et al., 1989). Ui-70K 
has an extensive serine/arginine (SR) domain (see section 1.4.7 for description) and 
exists in multiple states of phosphorylation both in vitro and in vivo (Woppmann et al., 
1990, 1993; Wooley etal., 1983). The phosphorylation state of U1-70K is essential for 
the splicing reaction but not for spliceosome formation (Tazi et al., 1993b). Chemical 
protein-protein crosslinking studies have shown that U1-70K interacts via its N-
terminus with the core proteins D2 and B' or B (Nelissen etal., 1994). 
In contrast to Ui-A and U1-70K, the Ui-C protein does not contain any recognised 
RNA binding motif, and depends on the other Ui snRNP proteins for its association 
with the Ui snRNP particle (Nelissen et al., 1994). Ui-C possesses a proline and 
methionine rich C-terminus, and a zinc-finger-like motif (see section 1.4.7 for 
description) at its N-terminus (Sillekens et al., 1988). The zinc-finger-like motif is 
necessary and sufficient for the binding of Ui-C to the Ui snRNP particle (Nelissen et 
al., 1991). Chemical crosslinking experiments have demonstrated that Ui-C interacts 
with the Sm B and B' proteins (Nelissen et al., 1994). Ui-C is needed for efficient 
interaction between the U 1 snRNP and the pre-mRNA 5' splice site (Heinrich et al., 
1990; Nelissen et al., 1991, 1994). 
The yeast Ui snRNP specflc proteins. The yeast homologues of the human 
Ui-A and U1-70K, Mudip and Snpip respectively, have been isolated (Liao et al., 
1993; Smith and Barreli, 1991). 
Mudip (for mutant-u-die) was identified in a synthetic lethal screen with a mutant Ui 
snRNA. It is a non-essential protein, and its depletion is not associated with any 
detectable splicing defect, a further splicing decrease is observed only for introns which 
are normally inefficiently spliced. The absence of Mudip slightly alters the mobility of 
the Ui snRNP. Mudip contains two RNA recognition motifs, and is proposed to help 
the stabilisation of the Ui snRNA (Liao et al., 1993). Both RRMs are important, with 
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the one located at the N-terminus being more likely to be involved in the association of 
Mud ip with the Ui snRNA, while the RRM located at the C-terminus may be involved 
in the splicing function of the protein (Tang and Rosbash, 1996). Chemical footprinting 
and nuclease Si protection analyses indicate that Mudip interacts with the yeast Ui 
snRNA stem-loop Ilic and its opposite single-stranded regions (region similar to the 
human stem-loop B) (Tang and Rosbash, 1996). 
Snplp shares 30% identity with the mammalian U1-70K protein (Smith and Barrell, 
1991). It binds specifically and directly to the yeast Ui snRNA stem-loop I (Kao and 
Siliciano, 1992). A splicing defect is associated with the lack of Snplp in cells, which 
can be complemented by a chimeric yeast-human Snp 1 p  containing the central 188 
amino acids of human U1-70K (Smith and Barrell, 1991). The carboxyl terminus of 
Snplp does not share the SR domain found in metazoan U1-70K. This region is 
completely dispensable, while the amino terminus does not tolerate mutations or 
deletion (1-lilleren et al., 1995). 
The gene encoding the yeast homologue of the human U 1-C has recently been 
identified by data base searching, and was named YU1C (Tang et al., 1997). 
Concomitantly, it has been isolated by purification and sequencing of the yeast Ui 
snRNP proteins (Neubauer et al., 1997). The conservation between the yeast and 
human U1C protein is limited to the common N-terminal domain zinc finger-like 
region (Tang et al., 1997). YTJ1C is essential for splicing, and its lack or the presence of 
a mutant protein affects the 5' end of the U 1 snIRNA which becomes more sensitive to 
RNase I digestion (Tang et al., 1997). 
The purification of the yeast Ul snRNP particle and its comparison with the human 
counterpart revealed that these two particles are different, the former being much larger 
(Fabrizio et al., 1994). Further extensive analysis indicated that the yeast Ui snRNP 
contains nine specific proteins (Neubauer et al., 1997; Gottschalk et al., 1998), whereas 
the human counterpart possesses only three specific proteins (LUhrmann et al., 1990). 
Among these yeast Ul snRNP specific proteins, Prp39p (Lockhart et al., 1994), Prp40p 
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(Kao and Siliciano, 1996) and Snu7lp, Snu65p, Nam8p, Snu56p (Gottschalk et al., 
1998) have been isolated which lack any human homologues. 
Prp39p is essential for splicing and is more likely to function at an early stage of 
spliceosome assembly. Prp39p is required to establish an efficient Ui snRNP/5' splice 
site interaction, and might also be involved in the release of the Ui snRNP particle 
from the spliceosome as spliceosome assembly proceeds (Lockhart and Rymond, 
1994). 
The gene encoding the Snu65 protein was isolated by others and named PRP42 
(McLean and Rymond, 1998). Prp42p is required for Ui snRNP biogenesis, since yeast 
strains depleted of Prp42p form incomplete Ui snRNPs that fail to produce stable 
complexes with pre-mRNA in vitro (McLean and Rymond, 1998). 
Both Prp39p and Prp42p possess multiple copies of a variant tetratrico peptide repeat 
(TPR), an element implicated in a wide range of protein assembly events (Ordway et 
al., 1995; Lamb et al., 1995). 
The gene encoding Prp40p was isolated in a genetic screen searching for suppressers of 
Ui snRNA cold-sensitive mutants (Kao and Siliciano, 1996). PRP40 is essential for 
cell viability and the lack of the corresponding protein is associated with a splicing 
defect in vitro. 
The genes encoding Snu56p, Nam8p and Snu65p were independently isolated in a 
synthetic lethal screen that causes lethality with otherwise viable mutations in Ui 
snRNA. They were named MUDJO, MUD15 and MUD16 respectively (MUD for 
mutant-Li1-ie) (Gottschalk et al., 1998). SNU561M1JDJO is essential for cell viability. 
The corresponding protein exhibits some RNA-binding activity in vitro, despite the 
lack of any known RNA binding motifs (Gottschalk et al., 1998). Snu56p is required 
for the stability and/or the formation of the commitment complex (Gottschalk et al., 
1998). Nam8p possesses three RNA binding motifs and is essential during meiosis and 
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for splicing of a meiosis-specific pre-mRNA (MER2 transcript) (Ogawa et al., 1995; 
Nakagawa and Ogawa, 1997). This protein is probably involved in the stabilisation of 
Ui snRNA-5' splice site interactions (Gottschalk et al., 1998). SNU71 is essential for 
cell viability. This gene encodes a protein which contains several RS-repeats, but unlike 
the mammalian SR proteins these repeats are not concentrated within a domain but 
spread over the polypeptide chain (Gottschalk et al., 1998). No known motifs of 
possible functional significance have been detected in SNU71. 
The mammalian U2 snRNP specflc proteins. Two distinct forms of the U2 
snRNP particle have been isolated: a 12S form containing two U2 snRNP specific 
proteins denoted A' and B", and a 17S form which contains nine additional U2 snRNP 
specific proteins with molecular weights ranging from 35 kD to 160 kD. The 17S U2 
snRNP is observed only under low salt conditions and appears to represent the 
functional form of this particle. 
The U2-B" protein interacts directly with the U2 snRNA stem-loop IV, while A' 
appears to be associated by way of interaction with B" (Scherly et al., 1990). 
Most of the 17S U2 snRNP specific proteins interact with the 5' half of the U2 snRNA 
(Behrens et al., 1993). These proteins have been the most studied of the snRNP specific 
proteins (reviewed in Hodges and Beggs, 1994; Kramer, 1995), and several names have 
been given for identical proteins isolated by different groups. At least seven of the 17S 
particle specific proteins have been isolated in HeLa cells as two tightly associated 
protein complexes named S1 73a and S173b. These two subunits are required for the 
assembly of the mature U2 snIRNP particle and for the targeting of this snRNP to the 
pre-mRNA. SF3b binds to the 12S U2 snRNP particle (Luhrmann et al., 1990) and the 
resulting 15S particle is converted into the active 17S U2 snRNP after interaction with 
SF3 a. SF3a does not associate by itself with the 12S particle. It is composed of three 
associated subunits of 60 kD (SF3a6Op), 66 kD (SF3a66p) and 120 kD (SF3al2Op) 
(Brosi et al., 1993a, 1993b). These same proteins were also named Sap6l, 62, 114 
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(pliceosome associated proteins) respectively (Bennett et al., 1992, Chiara et al., 
1993). Protein-protein interactions detected between the human U2 snRNP specific 
proteins are similar to those observed for their yeast homologues. Sap62p (human 
homologue of the yeast Prp lip)  interacts with Sap I 14 (human homologue of the yeast 
Prp2lp) (Bennett and Reed, 1993) and Sap6ip (human homologue of the yeast Prp9p) 
interacts with Sap 114p (Chiara et al., 1994). SF3b is composed of five proteins named 
Sap33p, 49, 130, 145, 155 (for review see Hodges and Beggs, 1994). With the 
exception of Sap33p, these proteins were found to be in close proximity to the 3' 
extremity of the nuclear pre-mRNA intron in the prespliceosome complex (Staknis and 
Reed, 1994). Behrens et al. (1993) have isolated nine proteins associated with the 17S 
complex, possessing apparent molecular weights of 35, 53, 60, 66, 92, 110, 120, 150 
and 160 kD. The 35, 53, 120, 150 and 160 kD polypeptides have been reported as 
SAP33, 49, 130, 145 and 155 respectively by Bennett et al., 1992, 1993 and Staknis 
and Reed, 1994. They have been isolated also by Brosi et al. (1993) and named 
SF3b53, 120, 150, and 160 according to their molecular weights, while the 35 kD 
polypeptide did not appear to be part of the SF3b complex. The 92 kD protein has been 
detected only by Behrens et al. (1993), and its presence in the U2 snRNP particle needs 
confirmation.  The protein-protein interactions occuring in this protein network are not 
very well known. It has been demonstrated that Sap49p and Sap 145p interact together 
and with the pre-mRNA and may be involved in tethering the U2 snRNP to the 
branchsite (Champion-Arnaud and Reed, 1994). 
The Yeast U2 snRNP specflc proteins. MSLJ (MUD synthetic lethal 1), 
encodes the yeast homolog (YU213") of the mammalian U2B" (Tang et al., 1996). The 
YU213" protein is much smaller that U213" and it contains only one RBD at its N-
terminus (Tang et al., 1996). 
Several lines of evidence have shown that the yeast proteins Prp9p and Prpl ip are the 
homologues of the human SF3a6Op (Sap6lp) and SF3a66p (Sap62p) respectively. Both 
function during prespliceosome assembly in yeast, and interact genetically and 
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physically with a third protein named Prp2lp (or Spp9lp) (Behrens et al., 1993; 
Legrain et al., 1993, 1993b; Chapon and Legrain, 1992). Prp2lp contains significant 
homology to the human SF3a12O protein. Prp9p possesses 30% identity to the human 
SF3 a6Op, the highest homology being present in a zinc finger-like region located at the 
C-terminus of both proteins. The Prp9p zinc finger-like motif has been replaced by the 
equivalent domain of mammalian SF3a6Op, the resulting chimeric polypeptide was able 
to rescue the temperature-sensitive phenotype of a PRP9-1 mutant strain, suggesting 
that the structure and the function of this domain were evolutionarily conserved 
(Kramer et al., 1994). Using the two-hybrid system, Legrain and Chapon (1 993b) show 
that the carboxyl terminus of Prpl I  binds to Prp2lp. Also, Prp2lp binds to Prp9p and 
to Prpl ip forming a bridge between them (Legrain and Chapon, 1993b) while no 
interaction was detected between Prp9p and Prpl ip. Prp9p, Prp11 p  and Prp2lp interact 
with a region of the U2 snRNA including the stem-loop ha. Like their human 
homologues, they mediate the association of the U2 snRNP with the pre-mRNA (Wells 
and Ares, 1994). 
To date, only two yeast homologues of the human SF3b proteins have been isolated 
(Cusip and Hsh49p) (Wells et al., 1996). GUS] (old-sensitive U2 suppressor) has 
been isolated as a suppresser of a cold-sensitive mutation associated with a mutation in 
U2 snRNA stem-loop ha (Wells et al., 1996). Cuslp is essential and shares significant 
homology with Sap145p, however, it is much smaller (Wells et al., 1996). Hsp49p 
(human SAP homologue 49) has been identified by computer sequence analysis as a 
putative homologue of the human Sap49p (Igel et al., 1998) Further investigations are 
required to determine if Hsh49p is the yeast counterpart of Sap49p. Interestingly, in an 
exhaustive two-hybrid screen using either Cus 1 p  or Yor3 l9p (other name for Hsh49p) 
as baits, Fromont-Racine et al. (1997) found that the two polypeptides interact together, 
and with other proteins. 
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The mammalian U5 snRNP spec ific proteins. The 20S U5 snRNP particle 
contains at least nine specific proteins (Bach et al., 1989). These proteins are retained 
following the formation of the U4fU6.U5 tri-snRNP complex. At least one of them, 
p220, remains in the spliceosome and is suspected to play a role in modulating or 
stabilising RNA-RNA contacts between the U5 snRNA and the pre-mRNA (for review 
see Newman, 1997). p220 is the human homologue of the yeast Prp8p (Garcia-Blanco 
et al., 1990). UV-crosslinking experiments have demonstrated that p220 interacts with 
the pre-mRNA (Garcia-Blanco et al., 1990) and it is in close proximity to the 5' splice 
spite before the first step of splicing reaction (Wyatt et al., 1992). 
The 20S U5 snRNP particle possesses an RNA-dependent ATPase activity associated, 
at least, with two polypeptides named U5-200 kD and U5-100 kD (Laggerbauer et al., 
1996). 
U5-200 kD possesses two conserved domains characteristic of the DEXH-box protein 
family of RNA-stimulated ATPases and putative RNA helicases (see section 1.4.7 for 
description) (Lauber et al., 1996). The depletion of U5-200 kD in a HeLa cell extract 
blocks the second step of the splicing reaction, suggesting that this protein probably 
remains in the spliceosome and may be involved in the second step of splicing (Lauber 
et al., 1996). This polypeptide is the first putative RNA helicase shown to be involved 
in splicing in humans. 
The U5-100 kD polypeptide has been recently characterised (Teigelkamp et al., 1997). 
This protein is a member of the DEAD-box family of ATP-dependent putative RNA 
helicases. In addition, it harbours at its N-terminal an RS domain. Protein analysis by 
two-dimensional gels revealed that U5-100 kD exists in three different stages of 
phosphorylation. Sequence analysis indicated that U5-100 kD is the human homologue 
of the yeast Prp28p, but its role in splicing remains unknown (Teigelkamp et al., 1997). 
The yeast Prp28p is also a member of the DEAD-box family and is required for the first 
step of splicing (Strauss et al. 1991). Unlike its human homologue, Prp28p is not stably 
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associated with snRNP particles and therefore is not considered a snRNP specific 
protein (Strauss and Guthrie, 1994). 
The U5-116 kD polypeptide has been recently characterised (Fabrizio et al., 1997). It 
contains a consensus sequence (G domain) involved in the binding and hydrolysis of 
GTP. UV-crosslinking experiments confirmed that this polypeptide specifically binds 
to GTP, and that this GTP-association was required for the protein function (Fabrizio et 
al., 1997). 
The yeast U5 snRNP specific proteins. Prp8p (Lossky et al., 1987) is the 
yeast homologue of p220 (Garcia-Blanco et al., 1990). This protein is exceptionally 
large (280 kD) and its size and sequence are highly conserved (Hodges et al, 1995). 
Prp8p is associated with the U5 snRNP and the U4/U6.U5 tri-snRNP (Lossky et al., 
1987; Brown and Beggs, 1992). It is required for the stable formation of the tri-snRNP 
and for its association with the spliceosome (Brown and Beggs, 1992). Prp8p remains 
in the spliceosome (Whittaker et al., 1991; for review see Beggs et al., 1995) and 
stabilises the interactions between U5 snRNA and the 5' and 3' splice sites, to anchor 
and align them in the reactive centre of the spliceosome (Teigelkamp et al., 1995; Dix 
et al., 1998). It is the only yeast splicing factor that has been demonstrated to affect 
both chemical steps of splicing (Jackson etal., 1988; Umen and Guthrie, 1995). 
The gene encoding the yeast homologue of the human U5-200 kD protein was found by 
computer data base search, and the corresponding polypeptide was named Snu246p 
(Lauber et al., 1996). This yeast protein is essential for cell viability and required for 
pre-mRNA splicing in vivo. Immunoprecipitation of an HA-epitope tagged Snu246p 
showed that it was associated with the tri-snRNP particle (Lauber et al., 1996). The 
same gene has been identified concomitantly by different groups and named differently: 
BRR2 (for had response to refrigeration) (Noble and Guthrie, 1996) was isolated as a 
cold-sensitive mutant; SLT22 (for synthetic lethal with U2) was isolated in a genetic 
screen as a synthetic lethal with a mutant U2 snIRNA (snr20-llnt) which potentially 
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disrupts U2/U6 snRNAs Helix II interaction (Xu et al., 1996); RSSJ was isolated in a 
genetic screen suppressing a splicing defect of an actin pre-mRNA-lacZ fusion 
construct, this defect was caused by the addition of an artificial secondary RNA 
structure in exon 2 adjacent to the 3' splice site (Lin and Rossi, 1996). This protein 
belongs to the DEXH ATPase/RNA helicases family (distantly related to the 
ATPase/RNA helicases of the DEAD and DEAR family) (Noble and Guthrie, 1996; Xu 
et al., 1996). Slt22p is essential for cell viability and exhibits an ATPase activity which 
is preferentially stimulated by annealed U2/U6 snRNAs (Xu et al., 1996). 
Immunoprecipitation analyses have shown that Brr2p is associated with the pre-mRNA 
and splicing intermediates (Raghunathan and Guthrie, 1997). The same authors 
demonstrated that Brr2p is indeed an RNA helicase which dissociates U4 snRNA from 
the U6 snRNA in an ATP-dependent fashion. 
The yeast homologue of the human U5-116 kD protein was identified and named 
Snul 14p (Fabrizio et al., 1997). Snul 14p is essential for cell viability and splicing in 
vivo. 
The yeast U6 snRNP particle specific proteins. As yet, no human U6 snRNP 
specific protein has been identified. In yeast, in addition to the Sm-like proteins (see 
section 1.4.3.2 for description), one U6 snRNP specific protein (Prp24p) has been 
identified (Shannon and Guthrie, 1991; Jandrositz and Guthrie, 1995; Ghetti et al., 
1995; Raghunathan and Guthrie, 1998). Prp24p was initially isolated as a suppresser of 
a single point mutation (G14C) in the U4 snRNA. This particular mutation destabilises 
the U4/U6 snIRNAs helix II and is associated with a cold-sensitive phenotype (Shannon 
and Guthrie, 1991). Prp24p contains three RNA-binding motifs and it directly contacts 
the U6 snRNA probably promoting the formation of the U4/U6 snRNP particle 
(Shannon and Guthrie, 1991). Prp24p may also be involved in the dissociation of 
U4IIJ6 snRNP prior to the first step of splicing. It has been proposed to distort helix II 
in the U4/U6 snRNAs partial hybrid helping another splicing factor (maybe an RNA 
helicase) to unwind this structure (Jandrositz and Guthrie, 1995; Ghetti et al., 1995). 
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Prp24p is involved in the recycling of U4 and U6 snRNPs and reanneals U4/U6 
snRNAs after the splicing reaction (Raghunathan and Guthrie, 1998). To date, Prp24p 
is the only splicing factor shown to contact directly the U6 snRNA (Jandrositz and 
Guthrie, 1995; Ghetti et al., 1995). A genetic interaction between Prp24p and Prp2lp 
has been reported, suggesting a link between the U2 snRNP and the U6 snRNP (Vaidya 
etal., 1996). 
The mammalian U41U6 snRNP specflc proteins. In the human lOS U4/U6 
snRNP particle two proteins (60 kD and 90 kD) are present in addition to the Sm 
proteins. They are named Sap60p and Sap90p respectively (Gozani et al., 1994), and 
are the human homologues of the yeast Prp4p and Prp3p respectively (Lauber et al., 
1997). Antibodies raised against the 60 kD and the 90 kD proteins specifically 
recognise the U4/U6 snRNP and the tri-5nRNP particles (Lauber et al., 1997). 
Like its yeast counterpart, the human 60 kD protein possesses at its C-terminus WD 
repeats, which are essential for its function during splicing (Hu et al., 1994; Ayadi et 
al., 1997). 
Not much is known about the 90 kD polypeptide. It possesses some similarity to a 
double-stranded RNA binding motif. 
The yeast U41U6 snRNP specific proteins. Two U4/U6 snRNP specific 
proteins, namely Prp4p and Prp3p, have been identified genetically (Banroques et al., 
1989; Petersen-Bjorn et al., 1989). 
Prp4p is required for the association of the U4/U6 snRNP with the US snRNP, and 
interacts with the conserved 5' stem-loop of the U4 snRNA (Banroques et al., 1989; 
Petersen-Bjorn etal., 1989; Bordonné etal., 1990; Xu etal., 1990). 
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Prp3p was proposed to be U4/1J6 snRNP-specific based on the observation that 
overproduction of Prp3p can compensate for a defective Prp4 protein (Last et al., 
1987). Further characterisation demonstrated that Prp3p was required for spliceosome 
formation (Anthony et al., 1997). It is needed for efficient assembly and/or stability of 
the U6 snRNP and U41U6 snRNP particles (Anthony et al., 1997). Antibodies raised 
against Prp3p recognise specifically the U4, U5 and U6 snRNAs, and only U4 and U6 
snRNA at higher salt concentrations, suggesting that this protein is associated with the 
U4/U6 snRNP and the tri-snRNP particles. 
The mammalian U41U6. U5 tri-snRNP specific proteins. In addition to the 
aforementioned 20S US snRNP and 12S U4/U6-specific proteins, the 25S tri-snRNP 
contains five other specific proteins which possess apparent molecular weights of 15.5, 
20,27,61 and 63 kD (Behrens et al., 1991). 
The 20 kD protein (also named SNU-CYP-20) has been recently purified and 
characterised (Teigelkamp et al., 1998). It shares significant homology with the 
cyclophilin protein family. Cyclophilins possess a peptidyl-prolyl cis-trans isomerase 
activity (PPIase) (see section 1.4.7 for description) which may be involved in protein 
conformation changes. Further investigations indicated that this polypeptide interacts 
with at least the 60 kD protein (Teigelkamp et al., 1998). 
The 27 kD contains at the N-terminus a region enriched in arginine and serine residues 
(SR domain). In contrast with the known SR proteins, it lacks any similarity with any 
of the characterised RNA binding domains (Fetzer et al., 1997). This protein can be 
differentially phosphorylated in vitro by a snRNP associated kinase activity (as yet 
uncharacterised) (Fetzer et al., 1997). 
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The yeast tri-snRNP specific proteins. The yeast and the human tri-snRNPs 
possess structural similarities which probably reflects similarities between the 
corresponding splicing machinery (Fabrizio et al., 1994). 
The yeast Prp6p is associated with the U4, U5 and U6 snRNAs and is required for the 
stability of the U4/U6.U5 tri-snRNP particle (Galisson and legrain, 1993). 
Prp38p is a component of the tri-snRNP (Xie et al., 1998). Its exact function remains 
speculative. It might be involved in the dissociation of U4/U6 snRNAs interactions as 
the tri-snRNP enters the prespliceosome (Xie et al., 1998). 
1.4.4 U2-Spliceosome assembly pathway 
The spliceosome assembly pathway is shown in Figure 7. It starts by the 
binding of the Ui snRNP to the pre-mRNA in an ATP-independent fashion (Rosbash 
and Séraphin, 1991). This binding commits the pre-mRNA to the splicing pathway and 
corresponds to the formation of the commitment complex (complex E in mammals). 
Subsequently the U2 snRNP associates with the branchsite to form the prespliceosome 
complex (complex A in mammals) (Konarska and Sharp, 1986; Zillmann et al., 1988). 
This interaction, as well as subsequent steps of spliceosome assembly, is ATP -
dependent. In the next step U4/U6 snRNP and U5 snRNP which are assembled as a 
U41U6.U5 tri-snRNP associate with the prespliceosome, resulting in the formation of 
an immature complex (complex B in mammals) (Lossky et al., 1987; Pikielny et al., 
1896; Cheng and Abelson, 1987). After conformational rearrangements, the immature 
spliceosome is converted into an active complex (complex C in mammals). Thus 
splicing occurs, followed by the release of the newly joined exons and dissociation of 
the spliceosome, then degradation of the intron-lariat product (Konarska and Sharp, 
1987; Cheng and Abelson, 1987; Blencowe et al., 1989). The very long half-life of the 
snRlNAs suggests that they are recycled and enter the spliceosome assembly pathway 
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1.4.4.1 The commitment complex 
It was originally defined in yeast nuclear extracts (Legrain et al., 1988; Séraphin 
and Rosbash, 1989). Two complexes (CC 1 and CC2) can be distinguished on a non-
denaturing gel electrophoresis system (Séraphin and Rosbash, 1989). The formation of 
CC1 requires only the 5' splice site sequence, whereas the formation of CC2 requires 
both the 5' splice site and the branchsite sequences (Séraphin and Rosbash, 1991). CC 1 
and CC2 assemble in an ATP-independent fashion and contain the Ui snRNP. 
A similar ATP-independent complex has been purified in mammalian extracts and was 
named complex E (Michaud and Reed, 1991). The formation of this complex requires, 
in addition to the 5' splice site and the branchpoint, the polypyrimidine tract (Jamison 
et al., 1992). Unlike CC! and CC2, complex E contains both Ui and U2 snRNPs, 
although the U2 snRNP is weakly associated (Hong et al., 1997). 
Both the human and the yeast commitment complexes involve base-pairing of the 5' 
end of the Ui snRNA to the 5' splice site region of the pre-mRNA (Zhuang and 
Weiner, 1989; Séraphin et al., 1988; Siliciano and Guthrie, 1988). This interaction is 
facilitated by several polypeptides. 
In mammals 
The Ui snRNP specific 70 kD and C proteins and the SR protein ASF 
(alternative splicing factor; also named SF2 for splicing factor 2) promote these 
contacts. ASF/SF2 recruits the U 1 snRNP to the 5' splice site by- interacting 
simultaneously with the pre-mRNA and the Ul-70K protein (kohtz et al., 1994), while 
the splicing factor U2AF (LiZ snRNP auxiliary factor) initiates the recognition of the 3' 
splice site (Zuo and Maniatis, 1996; Eperon et al., 1993; Kohtz et al., 1994; Staknis and 
Reed, 1994). 
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U2AF is a heterodimer composed of two subunits of 65 kD and 35 kD (named U2AF65 
and U2AF35 respectively), which are both required for splicing (Zamore and Green, 
1989). U2AF65 binds to the 3' splice site region prior to U2 snRNP addition (Ruskin et 
al., 1988; Zamore and Green, 1989). U2AF65 interacts with the SF1 splicing factor 
(Arning et al., 1996) and positions it to the branchpoint (Abovich and Rosbash, 1997; 
Berglund et al., 1997). U2AF35 possesses at its amino-terminal an RS domain, used to 
mediate interaction with other SR proteins (Zuo and Maniatis, 1996), while its 
carboxyl-terminal domain is required for formation of U2AF35/65 heterodimer 
(Zamore et al., 1992; Zhang et al., 1992). Thus U2AF35 functions as a bridge between 
U2AF65 and proteins containing one or more RS domain(s) (Reed, 1996). U2AF35 has 
also been proposed to link the 3' and the 5' splice sites by interacting with SR proteins, 
while SR proteins interact with the Ui snRNP U1-70K protein (Wu and Maniatis, 
1993). During the transition from commitment complex to prespliceosome, U2AF65 is 
phosphorylated and becomes less tightly bound to the pre-mRNA. U2AF65 remains 
loosely associated to the pyrimidine tract at least through complex-B assembly 
(Champion-Arnaud and Reed, 1994). 
In yeast 
Prp39p appears to facilitate the association of the Ui snRNP with the 5' splice 
site (Lochbart and Rymond, 1994; Kao and Siliciano, 1996). 
The yeast gene encoding for the homologue of U2AF65 was isolated in a synthetic 
lethal screen with Ui snRNA and was named MUD2 (Abovich et al., 1994). Like its 
metazoan counterpart, Mud2p interacts with the pre-mRNA prior to the addition of the 
U2 snRNP and its association with the commitment complex requires the branchpoint 
sequence. Mud2p mediates the association of the Ui snRNP and the 3' splice site 
region. 
37 
Genetic experiments indicate that Mud2p is associated with the Ui snRNP protein 
Mud ip and contacts the U2 snRNP protein Prp lip, suggesting that Mud2p is at the Ui-
U2 snRNP interface during spliceosome formation (Abovich etal., 1994). 
In yeast, few proteins containing a classical RS domain have been isolated. The SR 
dipeptides are scattered through the polypeptide (Abovich et al., 1994), therefore it is 
difficult to propose a picture of interactions between SR proteins that bridge the 5' and 
the 3' splice sites. However recently, the gene encoding a protein named BBP 
(branchpoint bridging protein) also named Msl5p (MUD synthetic-lethal 5p), has been 
isolated in a synthetic-lethal screen with MUD2 (Abovich and Rosbach, 1997). BBP is 
the yeast homologue of the mammalian SF1 splicing factor (Abovich and Rosbash, 
1997). BBP interacts with Mud2p and with the Ui snRNP specific protein Prp40p 
thereby bridging the 5' and the 3' splice sites (Abovich and Rosbash, 1997). BBP 
directly contacts the pre-mRNA near the branchpoint sequence during commitment 
complex assembly (Berglund et al., 1997). Further investigations indicated that BBP is 
the yeast homologue of the human SF1 which interacts with U2AF65 (Arning et al., 
1996; Abovich and Rosbash, 1997). 
It has been shown that in mammals the m 7  G cap binding proteins CBP20 and CBP80 
enhance the U1 snRNP-5' splice site interaction, at least in the case of cap-proximal 5' 
splice sites (Lewis et al., 1996a). A similar role in early splicing complex formation 
was also demonstrated for the yeast homologues of CBP20 and CPB80 (Mud 1 3p and 
yCbp80p, respectively) (Colot etal., 1996; Lewis et al., 1996b). This is consistent with 
reports suggesting that a m 7  G cap enhances yeast pre-mRNA splicing in vivo (Schwer 
and Shuman, 1996; Fresco and Buratowski, 1996). 
38 
1.4.4.2 The prespliceosome or complex A 
The recognition of the branchpoint sequence is essential for the assembly of the 
complex A. A short duplex is formed between the branchpoint sequence and U2 
snRNA (Madhani and Guthrie, 1994c) which is thought to bulge the branchsite 
adenosine residue that initiates the first trans-esterification reaction (for review see 
Moore etal., 1993). 
In mammals 
Stabilisation of this U2 snRNA-branchpoint interaction is mediated by the 
binding of several U2 snRNP proteins to a 20-nt region upstream of the branchpoint 
sequence which is designated the anchoring site (Gozani etal., 1996). 
Among these polypeptides, the mammalian U2 snRNP specific subunits SF3a and SF3b 
have been UV-crosslinked to the pre-mRNA (with the exception of the SAP 130 
polypeptide) (Brosi et al., 1993a, 1993b; Champion-Arnaud and Reed, 1994; Gozani et 
al., 1996), U2AF65 interacts directly with the polypyrimidine tract and lies adjacent to 
the branchpoint sequence (Zamore and Green, 1989; Singh etal., 1995). 
Until recently, the ATP requirement for this step was not clear, since none of the known 
mammalian factors necessary for complex A assembly has the sequence characteristic 
of proteins that hydrolyse ATP. However recently, a protein, named UAP56 (for U2 
associated protein), was identified (Fleckner etal., 1997). This polypeptide is a member 
of the DEAD box family of RNA-dependent ATPases. It was proposed to stabilise the 
U2 snRNP-branchpoint interaction and to be responsible for the ATP-dependency of 
complex A formation. 
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In yeast 
The composition of the prespliceosome is less well defined. It contains at least 
Prp5p, Prp9p, Prpl ip and Prp2lp. These polypeptides are required for U2 snRNP 
binding to the U  snRNP-containing complex (Ruby et al., 1993; Abovich et al., 1990; 
Legrain and Chapon, 1993b; Legrain et al., 1993; Chapon and Legrain, 1992; Arenas 
and Abelson, 1993). Prp2lp binds directly to Prp9p and Prpl ip acting as a bridge. 
PRP5 interacts genetically with PRP9, PRP21 and PRPJJ as well as with U2 snRNA. 
Prp5p is a member of the DEAD-box family of proteins (Dalbadie-McFarland and 
Abelson, 1990), and possesses an RNA-dependent ATPase activity (O'Day et al., 
1996). In particular, the ATPase activity of Prp5p is stimulated by the yeast U5 and U2 
snRNAs with U2 snRNA being the most effective, suggesting that U2 snRNA may be a 
natural substrate for this putative RNA helicase. Its association with the commitment 
complex is ATP-independent, but its activity is likely to require ATP-hydrolysis and to 
be responsible (maybe just partially) for the ATP-dependence of the prespliceosome 
assembly step. Prp5p is required for U2 snRNP entry (Ruby et al., 1993; Wells and 
Ares, 1994). 
1.4.4.3 Addition of the U4/U6.U5 tri-snRNP 
The association of the tri-snRNP with the prespliceosome has been less well 
characterised. 
In mammals 
Gradient-purified pre-spliceosomes can be chased into spliceosomes by addition 
of phosphorylated recombinant SR proteins (Roscigno and Garcia-Blanco, 1995). Thus 
SR proteins are proposed to escort the tri-snIRNP as it associates with the 
prespliceosome complex. Interestingly the analysis of the tri-snRNP specific 27 kD 
protein and the U5-snRNP specific 100 kD protein (which remains in the tri-snRNP) 
indicated that both contain an RS domain and were capable of being phosphorylated by 
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a snRNP-associated kinase activity (Fetzer etal., 1997; Teigelkamp etal., 1997). These 
proteins may interact with other SR proteins, leading to the association of the tri-snRNP 
particle with the prespliceosome. 
In yeast 
PRP31 encodes an essential factor required for the transition of prespliceosome 
to spliceosome complex (Weidenhammer et al., 1997), probably by mediating or 
stabilising the association of the tri-snRNP with the prespliceosome (Weidenhammer et 
al., 1997). 
Prp6p is also required for tri-snRNP assembly and addition to the prespliceosome 
(Galisson and Legrain, 1993). 
Prp38p is required for the maturation of the spliceosome. It may facilitate the 
unwinding of the U4 /U6 snRNA interactions within the tri-snRNP particle, to free the 
U6 snRNA and allow maturation of the spliceosome (Xie etal., 1998). 
1.4.4.4 Structural rearrangements of snRNAs toward formation of the active 
spliceosome 
Numerous conformational changes occur during spliceosome assembly. On the 
basis of compensatory mutation studies carried out in yeast, another conformation of 
the U6 snRNA has been proposed in which U6 interacts with U2 snRNA in the 
spliceosome (Madhani and Guthrie, 1992). This U6-U2 structure is mutually exclusive 
with the U4-U6 base-pairing and is therefore assumed to occur in the active 
spliceosome after, or concomitant with U4 and U6 dissociation (Wassarman and Steitz, 
1992). 
As tri-snRNP enters the spliceosome, destabilisation of the extensive base-pairing 
interaction between the U4 and U6 snRNAs occurs (Pikielny et al., 1986; Cheng and 
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Abelson, 1987; Lamond et al., 1988). U4 snRNA appears to remain within the splicing 
complex, but its presence is not essential for the subsequent catalytic steps (Yean and 
Lin, 1991). However, depending on the isolation conditions of the spliceosomal 
complexes, the U4 snRNA may be lost (Pikielny et al., 1986; Cheng and Abelson, 
1987; Konarska and Sharp, 1987). As U6 snRNA dissociates from the U4 snRNA, it 
starts to interact with the 5' splice site (Li and Brow, 1996) replacing the U1 snIRNA 
(Konforti and Konarska, 1994; Lesser and Guthrie, 1993; Sontheimer and Steitz, 1993; 
Kandel-Lewis and Séraphin, 1993; Sawa and Abelson, 1992; Sawa and Shimura, 1992). 
U 1 snRNA is not required for the catalysis of the splicing reaction (Yean and Lin, 
1996). At least in HeLa cells, the Ui snRNP remains associated with spliceosome 
complexes E, A, B and with the mature spliceosome (Ast and Weiner, 1996, 1997). 
However it is predominantly detected in the commitment complex (Bennett et al., 
1992) and its presence is weaker as U2 snRNP and U4/U6.U5 tri-snRNP assemble 
(Bennett et al., 1992). 
In the active spliceosome the Ui snRNA is supplanted by the US and the U6 snRNAs 
at the pre-mRNA 5' splice site (for review see Newman, 1994; Ares and Weiser, 1995). 
It has been suggested that the base-pairing between Ui snRNA and the pre-mRNA is 
disrupted even earlier, before U2 snRNA binds (Liao et al., 1992; Champion-Arnaud et 
al., 1995). U6 snRNA thus forms a new duplex with the U2 snRNA (Madhani and 
Guthrie, 1992), while the US snRNA interacts with a small number of poorly conserved 
exon nucleotides at both the 5' and the 3' splice sites (Madhani and Guthrie, 1994c). 
These interactions are stabilised by the Prp8 protein (or the 220 kD protein in human) 
(for review see Beggs et al., 1995; Dix et al., 1998). 
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1.4.4.5 The catalytic centre of the spliceosome 
A representation of some RNA-RNA interactions involved in the organisation 
of the catalytic centre of the spliceosome is shown in Figure 8. Base-pairing interaction 
between U2 and U6 snRNAs, in conjunction with the U6 snRNA-5' splice site duplex, 
are though to position the branchpoint sequence near the 5' splice site to catalyse the 
first step of the splicing reaction (Sun and Manley, 1995; for review see Madhani and 
Guthrie, 1994c). Mutations in either the U6 snRNA or the U2 snRNA portion of U6-U2 
helix I result in first or second step splicing defects (Fabrizio and Abelson, 1990; 
Madhani and Guthrie 1992; McPheeters and Abelson, 1992). A tertiary interaction 
between U6-G52 and the helix I (U2-A25) bulge has been demonstrated (Madhani and 
Guthrie, 1994a). This tertiary interaction might function in a network of RNA-RNA 
contacts that together form an active site involved in 3' splice site cleavage and exon 
ligation (Madhani and Guthrie, 1994a). 
The highly conserved loop I of U5 snRNA interacts with the 5' exon before the first 
step of pre-mRNA splicing and with both the 5' and 3' exons following the first step 
(Newman and Norman, 1991, 1992). US snRNA does not make an essential 
contribution to the selection of the 5' splice site but its loop I is important for the 
second step of the splicing reaction (O'Keefe et al., 1996; O'keefe and Newman, 1998). 
The interactions between the 5' and 3' exons and US snRNA loop I probably hold the 
exons in the correct orientation for the second step of splicing. Prp8p/p220 has been 
implicated in the recognition of both the 5' and the 3' splice sites (Reyes et al., 1996; 
Umen and Guthrie, 1995, 1996) and is closely associated with the intron branchsite in 
active spliceosomes (MacMillan et al., 1994). This raises the intriguing possibility that 
Prp8p/p220 might contribute functional groups to the catalytic centre of the 
spliceosome, in addition to assisting in the precise positioning of the U5 snRNA 
terminal loop at the 5' splice site (reviewed in Newman, 1997). 
Other essential features contributing to splicing are the phosphate-ribose backbone and 
the 2'-hydroxyl groups of the U6 snRNA molecule. The defects caused by site-specific 
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Figure 8. Schematic representation of the U2/U6 snRNA interactions in 
the catalytic centre of the yeast spliceosome (Madhani and Guthrie, 1992). 
Base-pairing between the stem I of U6 snRNA and U2 snRNA (helix I) allows 
the stem II region of U6 snRNA to refold into the same intramolecular helix 
present in the singular U6 form. In yeast, Helix lb and II are functionally 
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substitution of phosphate by thiophosphate groups, or incorporation of 
deoxyribonucleotides in the U6 snRNA have implicated particular phosphates or 
hydroxyl groups of the U6 snRNA in the catalysis of splicing (Fabrizio and Abelson, 
1992; Kim et al., 1997). 
The spliceosomal snRNAs are though to function as catalysts for the two reactive steps 
of pre-mRNA splicing. This hypothesis is founded on the knowledge that group I and 
group II introns are capable of selfsplicing (see sections for description), and the 
observation of several similarities between some snRNA-snRNA and snRNA-pre-
mRNA interactions and some features of group I and group II introns involved in 
splicing. However snRNAs are not able to drive splicing of nuclear introns by 
themselves; proteins are required for spliceosome assembly and splicing reaction. 
1.4.4.6 Spliceosome disassembly 
This is an active process that requires ATP and protein factors (Company et al., 
1991; Sawa and Shimura, 1991). In particular, the release of the spliced exons requires 
an RNA-dependent ATPase named Prp22p (Company et al., 1991). Prp22p is a putative 
RNA helicase which is required for spliceosome dissociation. In vitro assays show that 
Prp22p is an RNA-stimulated ATPase which can unwind RNA duplexes (Wagner et 
al., 1998; Schwer and Gross, 1998). 
Another putative ATP-dependent RNA helicase has been isolated and named Prp43p 
which is probably involved in the disassembly of the spliceosome after the release of 
mature RNA (Arenas and Abelson, 1998). The mouse homologue of Prp43p has been 
identified and named mDeah9p (Gee et al., 1998). The precise mode of action of those 
polypeptides remains unknown. 
After release of the snRNPs, the lariat-intron is linearised by a debranching enzyme 
which specifically cleaves the 2', 5' -phosphodiester bond, then the linearised product is 
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degraded (Ruskin and Green, 1985 and 1985b; Arenas and Hurwitz, 1987). In yeast 
cells, PRP26 codes for a debranching enzyme which is not essential for cell viability 
(Chapman and Boeke, 1991). Also in yeast cells, mutation in PRP27 results in 
accumulation of excised introns (Vijayraghavan, 1989) suggesting that the 
corresponding gene product may be involved in the debranching of the lariat-intron or 
the dissociation of the complex. 
1.4.5 Non-snRNP splicing factors required prior to or during the first 
catalytic step 
Among these factors, the yeast Prp2p, Spp2p, Prp28p proteins and the Prpl9-
complex are required for the first step of splicing (Kim et al., 1992; Plumpton et al., 
1994). 
The Prp 19 protein is a spliceosomal component, but is not tightly associated with small 
nuclear RNAs (Tarn et al., 1993; Maddock et al., 1996). It appears to associate with the 
spliceosome concomitant with, or just after, dissociation of the U4 small nuclear RNA. 
Prp l9p is associated with a protein complex which consists of at least seven other 
polypeptides (Tam et al., 1994b). The non-essential yeast SNT309 gene encodes a 
polypeptide which is in direct contact with Prp l9p and is a component of the Prp 19-
associated complex (Chen et al., 1998). 
Prp2p is required to promote the first step of splicing, leading to the production of 
lariat-intermediate and exon 1 (Lin et al., 1987). Prp2p interacts only transiently with 
the spliceosome prior to and during the first step of splicing (King and Beggs, 1990). A 
mutated form of Prp2p, carrying a mutation in the helicase motif, remains stably 
associated with the spliceosome blocking splicing before step I (Plumpton et al., 1994), 
suggesting that some conformational changes are required for this step. Further liv-
crosslinking experiments showed that Prp2p contacts the pre-mRNA in vitro in an 
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ATP-independent fashion (Teigelkamp et al., 1994) while ATP is required for the 
release of Prp2p from the pre-mRNA. 
The yeast SPP2 gene was previously identified as a high-copy suppresser of 
temperature-sensitive prp2 mutants (Last et al., 1987). Spp2 is an essential protein 
required for the first RNA cleavage reaction in vivo, and is likely to be released from 
the spliceosome following ATP hydrolysis by Prp2p (Roy et al., 1 995b). The Prp2p and 
Spp2p proteins are capable of physically interacting with each other. 
Prp28p is a member of the DEAD-box family of ATP-dependent putative RNA 
helicases (see section for description) (Strauss and Guthrie, 1991). Genetic interactions 
suggested that this polypeptide is associated with the tri-snRNP particle (Strauss and 
Guthrie, 1991). Its precise function remains obscure, no RNA helicase activity has been 
demonstrated. 
1.4.6 Non-snRNP splicing factors required for, or during, the second 
catalytic step 
The yeast splicing factors Pip l6p, Prpl7p, Prpl8p, Slu7p, Ssflp and Prp22p are 
required for the second catalytic step (Vijayraghavan and Abelson, 1990; Schwer and 
Guthrie, 1991; Horowitz and Abelson, 1993; Ansari and Schwer, 1995; Jones et al., 
1995). 
The earliest defined stage during the second catalytic step is the binding of Prp l6p to 
spliceosomes containing the 5' exon and lariat-intermediate. Prpl6p is a protein of the 
DEAH family of RNA dependent NTPases (Schwer and Guthrie, 1991). Its RNA 
unwinding activity has been shown in vitro, however the lack of sequence specificity 
does not bring any information about Prpl6p's substrate(s) in vivo (Wang et al., 1998). 
Prpl6p interacts transiently with the spliceosome and dissociates upon ATP-hydrolysis 
(Schwer and Guthrie, 1991; Brys and Schwer, 1996). The ATPase activity is essential 
46 
for the function in vitro and in vivo of Prp I 6 in the splicing reaction, since there is a 
correlation between reduced ATP hydrolysis and impaired splicing (Schwer and 
Guthrie, 1992b). ATP-hydrolysis by Prpl6p lead to a conformational change in the 
spliceo some that results in protection of the 3' splice site from oligonucleotide-directed 
RNase H digestion (Schwer and Guthrie, 1992a). The Prpl6p-induced conformational 
change requires the recruitment of Slu7p, Prpl8p and Ssflp (Ansari and Schwer, 1995; 
Brys and Schwer, 1996). 
Slu7p and Prp I 8 function during step 2, after Prp 16p, in an ATP-independent fashion. 
Unlike Prpl6p, Slu7p remains until the spliceosome is disassembled (Brys and Schwer, 
1996). Biochemical and genetic studies implicate Slu7p in 3' splice site selection 
(Franck et al., 1992; Brys and Schwer, 1996). Slu7p is essential for splicing in vitro of 
precursor RNAs in which the distance between the branchpoint and 3' splice site is >9 
nt (Brys and Schwer, 1996). Prpl8p is a non-essential protein (Horowitz and Abelson, 
1993), only a reduction of the second step of splicing is observed in the absence of 
Prpl8p (Horowitz and Abelson, 1993). Genetic interactions have been reported 
between PRP]8, SL U7 and U5 snRNA (Jones et al., 1995; Frank et al., 1992). Prpl8p 
is dispensable for splicing in vitro of precursor RNAs in which the 3' splice site is in 
close proximity to the branchpoint. It is required only when this distance is >9 nt 
(Zhang and Schwer, 1997). The need for Prpl8p in the second step in vitro can be 
bypassed by excess Slu7p (Zhang and Schwer, 1997). 
Ssflp is required for the second step of splicing, however its function remains unknown 
(Ansari and Swcher, 1995). 
Both PRPJ 7 and PRP]8 were identified from temperature-sensitive mutants, prpl 7-1 
and prpl8-1, that specifically block the second step of splicing (Vii ayraghavan et al., 
1989, Vijayraghavan and Abelson, 1990). A mutant allele of PRPJ 7 is synthetic lethal 
with a loop mutation in U5 snRNA. Prpl7p is not essential for splicing as its absence 
causes only a partial block to the second step of splicing in vitro (Horowitz and 
Abelson, 1993a). Like Prpl6p, Prpl7p acts before or concomitant with an ATP- 
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dependent reaction (Horowitz and Abelson 1993b, Jones et al., 1995). It thus acts 
before Slu7p and Prp 18p. 
The contribution of Prp22p for the catalysis of step 2 has been recently reported 
(Schwer and Gross, 1998). Indeed this factor possesses a double function in splicing, it 
effects the release of mRNAs from the spliceosome in an ATP-dependent fashion and it 
functions during step 2 in an ATP-independent fashion. Prp22p is required for the 
splicing of precursor-RNAs only when the distance between the branchsite and the 3' 
splice site is >21 nt (Schwer and Gross, 1998). It probably acts in concert with Slu7p 
and Prpl8p to position the 3' splice site and the 3'-OH terminal of the S'exon. 
1.4.7 Protein motifs in splicing factors 
A large variety of protein-protein and protein-RNA interactions occur during 
spliceosome assembly and the splicing reaction. A number of splicing proteins contain 
essential characteristic motifs, some of these have been suggested to be directly 
involved in the protein's function. This is, for example, the case for the polypeptides 
(Prp2p, Prp5p, Prpl6p, Prp28p, S1t22p ... ) harbouring an NTPase activity and/or an 
NTP-dependent RNA helicase activity, suggesting that these proteins might be 
responsible for some RNA conformational changes. Many splicing factors contain an 
RNA binding motif, a sequence element important for specific, high affinity binding of 
the protein to the target RNA. Other protein motifs (for example SR repeats) are 
involved in protein-protein interactions. 
1.4.7.1 RNA binding motif 
This RNA recognition motif (RRIVI or RBD) is typically 70-90 amino acids long 
and contains two short, well conserved elements, RNP1 and RNP2, embedded within a 
more weakly conserved sequence (reviewed in Birney et al., 1993). Proteins that 
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contain this motif are capable of binding a variety of RNA conformations including 
single-strand and stem-loop structures. The RRM is important for efficient interaction 
between the protein and its target RNA, but multiple sequence elements have the 
potential to influence RNA-binding specificity (Scherly etal., 1990; Kenan etal., 1991; 
Boelens et al., 1991; Nelissen etal., 1994). 
1.4.7.2 Proteins harboring a DEAD/H box motif 
Prp5p, Prp28p and the human UAP56 are members of the DEAD-box family 
while Prp2p, Prp l6p, Prp22p and Prp43p form a subgroup of the DEAH-box proteins 
(review in Beggs, 1993). Recently the U5 snIRNP specific human protein U5-200 kD 
and its yeast counterpart Slt22p/Brr2p/Rsslp/Snu246p have been shown to belong to 
another related subgroup (DEXH-box) of RNA helicases. Unexpectedly these proteins 
harbour two DEXH motifs (Lauber et al, 1996). Proteins bearing these motifs belong to 
a superfamily of putative ATP-dependent RNA helicases. Spliceosome assembly and 
disassembly involves multiple RNA-RNA interactions that must be continuously 
formed, rearranged and disrupted to allow each step of splicing to proceed. These RNA 
conformational rearrangements are most likely mediated by protein factors. In yeast and 
in mammals, ATP-dependent RNA helicases have been identified as potential 
candidates for performing this function (reviewed in Will and LUhrmann, 1997). The 
involvement of these proteins at every step in the splicing reaction may account for the 
requirement of ATP. However, an RNA-unwinding activity has been demonstrated only 
for few of these proteins (Prpl6p, Prp22p, S1t22p) while only an RNA-stimulated 
ATPase activity as been demonstrated in vitro for Prp2p (Kim et al., 1992). It is 
possible that the failure to detect an RNA helicase activity for these putative helicase 
proteins may be due to the requirement for additional polypeptide(s) and cofactor(s). - 
This would be analogous to the prototype of the DEAD-box protein family, the 
eukaryotic transcription factor eIF-4A (Fuller and Lane, 1992). Indeed, eIF-4A requires 
eIF-4B for helicase activity in vitro. The yeast S1t22p/Brr2pfRsslp was shown to 
exhibit an RNA-dependent ATPase activity which is particularly stimulated by U2-U6 
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snRNA duplex, thus providing the first indication of a probable substrate for this RNA 
helicase (Lin and Rossi, 1996; Noble and Guthrie, 1996; Xu et al., 1996). 
1.4.7.3 Zinc-Finger like motif 
A number of proteins involved in splicing harbour sequences that relate to the 
proteins of the zinc-finger family of DNA binding proteins (reviewed in Harrison, 
1991). This motif is involved in protein-RNA interactions. 
1.4.7.4 RS domain of the SR proteins 
In higher eukaryotes, commitment complex formation relies on a complex set of 
molecular interactions involving members of the SR (serine-arginine-rich) protein 
superfamily (Staknis and Reed, 1994). These SR proteins are characterised by a domain 
rich in arginine-serine dipeptides (RS domain) and often one or more RNA-binding 
domains (RBD) (for review see Fu, 1995; Manley and Tacke, 1996). As a result of their 
modular organisation, SR proteins can bind to the pre-mRNA and recruit other factors 
through protein-protein (through their RS domain) or protein-RNA interactions. All SR 
proteins tested so far are phosphorylated, and studies suggest that both phosphorylation 
and dephosphorylation play important roles in splicing and splice site selection 
(reviewed by Mermound et al., 1994). Previous studies investigating the effects of 
phosphorylation on the interactions between SR proteins have demonstrated that 
phosphorylation of the RS domain of ASF/SF2 enhances its interaction with the Ul-
70K protein (Xiao and Manley, 1997). These results support the idea that SR protein 
interactions are dynamic and regulated by the activity of kinases and phosphatases. 
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1.4.7.5 Isomerases 
Some spliceosomal proteins have been proposed to act as isomerases or 
chaperones, directly promoting protein conformational changes and thereby 
contributing to the dynamics of the splicing process. Consistent with this hypothesis, 
recent studies have demonstrated that purified tri-snRNP possess peptidyl-prolyl 
cis/trans-isomerase (PPIase) activity. In particular the tri-snRNPs specific 20 kD 
protein shares extensive homology with cyclophilin B, a known PPIase (Teigelkamp et 
al., 1998). Cyclophilins are a highly conserved family of proteins which have been 
shown to catalyze the cis-trans isomerisation of proline residues within peptides (Fisher 
et al., 1989; Takahasi et al., 1989). 
1.4.7.6 G-transducin motif 
This motif is characterised by a succession of 4-10 repeats of a conserved unit 
usually ending with the dipeptide Trp-Asp (WD) (reviewed in Simon et al., 1991; Neer 
et al., 1994; Neer, 1995) The C-terminal region of Prp4p contains these repeated units, 
which have been shown to be important for its function during splicing (Dalrymple et 
al., 1989; Hu et al., 1994; Ayadi et al., 1997). Both Prp4p and its human homologue 
the 60 kD protein, possess seven WD-repeats which can potentially form a seven-
bladed propeller structure characteristic of the G3 subunit of heteromeric G proteins 
(Wall et al., 1995; Lambright et al., 1996; Sondek et al., 1996). This WD-protein motif 
is though to function as a protein-protein interactive surface. This is consistent with the 
fact that several of the known proteins carrying the WD-repeats form multiprotein 





1.4.8 The U12-type spliceosome 
1.4.8.1 Description of the introns spliced by the U 1 2-spliceosome 
These introns are found in plants, Drosophila and vertebrates and coexist within 
genes with introns excised by the U2-spliceosome (for review see Sharp and Burge, 
1997). Thus the U 1 2-spliceosome coexists with the U2-spliceosome. 
Introns are defined by the 5' and 3' splice sites and by the branchpoint sequences which 
are shown in Table 3. 
Table 3. Consensus sequences of the introns excised by the U12-type spliceosome. 
Subclasses of 5' splice site Branchsite 3' splice site 
introns 
AT-AC /AUAUCCUUU 5'-UUCCUURACYCY-3' YAC/ 
GT-AG U/GUAUCCUTJTJ 5'-UUCCUUAACY-3' YAG/A 
The structure of the 3' splice site is distinct for these introns. There is typically no 
polypyrimidine tract and a relative small number of nucleotides (10-16 nts) separating 
the branchsite from the 3' splice site. Interestingly it has been noticed that this intron 3' 
end structure is quite similar to that of group II introns (Tam and Steitz, 1997). This 
similarity may indicate that the U12-type spliceosome may be more closely related to 
group II introns than the more common U2-spliceosome. 
1.4.8.2 The U12-type splicing machinery 
The U12-spliceosome is composed of four low abundance snRNPs Ull, U12, 
U4atac and U6atac (Hall and Padgett, 1996; Tarn and Steitz 1996, 1996b; Kolossova 
and Padgett, 1997), and it shares the U5 snIRNP with the U2-spliceosome. 
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The secondary structure of the four low-abundance snRNAs U4atac, U6atac, U  1 and 
U12 snRNAs is shown in Figures 9 and 10. These snRNAs and the U5 snRNA are 
essential for the splicing reaction (Tarn et al., 1996, 1996b; Hall et al., 1996) which 
involves a two-step trans-esterification mechanism with a lariat-intron-intermediate 
(Hall and Padgett, 1994; Tarn and Steitz, 1996a). 
Analogous RNA-RNA interactions are observed between the U2 and the U12-
spliceosomes. Thus the U12 snRNA base-pairs to the branchsite like the U2 snRNA 
(Hall and Padgett, 1996; Tarn and Steitz, 1996); U  1 snRNA was proposed to base-pair 
to the 5' splice site like the Ui snRNA (Hall and Padgett, 1994). U12 and a fraction of 
Ui 1 snRNA form a di-snRNP particle (Wassarman and Steitz, 1992), likewise, 
interactions between a small fraction of U2 and Ui snRNPs have been detected in 
Xenopus (Mattaj et al., 1986). Similarly, U4atac and U6atac are partially base-paired in 
the U4atac/LJ6atac snRNP like the U4 and the U6 snRNAs in the U4/U6 snRNP (Tarn 
and Steitz, 1996b). 
To date, little is known about the proteins involved in the formation of the U12-
spliceosome and the splicing reaction. SR proteins (see section 1.4.7 for definition) 
appear to be required (Tarn and Steitz, 1996a). 
1.5 	This Thesis 
This thesis describes the detection of proteins interacting directly with the yeast 
U6 snRNA. A complex in vitro system has been established to study those contacts. 
Using this system several proteins binding to the U6 snRNA have been detected, and 
their association with the U6 snRNA in the different snRNP particles and in the 
spliceosome has been investigated. The identification of these polypeptides in close 
proximity to the U6 snRNA has been attempted. The effect of mutations or the removal 
of the last 18 nt of the U6 snRNA molecule on these protein-RNA contacts has been 
53 
Figure 9. Predicted secondary structure of the human U6atac snRNA and 
U4atac snRNA (Tarn et al., 1996b). 
U6atac snRNA nucleotides potentially involved in base-pairing with the 5' 
splice site are underlined. Over 32 nucleotides in its central region, U6atac 
snRNA is 80% identical to all U6 snRNAs, presumably reflecting a critical 
function in splicing. The U4atac snRNA is shown base-paired with the U6atac 
snENA. Potential RNA-RNA base-pairs are indicated by straight lines. 
Crosslinking results support the presence of two stem structures (stem I and II) 
resulting from U4atac/U6atac snRNAs base-pairing interaction. The U4atac 
and the U6atac snRNAs sequences exhibit only 40% similarity to human U4 
snRNA and U6 snRNA respectively. The putative structures of the U4atac 
snRNA and the U6atac snRNA are more closely related to that of the yeast U4 
snRNA and U6 snRNA respectively. Northern blotting analysis revealed that 
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Figure 10. Potential secondary structure of the low-abundance Ull 
snRNA and U12 snRNA isolated from HeLa cells (Montza-Wassarman et 
al., 1992). 
Despite their limited sequence conservation, Ui 1 and U12 snRNAs can fold 
into secondary structures that are remarkably similar to that of the Ui snRNA 
and the U2 snRNA respectively. U  1 snRNP and U12 snRNP interact together 





A - U 
A - U 
C - G 
GC U 
G GU U 
G - C C -G -' 
A - U U  
U - G A - U 
G - C G - C 
C-G U 




U — G 
-A 
11111 1111111 C - G 
G u GCUGU 	GCUUUAGA 	C 0 — C c G-10 GA A 
U  C  
U  0-C 
c-G G - C 
















40-G 0 A 
C' 	G 0-C U-G 
A A 0-C - 	G-C 
G - C 0-C 
A-(Uf 
U-Ak 





2.2.7 	 A 	 ..-.. 	A-U 	 UG 
.GLAAAUAACG - C ACGAUUUUUG 	U U GCGGG A 	
C 	0 m3Gpppft4JCfr 
C  iitii	iii 	0 
U-A CA,UUG 






studied. Also, preliminary experiments have been carried out to map the region of 
interaction of these proteins to the U6 snIRNA molecule. 
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CHAPTER TWO 
Materials and Methods 
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2.1 Materials 
2.1.1 Chemicals and enzymes 
Standard laboratory reagents were purchased from Sigma, Fisons, BDH, Serva, 
Bio-Rad, Boehringer Mannheim. 
Phenol: Rathbum Chemicals. 
Urea: Fisons. 
Acrylamide and N, N'-methylene bisacrylamide stock solutions: Scotlab. 
Ultra-Pure Sequagel and Complete Buffer Reagent: National Diagnostics. 
Solvents: Scotlab, National Diagnostics. 
Agarose: Boebringer Mannheim. 
Deoxyribonucleotides: Boehringer Mannheim, United States Biochemical. 
Ribonucleotides: Pharmacia. 
4-thioUG and UG: Sigma. 
Antibiotics: Beecham Research. 
BCIP/NBT: Promega. 
Growth media reagents: Difco Laboratories, Sigma, Beta Lab., Oxoid. 
Xgal: Sigma 
Radiochemicals: Amersham. 
Restriction endonucleases and DNA modifying enzymes: Gibco BRL, Boehringer 
Mannheim, New England Biolabs, Pharmacia. 
Highly concentrated T4 DNA ligase (2, 000 units/pA): Biolabs. 
RNases A and Ti: Pharmacia, Boehringer Mannheim. 
RNasin (RNase inhibitor): Promega. 
T7 and SP6 RNA polymerases: Pharmacia. 
T7 DNA polymerase: United States Biochemical. 
Taq DNA polymerase: Promega, VentR DNA polymerase: New England Biolabs and 
Pfu DNA polymerase: Stratagene. 
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2.1.2 Growth media 
Except where otherwise indicated, solutions were autoclaved and stored at room 
temperature. 
Antibiotics were added to liquid media immediately prior to use or after autoclaving 
solid media. 
To make agar plates, bacto-agar was added to 2% (wfv) prior to autoclaving. 
Given quantities are for one litre volume except when indicated. 
2.1.2.1 Bacterial media 
Luria-Bertani medium (LB): 10 g bacto tryptone, 5 g yeast extract, 5 g NaCl, 
adjusted to pH 7.2 with NaOH. For cc-complementation test, 40 pl of a stock solution of 
X-gal (Table 4) and 4 tl of a stock solution of IPTG (Table 4) were spread on the 
surface of a pre-made agar plate. 
YT: 8 g bacto tryptone, 5 g bacto yeast extract, 5 g NaCl. 
M9 medium: 6 g Na2HPO4, 3 g KH2PO4, 0.5 g NaCl, 1 g NH4C1, 0.25 g MgSO4.7H20, 
2 g glucose. After autoclaving, amino acids were added to a final concentration of 40 
pg/ml. 
2.1.2.2 Antibiotics and a-complementation stock solutions 
All the stock solutions indicated below were stored at -20 °C. 
The antibiotic solutions were diluted one thousand fold in bacterial media. 
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Table 4. Antibiotics and a-complementation test stock solutions 
Stock Solution 
Chemical 	 Solvent 
(mg/ml) 
Amp icillin 	 100 	 Water 
Chioramphenicol 	 30 	 100% Ethanol 
Kanamycin 	 50 	 Water 
IPTG 	 200 	 Water 
X-gal 	 20 	 Dimethyiformamide 
2.1.2.3 Yeast media 
YPDA: 10 g yeast extract, 20 g bacto peptone, 20 g glucose, 3 mg adenine. 
YPGa1A: 10 g yeast extract, 20 g bacto peptone, 20 g galactose, 3 mg adenine. 
YMG/CAS: 6.7 g yeast nitrogen base w/o amino acids, 20 g casamino acids, 20 g 
glucose. 
YMGa1/CAS: 6.7 g yeast nitrogen base w/o amino acids, 20 g casamino acids, 20 g 
galactose. 
YMM: 6.7 g yeast nitrogen base w/o amino acids, 20 g glucose. 
YMGIyLac: 6.7 g yeast nitrogen base w/o amino acids, 10 g casamino acids, 2% (v/v) 
lactate (adjusted to pH 5.7 with KOH), 2% (v/v) glycerol. 
For Gall promoter induction, galactose was added to a final concentration of 2% (w/v). 
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Drop-out medium: 6.7 g yeast nitrogen base w/o amino acids, 20 g glucose or 
galactose, 2 g drop-out powder, adjusted to pH 6 with NaOH. 
Drop-out powder: mix 2 g of each amino acid: adenine, alanine, arginine, asparagine, 
aspartic acid, cysteine, glutamic acid, glutaminé, glycine, histidine, isoleucine, lysine, 
methionine, phenylalanine, proline, serine, threonine, tyrosine, tryptophan, uracil, 
valine, plus 4 g of leucine. 
2.1.2.4 Nutrient supplements 
Table 5. Amino acids solutions 
Constituent 	Stock Solution Final Concentration 	Amount of Stock 
(g per 100 ml) 	(mg per L) 	(ml per L of medium) 
Adenine sulfate 0.2 20 10 
Uracil 0.2 20 10 
L-Tryptophan 1.0 20 2 
L-Histidine 4 1.0 20 2 
L-Methionine4 1.0 20 2 
L-Leucine o 1.0 30 3 
, Store at 4 0C.. 
2.1.3 Commonly used buffers 
lox PBS: 15 mM KH2PO4 , 43 mM Na2HPO4, 1.37 M NaCl, 27 mM KC1, pH 
adjusted to 7.2. 
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lox TAE: 	0.4 M Tris-acetate pH 7.5, 20 mM EDTA. 
lox TBE: 0.9 M Tris-borate pH 8.3, 20 mM EDTA 
lox TBSP : 	0.5 M Tris-HC1, 1.5 M NaCl, pH adjusted to 7.5. 
lox TE: 	0.1 M Tris-HC1, 0.01 M EDTA, pH adjusted to 7.5. 
20 SSC: 	3 M NaCl, 0.3 M Sodium citrate. 
p, solutions were sterilized by autoclaving. 
2.1.4 Bacterial strains 
Table 6. Bacterial Strains 
Strain 	 Genotype 	 Source 
DH5aF' 	F, 80dlacZM15, A(1acZYA-argF), U169, deoR, 	Gibco BRL 
recAl, endAl, hsdRl7 ( rK-, mK+), supE44, ?, 
thi-1, gyrA96, relAl 
CJ236 	dutl, ungl, thil, relAl; pCJ105 (Cm RF) 	 Kunkel et al. 
(1987) 
+ 
BMH 	L(lac pro), thil, supE, F (lad , lacZ AM15,pro ) 	Messing etal. 
71-18 	 (1977) 
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2.1.5 Yeast strains 
Table 7. Yeast Strains 
Strain 	 Genotype 	 Source 
S150 2B 	MATa, his3-1, leu2-3, 112, trpl-289, ura3-52, 
GAL 
MCY4 	MATa, adel-101, his3-1 , leu2-3,1 12, trpl-289, 
ura3-52, LEU2-GALJ-USSJ, GAL 
SC261 	MATa, ura3-52, leu2, trpl , pep4-3 , prbl-1 132, 
prcl-407 
Rok8 	M4Ta, ade2, arg, leu2 -3 , leu2-1 12, trpl-289 
ura 3-52, snr7. .LEU2, (pROK8; Table 7) 
prp24-a 	MATa, ura3-52, lys2-801, ade2-101, his3-A200, 
prp24-4 
prp24-a 	MATcL, ura3-52, lys2-801, ade2-101, his3-t200, 
prp24-4 
DJ-Y`84 	MA Ta/a, ura3 -52/ura3 -52, his3 -A200/his3-A1, 
ADE21ade2. lObe  L YS21lys 2-801 am , 
trp 1 -1x901/trp 1-289, LEU21leu2-3, 112, GAL 
Glaxo 
This lab. 










YCLUCK (Undetermined mating type), ura3-52, his3, 	 This work 
14 	LEU2, LYS2, ade2101OC,  trpl, prp24::HIS3, 
URA3-PRP24-CEN 
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YVDP24 MA Ta/a, ura3-521ura3-52, his3-A2001his3-A1, 	This Work 
ADE21ade2. 1010, LYS21lys2-801'", 
trpl -iX901/trp] -289, LEU211eu2-3, 112, 
prp24::HIS3, GAL +  
	
AEMY28 M4Ta, trplAl, his3-11,-15, ura3-1, leu2-3,-112, 	A.Mayes 
ade2-1, canl-100, HA:SPB8 	
(1998) 
AEMY29 M4Ta, trplAl, his3-11,-15, ura3-1, leu2-3,-112, 	A.Mayes 
ade2-1, can]-100, YER146wA:HIS3; (pAEM70; 
1998 Table 9) 
AEMY30 MATa, frp1z1, his3A200, ura3-1, leu2-3,-112, 	A.Mayes 
ade2-1, can]-100, YBL026wk:HIS3; (pAEM55; 
1998 Table 9) 
AEMY31 MATa, trplAl, his3-11,-15, ura3-1, leu2-3,-112, 	A.Mayes 
ade2-1, can]-100, YLR438ct\::TRPJ (pAEM64; 
(1998) Table 9) 
AEMY42 MATa, trp]A1,his3A200, ura3-1, leu2-3,-112, 	A.Mayes 
ade2-1, can]-100, YNL147cA :HIS3; (pAEM59) 
(1998) 
AEMY43 MA Ta, trpliXl,his3A200, ura3-1, leu2-3,-112, 	A.Mayes 
ade2-1, can] -100, YNL147czX :HIS3; (pAEM62) 
(1998) 
AEMY44 MATa, trpltxl, his3A200, ura3-1, leu2-3,-112, 	A.Mayes 
ade2-1, can]-100, YDR378cA::HIS3; (pAEM34, 
(1998) Table 9) 
AEMY45 MATa, trp]A1, his3iX200, ura3-1, leu2-3,-112, 	A.Mayes 
ade2-1, can]-100, YDR378cA::HIS3 (pAEM61, 
(1998) Table 9) 
AEMY46 M4Ta, trplA], his3A200, ura3-1, leu2-3,.-112, 	A.Mayes 
ade2-1, canl-100, YBL026wA::HIS3; (pAEM68; 
(1998) Table 9) 
LMA4- MATa, trplAl, his3-11, 15, ura3-1, leu2-3,-]12, 	A.Mayes 
2A ade2-1, canl-100, YJR022wA::TRPJ; (pAEM71;  
Table 9) 	 (1998)  
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2.1.6 Synthetic oligonucleotides 
Oligodeoxynucleotides were synthesised at: 
- Bioline (London): V538. 
- Oswel DNA service (Southampton): T7, G6570, T0314, T0315, P5117, P5118, 
V4528, S3324, T1850, T1849, T1851, N6088, N6089, S8948, S8949, V5578, S5760, 
S5761, W3464, W3462, W3463. 
- Perkin Elmer Ltd. service (Warrington): JJv[B10, JMB1 1, Oligol, Oligo2, Oligo3, 
SRU2. 
- Genosys Biotechnologies Ltd. service (Cambridgeshire): BFUO, FU6, T7b, US383, 
U359, UB59, UB38, BU80, UFO, U559, U380, U383. 
- Oligos 483A, and 485A were a gift from D. Brow. Oligo Rok8L and Rok8R were a 
gift from A. Newman. 
Table 8. Oligodeoxynucleotides 
Oligo 	 Description 	 Sequence (5 1 -3 1 ) 
486A Complentary to yeast Ui snRNA CTTAAGGTAAGTAT 
sequence. 
G1803 Complementary to yeast U2 snRNA CTACACTTGATCTAAGCCAAA 
sequence. 	
AGGC 
SRU2 U2 snRNA knockout oligo. CAGATACTACACTTG 
Complementary to yeast U2 snRNA 
sequence 29-43. 
483A 	Complementary to yeast U4 snRNA CCGTGCATAAGGAT 
sequence 1-14. 
T0314 Complementary to yeast U4 snRNA GAGACGGTCTGGTTTATAATT 
sequence 72-92. 
63 
T0315 Complementary to yeast U4 snRNA CTGGTTTATAATTAAATTTC 
sequence 65-84. 
485A 	Complementary to yeast U5 snRNA AATATGGCAAGCCC 
sequence 156-169. 
Rok8L U5 snRNA knockout oligo 	 TTTCTCCCATGTTCGTTATA 
Rok8R U5 snRNA knockout oligo 	 CGGATGGTTCTGAAGAACCAT 
OTT 
Loryl T7 promoter sequence followed by six CGTAATACGACTCACTATAGG 
extra nucleotides (which improve the GAGAGTTCGCGAAGTAACCC 
transcription efficiency) and the U6 
snRNA gene sequence 1-11. 
P0052 Complementary to the PRP24 ORF GGCGCCATTGAAGTCGCTAAC 
sequence 270-304 followed by GAGAAGTATTTTCCCTCTTGG 
sequence 338-321 of the HIS3 gene. CCTCCTCTAG 
P0052 Contains the PRP24 ORF sequence GCCGCAGGATTAACTTCTAAG 
64-92 followed by sequence 1330- AAGGCGAACGAAGCTCGTTC 
1313 of the HIS3 gene. 	 AGAATGACACG 
S5760 T7 transcription promoter sequence CGTAATACGACTCACTATAGG 
followed by the yeast U6 snRNA gene TTCGCG 
sequence 1-7, an extra G was added at 
the 5' end of the wild-type U6 snRNA 
gene sequence. 
S5761 Complementary to the 3'end of the AAAACGAAATAAATCTCTT 
yeast U6 snRNA sequence 85-112. 	
TGTAAAAC 
Taq6A Complementary to yeast U6 snRNA TCATCTCTGTATTG 
sequence 43-56. 
T1849 Complementary to yeast U6 snRNA TCATCTCTTTATTGTTTC 
sequence 3 9-56 with a mismatch at 
position C48. 
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T1850 Complementary to yeast U6 snRNA GGGAACTGGTGATCATC 
sequence 52-72 with a mismatch at 
position G60. 
T1851 Complementary to yeast U6 snRNA GGAACTGCAGATCATC 
sequence 56-68 with a mismatch at 
position A59. 
V4528 Yeast U6 snRNA knockout oligo. ATCTCTGTATTGTTTCAAATTG 
and 
Complementary to yeast U6 snRNA ACCAA 
sequence 28-54. 
S3324 
V5578 Complementary to yeast U6 snRNA CTCTTTGTAAAACGGTTC 
sequence 81-98. 
W3462 Complementary to yeast U6 snRNA ATGCAGGGGAACTGCTGATCA 
sequence 34-74. 
TCTCTGTATTGTTTCAAATT 
W3363 Complementary to the T7 GCGCTAATACGACTCACTATA 
transcription promoter 	sequence 
TGATCAGCAGTTCCCCTGCAT 
followed by the yeast U6 snRNA gene 
sequence 55-74. 
W3364 Complementary to yeast U6 snRNA TCTCTGTATTGTTTCAAATTG 
sequence 33-53. 
T7b 	T7 transcription promoter sequence. 	GCGCTAATACGACTCACTATA 
JMB10 Complementary to PRP24 ORF CGCCTTTCATGAACAG 
downstream sequence. 
JMB11 Complementary to PRP24 ORF GGTGTCACCAAGCTTAATC 
sequence 966-983. 
N6088 Prp24p coding sequence 1320-1332, CCCGGATCCTCACCTAGAAAC 
the A of the TAG stop codon was 
changed by a C introducing a BamHI 
restriction site, eight extra nucleotides 
were added at the 3' end. 
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N6089 Complementary to PRP24 ORF GTATACGGCTTCCCAG 
sequence 437-451. 
Oligol Prp24p encoding sequence 83-98. 	GCTTCGTTCGCCTTC 
Oligo2 Prp24p encoding sequence 210-226. CGCAATCCGCAACATC 
Oligo3 Prp24p encoding sequence 628-675. 	GCGCCCTCTAGTGTG 
P5117 Complementary to Prp24p encoding GGCGCCATTGAAGTC 
sequence 1050-1065. 
P5118 Complementary to Prp24p encoding GAAGGCGAACGAAGC 
sequence 83-98. 
S8948 Complementary to the 5' end of CCCGGATCCATGGAGTATGGA 
Prp24p encoding sequence 1-20, 
CATCACGC contains a BamHI site. 
S8949 Complementary to the 3' end of CCACTCTAGAGTCTACTCACC 
Prp24p encoding sequence 1320-• 
TAGAAAC 1333, contains anXbal site. 
M5392 Stop codon linker. 
M5393 Stop codon linker. 










2.1.7 Plasmid vectors and constructs 
Table 9. Plasmid vectors and constructs 
Plasmid 
	
Features 	 Reference 
pBluescript Phagemid cloning vector: Multiple cloning site 	Stratagene. 
KS 	 R 
+1- flanked by T3 and T7 transcription promoters, fl 
origin, lacZa, Amp 
pATH3 	E. coli expression vector: Used to produce an Koerner et al. 
incomplete trpE fusion protein. Expression of the 	
"1990 fusion protein controlled by the indoleacrylic acid- 
inducible trp promoter. Multiple cloning site; 
AMP R. 
pGEX-2T 	E. coli expression vector: Used to produce a 	Pharmacia. 
glutathione S-transferase (GST) fusion protein. 
Expression of the fusion protein controlled by the 
IPTG-inducible tac promoter. A designed 
thrombin protease recognition site can be used to 
cleave the protein of interest from the fusion 
product. Multiple cloning site; AmpR,  lacP. 
pUR288 	E. coli expression vector: Used to produce a - 	RUther et al. 
galactosidase fusion protein. Expression of the 
1983 fusion protein is controlled by the IPTG-inducible 
lac promoter. Multiple cloning site; Amp'. 
pQE30 	E. coli expression vector: Used to produce a 6X 	Qiagen. 
Histidine fusion protein. Expression of the fusion 
protein is controlled by the IPTG-inducible lac 
promoter. Multiple cloning site; AmpR. 
pBM125 	Yeast-E. coli shuttle vector: Gal l -Gal lO promoter Johnston et al. 
sequence, CEN4, ARSJ, URA3, tetR , AmpR. 	 (1984) 
YCp 	Yeast-E. coli shuttle vector: Multiple cloning site, 	Gietz et al. 
lacZ, Am/, CEN4, ARS], TRPJ. 
LAC22 	 (1988) 
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pATP24 	Modified pATH3: Contains Prp24p encoding 	This work. 
sequence amplified by PCR from yeast genomic 
DNA with primers S8948 and S8949. The PCR 
product was BamHl/XbaI digested, gel purified 
and cloned in BamHI/XbaI-opened pATH3 vector. 
pBXPR24 	Modified pBluescript: The XbaI-Prp24p containing 	This Work. 
ORF fragment isolated from plasmid YCpXba was 
cloned in XbaI-opened pBluescript. 
pGEX24 	Modified pGEX-2T: Contains Prp24p coding 	This work. 
sequence in frame with the GST gene. The Prp24p 
gene was isolated as a BamHI/SalI restriction 
fragment from pATP24 plasmid, and cloned in 3 
steps in BamHI/SmaI opened pGEX-2T vector: 
First, the BamHI compatible Vector/insert ends 
were ligated together. Then the Sall-3' recessed 
end of the insert was filled-in by the kienow 
enzyme. Finally, the blunted 3' end of the Prp24p 
gene was ligated to the vectors' Smal end. 
pGAP24 	Modified pUR288: contains Prp24p coding 	This work. 
sequence in frame with the -galactosidase gene. 
PRP24 ORF was gel isolated from BamHI/XbaI-
digested pGEX24 plasmid and cloned in 
BamHI/XbaI opened pUR288 vector. 
pIP24 	Modified pQE30: contains PRP24 ORF cloned in 	This work 
frame with the 6X histidine encoding sequence. 
PRP24 ORF was gel isolated from BamHI/SalI-
digested pATP24 plasmid and cloned in 
BamHI/SalI opened pQE30 vector. 
YCpXba 	Modified Ycp50: Contains a 3.5 Kb XbaI fragment Shannon et al. 
harboring the Prp24p coding sequence with 	
1991 upstream and downstream sequences. 
YCpL24 	Modified YCpL22: Contains the XbaI fragment of 	This work. 
YCpXba cloned into XbaI-opened YCpLac22. 
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YCR24 	Modified YCpL24: This construct was 	This work. 
ClaIIBamHI digested and the ClaI/BamHI 
fragment replaced by a PCR product obtained 
using oligos N6088 and N6089. This PCR product 
was ClaI/BamHI digested and contains the 3' end 
of the PRP24 ORF. The resulting YCR24 plasmid 
possesses the Prp24p coding sequence but no stop 
codon. 
YRFL24 	Modified YCR24: The Flag-Stop cassette from 	This work. 
pBFAST was isolated by BamHl digestion and 
inserted into YCR24 linearised with BamHI. The 
Flag epitope coding sequence was cloned in frame 
at the 3' end of the PRP24 ORF. 
pBM24 	Modified pBM125: PRP24 ORF was isolated from 	This work. 
pATP24 BamHI-Sall digested and inserted into 
BamHI-SalI cut pBM 125 plasmid. 
pBSTP 	Contains stop codons in 3 different ORFs: Stop 	This Work. 
linkers M5392 and M5393 were phosphorylated, 
annealed and cloned into Sail cut pBluescript. 
pBFAST 	Contains the Flag epitope coding sequence 	This Work. 
followed by stop codons in all three frames: The 
FLAG linkers N4804 and N4805 were 
phosphorylated, annealed and inserted into pBSTP 
linearized with Sail. 
pACT!! 	Yeast-E. coli shuttle and expression vector used for 
the two-hybrid system: The gene of interest can be 
cloned in frame with the sequence coding for the 
Ga14 DNA binding domain and the HA-epitope. 
The expression of the gene is under the control of 
the constitutive ADHJ yeast promoter. Multiple 
cloning site, 2p. origin, TRPJ, fl origin, AmpR. 
pAS2AA 	Yeast-E. coli shuttle and expression vector used for 
the two-hybrid system: The expression of the 
inserted gene is under the control of the 
constitutive ADHJ yeast promoter. The protein of 
interest is produced as a fusion protein with the 
Ga14 DNA binding domain. Multiple cloning site, 
2j.i origin, TRPJ, f1 origin, Amp'. 
Clontech 
Fromont- 




pBTM116 	Yeast-E. coli shuttle and expression vector used for 	Gift from 	A. 
the two-hybrid system: Use to produce a LexA 
Brown. DNA binding domain fusion protein. The 
expression of the gene is under the control of the 	(Glaxo) 
constitutive ADHJ yeast promoter. Multiple 
cloning site, 2p. origin, TRPJ, fl origin, A mpR . 
YCpIF16 	Yeast expression vector: Use to overproduce an 	Foreman and 
HA epitope-tagged protein. This vector contains a Davis. 
 sequence encoding an HA epitope upstream from  
the multiple cloning site. The expression of the (1994) 
gene is under the control of the GAL] promoter. 
CEN4, TRPJ. 
pAEM13 Modified pAS2z\L: The Ussip coding sequence 	A. Mayes. 
was cloned in frame with the Ga14 DNA binding 
(This Lab.) domain.  
pAEM34 Modified pBTM1 16: The YDR378c ORF was 	A. Mayes. 
cloned in frame with the sequence coding for the 
(This Lab.) LexA DNA binding domain. 
pAEM55 Modified pACTII: YBL026w ORF was cloned in 	A. Mayes. 
frame with sequence coding for the Ga14 DNA 
(This Lab.) binding domain and the HA-epitope. 
pAEM59 Modified pBTM1 16: The YNL147c ORF was 	A. Mayes. 
cloned in frame with the sequence coding for the 
(This Lab.) LexA DNA binding domain. 
pAEM61 Modified YCpIF16: The YDR378c ORF was 	A. Mayes. 
cloned in frame with the sequence coding for the 
(This Lab.) HA epitope. 
pAEM62 Modified YCpIF16: The YNL147c ORF was 	A. Mayes. 
cloned in frame with the sequence coding for the 
(This Lab.) HA epitope. 
pAEM64 Modified pBM125: Contains the HA-YLR438c 	A. Mayes. 




pAEM68 Modified pBM125: Harbours the YBL026w-HA 	A. Mayes. 
ORF encoding Uss6p fused at its C-terminus with 
(This Lab.) the HA epitope. 
pAEM70 Modified pACTII: YER146w ORF was cloned in 	A. Mayes. 
frame with sequence coding for the Ga14 DNA 
(This Lab.) binding domain and the HA-epitope. 
pAEM71 Modified pACTII: YJR022w ORF was cloned in 	A. Mayes. 
frame with the sequence coding for the Ga14 DNA 
(This Lab.) binding domain and the HA-epitope. 
pGPRP24 Modified pAS2M: The PRP24 ORF was cloned in 	A. Colley. 
frame with the Ga14 DNA binding domain. 
(This Lab.) 
pUC12U6 	Contains the yeast SNR6 gene cloned in pUC12 	I. Kelly. 
vector. This gene possesses the T7 promoter 
(Cambridge) sequence and an extra G nucleotide at its 5' end. 
This plasmid was linearized with DraI for run-off 
transcription. 
pU66bo 	Modified pUC12U6: A hairpin ribozyme was 	I. Kelly. 
cloned 3' to the U6 gene sequence. This plasmid 
was linearized with EcoRJ for run-off (Cambridge) 
transcription. 
pUCU6II 	Modified pBluescript KS: pUC12U6 plasmid was 	I. Kelly. 
BglI digested and the fragment containing the T7- 
(Cambridge) SNR6 gene was cloned in BglI-opened pBluescript 
KS vector. 
pU6C48A 	Modified pUC6fl: The SNR6 wild-type gene 	This work. 
sequence was subjected to site directed 
mutagenesis using DNA oligo T1849. C48 
nucleotide was mutated to A. 
pU6A51U 	Modified pUC6fl: The SNR6 wild-type gene 	I. Kelly. 
sequence was subjected to site directed 
(Cambridge) mutagenesis. A51 nucleotide was mutated to T. 
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pU6A59U Modified pUC6fl: The SNR6 wild-type gene 	This work. 
sequence was subjected to site directed 
mutagenesis using DNA oligo T1 851. A59 
nucleotide was mutated to T. 
pU6G60C Modified pUC6fl: The SNR6 wild-type gene 	This work 
sequence was subjected to site directed 
mutagenesis using DNA oligo T1850. G60 
nucleotide was mutated to C. 
p283 	Modified pGEM1 vector: Contains an Alu! O'Keefe et al. 
fragment of the yeast ACT] gene inserted at the 	
1996 Smal site in the T7 orientation. The plasmid was 
linearized with BamHI for run-off transcription. 
pROK8 	Harbours a modified SNR7 gene coding for the US O'Keefe etal. 
snRNA containing a 30 nucleotide-insertion 	
1996 required for US snRNA depletion. 
pSPrp5lA Contains the RP5 1A gene. SP6 run-off transcripts Pikielny et al. 
were generated with a 100 nt long poly(A) tail 	
1986 when linearized with BamHI; this tail was missing 
when linearized with EcoRI. 
pBM- 	Modified pBM125: Contains the dominant 	This Lab. 
PRP2LAT negative mutant p2LATp encoding gene under the 
control of the GAL] inducible promoter. 
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2.1.8 Antisera 
Table 10. Description of antibodies 
Antibody 	 Description 	 Origin 
Anti-8.6 
(666) 
Rabbit polyclonal antibodies: Raised against a 35 	This lab. 
amino acid synthetic peptide of the N-terminal 
region of Prp8p. 
Anti-PAB 	Rabbit polyclonal antibodies: Raised against the Whittaker et 
(170) 	yeast poly(A)-binding protein. 	 al. 
(1991) 
Anti-Prp2 	Rabbit polyclonal antibodies: Raised against an Teigelkamp 
(140) 	internal region of Prp2p as -galactosidase fusion 	et àl. 
protein. 	 (1994) 
Anti-Ussi 	Rabbit polyclonal antibodies: Raised against the 	This lab. 
(756 	entire Ussip as a 3-galactosidase fusion protein. 
and 763) 
Anti-Prp24 Rabbit polyclonal antibodies: Raised against the This work. 
(1015 	entire Prp24p as a -galactosidase fusion protein. 
and 1016) 
Anti-Rabbit Alkaline phosphatase conjugated anti-rabbit IgG Promega. 
IgG 	
(Fe) antibodies. 
Anti-HA 	Monoclonal antibodies raised against the Gift from D. 




2.2 General Methods 
2.2.1 Deionization of solutions 
Formamide and Acrylamide/Urea solutions were deionized by mixing with 0.1 
volume of analytical mixed-bed resin (20-50 mesh; Bio-Rad Laboratories), stirring for 
30 mm. The resin was removed by filtration through Whatman No.1 filter paper. 
2.2.2 Autoradiography 
[32P]-labelled nucleic acids in gels or on membrane were detected by exposure 
to Cronex X-ray film (Du Pont) at -70 °C in a light-proof cassette with a calcium 
tungstate intensifying screen. For the detection of [32P.RNA-protein] UV-crosslinking 
signals, a hypersensitive film (Biomax MS, Kodak) was used in combination with a 
Biomax MS intensifying screen (Kodak). 
[35S]-labelled DNA was also detected by exposure to Cronex X-ray film, at room 
temperature and without any intensifying screen. 
2.2.3 Cerenkov counting 
Cerenkov counting of [32P] was performed in a Tri-Carb 2 1 OOTR Packard 
(Canberra compagny) scintillation counter. 
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2.3 Microbiological Methods 
2.3.1 Propagation and storage of strains 
2.3.1.1 	E. coli strains 
Strains were routinely grown at 3 7 °C, in rich LB medium (Section 2.1.2.1) or in 
minimal M9 medium supplemented with nutrients (Table 5) if necessary. To maintain 
the plasmid DNA selection in bacteria, antibiotics were added to growth media (Table 
4). 
2.3.1.2 Yeast strains 
Strains were routinely grown at 30 °C (or different temperature according to 
strain thermosensitivity) in complete YPDA or YPGa1A media (Section 2.1.2.3). To 
maintain plasmid DNA selection transformed yeasts were grown in selective media 
supplemented with amino acids (Table 5) according to strain genotype (Table 7), or in 
drop-out medium lacking the relevant amino acids. 
Both yeast and bacterial strains were preserved for short periods at 4 °C on plates. For 
long term storage: 400 .il of yeast or E. co/i liquid culture were transferred to a 2 ml 
cryovial containing 600 p.1 of 100% sterile glycerol. The contents were gently mixed 
and rapidly frozen in dry ice. The vial was kept at -70 °C for an indefinite period. 
2.3.2 Transformation of E. coli 
2.3.2.1 Preparation of competent cells 
Competent cells were prepared according to a modified method of Hanahan 
(1983): a culture was grown overnight at 37 °C to stationary phase in 5 ml LB-medium 
(Section 2.1.2.1). The following day 1 ml of this culture was used to inoculate 100 ml 
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LB-medium. Cells were grown at 37 °C for 2-3 h (until 0D 550= 0.5). The culture was 
transferred to sterile JLA 10-500 centrifugation bottles (Beckman, AvantiThl J 25 
centrifuge), cooled on ice for 10 mm, then sedimented by centrifugation for 10 mm at 
4000 rpm (4 0C). The supernate was discarded, the pellet resuspended in 17 ml of ice-
cold Tfb- 1 solution and kept on ice for at least 20 mm. The cells were sedimented by 
centrifugation for 10 min at 4000 rpm (4 °C) and resuspended very gently in 8 ml of ice-
cold Tfb-2 solution. Competent cells were aliquoted in Eppendorfs tubes, snap-frozen 
in dry ice and stored for months at -70 °C. 
• Tth-1 solution: 30 mM KOAc, 50 mM MnC12, 100 mM KC1, 10 mM CaC12, 15% 
(v/v) glycerol. 
• Tbf-2 solution: 10 mM Na-MOPS pH 7.0, 75 mM CaC1 2, 10 mM KC1, 15% (v/v) 
glycerol. 
Both solutions were sterilized by filtration through a sterile acrodisc filter (0.45 p.m) 
(Gelman Sciences). 
2.3.2.2 Transformation of competent cells 
Frozen competent cells were thawed on ice, 50-200 p.1 aliquots of cells were 
gently mixed with transforming DNA. The mixture was incubated on ice for 30 mm 
then heat shocked at 42 °C for 45 sec and placed on ice for 2 mm. 1 ml of LB-medium 
was then added and the cells incubated for 1 h at 37 °C on a rotating wheel. Aliquots 
(5 0-200 p.1) of diluted or undiluted cells were plated onto selective agar medium. To 
assay for the lac-complementation, plates were supplemented with X-ga1IIPTG (section 
2.1.2.1) and incubated overnight at 3 7 °C. 
76 
2.3.3 Transformation of yeast 
Yeast transformation was carried out according to the method of Gietz et al. 
(1992). 
Yeast cells to be transformed were inoculated into 10 ml liquid YPDA medium (section 
2.1.2.3) and grown overnight to 1-2 x 10 cells/mi. The following day the cells were 
diluted to 2 x 10 6  cells/ml in fresh liquid YPDA medium and regrown to 1 x 10 7  
cells/mi. Cells were then harvested by centriftigation at 3000 rpm for 5 mm (Mistral 
1000 centrifuge) in sterile Falcon tubes (Greiner). The supernate was discarded and the 
cell pellet washed in 30 ml sterile water. The cells were pelleted by centrifugation, 
washed twice in 1 ml water and transferred into a sterile 1.5 ml microfuge tube. The 
cells were washed in 1 mliX TE/LiAc (made fresh from i OX autoclaved TE and LiAc 
stock solutions) and resuspended at 2 x i0 9 cells/ml in lx TE/LiAc. In a 1.5 ml 
microfuge tube, 50 jil of the yeast cell suspension was mixed with 1 tg transforming 
DNA, 50 tg of single-stranded salmon sperm carrier DNA and 300 p1 of sterile 40% 
PEG/TE/LiAc solution (made fresh from 50% PEG 3500, lOX TE and lOX LiAc 
stocks). The mixture was homogenized by inversion of the tube and incubated at 30 °C 
for 30 min on a rotating wheel. Cells were heat-shocked at 42 °C for 15 min then spun 
down in a microfuge for 5 sec. The supemate was discarded and the cells gently 
resuspended in 1 ml of lx TE (made fresh from a iox stock). The cell suspension was 
diluted appropriately and plated onto selective medium. Plates were incubated at the 
appropriate temperature for 2-3 days until the appearance of colonies. Cells from a 
yeast colony were restreaked onto selective plates for colony isolation. 
• lox TE: 0.1 M Tris-HC1, 0.01 M EDTA, pH adjusted to 7.5. 
• i ox LiAc: 1 M LiAc pH adjusted to 7.5 with diluted acetic acid 
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2.3.4 Sporulation of yeast 
2.3.4.1 Growth of diploid cells in liquid medium 
YPDA medium (10 ml) (section 2.1.2.3) was inoculated with the diploid yeast 
strain to be sporulated and the culture grown at 30°C to an optical density at 600 nm of 
2.5-3.0. 1 ml of cells was transferred to a sterile Eppendorf, washed once with sterile 
water and resuspended in 1 ml of liquid sporulation medium supplemented with 
nutrients (Table 5) required for the growth of the diploid strain. The cells were grown in 
sporulation medium for at least 3 days at 30°C to induce tetrad formation. Tetrad 
formation was observed under the microscope. 
• Liquid sporulation medium: 10 g/l potassium acetate, lg/1 bacto yeast extract, 0.5 g 
glucose, relevant amino acid (Table 5). 
2.3.4.2 Growth of diploid in solid medium 
Diploids to be sporulated were grown on YPDA or selective plates for 3-4 days. 
A small dab of cells was collected from the plate and washed in 1 ml sterile water. Cells 
were resuspended in 100 p.1 of sterile water and spread onto a sporulation plate 
(Sporulation medium supplemented with 2% (w/v) agar). The plate was left at 30 °C for 
at least 4 days or at lower temperature which sometime increases the sporulation 
efficiency. Tetrads were visualized by microscopy. 
2.4.3.3 Tetrad dissection 
Following growth in sporulation medium the culture was transferred to an 
Eppendorf, the cells pelleted by centrifugation, washed twice with sterile water, then 
resuspended in 5 ml sterile water. 30 p.1 of cells were diluted in 270 p.1 of sterile 
distilled water and incubated with 20 p.! of 3-Glucuronidase/Arylsulfatase (Boebringer 
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Mannheim) for 30-60 min at room temperature. Cell wall digestion was analysed 
microscopically during this incubation period. Tetrads were dissected on a thin YPDA 
plate using a Singer MSM system micro-manipulator. 
2.4 Nucleic Acid Methods 
2.4.1 Spectrophotometric determination of DNA and RNA concentrations 
Nucleic acid concentrations were determined by measuring the absorption of 
diluted solutions at 260 nm using a Cecil CE 2040 spectrophotometer and a quartz 
cuvette (Cecil instruments). 
For double-stranded DNA an 0D260 value of 1 represents a DNA concentration of 50 
igIm1, and 40 j.ig/ml of single-stranded DNA or RNA. 
For single-stranded RNA an 0D 260 value of 1 represents a RNA concentration of 37 
pg/ml. 
2.4.2 Precipitation of nucleic acids 
Nucleic acids were precipitated with ethanol in the presence of salts. The salt 
concentration was adjusted by adding 0.1 volume of 3 M NaOAc (pH 5.3) or by adding 
0.5 volume of 7.5 M NH40Ac solutions plus 2.5 volume of 100% ice-cold ethanol and 
the mixture inverted several times. Nucleic acids were precipitated at -20 °C for 30 mm 
or at -70°C for 15 mm, followed by centrifugation at 4 °C for 15 mm. The nucleic acids 
pellet was washed with 70% ethanol, dried under vacuum and resuspended in the 
appropriate volume of 1X TE buffer (section 2.1.3). 
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2.4.3 Deoxyribonucleic acid methods 
2.4.3.1 Plasmid DNA preparation 
Small scale preparation 
The following protocol is based on the alkaline lysis method of Zhou et al. 
(1990). 
LB-medium (5 ml, containing selective antibiotic, section 2.1.2.1) was inoculated with 
a single colony of the plasmid-bearing E. coli strain and incubated overnight with 
continuous shaking at 37'C. A 2 ml aliquot of the culture was centrifuged for 2 mm, the 
supernate discarded and the cell pellet resuspended by vortexing in 300 jil of TENS 
solution. 150 p.1 of 3 M NaOAc (pH 5.2) was added to the cell suspension and the 
mixture vortexed 2-5 sec. The cell debris and chromosomal DNA were pelleted by 
centrifugation at high speed for 2 min in a table centrifuge. The pellet was removed 
from the supernate with a sterile toothpick. Residual protein debris was removed from 
the supernate by phenol: chloroform extraction. To the aqueous phase, 900 p.1 of 
precooled 100% ethanol was added, and the nucleic acids pelleted by centrifugation at 
high speed for 5 mm. The pellet was washed with 70% ethanol, dried and resuspended 
in 30 j.d of 1X TE/RNase A. The resuspended DNA was incubated at 37 °C for 30 mm 
then frozen. 
• lx TEIRNase A: Prepared from i OX TE stock solution (section 2.1.3), contains 
RNase A at a final concentration of 20 j.ig/ml. 
• TENS: 1X TE, 0.1 M NaOH, 0.5% (w/v) SDS. 
Medium scale preparation 
LB-medium (50 ml, containing selective antibiotic, section 2.1.2.1) was 
inoculated using 1 ml of a saturated plasmid-bearing E. coil strain and incubated at 
37°C with shaking overnight. The culture was centrifuged for 10 min at 4000 rpm in a 
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Beckman centrifuge (Beckman JLA 10-500 rotor). The supernate was discarded and the 
cell pellet resuspended in 4 ml of LETR solution. This cell suspension was transferred 
to a 50 ml polycarbonate tube and incubated at room temperature for at least 30 mm 
with occasional mixing by inversion. 80 tl of 10% (v/v) Triton X-100 in TE was 
added, the mixture homogenized by inversion and incubated at room temperature for 
10-30 mill. The cell debris and chromosomal DNA were pelleted by centrifugation for 
30 min at 12000 rpm in a Beckman centrifuge (Beckman JA-25 rotor). The DNA-
containing supernate was transferred into a new polycarbonate tube and 300 p.! of 3 M 
NaC1 was added. Proteins were extracted by addition of 4 ml phenol/chloroform 
solution. Aqueous and organic phases were separated by centrifugation for 20 min at 
10000 rpm (40C). The organic phase was discarded, 1.5 ml of chloroform was added 
and the mixture vigorously shaken followed by centrifugation for 5 min at 10000 rpm. 
The aqueous phase was transferred to a fresh tube and 0.5 volume of isopropanol was 
added. The mixture was incubated at room temperature for 10 mm, and the plasmid 
DNA pelleted by centrifugation for 30 min at 11000 rpm (4 0C). The supernate was 
discarded and the pellet washed with 75% ethanol, dried and dissolved in 0.5-1 ml TE. 
The DNA solution was transferred in a sterile Eppendorf tube and stored at 4 °C for an 
indefinite time. 
• LETR solution: 2 g/l lysozyme, 100 mM EDTA, 50 mM Tris-CI pH 8.0, 0.1 mg/ml 
RNaseA, 10% (v/v) glycerol. 
Large scale preparation 
LB-medium (500 ml, containing selective antibiotic, section 2.1.2.1) was 
inoculated using 5 ml of a saturated plasmid-bearing E. coli strain and incubated at 
37°C with shaking overnight. The culture was centrifuged for 10 min at 4000 rpm in a 
Beckman centrifuge (Beckman JLA 10-500 rotor). The supernate was discarded and the 
cell pellet resuspended in 7.5 ml of [25% (w/v) sucrose, 50 mM Tris-CI pH 7.5] 
solution. This cell suspension was transferred in a 50 ml polycarbonate tube and left on 
ice for 5 min then 2.5 ml of fresh 10 mg/ml lysozyme solution in water was added and 
incubated on ice for 5 mm. 3 ml of 0.25 M EDTA pH 8.0 were added and the mixture 
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kept on ice for 5 mm, then 12 ml of lysis buffer was added and the mix incubated for an 
extra 30 min on ice. The cell debris and chromosomal DNA were pelleted by 
centrifugation for 30 min at 16000 rpm (4 °C) in a Beckman centrifuge (Beckman JA-25 
rotor). The DNA-containing supernate was transferred into a Falcon tube and the 
volume adjusted to 30 ml with water. 30 g of CsC1 was added and the salt carefully 
dissolved by inversion of the tube until complete dissolution. 1.5 ml of a 10 mg/ml 
ethidium bromide solution was added and the mix was separated in two 18 ml 
Quickseal tubes (Beckman). The tubes' weight were precisely equilibrated (between 
each others): A maximal weight difference of 10 mg was allowed. The tubes were spun 
for at least 17 h at 45000 rpm (room temperature) in a Beckman XL-100 
Ultracentrifuge (Rotor Ti70). A CsC1 gradient established during spinning. After 
centrifugation the plasmid DNA, as well as the genomic DNA, RNAs and proteins, was 
visualized by UV-exposure of the tube. The plasmid DNA band was collected by 
suction through a needle with a 2 ml syringue. The ethidium bromide was extracted 
from the DNA by successive extractions with water-saturated butan-2-ol. 
Approximately 5 ml of DNA-containing phase was usually recovered and split between 
two tubes. To each 2.5 ml solution, 8 ml of 1X TE was added and the DNA precipitated 
by addition of 8 ml of propan-2-ol and incubation for 30 min at -20 °C. After 
centrifugation the DNA pellet was resuspended in 500 j.il of lx TE and kept at -20 °C 
for an indefinite time. 
• Lysis buffer: 0.1% (v/v) Triton X-100, 63 mM EDTA pH 8.0, 50 mM Tris-Cl pH 
8.0. 
2.4.3.2 Yeast genomic DNA preparation 
Genomic DNA was routinely prepared from a 5 ml mid-logarithmic culture 
grown in YPDA medium (section 2.1.2.3). The culture was harvested by centrifugation 
for 5 min at 3000 rpm (Mistral 1000 centrifuge). The supernate was discarded, the cells 
resuspended in 0.5 ml of [1 M sorbitol, 0.1 M EDTA] solution containing 2 mg of 
lyticase. This cell suspension was transferred to a 1.5 ml Eppendorf tube and incubated 
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at 37°C for 1 h with continuous slow shaking until conversion to spheroplasts was 
complete. Spheroplasts were sedimented by centrifugation in a microfuge for 1 mm. 
The supemate was discarded and the pellet gently resuspended in 0.5 ml of [50 MM 
Tris-HC1 pH 7.4, 20 mM EDTA] solution. 50 p1 of 10% (w/v) SDS was added and 
mixed well. The mixture was inbubated at 65°C for 30 mm. 200 jii of 5 M potassium 
acetate was then added, the suspension mixed by inversion and placed on ice for 60 
mm. The suspension was then centrifuged in a microfuge for 5 min and the lysate 
transferred in a fresh Eppendorf tube. The DNA was finally precipitated in the presence 
of one volume of isopropanol. The mix was incubated at room temperature for 5 mm 
and the DNA pelleted by briefly spinning in a microfuge. The supernate was pour off 
and the pellet air dried. The final DNA pellet was resuspended in 300 p.1 lx TE buffer 
(section 2.1.3), 15 p.1 of a 1 mg/ml of RNase A solution was added and incubated at 
37°C for 30 mm. The DNA solution was then kept for an indefinite time at -20 °C. 
2.4.3.3 Restriction digest of DNA 
Restriction endonuclease digestion of DNA was performed in volumes of 10-20 
p1. These contain the required quantity of DNA and the appropriate Boebringer 
Mannheim restriction buffer at 1X concentration. The restriction enzyme volume was 
kept below 10% of the digestion volume to avoid any star activity of the enzyme due to 
excess glycerol. The restriction digest was incubated at the temperature recommended 
by the supplier for a period of 2-10 h. The products of the digestion were either 
analysed directly by agarose gel electrophoresis, or extracted with phenol: chloroform 
then ethanol precipitated and finally resuspended in 1X TE buffer (section 2.1.3) in a 
suitable volume for further manipulations. 
• Phenol:chloroform extraction mixture: these organic solvents were mixed with a 
volume ratio of 25:24 respectively with 1 volume of isoamyl alcohol. 
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2.4.3.4 Agarose gel electrophoresis 
Agarose gel electrophoresis analysis of DNA was always performed using TAE 
buffer (section 2.1.3). Gels were prepared by melting the agarose (typically 0.7-1% 
(w/v)) in 1X TAE buffer. Ethidium bromide was added to a fmal concentration of 0.5 
jig/ml for the visualisation of DNA. Samples to be analysed by gel electrophoresis were 
loaded directly using 6X Ficoll loading buffer. 
• 6X Ficoll Loading Buffer: 0.25% (w/v) Bromophenol blue, 0.25% (w/v) Xylene 
cyanol blue, 15% (w/v) Ficoll. 
2.4.3.5 Isolation of DNA from agarose gel slices 
To isolate and purify DNA from agarose gels, the Qiagen gel extraction kit 
(Qiagen) was employed. QIAEX utilises a silica gel suspension which binds to DNA in 
high-salt solutions only. After several washes DNA was recovered by elution in low 
salt concentration buffer or water. 
DNA fragments were separated on a TAE/agarose gel (section 2.4.3.2). The band of 
interest was detected by UV-transillumination (UVT 28M Herolab) on low power and 
cut out using a clean razor blade. The gel slice was transferred to an Eppendorf, the 
weight of the gel slice determined and three volumes of QX1 solution (Qiagen) added. 
10 tl of QIAEX matrix was then added and the Eppendorf incubated at 50 °C for 10 
min until the gel slice had dissolved; the Eppendorf was vortexed 2-3 times during the 
incubation period in order to help the dissolution of the gel and the DNA-silicagel 
particles interaction. The QIAEX matrix was sedimented by centrifugation for 30 sec, 
the supernate removed and the pellet washed twice in 500 jt1 of QX1 solution. A last 
wash was done with 500 p.! of PE solution (Qiagen), the pellet was air-dried for 10-15 
min and the DNA eluted by resuspending the matrix in 20 p.1 1X TE or water. Finally, 
the DNA-containing solution was separated from the QIAEX by centrifugation and the 
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supemate transferred to a new Eppendorf tube. The DNA was directly used for further 
manipulations or kept at -20 °C. 
2.4.3.6 Ligation of DNA molecules 
Ligations were typically performed in a final volume of 10-20 pl. These 
contained 0.5-1.0 ig total DNA, 1X ligation buffer and T4 DNA ligase. 
Cohesive DNA termini were ligated with 1 unit of ligase at RT for 1-2 h, the ligation of 
blunt-ended molecules was performed overnight at 4 °C. Vector and insert DNA were 
typically present in a 1:2 or 1:3 ratio. 5 j.il of the ligation reaction was used to transform 
competent E. coli cells (section 2.3.2). 
• 1X ligation buffer: 300 mM Tris-CI (pH adjusted to, 7.5), 100 MM  MgC12, 100 MM 
DTT, 10 mM ATP. 
2.4.3.7 "Filling in" of recessed 3' termini 
Kienow DNA polymerase I was used to fill-in recessed 3'termini generated by 
various restriction endonucleases or some DNA polymerases. Reactions were 
performed in a final volume of 20-50 p.1 containing 1X buffer (supplied by the 
manufacturer). All four deoxyribonucleotides were present at a concentration of 20 mM 
each with 2 units of klenow DNA polymerase I. The reaction was incubated for 1 h at 
37°C and the unincorporated dNTPs removed by phenol/chloroform extraction (section 
2.4.3.1). The DNA was ethanol precipitated (section 2.4.2) and resuspended in a 
suitable volume of 1X TB (section 2.1.3). 
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2.4.3.8 Amplification of DNA using the polymerase chain reaction 
Usually 10-20 ng of circular plasmid DNA or up to 1 pg of genomic DNA were 
used as reaction templates. PCR was also done directly on yeast colonies simply by 
mixing the yeast cells with the reaction mix just prior starting the cycles. Transformant 
E. coli colonies were also screened by PCR: cells were boiled in 200-500 tl of sterile 
water for 5 min and 5-10 tl of the supernate was used as DNA template in a PCR 
reaction. 
Specific DNA oligonucleotide primers were obtained commercially (Table 8) and used 
at a concentration of 0.1-1 tM. Deoxyribonucleotides were present at a concentration 
of 1 mM and MgC12 at 2.5 mM-4 mM. A lOX DNA polymerase reaction stock buffer 
was supplied by the manufacturer and diluted to 1X concentration in the reaction mix. 
Pfu or VentR DNA polymerases were used when an accurate amplification of the DNA 
template was needed. Both enzymes possess a high-fidelity polymerase ability due to 
their 3'-5' proofreading exonuclease activity. Taq DNA polymerase was used when this 
high fidelity activity was not required. 
PCR reactions were carried out in a Hybaid TM Thermal Reactor or a PTClOOTM Hot 
Lid (Genetic Research Instrumentation Ltd) apparatus. The three-steps cycle reaction 
was programmed according to the length of the desired product and the appropriate 
melting temperature of the primer/template duplex. A typical program was containing 
the following steps: 
Step I: Double-stranded DNA was denatured by heating, usually for 2 min at 92-94 °C. 
Step II: Primers were annealed to their complementary sequences by briefly cooling 
down the temperature of the sample reaction. This annealing temperature depends on 
the length and the sequence of the primers. The following formula was used to estimate 
the annealing temperature of 20 bases long primers (or shorter) : T = 2(A+T) + 4(G+C), 
where A, T, G and C were the numbers of those bases in the oligonucleotide (Kidd et 
al. 1995). 
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Step III: Polymerisation occurred, the annealed primers were extended by the DNA 
polymerase. Usually a temperature between 70 and 75°C was used for this step. one 
minute polymerisation was utilised per Kb to be amplified. 
2.4.3.9 Labelling DNA fragments by random priming 
DNA fragments of cloned genes were radiolabelled by the random priming 
method of Feinberg and Vogelstein (1983, 1984). 
The DNA to be labelled was gel-purified as described in section 2.4.3.5. 50 ng to 100 
ng of this DNA was made up to a 35 p,1 volume with water, denatured by boiling for 5 
mm, then cooled down on ice. The random priming reaction was prepared as follows 
and incubated overnight at room-temperature: 
Oligo Labelling Buffer (OLB) 	 10 p,l 
BSA (20 mg/ml; Boehringer Mannheim) 	 2 p,l 
Icx-32P1 dCTP (10 mCi/mi) 	 3 p,l 
Denatured DNA in water 35 j.tl 
Kienow DNA Polymerase I 
	
2 units 
• OLB: consists of a 1:2.5:1.5 mixture of solutions A:B : C prepared as follows: 
Solution A: 18 p,1 -mercaptoethanol, 5 p,l of each 0.1 M dNTPs prepared in 1 ml 
solution 0. Stored at -20 °C. 
Solution B: 2 M Flepes buffer (pH adjusted to 6.6 with KOH). Stored at 4 °C. 
Solution C: Random hexadeoxyribonucleotides (Pharmacia) at 90 OD Units/ml in 
sterile water. Stored at -20 °C. 
Solution 0: 1.25 M Tris-HC1 pH 8.0, 0.125 M MgC12. Stored at 4°C. 
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Random primed DNA was separated from unincorporated nucleotides using a NAP-5 
gel filtration column (Pharmacia) according to the manufacturer's instructions. 
2.4.3.10 End-labelling of oligonucleotides 
Oligonucleotides were labelled in a 20 tl reaction at 37 °C for 45 min using New 
England Biolab T4 Polynucleotide Kinase as follows: 
Oligonucleotide 	 10 pmoles 
lox T4 PNK buffer (supplied by NEB) 	 2 t1 
h'-32P1 ATP (5 000 Ci/mmole, 10 mCi/mi) 	 2 tl 
T4 PNK 	 2 units 
The total volume was adjusted to 20 j.tl with water. 
Radiolabelled oligonucleotides were separated from unincorporated nucleotides using 
the gel filtration NAP-5 column (Pharmacia) according to the supplier's instructions. 
2.4.3.11 	Southern blotting 
DNA was digested with the desired restriction enzymes and electrophoresed 
through an agarose gel (sections 2.4.3.4). The gel was first immersed in denaturing 
buffer with gentle agitation for 30 mm, then transferred to neutralisation buffer for a 
further 30 mm. 
Transfer of DNA from agarose gels to nylon membranes 
Transfer of DNA fragments was as described by Southern (1975). HybondTM-N 
nylon membrane (Amersharn) and four sheets of Whatman 3MM paper were cut to the 
same size as the gel. One sheet of blotting paper was saturated with 20X SSC (section 
2.1.3) and placed over a clean glass plate, arranged so that it hung over the edge of the 
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plate with the ends of the paper in a plastic tray containing 20X SSC. The pre-treated 
gel was placed on top of the saturated Whatman 3MM paper and Saran wrap carefully 
placed on top of regions of the paper left uncovered by the gel to prevent unnecessary 
evaporation. The nylon membrane was placed on top of the gel, taking care to ensure 
no air bubbles formed between the gel and the membrane. The four sheets of pre-cut 
Whatman 3MM paper were saturated in 20X SSC and placed on top of the membrane, 
again taking care to prevent the formation of bubbles between the layers. On top of this, 
2-4 cm of dry paper towels were arranged, and the whole structure weighted to provide 
even pressure. Transfer was allowed to. take place overnight. Once the transfer was 
complete, the membrane was briefly rinsed in 20X SSC, blotted dry, and UV-irradiated 
in a Stratagene UV StratalinkerTM using the "autocrosslink" setting (1200 jtjoules, 254 
nm) to immobilise the DNA to the filter. 
Hybridisation of ran domly-labelled probes to nylon membranes 
Flybridisations were performed in Hybaid 'Hybridiser ovens' using an adaptation 
of the method of Church and Gilbert (1984). 
The nylon membrane was pre-hybridised in 20 ml of hybridization buffer for at least 3 
h at 60°C-65 0C to prevent non-specific hybridisation of the probe to the membrane. 
Fresh hybridization buffer was added to the membrane immediately before the addition 
of the radiolabelled probe. The labelled probe (section 2.4.3.9) was denatured by 
heating to 100°C for 5 min,then added to the hybridization buffer and the incubation 
continued overnight at 60°C (or lower temperature depending on the annealing 
temperature of the target DNA-prode hybrid); this hybridisation temperature was 
increased or decreased depending on the desired stringency conditions. The following 
morning the probe was decanted off and stored at —20°C for possible re-use. The 
membrane was then washed with washing buffer for 20 min at 60°C; this temperature 
was varied to suit the stringency required. This was repeated four times. The membrane 
was then blotted dry, placed between Saran wrap, and the result of the experiment 
visualised by autoradiography. 
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• Denaturing Buffer: 0.5 M NaOH, 1.5 M NaCl. 
• Neutralisation Buffer: 1.5 M NaCl, 0.5 M Tris-HC1 pH 7.5, 1 mM EDTA. 
• Hybridization buffer: 7% (w/v) SDS, 1 mM EDTA pH 8.0, 0.5 M Sodium 
phosphate buffer pH 7.2. 
• Washing buffer: 5% (w/v) SDS, 1 mM EDTA pH 8.0, 40 mM Sodium phosphate 
buffer pH 7.2. 
2.4.3.12 	Site directed mutagenesis 
The following mutagenesis technique was based on a method described by 
Kunkel (1987): The DNA sequence to be mutated was cloned into the phagemid vector 
pBluescript KS' (Table 9). The construct was transformed into the E. coli strain CJ236 
(Table 6). This strain was a double mutant duf ung bacterium and produces nascent 
DNA carrying a number of uracils in thymidine positions. Single-stranded copies of 
DNA were isolated from this transformed strain. A mutagenic oligonucleotide 
complementary to the region to be mutated was designed (Table 8) and hybridized 
(except for the altered region) to the single-strand copy of the plasmid DNA. A 
complementary strand was then synthesized by T4 DNA polymerase using the 
oligonucleotide as a primer. T4 DNA ligase was then used to seal the new strand to the 
5' end of the oligonucleotide. The double stranded DNA, containing a mismatch at the 
mutated sequence was transformed into E. coli strain DH5aF' (Table 6), resulting in 
two classes of progeny: The parental one (containing the wild-type DNA sequence and 
a number of uracils) and the mutated one (containing the mutated sequence and no 
uracils). Due to the wild-type uracil N-glycosylase activity of DH5aF', the parental 
uracil-containing strand was inactivated with high efficiency leaving the mutated strand 
to replicate and an enrichment for the cells carrying the mutated DNA. 
90 
Propagation of uracil-containing phagemids 
Competent CJ236 cells (Table 2.3) were transformed with phagemid DNA 
(pBluescript KS' containing the insert to be mutated; Table 9) as described (section 
2.3.2). An isolated colony of CJ236 containing the phagemid was used to inoculate 20 
ml of LB-Cm/Amp medium (section 2.1.2.1, Table 4) and the culture grown overnight 
with shaking at 37 °C. The following morning, 50 ml of YT-Amp medium (section 
2.1.2.1) was inoculated with 1 ml of the overnight culture and the cells grown at 37 °C 
with shaking. When 0D 600= 0.3 (this corresponds to approximately 1x10 7 cfu/ml, the 
helper phage M13K07 was added in the culture to obtain a M.O.I. of 20 phage/cell. The 
culture was incubated for an additional 1 h, then 70 tl of the 50 mg/ml kanamycin 
stock (Table 4) were added and the incubation continued for a further 4-6 h. 
Harvesting phagemid 
Cultures (30 ml) were transferred to a sterile 30 ml corex tube and the cells 
pelleted by centrifugation at 12000 rpm for 15 mm (4 °C; Beckman centrifuge JA 25-50 
rotor). The phagemid-containing supernate was transferred to a fresh corex tube and 
150 jxg RNase A were added, the contents were mixed by inversion and incubated at 
room temperature for 30 mm. A quarter volume of 3.5 M ammonium acetate/20% (w/v) 
PEG-6000 was added, the contents of the tube were mixed thoroughly and kept on ice 
for 30 mm. Phagemids were collected by centrifugation at 12000 rpm for 15 mm, the 
supernate discarded, the pellet drained well and resuspended in 200 p.1 of high salt 
buffer (300 mM NaCl, 100 mM Tris-HC1 pH 8.0, 1 mM EDTA). The prepared 
phagemid suspension was transferred to an Eppendorf tube and chilled on ice for 30 
mm. The suspension was centrifuged for 2 min and the phagemid-containing supernate 
transferred to a fresh Eppendorf tube. The phagemid DNA was either extracted 
immediately or stored as phagemid particle for up to one week at 4 °C. 
Titering phagemid stock 
Since the phagemids contain uracil in their DNA, they should survive far more 
readily in a bacterium missing an active uracil N-glycosylase (ung; 0236) than in one 
with an active enzyme such as DH5aF' 
91 
Cultures of CJ236 and DH5aF' were grown overnight at 37 °C in LB-medium (section 
2.1.2.1). The following morning, 50 ml of fresh LB-medium was inoculated with 1 ml 
of CJ236 culture or 0.5 ml DJ45aF' culture. These were incubated with shaking at 37 °C 
until 0D600 0.3 to 0.35; if one of the cultures reached this OD value before the other it 
was kept on ice. Once the desired OD was reached, 10 p.1 of uracil-containing phagemid 
stock was added and each culture incubated for a further 2 h at 37 °C. An aliquot of 
DH5aF' culture was diluted 10 and 100 fold, then 50 p.1 of each dilution and undiluted 
culture spread onto LB-Amp plates. An aliquot of CJ236 culture was diluted 103_' 1 04-, 
and 105  -fold  and 50 p.1 of each of those dilutions spread onto LB-Amp plates. The 
plates were incubated overnight at 37 °C. 
Extraction of the phagemid DNA 
DNA was recovered from the phagemid stock by successive extractions with 
phenol, phenol:chloroform and chloroform, followed by precipitation with ethanol in 
the presence of 0.1 volume of 7.8 M ammonium acetate. The DNA pellet was washed 
carefully with 70% (v/v) ethanol, dried and resuspended in 20 p.1 lx TE. 
Synthesis of the mutagenic strand 
Synthesis of the mutagenic strand was achieved by priming synthesis from the 
single-stranded uracil-containing DNA template with the oligonucleotide containing the 
sequence of the desired mutation (Table 8). This synthesis can be divided into three 
steps. 
Phosphorviation of mutagenic oligonucleotide. Up to 200 pmoles of mutagenic 
oligonucleotide was phosphorylated by preparing the following mix: 
200 pmole Mutagenic oligonucleotide 	 variable volume 
1 M Tris-Ci, pH 8.0 	 3 p.1 
0.2 M M9C12 	 1.5 p.1 
0.1MDTT 	 1.5p.i 
1mMATP 	 13 g 
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Sterile water 	 Adjusted to a final volume of 30 l 
To this mix 4.5 units of T4 Polynucleotide Kinase was added and the mixture incubated 
at 37°C for 45 mm. The reaction was stopped by heating at 65 °C for 10 mm. The 
phosphorylated oligo was diluted to 6 pmole/jtl with TE (section 2.1.3) and stored 
frozen. 
Annealing of mutagenic oligonucleotide to template DNA. The following reaction 
was prepared in an Eppendorf: 
10 pmole Mutagenic oligonucleotide 
0.2 jig Uracil-containing template DNA 
lox Annealing buffer 




Adjusted to a final volume of 10 p.! 
• lox Annealing buffer: 200 mM Tris-Cl pH 7.5, 20 MM  MgC12 500 mM NaC1. 
The mixture was incubated for 5 min at 70°C. The reaction was allowed to cool slowly 
to room temperature over 40-60 mm, then stored on ice. A control reaction containing 
all of the above ingredients but lacking the mutagenic primer was also set up to test for 
non-specific endogenous priming, caused by contaminating nucleic acids in the 
template preparation. 
Synthesis of the complementary strand. To the mixture prepared previously, 1 p.1 of 
lOX synthesis buffer, 3 units of T4 DNA ligase and 1 unit of T4 DNA polymerase were 
added. The reaction was incubated for 5 min on ice to stabilize the primer by initiation 
of DNA synthesis under conditions that favour binding of the primer to the template. 
The mixture was then incubated at 25 °C for 5 min and finally at 37 °C for 90 mm. After 
this time, 90 p.1 of stop buffer were added and the reaction stopped by freezing. This 
mixture can be kept at -20°C for at least one month. The successful production of 
circular double standed DNA can be analysed by agarose gel electrophoresis (section 
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2.4.3.4). A 9 j.il aliquot of each in vitro mutagenesis reaction (with and without primer 
added) were loaded on an agarose gel: The conversion of the single stranded DNA to a 
slower migrating double stranded form should be noticed only when the primer is 
added in the reaction mix. 
• lox Synthesis buffer: 4 mM each dNTPs, 7.5 mM ATP, 175 mM Tris-CI pH 7.4, 
37.5 MM  MgC12 , 5 mM DTT. 
Stop buffer: 10 mM Tris-CI pH 8.0, 10 mM EDTA. 
Transformation of the reaction mix into E. coli DH5ctF and screening for the 
mutated clones 
In vitro synthesised mutagenic double stranded DNA (5 tl) was used to 
transform 150 tl of competent DH5aF' cells (section 2.3.2). As a control another 
transformation was done using 3 tl of the no primer reaction. Plates were incubated at 
37°C overnight. Double-stranded DNA sequence analysis was used to identify the 
desired mutant clones (section 2. 4. 3. 13). 
2.4.3.13 DNA sequencing 
All sequencing reactions were carried out using the Sequenase Version 2.0 
sequencing kit (USB) according to the manufacturers' instructions. Templates for the 
reactions were either double-stranded DNA plasmid clones or single-stranded 
preparations of phagemid. 
Preparation of single-stranded plasmid DNA templates 
DH5aF' cells carrying the DNA of interest to be sequenced on a phagemid were 
grown at 37°C overnight to stationary phase in selective LB-medium (section 2.1.2.1). 
A phage-infected culture was prepared by adding 50 t1 of the overnight culture to 2 ml 
of LB-medium in a sterile 20 ml bijoux tube, growing the cells for 30 min at 37°C and 
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then adding one tenth of a suspension of M13K07 helper phage (lxlOil phi/ml). The 
infected culture was then incubated for 5-6 h at 37°C with constant vigorous agitation. 
1.5 ml of the infected culture were transferred to an Eppendorf and centrifuged for 5 
min at 4°C. 1 ml of the supernate was then transferred to a fresh Eppendorf and 200 p1 
of 20% PEG 8000 in 2.5 M NaC1 [prepared fresh from sterile 40% (wlv) PEG 8000 and 
5 "M NaCl solutions] was added, the solutions mixed by vortexing and incubated at 
room temperature for 15 mm. Bacteriophage particles were sedimented by 
centrifugation for 10 min at 4°C and the supemate discarded. The sample was briefly 
re-centrifuged, any residual supernate carefully removed and the pellet resuspended in 
100 p1 of 1X TE (pH 8.0). Single-stranded DNA was recovered from the phage-
suspension by successive extractions with phenol, phenol: chloroform and chloroform, 
and finally ethanol precipitated. The DNA pellet was washed in 70% (v/v) ethanol, 
dried and dissolved in 20 p1 of sterile water. 1 jig of single stranded DNA was used per 
sequencing reaction. 
Preparation of double-stranded plasmid DNA templates 
Plasmid DNA (3-5 jig; section 2.4.3.1) to be sequenced was dissolved in 
distilled water such that the total volume was 20 p1. The DNA was denatured by adding 
0.1 volume of [2 M NaOH, 2 mM EDTA] and incubated 30 min at 37°C. The 
denaturation reaction was neutralised by the addition of 0.1 volume of 3 M sodium 
acetate (pH 5.2), and the DNA precipitated with 2-4 volumes of 100% ethanol. The 
denatured DNA-template was recovered by centrifugation for 10 min at 4°C, the pellet 
washed with 70% (vlv) ethanol and dried. The DNA pellet was resuspended in 7 p1 of 
water and ready to be sequenced. 
Three steps (annealing template and primer, labelling reaction and termination reaction) 
were followed for DNA sequencing: 
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Primer annealing reaction 
Single- or double-stranded DNA (7 j.il) were mixed with 2 il of 5X Sequenase 
buffer (Sequenase Version 2.0 sequencing kit) and 1 1 of sequencing primer (1 pmole). 
This annealing mix was heated at 65 °C for 2 min then cooled down slowly to room 
temperature over 30-40 mm. The mixture was then centrifuged briefly and left on ice 
until used. 
Labelling reaction 
A labelling reaction mixture was set up in a separate Eppendorf as follows, 
adding the individual components in the following order: 




35s dATP (10 tCiflJ) 
	
0.5-1 pJ 
Sequenase Enzyme (diluted) 
	
2 j.il 
5-6 V d of this labelling reaction mix were added to the 10 p.l annealed template/primer 
reactions stored on ice, the solutions gently mixed then incubated at room temperature 
for 2-5 mm. 
The sequenase DNA polymerase was diluted eight-fold in glycerol enzyme dilution 
buffer (USB) just prior use. 
For standard sequencing reactions the dGTP labelling mix was 5-fold diluted in water, 
for sequencing reactions close to the primer this mix was 15-fold diluted. To read 
sequences close to the primer, Mn buffer (USB) was added in the labelling cocktail (1 
p.1 of 1 M stock solution) to emphasize bands close to the primer. 
Termination reaction 
For each template to be sequenced, four Eppendorf tubes were labelled 'A', 'C', 
'G' and 'T' respectively and 2.5 p.1 of each of the four ddNTP termination mixes were 
placed into the appropriately labelled Eppendorfs; these tubes were pre-incubated at 
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37°C until use. Termination reactions were initiated by adding 4.5 tl of the labelling 
reaction to each of the pre-warmed ddNTP mixes. The solutions were gently mixed, the 
Eppendorfs placed back at 37°C for 5 mm, then 4 p1 of Sequenase stop-solution (USB) 
was added to each Eppendorf. Reactions were stored at —20°C until required for 
electrophoresis. 
The sequencing reactions were heated at 85°C for 3 min immediately before loading 
onto a 6% (w/v) denaturing polyacrylamide gel (section 2.4.4.2). Gels were run at 33 
watts for 4-10 h then dried on a vacuum gel drier (Hybaid) at 80°C for 2 h. Sequence 
was visualised by autoradiography (section 2.2.2). 
2.4.4 Ribonucleic acid methods 
2.4.4.1 In vitro RNA transcription 
T7 and SP6 polymerase-directed in vitro transcription reactions were performed 
essentially as described by Yisraeli et al. (1989) and Milligan et al. (1989). Three 
different types of DNA templates were used to transcribe RNA molecules in vitro: 
- Plasmid DNAs (prepared according to the large scale cesium chloride preparation 
method described in section 2.4.3.1). For run-off transcription, plasmids were linearized 
by endonuclease digestion (section 2.4.3.2), phenol/chloroform extracted and ethanol 
precipitated. The DNA template was finally resuspended in water in a suitable volume 
to give a DNA concentration of 1 mg/ml. 
- PCR DNA templates (section 2.4.3.8): Primer oligos described in Table 8 were used 
in the PCR reaction. 
- DNA oligonucleotides containing at their 3' end the T7 promoter sequence: This oligo 
was annealed to the T7 primer (Table 8). The T7 transcription was initiated from this 
[primer-DNA oligo] hybrid. 
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Production of unlabelled RNA molecules 
Usually a 100 jil reaction was performed in order to produce a large quantity of 
RNA. This reaction was prepared as follows and incubated for 2 h at 37'C: 
lox Transcription buffer 	 10 jil 
iox rNTPs mix 	 10 jil 
DNA template 	 10 jig 
RNasin 	 3 p.1 
T7/SP6 RNA Polymerase 	 350 units 
Sterile water 	 To a final volume of 100 p.1 
When the transcription template was a DNA oligo, between 5 and 10 pmole of this 
oligo was mixed with 50-100 pmole of T7b primer (Table 8); other transcription 
components were added as indicated above. 
• lox T7 RNA polymerase-mediated transcription buffer: 400 mM Tris-Cl pH 7.5, 
20 mM spermidine, 100 mM DTT, 60 MM  MgCl2 100 mM NaCl. 
• iox SP6 RNA polymerase-mediated transcription buffer: 400 mM Tris-Cl pH 7.5, 
40 mM spermidine, 100 mM DTT, 100 MM  MgC12 100 mM NaCl. 
• i ox rNTPs mix: 10 mM each ATP, CTP, UTP and GTP in sterile water. 
The reaction was stopped by addition of 2 p.1 of 0.5 M EDTA. Phenol/chloroform (100 
p.1) was added to the reaction mix, after vortexing and centrifugation in a microfuge, the 
aqueous phase containing the RNA was extracted and transferred to a fresh Ependorf 
tube. The RNA was precipitated with ethanol, after centrifugation, the RNA pellet was 
resuspended in 20 p.1 of sterile water and 20 p.1 of 100% formamide loading dye was 
added. The sample was boiled for 5 min and loaded on an Acrylamide/LJrea/TBE gel 
(section 2.4.4.2). The RNA molecule was detected by UV-shadowing and isolated from 
the abortive initiation products according to the method described in section 2.4.4.3. 
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Production of 32  P-radiolabelled RNA molecules 
The commonly 32P-radiolabelled RNA molecules were the substrate pre-mRNA 
and the U6 snRNA. Those RNA molecules were produced with a different specific 
activity because of their different use. 
Transcription ofP-radiolabelledpre-mRNA: When the substrate was prepared for 
subsequent in vitro splicing reaction (section 2.6.2), a 10 tl reaction was set-up in a 
sterile Eppendorf tube and incubated for 30 min at 37 0C. The following components 
were present: 
DNA Template 
lox T7or SP6-Transcription buffer 
RNasin 
10 mM each ATP, CTP and GTP in sterile water 
250 gM cold UTP 
T7 or SP6 RNA polymerase 









To a final volume of 10 d 
Typically the DNA template used was the actin gene cloned in the plasmid p283 (Table 
2.6), linearized with the BamHI restriction enzyme. The RP51 pre-mRNA was also 
transcribed and was linearized either with BamHI to produce a pre-mRNA with a 100 
nucleotides long poly(A) tail, or linearized with EcoRI endonuclease to produce a pre-
mRNA lacking this poly(A) tail. 
RNA molecules produced according to the recipe described above possessed a specific 
activity of 230 Ci/mmole. 
Susbtrates prepared for UV-crosslinking experiments (section 2.7) required a higher 
specific activity, therefore only 20 pmole of cold UTP were added instead of 125 pmole 
recommended in the given protocol. This lead to the transcription of a pre-mRNA with 
a specific activity of 570 Ci/mmole. 
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Following transcription, an equal volume of 100% formamide loading dye was added 
(section 2.4.4.3). The sample was boiled for 5 min and then loaded on an 
Acrylamide/UreaJTBE gel. The radiolabelled U6 snRNA was detected by 
autoradiography (section 2.2.2) and subsequently gel purified according to the method 
described in section 2.4.4.3. 
Transcription ofP-radiolabelled-U6 snRNA: This snRNA was subsequently used 
for reconstitution and UV-crosslinking reactions (sections 2.6.2.3 and 2.7), therefore a 
high specific activity-containing RNA was needed. The following reaction mixture was 
prepared in a sterile Eppendorf tube and incubated for 1 h at 37'C: 
U6 DNA Template 
lox T7-Transcription buffer 
RNasin 
10 mM each UTP, CTP and GTP in sterile water 
100 pMATP 
T7 RNA polymerase 








Sterile water 	 To a final volume of 10 p1 
The wild-type U6 snRNA gene template was provided by the plasmid pUC 12U6 (Table 
9), linearized with the Dral restriction enzyme. Mutated U6 snRNAs were also 
produced using template DNA plasmids pU6C48A, U6A5 lU, U6A59U and U6G60C 
(Table 9) Dral digested. Shorter U6 snIRNA molecules (lacking 17 nucleotides at the 3' 
end of the wild-type sequence) were transcribed using as DNA template the pUC 1 2U6 
plasmid digested with FokI restriction enzyme. The U6-ribozyme was transcribed from 
pU6ribo linearized with EcoPJ. 
Although the transcription recipe given was for a 10 p.1 reaction, it was usually scaled-
up in order to produce the larger quantities of U6 snRNA necessary for several U6 
snRNP reconstitution reactions (section 2.6.2.3). The transcribed U6 snRNA possesses 
a specific activity of 330 Ci/mmole. 
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Following transcription, an equal volume of 100% formamide loading dye was added 
(section 2.4.4.3). The sample was boiled for 5 min and then loaded on a 8% 
Acrylamide/UreaITBE gel. The radiolabelled U6 snRNA was detected by 
autoradiography (section 2.2.2) and subsequently gel purified according to the method 
described in section 2.4.4.3. 
2.4.4.2 Acrylamide gel electrophoresis of RNA 
Six or eight percent acrylamide/8M urea/1X TBE gels were prepared by mixing 
ready to use Ultrapure sequagel solutions, "Complete Buffer Reagent" and APS in a 
volume recommended by the manufacturer. For other percentages of acrylamide gels, a 
40% (w/v) acrylamide/2. 1 % (w/v) bisacrylamide stock solution was diluted according 
to the final percentage required and mixed with powder urea and lox TBE to finally 
obtain an acrylamide/8M urea/IX TBE solution. APS and TEMED were then added to 
a final concentration of 1.25 % (w/v) and 0.08% (w/v) respectively. 
- Acrylamide gel electrophoresis was performed using a I  TBE buffer (section 2.1.3). 
- Before loading the acrylamide/ureaJTBE gel, RNA samples were boiled for 5 min in 
100% formamide loading dye. 
• 100% Formamide loading dye: 40 mM EDTA, 0.3% (wlv) xylene cyanol, 0.3% 
(w/v) Bromophenol blue, 93% (v/v) deionised formamide. 
2.4.4.3 SnRNA blotting 
Co-immunoprecipitated snRNAs were prepared as indicated in section 2.9 and 
loaded on a 6% UreaJTBE/Acrylamide gel (section 2.4.4.2) using the glass plates 'Base-
Runner System', assembled as instructed by the manufacturer (IBI, Kodak). As a 
control, a total yeast RNA sample was prepared by treating 5 jil of yeast extract with 
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proteinase K (sections 2.9 and 2.7.1). The total RNAs were extracted with 
phenol/chloroform and precipitated with ethanol. The RNA pellet was resuspended in 5 
.il of water and an equal volume of 100% formamide loading dye was added (section 
2.4.4.2). After boiling the sample was loaded along with the co-precipitated snRNAs on 
the denaturing polyacrylamide gel. The gel was run at 33 watts until the bromophenol 
blue dye was 2 cm from the bottom of a plate of 43 cm height. The gel system was 
disassembled and the glass plates separated. The top seven centimetres of the gel, 
containing the Ui and U2 snRNAs, was cut and the RNA electrophoretically 
transferred on to a Hybond-N nylon membrane (Amersham). From the remaining 
gel, the next 16 cm were cut and transferred to a nylon membrane: This contains the 
U4, U5 and U6 snRNAs. The RNA transfer was achieved by using the same procedure 
as indicated in section 2.5.5, except that the transfer buffer used was a 0.5X TBE 
solution and the transfer was performed at 60 volts for 1 h. 
Once the transfer was complete, the nucleic acids were immobilised on the membrane 
by UV-irradiation of the filter in a Stratagene UV StratalinkerTM using the 
"autocrosslink" setting (1200 joules, 254 nn). 
SnRNA hybridisation 
Hybridisations were performed in Hybaid 'Hybridiser ovens' using an adaptation 
of the method of Church and Gilbert (1984): The nylon membrane was pre-hybridised 
in 20 ml of SES 1 Buffer for at least 3 h at 65°C to prevent non-specific hybridisation of 
the probe to the membrane. Fresh SES1 buffer was added to the membrane and also the 
radiolabelled probe. The labelled probes consist of DNA oligos complementary to Ui, 
U2, U4, US and U6 snRNAs (Table 8), 32P-end labelled according to the method 
indicated in section 2.4.3.10. The hybridisation temperature was adjusted to 5°C below 
the melting temperature of the oligonucleotide/snRNA hybrid. The hybridisation was 
carried for at least 6 h, then the hybridisation solution was poured off and stored at - 
20°C for possible re-use. Filters were washed three times for 30 mill with fresh 20 ml of 
SES2 buffer each time. Usually the washing temperature was the same as the 
hybridization one. The radioactive activity of the filter was checked by monitoring it 
with a Geiger counter, and extra washes were carried out if too much radioactive 
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background was detected. The radioactive background was kept as low as possible. 
Finally, the membrane was placed between Saran wrap avoiding any air bubbles, and 
the result of the experiment visualised by autoradiography (section 2.2.2). 
• SES1 buffer: 7% (w/v) SIDS, 1 mM EDTA pH 8.0, 0.5 M Sodium phosphate buffer 
pH 7.2. 
• SES2.buffer: 5% (w/v) SIDS, 1mM EDTA pH 8.0, 0.5 M Sodium phosphate buffer 
pH7.2. 
Membrane stripping for reprobing 
For successful removal of probes, membranes were never allowed to dry during 
or after hybridisation and washing. A boiling solution of 0.1% (w/v) SDS was poured 
onto the HybondTM-N nylon membrane to be stripped and allowed to cool to room 
temperature. The membrane was blotted dry and stored between Saran wrap for future 
use. 
2.4.4.4 Isolation and purification of RNA molecules from acrylamide gel 
RNA molecules were resolved on an Acrylamide/UreaITBE denaturing gel 
(section 2.4.4.1) and visualised either by UV-shadowing or detected by 
autoradiography when 32P-radiolabelled. The located band was cut out with a sterile 
razor blade, and depending on the RNA molecule size to be isolated two different 
methods of purification were followed: 
For short RNA molecules (below 35 bp) 
The RNA was passively eluted from the gel slice by incubating overnight at 4 °C 
in 400 il elution buffer. The following day the elution buffer containing the eluted 
RNA was transferred in a fresh sterile Eppendorf tube. The RNA was 
phenol: chloroform extracted and ethanol precipitated (section 2.4.3). The RNA pellet 
was resuspended in a suitable volume of water. The concentration was estimated by 
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spectrophotometry (section 2.4. 1) or by Cerenkov counting (section 2.2.3) for a 
radiolabelled molecule. 
• Passive elution buffer: 0.5 M NaOAc (1H 5.2), 1 mM EDTA, 2.5% (v/v) 
phenol: chloroform. 
For long RNA molecules (above 35 bp) 
The gel slice was transferred to a Centrilutor tube (Amicon) and the tube 
inserted in the sample reservoir of the Centricon concentrator C-10, C-30 or C-100 
(Amicon) depending of the length of the RNA to be purified. The Centricon 
concentrator and the Centrilutor tube were assembled in a Micro-electroeluter (Amicon) 
apparatus and the electroelution chambers were filled with electroelution buffer. The 
RNA was electroeluted at 200 Volts for 1 h, then the electroelution system was 
disassembled and the Centrilutor tube removed from the Centricon concentrator. The 
electroelution buffer retained in the sample concentrator reservoir was concentrated by 
centrifugation according to the manufacturers'instructions. Finally, to the concentrated 
retentate, an equal volume of phenol: chloroform was added. After vortexing and 
centrifugation in a microfuge, the aqueous phase containing the RNA was extracted and 
transferred to a fresh Ependorf tube. The RNA was precipitated with ethanol, after 
centrifugation, the RNA pellet was resuspended in a suitable volume of water. The 
RNA concentration was estimated either by spectrophotometry (section 2.4. 1) or by 
Cerenkov counting (section 2.2.3). 
• Centricon concentrators C-10, C-30 and C-100 differ by the molecular weight cut-
off of the polycarbonate membrane used to retain the molecules. This cut-off was 
respectively 30, 60 and 125 nucleotides long RNA molecules. 




RNA Electroelution Diagram. 
Micro-electroelution apparatus 
2.4.4.5 Site specific incorporation in RNA molecule of photoactivatable 32P-UpG or 
32P-4thioUpG 
The method used was described by Sontheimer (1994) and Newman et a! 
(1995). Three steps were involved for the preparation of such RNA molecules: 
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Production of the RNA moieties 
The RNA molecule to be radiolabelled was constructed from two halves split at 
the site of the 4-thioU incorporation. This site lies obligatorily within a UG 
dinucleotide. The 5' and 3' halves were transcribed from a PCR product containing at 
its 5' end the T7 RNA polymerase promoter region or, for the synthesis of short RNA 
molecules (< 40 nucleotides), the transcription was initiated from a T7 primer annealed 
to a DNA oligo template. 4-thioUpG or UpG were used to prime the transcription of the 
3' half. 
Ligation 
• Bridging oligo 
Site specifically radiolabelled RNAs 
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Two transciption recipes were followed whether the 5' or the 3' half were produced: 
Production of the 5' half The transcription was performed in a 250 l reaction and 
incubated for 2 h at 37°C. The reaction was prepared as follows: 
lox Transcription buffer 
100 MM  MgC12 
30% (w/v) PEG 8000 
DNA template 
10 mM each rNTPs 
RNasin 









to a final volume of 250 p1 
• lox Transcription buffer: 400 mM Tris-CI pH 7.5, 10 mM spermidine, 50 mM 
DTT, 0.1% (v/v) Triton X- 100. 
The transcription reaction was stopped by adding 25 p1 of 0.5 M EDTA. 
Phenol/chloroform (250p1) was added to the reaction mix, after vortexing and spin in a 
microfuge, the aqueous phase containing the RNA was extracted and transferred to a 
fresh Ependorf tube. RNA was precipitated with ethanol. The RNA pellet was 
resuspended in 15 p1 water and an equal volume of 100% formamide loading dye was 
added. The RNA sample was boiled for 5 min and loaded on a denaturing acrylamide 
gel. The transcribed RNA was detected by UV-shadowing and purified according to the 
technique described in section 2.4.4.3. 
Production of the 3' ha/ The transcription was performed in a 50 tl reaction and 
incubated for 2 h at 37°C. The reaction was prepared as follows: 
5X Transcription buffer 	 10 p1 
DNA template 	 7 pg 
5X rNTPs mix 	 10 p1 
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RNasin 	 2 jil 
T7 RNA polymerase 	 300 units 
50 mM 4-thioUpG or 50 mM UpG 	 4 jil 
Sterile water 	 to a final volume of 50 .il 
• 5X Transcription buffer: 200 mM Tris-Ci pH 7.5, 10 mM spermidine, 50 mM DTT, 
100 MM  MgCl2 . 
• 5X rNTPs mix: 5 mM each ATP, CTP and UTP, 2.5 mM GTP. 
Typically one transcription reaction was prepared with 4-thioUpG and another one with 
UpG. The RNA produced with UpG was subsequently used as a control in UV-
crosslinking experiments (section 2.7), the UpG being non-photoactivable should not 
give any UV-crosslinking signal. 
The transcription reaction was stopped by adding 12.5 tl of 0.5 M EDTA. 
Phenol/chloroform (50 j.il) was added to the reaction mix, after vortexing and spin in a 
microfuge, the aqueous phase containing the RNA was extracted and transferred to a 
fresh Ependorf tube. RNA was precipitated with ethanol. The RNA pellet was 
resuspended in 15 p1 water and an equal volume of 100% formamide loading dye was 
added. The RNA sample was boiled for 5 min and loaded on a denaturing acrylamide 
gel. The RNA was visualized by UV-shadowing and purified according to the 
technique described in section 2.4.4.3. 
5' labelling of the 3' half RNA moiety 
The 3' half-transcript was 5' phosphorylated in order to serve as a donor in the 
ligation reaction. The incorporation at this site of a 32P allows incorporation of a single 
label within the RNA immediately adjacent of the site of crosslinking (the 4-thioU or 
the U residue). 
The labelling reaction was prepared as follows and incubated for 30 min at 37 0C: 
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50 pmole of 3 1 half transcript 
32P-yATP (5000 Cilmmole, 10 pCiJ.t1) 
12 JIM ATP 
RNasin 
lox pRNA cocktail 








to a final volume of 30 .il 
• lox pRNA cocktail: 500 mM Tris-Cl pH 8.0, 100 MM  MgC12, 50 mM DTT. 
2 p1 of 0.5 M EDTA were added to stop the reaction and Phenol/chloroform (30 tl) 
was added to the reaction mix. After vortexing and spin in a microfuge, the aqueous 
phase containing the RNA, was extracted and transferred to a fresh Ependorf tube. 
RNA was precipitated with ethanol and pelleted by centrifugation at 4 °C for 15 mm. 
Ligation of the two half-transcripts 
This ligation was mediated by a bridging DNA oligo complementary with the 
last 15-20 nucleotides of the 5' RNA half and with the first 15-20 nucleotides of the 3' 
RNA half (including the uridine or 4-thiouridine at the S'extremity). The RNA ligation 
was mediated by a highly concentrated T4 DNA ligase. The protocol was applied as 
follows: 
To the 32P-3'half RNA pellet, 100 pmole of the 5' half was added and the volume 
adjusted to 10 p1 with sterile water. To this RNA solution were added: 
lox pRNA cocktail 	 1.2 p1 
1OmMATP 
50 mM Bridging oligo 	 2 p1 
The mixture was boiled for 2 min at 90 °C, then left to cool to room temperature over a 
period of 15 mm. The following compounds were then added: 
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Ligase buffer 	 1 jil 
0.4MDTT 	 lp.l 
RNasin 	 1 j.il 
Highly concentrated T4 DNA ligase (2000 units/pt) 	 2 p1 
• lox Ligase buffer: 500 mM Tris-Ci pH 8.0, 10 mM ATP, 10 MM  MgC12, 1 pg/pl 
acetyl BSA. 
The ligation reaction was incubated for 90 min at 37 °C. An equal volume of 100% 
formamide loading dye was then added, the sample was boiled for 5 min and loaded on 
a denaturing acrylamide gel (section 2.4.4.2). The ligated product was detected by 
autoradiography (section 2.2.2) and purified according to the method described in 
section 2.4.4.3. 
2.5 Proteins Methods 
2.5.1 Quantification of total cellular protein 
Protein concentrations were determined by the Bradford method using Bio-Rad 
protein detection solution as instructed by the manufacturer. BSA was used as standard. 
2.5.2 Extraction of total cellular protein 
Small scale E. coli extracts 
E. coli cells were grown overnight at 37°C to saturation in the appropriate 
selective medium, typically LB-Amp (section 2.1.2.1). The following day, 50 p1 of the 
overnight culture was used to inoculate 5 ml of fresh LB-Amp medium and the culture 
incubated at 37°C until the optical density at 550 nm reached 0.4. The culture was 
chilled on ice for 15 mm, then 1 ml was transferred to an Eppendorf and the cells 
sedimented by centrifugation for 5 min at 4°C. The supernate was discarded, the cell 
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pellet resuspended in 100 p1 of water and an equal volume of 2X SDS-sample buffer 
was added. The cells were lysed by heating to 100°C for 5 mm. The lysate was 
centrifuged for 5 min to pellet cell debris, then 15-20 p1 of the lysate loaded onto a 
SDS-polyacrylamide gel (section 2.5.3). The remaining supernate was frozen in dry ice 
and stored at -70°C. 
Large scale E. coli extracts 
E. coli cells were grown overnight at 37°C to saturation in the appropriate 
selective medium, typically LB-Amp (section 2.1.2.1). The following day 100 p1 of the 
overnight culture was used to inoculate 100 ml of fresh LB-Amp medium and the 
culture incubated at 37°C until the optical density at 550 nm reached 0.4. The culture 
was chilled on ice for 15 min then transferred to centrifugation bottle and centrifuged 
for 5 min at 4°C (Beckman JLA-25-10 rotor). The supernate was discarded, the cell 
pellet resuspended in 7 ml of lysis buffer and an equal volume of 2X SDS-sample 
buffer was added. The cells were lysed by heating to 100°C for 5 mm. The lysate was 
centrifuged for 5 min to pellet cell debris. 15-20 p1 of the lysate was loaded onto a 1 
mm thick SDS-polyacrylamide gel (section 2.5.3) in order to check the protein content 
by coomassie staining (section 2.5.5). 0.5-1 ml of lysate was loaded on a 2 mm thick 
SDS-polyacrylamide gel for further purification of the protein of interest (section 
2.10.2). The remaining supernate was frozen in dry ice and stored at -70°C. 
• 2X SDS loading sample buffer: 125 mM Tris-Ci pH 6.8, 200 mM DTT, 4% (w/v) 
SDS, 40% (v/v) glycerol, 0.02% (w/v) Bromophenol blue dye. 
• Lysis buffer: 50 mM Tris-Ci pH 7.5, 5 mM EDTA. 
Yeast protein extracts 
Yeast cells were grown in 1 1 of rich or selective medium (section 2.1.2.3) such 
that at the time of harvesting cells the optical density at 600 nm was between 0.6 and 2. 
The culture was harvested by centrifugation for 5 min at 3000 rpm and the supemate 
discarded. The cell pellet was treated according to the yeast splicing extract preparation 
protocol (section 2.6.1). After the homogenisation step, the homogenate was 
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centrif'ugated for 30 min at 17000 rpm (Rotor JLA-25 Beckman) (4 °C). The supernate 
was harvested, aliquoted in Eppendorf tubes and snap frozen in dry ice. Samples were 
kept at -70°C for an indefinite time. 
For SDS-polyacrylamide gel electrophoresis, protein extracts (typically 100 p.g of total 
proteins) were mixed with an equal volume of 2X SDS-sample buffer (section 2.5.2) 
and the contents of the tube heated to 100°C for 5 min immediately prior to loading the 
gel. 
2.5.3 	SDS polyacrylamide gel electrophoresis (SDS-PAGE) 
Proteins were separated as described by Laemmli (1970). All SDS-
polyacrylamide gels were run using two 16 X 16 cm glass plates separated by either 1.5 
or 2.0 mm spacers; 14 well combs accommodating up to 40 p1 of sample, or single well 
combs for preparative gels were used. The resolving polyacrylamide gel solution was 
prepared following the recipe indicated in Table 5.1 and poured between the plates to a 
level of 4 cm from the top. The gel was layered with water-saturated butan-2-ol and 
allowed to polymerise at room temperature. After polymerisation the butan-2-ol was 
washed off with distilled water and a 4.8% polyacrylamide stacking gel (Table 11) 
poured on top of the resolving gel; the comb was inserted between the two plates, and 
the gel allowed to polymerise for at least 30 min at 37C. Prior to electrophoresis the 
seal was removed from the plates, the comb gently taken out of the gel and the wells 
washed with distilled water. The plates were firmly fixed in the 'ATTO' electrophoresis 
apparatus and the chambers filled with 1X protein gel running buffer. Samples were 
loaded onto the gel beside pre-stained molecular weight markers, and the gel then run at 
30 mA for the required time appropriate to the experiment or overnight at 8-10 mA. 
• lox Protein gel running buffer: 250 mM Tris-Base, 2.5 M glycine, 1% (w/v) SDS. 
• High Molecular Weight pre-stained protein standards: Size range of 33-180 or 6.5-
175 kD (Respectively obtained from Sigma and Biolabs). 
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• Low Molecular Weight pre-stained protein standards: Size range of 2.8-43 kD 
(Obtained from Gibco BRL). 
Table 11. SDS-Polyacrylamide gel electrophoresis recipe 
Components 	 RESOLVING GEL 	STACKING GEL 
	
6.0% 7.5% 8.5% 15% 	4.8% 
Water (ml) 
	
16.5 	15 	14 	7.5 
	
5.9 
30% Acrylamide (ml) 
	
6.0 	7.5 	8.5 	15.0 
	
1100 
4X Gel Buffer (ml) 
	
7.5 	7.5 	7.5 	7.5 
	
2.5 





27.5 	27.5 	27.5 	120 
	
10 
• 4X Resolving gel buffer: 1.5 M Tris-Cl pH 8.8,0.4% (w/v) SDS. 
• 4X Stacking gel buffer: 500 mM Tris-Cl pH 6.8,0.4% (w/v) SDS. 
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2.5.4 Native gel for spliceosome complexes resolution 
Two 16 X 16 cm glass plates separated by 1.5 mm spacers were taped together 
and prewarmed at 65°C. A blocking-gel was poured immediately and the gel-assembly 
left to stand at 65°C for 5 mm. A separating-gel was then poured on top of the 
blocking-gel up to the top of the plates and a 10 x 1.0 cm comb was inserted. The gel 
was allowed to polymerise at room temperature for 30 min then stored at 4°C until use. 
Non-denaturing gels were run at 4°C in pre-chilled 1X native gel running buffer at 80 
Volts for 10-12 h, or overnight at 40 Volts until the xylene blue dye front (section 
2.6.2.2) had reached the blocking gel. 
• Blocking Gel: 1 ml of 30% Acrylamide [30% (w/v) acrylamide:0.8% (w/v) bis-
acrylamide], 100 p1 of 0.5 M EDTA, 250 p1 of lox TB, sterile water to 5 ml. Then 50 
p.1 of 10% (w/v) APS and 20 p.1 TEMED were added to allow gel polymerisation. 
• Resolving Gel: 0.25 g agarose was dissolved in 40 ml sterile water and kept at 
65°C. In another container, 5 ml of 30% Acrylamide [30% (w/v) acrylamide:0.8% 
(w/v) bis-acrylamide], 1 ml of 0.5 M EDTA, 2.5 ml of lOX TB were added. The 
dissolved agarose was added to this mixture and the volume adjusted to 50 ml. 400 p.1 
of 10% (wlv) APS and 50 p.1 of TEMED was added and the gel poured immediately. 
• lOX Native gel running buffer: 5X TB, 100 mM EDTA pH 8.0. 
• lox TB: 1.2 M Tris, 400 m Boric acid. 
2.5.5 Coomassie blue staining of polyacrylamide gels 
100-500 ng of protein were detected,by using this method. After electrophoresis 
the polyacrylamide gel was transferred to a clean plastic container and stained by 
addition of 5 gel volumes of Coomassie Blue staining solution. The gel was soaked in 
this solution for at least 30 min at room temperature with gentle shaking then the 
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staining solution was removed and the gel destained by incubating in [25% (v/v) 
methanol/10% (v/v) acetic acid] at room temperature. The destaining baths were 
regularly changed in order to accelerate the destaining process. 
• Coomassie Blue staining solution: 0.25% (wlv) coomassie brilliant blue R250, 50% 
(v/v) methanol, 10% (v/v) acetic acid. 
2.5.6 Western blotting 
Following SDS-PAGE, proteins were electrophoretically transferred onto a 
polyvinylidene fluoride (PVDF) microporous membrane in a Trans-Blot Electroblotting 
Cell (Bio-Rad) with plate electrodes. Transferred proteins were visualized by Ponceau 
S (Sigma) staining, and the presence of the protein of interest detected using antibodies 
directed against this protein: 
Electrophoretic transfer ofproteins onto PVDF Immobion-P membrane 
Proteins were transferred electrophoretically onto Immobilon-P membrane 
(Millipore) using the Bio-Rad transfer system as instructed by the manufacturer. The 
gel was "sandwiched" as indicated in Figure 5. 1, extreme care was taken to ensure that 
there were no air bubbles between the gel and membrane. Transfers were performed at 
100 Volts using 1X western transfer buffer; for a time depending on the size of the 
proteins. For a 10-140 kD protein 30-60 min transfer was necessary; for a 140-220 kD 
protein 2-3 h were required. 
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Figure 11. Sandwich for the protein transfer. 
• lox Western transfer buffer: 1.5 M glycine, 200 m Iris-CI pH 8.3. 
Blotting procedure 
Non-specific protein interactions were blocked by incubating the membrane in 
5% (w/v) dry-milk or BSA (w/v) in 1X TBS (section 2.1.3) for 2 h at room temperature 
or overnight at 4°C. To this blotting solution, primary antibody was added at the 
appropriate dilution and incubated for further 2 h at room temperature. The membrane 
was then washed in IX TBS for 15 mm; this was repeated three times. Secondary 
antibody conjugated to alkaline phosphatase was diluted in 1X TBSI5% (w/v) dry-milk 
or BSA (w/v), added to the membrane and incubated for 1 h at room temperature. The 
membrane was washed thoroughly as before. Development of the membrane was 
achieved by exposing the membrane to alkaline phosphate substrates, NBT and BCIP 
according to the manufacturer's instructions. 
2.6 	In vitro splicing reaction 
2.6.1 	Yeast splicing extract preparation 
The method described was adapted from R.J. Lin et a! (1985). The splicing 
extract preparation required great care in order to avoid any RNase or protease 
contaminations, for this reason all the glass or plastic containers used were sterile. The 
dounce homogeniser used to homogenise cells was kept overnight in ethanol and then 
rinsed with water and finally with buffer A before use. A freshly grown yeast colony 
was used to inoculate the preculture, and a fresh preculture was used to inoculate the 
culture. The optical density (at 600 nm) at which the cells were collected varies from 1 
to 2.4; for the SC261 yeast strain an 0D 600=2.4 was preferred. 
The extract was prepared as follows 
Rich or selective medium (3 1) (section 2.1.2) were inoculated with a mid-
logarithmic phase culture of the selected yeast strain and the culture grown overnight at 
30'C. When the optical density at 600 rim was between 1 and 2.4 the cells were 
harvested by centrifugation for 5 min at 4000 rpm (Beckman JLA-10 500 rotor). The 
supemate was discarded, the cell pellet resuspended in 50 ml of 50 MM Potassium 
phosphate buffer pH 7.5 and transferred to a sterile 50 ml Falcon tube. Cells were 
pelleted by centrifugation for 5 min at 3000 rpm (Mistral 1000 centrifuge), the 
supemate discarded, and the pellet resuspended in 40 ml of lyticase buffer. The cell 
suspension was transferred to a 250 ml flask, 1 ml of a lyticase solution containing 
2500 units enzyme dissolved in water was added, and cell suspension incubated at 30°C 
for 40-60 min with continuous slow shaking until 70-80% of the cells had formed 
spheroplasts, as determined microscopically. Spheroplasts were harvested by 
centrifugation for 5 min at 2000 rpm (Mistral 1000 centrifuge). The supernate was 
discarded and the spheroplasts then washed once with 1.2 M sorbitol and once with ice-
cold SB-3 buffer; after each wash spheroplasts were gently resuspended using a sealed 
sterile pasteur pipette. After the final SB-3 wash the pellet was weighed, resuspended in 
approximately 1 mug of ice-cold Buffer A and transferred to a chilled Dounce 
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homogeniser. Spheroplasts were broken by 10-13 slow, rotating strokes of the tight 
fitting pestle; this was performed with the homogeniser maintained on ice. After 
homogenisation the lysate was transferred to a chilled, sterile 20 ml glass beaker, the 
volume of lysate measured and 119th  volume of cold 2 M KC1 added dropwise while 
stirring with a magnetic stirrer. The homogenate was continuously stirred for 30 min at 
4°C, then transferred to a chilled 15 ml polycarbonate tube and centrifuged for 15 mm 
at 17000 rpm at 4°C in a pre-cooled Beckman JLA 25-10 rotor. Without disturbing the 
lipid layer, the supernate was then transferred to a chilled UltraPlus polycarbonate tube 
(Nalgene), and centrifuged at 38000 rpm for 70 min at 4°C in a pre-cooled Ti-70 rotor 
using a chilled Beckman )(L-100 Ultracentrifuge. The final supernate was transferred to 
dialysis tubing (Visking size 1-8/32", 12-14 kD cut off) and dialysed against two 
changes of 1.5 1 of ice cold Buffer D at 4°C over a period of 3 h. Following dialysis the 
extract was transferred to chilled Eppendorfs, centrifuged for 10 min at 4°C to remove 
insoluble matter, then aliquoted into fresh Eppendorfs and frozen in dry ice. Extracts 
were stored for long periods at -70°C; repeated freeze-thawing was avoided by storing 
the extract in small volumes. 
• Lyticase buffer: 1.2 M Sorbitol, 50 mM Potassium phosphate buffer pH 7.5, 30 mM 
DTT. 
• SB-3 Buffer': 1.2 M Sorbitol, 50 mM Tris-HC1 pH 7.5, 10 MM  MgCl2, 3 mM 
DTT. 
• Buffer AW:  10 mM HEPES-KOH pH 7.9, 1.5 mlvi MgC12, 10 mlvi KC1, 0.5 mlvi 
DTT. 
• Buffer D": 20 mM HEPES-KOH pH 7.9, 0.2 mM EDTA, 0.5 mM DTT, 50 mM 
KCI, 20% (v/v) Glycerol. 
All solutions were prepared in advanced (without DTT), sterilised by autoclaving. DTT 
was added to the solution just prior use. 
+', prepared in advance and chilled overnight at 4°C. 
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For the preparation of splicing extracts from galactose induced yeast cells 
Yeast cells were grown in YMGlyLacCas medium (section 2.1.2.3) containing 
the required amino acids for growth (Table 5). When the culture reached an 0D 600=0.5-
1.0, sterile galactose solution was added to a final concentration of 2% (w/v). The cells 
were grown for an extra 5-6 h then harvested and the splicing extract prepared as 
indicated above. 
2.6.2 In vitro splicing assay 
2.6.2.1 In vitro splicing reaction and analysis of the splicing species on a denaturing 
gel 
The assay for the production of spliced RNA and splicing intermediates was 
performed essentially as described by Newman et al. (1985). In a sterile Eppendorf tube 
the following components were added: 
Splicing extract 4 p.1 
5X Splicing buffer 2 p.1 
30% (w/v) PEG 8000 1 p.1 
32P- pre-mRNA (20 000 cpm) 1 p.1 
Sterile water 2 j.il 
• 5X Splicing buffer: 12.5 MM  MgC12, 10 mM ATP, 300 mM potassium phosphate 
buffer pH 7.5. 
The mixture was incubated in a water bath at 24 °C for 25 mm, then stopped on ice. 
For analysis of the RNA products, 6 p.1 of proteinase K solution was added to the 
splicing mix and the contents incubated at 37 °C for 15 mm. Following this incubation, 
100 p.1 of splicing cocktail and an equal volume of phenol/chloroform were added. 
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After vortexing and centifugation, the aqueous phase containing the RNA was 
recovered and tranferred to a fresh Eppendorf tube. RNA was precipitated with ethanol. 
The RNA pellet was centrifuged, dried and resuspended in 1.5 p.1 of water. 2 p.1 of 
100% formamide loading dye was added, and the sample boiled for 5 mm. The 
prepared RNAs were loaded on a 6% denaturing polyacrylamide gel to allow resolution 
of the splicing species which were subsequently visualised by autoradiography (section 
2.2.2). 
• Proteinase K solution: 2 mglml proteinase K, 50 mM EDTA, 1% (w/v) SDS. 
• Splicing cocktail: 50 mM NaOAc pH 5.3, 1 mM EDTA, 0.1% (wlv) SDS, 25 p.g/ml 
E. coli tRNA. 
2.6.2.2 Analysis of spliceosome complexes on a native gel 
This method was described by Pikielny et al. (1986). For the analysis of 
splicing complexes, the splicing reaction was stopped on ice, mixed with an equal 
volume of Q Buffer and incubated on ice for 10 min and then loaded directly onto a 
non-denaturing polyacrylamide gel (section 2.5.4) using non-denaturing gel-loading 
buffer. 
• Q Buffer: 0.4 M KC1, 2 mM Magnesium acetate, 20 mM EDTA pH 8.0, 16 mM 
Tris-Cl pH 7.4, 2 mg/ml Yeast total RNA. 
• 4X Non-denaturing gel loading dye: 50% (v/v) glycerol, 2.5% (v/v) i OX TB, 50 
mM EDTA, 0.2% (w/v) bromophenol blue, 0.1% (w/v) xylene cyanol. 
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2.6.2.3 In vitro U6 snRNP reconstitution 
The method used was adapted from Fabrizio et al. (1989). This is a two step 
reaction. During the first step the endogenous U6 snRNA was depleted due to 
endogenous RNase H activity of the splicing extract: A DNA oligo complementary to 
the U6 snRNA sequence 28-54 (Oligos V4528 and S3324, Table 8) was added to the 
splicing extract and the endogenous RNase H activated by incubating the extract at 
300C. This enzyme will then degrade all RNA involved in a RNA-DNA duplex. At this 
stage the splicing extract had lost its ability to splice due to the lack of U6 snRNA. The 
second step involves reconstitution of the U6 snRNP and the recovery of the splicing 
activity of the treated extract. The U6 snRNP was reconstituted by addition of in vitro 
transcribed U6 snRNA (section 2.4.4.1). 32P-radiolabelled pre-mRNA was also added 
in order to monitor the recovery of splicing acivity of the extract. 
Depletion of the endogenous U6 snRNA 
In a sterile eppendorf the following components were present and incubated for 
35 min at 30°C: 
Splicing extract 	 4 tl 
30% (w/v) PEG 8000 	 1 jil 
5X Splicing buffer 	 2 j.il 
lox Knockout oligo 	 1 p.! 
Sterile water 	 1 p.1 
After incubation, sample were placed on ice. 
• Splicing buffer: 12.5 MM  MgCl2, 10 mM ATP, 300 mM Potassium phosphate 
buffer p1-I 7.5. 
• lox Knockout oligo: The concentration of this oligo stock varies from one extract 
to another. Preliminary experiments were done for each extract in order to determine 
the minimum amount of this oligo needed to deplete the endogenous U6 snRNA and 
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abolish the splicing activity of the extract. Typically a concentration of 1.1-1.4 [IM of 
this i OX oligo stock solution was required. 
U6 snRNP reconstitution 
The U6 snRNA produced by transcription in vitro was added at the same time 
as the radiolabelled substrate. The following components were added to the cooled 
sample and incubated for 25 min at 24°C: 
In vitro transcribed U6 snRNA 	 lp.1 
32P-pre-mRNA (20000 cpm) 1 jt1 
• The quantity of in vitro transcribed U6 snRNA added in the reconstitution reaction 
varies from 20 fmole to 1 pmole. This snRNA can be either unlabelled or 
radiolabelled. 
The reaction was stopped by placing the sample on ice. For the analysis of the splicing 
species, the sample was treated as indicated in section 2.6.2.1. For the detection of 
RNA-Protein interactions the sample was then submitted to UV irradiation as indicated 
in section 2.7. Depending on the purposes of the study, an, immunoprecipitation was 
carried out (section 2.8). 
2.6.2.4 Depletion of the endogenous US snRNA in a yeast splicing extract 
The depletion was done as described by O'Keefe et al. (1996). Splicing 
extracts were prepared from the Rok8 strain (Table 2.4) which contains as the only 
source of U5 snRNA a modified US snRNA containing 30 extra nucleotides inserted 
between nucleotides 85 and 86. With this additional sequence the modified US snRNA 
was then succeptible to RNase H degradation using knockout oligos Rok8L and Rok8L 
(Table 2.5). The depletion reaction was prepared as follows: 
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Rok8 Splicing extract 	 4.8 tl 
5X Splicing buffer 	 2 p1 
15X Rok8L and Rok8R Knockout oligos 	 0.7 jil 
Water 	 To final volume of 10 p1 
The mix was incubated at 34 °C for 30 min then placed on ice. 
• 1 5X Rok8L and Rok8R knockout oligo: each oligo was present at a concentration 
of 700 nM. 
2.6.2.5 Depletion of the endogenous U2 snRNA in a yeast splicing extract 
The depletion was done as described by McPheeters et al. (1989). Using the 
same principle and recipe as for the endogenous U6 snRNA depletion, a U2 snRNA 
knockout oligo SRU2 (Table 8) was added to the yeast splicing extract. SRU2 was 
present at a final concentration of 600 nM. In order to completely degrade the 
endogenous U2 snRNA, the amount of SRU2 oligo added is in excess compared to the 
minimal quantity required to deplete the endogenous U2 snRNA. 
2.7 	Protein-RNA UV-Crosslinking 
The sample to be crosslinked was placed in a pre-cooled microtiter plate 
(Greiner). 1[d of a 10 mg/ml E. coil t-RNA stock was added, the plate directly 
positioned under the UV-lamp bulb and kept on ice. 
For the UV-crosslinking of protein to 32P-RNA: Samples were exposed to a UV 
light with a wavelength of 254 nm for 25 mm (Stratagene UV StratalinkerTM) 
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For the UV-crosslinking of protein to 32P-RNA containing a photoactivatable 
4-thiouridine: Samples were exposed to a UV light with a wavelength of 365 nm for 5 
mm (UVP,inc; Model B-100AP). 
After the irradiation, samples were transferred to pre-cooled sterile Eppendorf tubes and 
were ready for subsequent experiments. 
2.8 Immunoprecipitation 
Antibodies (Table 10) were bound to pre-swollen protein A-Sepharose beads (8 
mg PAS per immunoprecipitation sample; Sigma) in NTN buffer for 2 h at room 
temperature. To PAS-bound antibodies, 200 tl of blocking solution was added and 
samples incubated for a further 1 h at room temperature. The PAS-bound antibodies 
were washed four times with NTN buffer and ready for use. 
To the sample to be immunoprecipitated, an equal volume of 2X IQ buffer was added 
and the volume was adjusted (if necessary) to 300 pi with 1X IQ buffer. Samples were 
incubated at 4°C with PAS-bound antibodies for 2 h with constant rotation. The 
antibody complexes were then washed four times with NTN, and once with NT (NTN 
without NP-40); the salt concentration of NTN was varied according to the stringency 
of the wash required. Depending on the purpose of the immunoprecipitation, the 
immunoprecipitate was treated with different methods: 
2.8.1 Immunoprecipitation of proteins 
Immunoprecipitated proteins were recovered from the PAS-bound antibodies by 
resuspending the PAS-matrix in 50 tl of 2X SDS-sample buffer (section 2.5.2), heating 
the sample to 100°C for 5 min then pelleting the matrix by centrifugation for 5 mm. The 
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protein-containing supernate was resolved on an SDS-polyacrylamide gel (section 
2.5.3). 
2.8.2 Immunoprecipitation of snRNAs 
Co-immunoprecipitated snRNAs were recovered from the PAS-bound 
antibodies by treatment with 50 .il of 2 mg/ml proteinase K (IP grade) for 30 min at 
37°C. Sterile water (100 jil) was added to the Eppendorf and the resulting mixture 
extracted once with an equal volume of phenol: chloroform. Approximately 200 p.1 of 
the aqueous phase was transferred to a fresh Eppendorf, a further 100 p.1 of splicing 
cocktail (section 2.7.2.1) was then added to the remaining solution and the extraction 
repeated. 1 j.il of 10 mg/ml E. coil tRNA solution and 0.1 volume of 3 M sodium 
acetate (pH 5.2) were added to the pooled aqueous phases and the RNA recovered by 
ethanol precipitation. The RNA pellet was dried, resuspended in 5 p.1 of sterile water 
and 5 p.1 of 100% formamide loading dye and then fractionated on a denaturing 
polyacrylamide gel (section 2.4.4.1). 
• NTN: 150 mM NaC1, 50 mM Tris-HC1 pH 7.5, 0.1% (v/v) NP-40. 
• Blocking solution: 100 jig/mi BSA, 100 p.g/ml glycogen, 100 p.g/ml E. co/i tRNA. 
• 2X IQ buffer: 300 mM NaCl, 5 MM  MgC12, 15 mM Hepes pH 7.5, 0.1% (v/v) NP-
40. 
• Proteinase K (IP Grade): 50 mM Tris-CI pH 7.5, 300 mM NaCl, 5 mM EDTA, 
1.5% (w/v) SDS, 2 mg/ml proteinase K. 
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2.9 Immunisation Procedure 
2.9.1 Expression of LacZ, trpE and GST fusion proteins 
Three expression systems were used to produce large amounts of fusion protein 
in bacteria. LacZ-gene fusions were generated using the pUR series of vectors (Rüther 
and MUller-Hill, 1983), trpE-gene fusions were constructed using pATH vectors 
(Koerner et al., 1990) and finally GST-gene fusions were constructed using pGEX-2T 
vector (Pharmacia). The gene of interest was subcloned into either a pUR, pATH or 
pGEX-2T vector to create an in-frame fusion with respectively the lacZ, trpE or GST 
open reading frame (ORF) (Table 9) 
2.9.1.1 Induction of lacZ fusion proteins 
E. coil cells (BMH71-1 8; Table 6) carrying the desired iacZ-gene fusion were 
grown overnight to saturation at 37°C in LB-Amp medium. The following morning, the 
culture was diluted by a factor of ten with fresh, pre-warmed LB-medium and the 
incubation continued with vigorous shaking at 37°C until 0D 550=0.4-0.7. IPTG was 
added to the culture to a final concentration of 0.2 mM-i mM and the culture then 
incubated at 37°C for a further 2-4 h. 
2.9.1.2 Induction of trpE fusion proteins 
Induction of trpE-fusion protein synthesis was performed as described by 
Koerner et al. (1990). E. coil cells (DH5aF'; Table 6) carrying the desired IrpE-gene 
fusion were grown overnight to saturation at 37°C in synthetic M9 medium 
supplemented with 20 tg/ml tryptophan. The following morning, the culture was 
diluted by a factor of ten with fresh, pre-warmed synthetic M9 medium lacking 
tryptophan, and incubation continued with vigorous shaking at 37°C for 1 h. 
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Indoleacrylic acid (IAA; 2 mg/ml in 95% ethanol) was added to a final concentration of 
0.01 mg/ml and the culture incubated at 37°C for a further 4 h. 
2.9.1.3 Induction of GST-fusion proteins 
Induction of GST-fusion protein synthesis was performed according to the 
manufacturer's instructions (Pharmacia). E. coli cells (DH5ctF'; Table 6) carrying the 
desired GST-gene fusion were grown overnight to saturation at 37°C in LB-Amp 
medium (Section 2.1.2.1). The following morning, the culture was diluted by a factor of 
ten with fresh, pre-warmed LB-Amp medium, and incubation continued with vigorous 
shaking at 37°C until 0D 600=1 -2. IPTG was added to a final concentration of 1 mM and 
the culture incubated at 37°C for additional 2-6 h. 
2.9.1.4 Induction of 6X histidine-fusion proteins 
Induction of 6X His-fusion protein synthesis was performed according to the 
manufacturer's instructions (Qiagen). E. coli cells (BMH71-18; Table 6) carrying the 
desired 6X His-gene fusion were grown overnight to saturation at 37°C in LB-Amp 
medium (Section 2.1.2.1). The following morning, the culture was diluted by a factor of 
ten with fresh, pre-warmed LB-Amp medium, and incubation continued with vigorous 
shaking at 37°C until 0D 600=1-2. IPTG was added to a final concentration of 1 mM and 
the culture incubated at 37°C for additional 2-6 h. 
The amount of inducing compound required to induce a high fusion protein expression 
varies. Preliminary experiments were done testing different amounts of inducing 
chemicals, induction times and growth temperatures in order to optimize the induction 
conditions. 
Induced cultures were harvested by centrifugation and processed according to the 
method described in section 2.5.2, depending on the purposes of the experiment. 
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2.9.2 Partial purification of fusion protein 
Large scale protein extracts prepared from E.coli cells overproducing fusion 
protein were fractionated on a preparative 2 mm thick 8% SDS-polyacrylamide gel 
(sections 2.5.2 and 2.5.3). The protein sample was run beside a pre-stained molecular 
weight and the gel run such as a good resolution of the fusion protein was obtained. 
Following electrophoresis, 0.5 cm strips were cut from either side of the 
polyacrylamide gel and briefly stained with Coomassie Blue (section 2.5.5) to locate 
the fusion protein, the remainder of the gel was kept at 4 °C wrapped in a plastic film 
with 3 ml of 1X protein gel running buffer. The stained strips were aligned with the 
remainder of the polyacrylamide gel and the band of interest excised. This gel slice was 
placed in dialysis tubing (Visking size 1-8/32", 12-14 kD cut off) and filled with 2-3 ml 
of 1X protein gel running buffer (section 2.5.2). The dialysis tubing was sealed, placed 
crosswise in a horizontal electrophoresis chamber containing lX protein gel running 
buffer, and the protein electroeluted from the gel slice for 3-4 h at 100 V. Following 
electroelution, the current was reversed for 1 min and the gel buffer removed from the 
dialysis tubing. The protein-containing buffer was placed in the sample reservoir of a 
Centricon centrifugal concentrator and concentrated according to the manufacturers' 
instructions. The concentrated fusion protein was aliquoted in sterile Eppendorf tubes 
and stored at -70°C. The fusion protein concentration was estimated by running several 
dilutions of the concentrate beside known quantities of BSA on an SDS-polyacrylamide 
gel. The gel was then Coomassie stained (section 2.5.2) and the fusion-protein 
concentration evaluated by comparison with the known BSA amounts present on the 
same gel. 
2.9.3 Immunisation of rabbits 
All experiments on live animals were performed in compliance with the 
"Cruelty to Animals Act" 1986 under licence 63181. New Zealand White female 
rabbits were used. 
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2.9.3.1 Immunisation 
For the initial immunisation, 150 jtg of partially purified fusion protein (section 
2.9.2) was diluted into sterile water to give a final volume of 500 91. An equal volume 
of Freund's Complete adjuvant (Sigma) was added and the compounds mixed by using 
a 2 ml syringe: an emulsion forms by vigorous, prolonged mixing. This was injected 
into the rabbit subcutaneously. All subsequent injections consisted of 100 ig of fusion 
protein mixed with Freund's Incomplete adjuvant. Immunisations were performed at 4-
6 weekly intervals, and a test bleed done 10 days after the injection. 
2.9.3.2 Bleeds 
Blood was collected from the rabbit prior to the first immunisation (pre-
immune) and 10-12 days after the fourth and all subsequent injections. 10 days after the 
final immunisation, when the immune response had reached a peak, the rabbit was 
anaesthetised with Sagatal, 100-150 ml of blood withdrawn directly from the heart and 
the rabbit killed with a further injection of Sagatal. 
2.9.4 Serum preparation and storage 
After collection the blood was allowed to clot at 4 °C overnight. The clot was 
then detached from the side of the container using a sterile Pasteur pipette, and serum 
aspirated from the container with the pasteur pipette avoiding disturbing the clot. The 
serum was separated from blood cells by centrifugation for 5 min at 2000 rpm, 
transferred to a fresh tube and aliquoted into Eppendorf tubes stored at -70°C. 
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2.9.5 Affinity purification of antibodies 
Crude lysate from E. coli overexpressing a fusion protein detected by the 
antibodies to be purified was loaded on a SDS polyacrylamide gel (section 2.5.3). The 
proteins were transferred onto a PVDF-immobilon-P membrane according to the 
transfer method described in section 2.5.5 and stained by ponceau staining (Sigma) 
according to the manufacturers' instructions. The band corresponding to the fusion 
protein was cut out and the membrane incubated for 2-4 h at room temperature in lx 
TBS/1% (w/v) BSA or 1% (w/v) low fat milk powder. After this incubation several 
dilutions of crude serum (between 1/100 and 1/300 dilution) were added to blotted 
membrane strips and left to bind to the membranes for 2-3 h at room temperature with 
gentle shaking. The strips were washed five time with 1X TBS/0.1% (v/v) NP-40 
solution (section 2.1.3) over a period of 1 h. Antibodies were eluted by incubating the 
membrane with 2 ml of elution solution for 5 mm, the eluate was recovered and 
immediately neutralized by the addition of 0.5 ml of 1 M Tris-Ci pH 7.5. A second 
elution was done using 2 ml of the elution solution and left to incubate for 10 mm, then 
the eluate was collected and neutralised as indicated previously. The two eluates were 
pooled and dialysed against three changes of 11 each of 1X TBS (section 2.1.3) at 4 °C 
over a period of 16-20 h. Affinity purified antibodies were stored at 4 °C in the presence 
of 0.1% (wlv) sodium azide. 
• Elution solution: 0.1 M glycine-HCL pH 2.5, 0.1% (w/v) BSA. 
2.9.6 Covalently coupling of antibodies to the Affi-Gel HZ matrix 
Affi-Gel HZ is an agarose support (purchased from Bio-Rad) which reacts with 
the aldehydes of oxidized carbohydrates to form stable, covalent hydrazone bonds. In 
order to covalently attach antibodies to the matrix, the heavy chain of the 
immunoglobulin G is oxidized with periodate. The antibodies are therefore attached to 
the agarose gel matrix by their Fc region which orientate the coupling to the support 
and improve the binding capacity of the Ab-agarose gel. The preparation of the 
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Preparation of Anti-Prp24 Antibodies as a Tool to Investigate 
Protein-U6 SnRNA Interactions in the U6 SnRNP 
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INTRODUCTION 
prp24-1 was originally identified as a temperature-sensitive yeast mutant which 
accumulates pre-mRNA at the non-permissive temperature (Vijayraghavan et al., 
1989). Mutations in the PRP24 gene were shown to suppress a cold-sensitive 
phenotype associated with the snrl4-GJ4C mutation (Shannon and Guthrie, 1991). The 
snrl4-G]4C mutant contains a G to C change at U4 snRNA position 14 within the 
region of interaction with U6 snRNA (stem II) which affects U411J6 snRNP stability. 
Further analysis indicated that Prp24p possesses three RNA-binding domains and it 
directly contacts the U6 snRNA in the U6 snRNP particle (Shannon et al., 1991; 
Jandrositz and Guthrie, 1995). In vitro binding assays demonstrated that Prp24p 
purified from E. coil can bind to the U6 snRNA at nucleotides 39-56 and to the U6 
snRNA at nucleotides 39-56 and 64-76 when U6 snRNA is base-paired with the U4 
snRNA (Ghetti et al., 1995). In yeast Prp24p interacts transiently with the U4 snRNA 
and the U6 snRNA promoting U4/LJ6 snRNP formation but it must leave this complex 
to allow completion of U4/U6 snRNA interaction (Shannon and Guthrie, 1991; 
Jandrositz and Guthrie, 1995). In addition, Prp24p in the free U6 snRNP promotes the 
reannealing of the U6 snRNA with the U4 snRNA freed from the disassembled 
spliceosomes, recycling the U4/U6 snRNP (Raghunathan and Guthrie, 1998). 
As an internal positive control in our UV-crosslinking studies, we wanted to show 
using anti-Prp24 antibodies that Prp24p contacted U6 snRNA. As no anti-Prp24 
antiserum was available in our laboratory, Prp24p was tagged with a FLAG epitope. 
The description of the cloning and the functional analysis of epitope-tagged Prp24p will 
be presented in this chapter. The generation of polyclonal anti-Prp24 antisera by 
immunising rabbits with Prp24p expressed in and purified from E. coli will be 
described. 
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3.1 Disruption of the PRP24 Gene in Saccharomyces cerevisiae 
The PRP24 gene was disrupted according to the method described by Baudin et 
al. (1993) (Figure 12, Panel A). For this purpose a disrupted version of the PRP24 gene 
was constructed which contains the HIS3 selectable marker and 34 and 28 nucleotides 
of homology with the 5' and the 3' ends respectively of PRP24 ORF. The HIS3 ORF 
was inserted in the opposite orientation to the PRP24 ORF to avoid any potential fusion 
with the remaining Prp24p-encoding sequence. Diploid yeast cells (DJY84; Table 7) 
were transformed (section 2.3.3) with the disrupted construct and selected for their 
histidine prototrophy. Yeast colonies containing a disrupted genomic copy of PRP24 
were identified by PCR (section 2.4.3.8) with oligodeoxynucleotides P5118 and P5117 
(Table 8) used as 5' and 3' primers respectively. A 982 bp DNA fragment was expected 
from the amplification of the wild-type copy of PRP24 while a 1030 bp DNA fragment 
was expected for the amplification of the disrupted copy. All nine transformants tested 
gave the correct PCR products. 
One diploid (YVDP24; Table 7) harboring a disrupted copy of PRP24 was sporulated 
and twenty tetrads were dissected (section 2.3.4). Only two spores were viable, and 
neither of these contained the HIS3 marker used for the disruption, demonstrating that a 
lethal phenotype was associated with PRP24 gene disruption. 
PRP24 gene disruption was confirmed by Southern blotting analysis (section 2.4.3.11) 
(Figure 12; Panel B). The genome analysis of haploid cells obtained from the 
germination of the two viable spores demonstrated that both possessed a wild-type copy 
of the PRP24 gene. 
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Figure 12. Disruption of the PRP24 gene in yeast. 
Construction of a disrupted prp24: :HIS3 allele. This construct was 
generated by PCR (section 2.4.3.8) carried out on YIP1 plasmid DNA 
containing the HJS3 gene (Table 9). Oligodeoxynucleotides P0052 and P0053 
(Table 8) were used as 5' and 3' primers respectively. The amplified DNA 
fragment possesses the HIS3 sequence and 34 nt and 28 nt homology with the 
5' and the 3' ends respectively of PRP24 ORF. 
Southern blotting analysis. Genomic DNA was prepared (section 2.4.3.2) 
from diploid yeast strain DJY84 (Table 7) (lane 1) and strain YVDP24 (shown 
by PCR analysis to contain a disrupted genomic copy of PRP24) (lane 2). 
Genomic DNA was also prepared from the two viable haploid cells obtained 
after sporulation of YVDP24 and tetrad dissection (lanes 3 and 4). Genomic 
DNA preparations were completely digested with XbaI and BglI restriction 
enzymes and DNA fragments were resolved on an agarose gel then transferred 
to a Nylon membrane (section 2.4.4.3). The probe used to detect PRP24 gene 
was amplified by PCR from YCpXba plasmid (Table 9) using 
oligodeoxynucleotides JMB1O and JMB1 1 (Table 8) as primers. This probe 
annealed to the last 369 bp of PRP24 ORF and to 396 bp of the downstream 
sequence and was radiolabelled by random priming (section 2.4.3.9). A DNA 
fragment of 3.5 kb was expected for the detection of the wild-type PRP24 
gene, while a 1.3 kb fragment was expected for the detection of the disrupted 
allele. 
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Southern blot analysis 
3.2 Cloning of the Gene Encoding the FLAG Epitope-Prp24 Fusion 
Protein 
Prp24p was tagged with the FLAG epitope (Kodak, IBI FLAG system) which is 
a highly hydrophilic octapeptide (N terminus-D-Y-K-D-D-D-D-K-) against which 
mouse monoclonal antibodies are commercially available (Kodak). It was hoped that 
the insertion of the FLAG epitope at the C-terminus of Prp24p would not interfere with 
its function. The cloning strategy to fuse the FLAG-epitope DNA sequence to the 
PRP24 gene is described in Figure 13. The PRP24 gene sequence was communicated 
by A. Ghetti (laboratory of J. Abelson, Cal. Tech) (Annex I), and the YCpXba plasmid 
(CEN-URA3-PRP24; Table 9) was provided by P. Raghunathan (laboratory of C. 
Guthrie, UCSF). YCpXba contains a 3.5 kb insert including the PRP24 ORF and 
flanking sequences (Shannon et al., 1991). Sequence analysis indicated that the fusion 
between the PRP24 ORF and the FLAG encoding sequence in the YRFL24 construct 
(Figure 13) was correct. The functionality of the tagged Prp24p was tested by 
complementation of a lethal phenotype associated with PRP24 disruption. For this 
purpose, the diploid yeast strain YVDP24 (prp24: :HIS3/PRP24; Table 7) was 
transformed (section 2.3.3) with the plasmid YRFL24. The selected transformants were 
sporulated (section 2.3.4), tetrads dissected and grown on YPDA agar (section 2.1.2.3). 
For each tetrad dissected, only two spores grew out of four, the analysis of their 
genotype showed that the viable cells contained a wild-type copy of the PRP24 gene. 
No rescue of the PRP24 null allele was obtained with the plasmid YRFL24. Several 
explanations can be proposed: 
No transcription termination sequence was present at the 3' end of PRP24-FLAG 
ORF. Therefore the mRNA may be incorrectly processed at its 3' end and consequently 
made unstable. This would result in fusion protein not being produced. 
Although the sequence of the PRP24-FLAG junction was correct, the high fidelity 
pfu polymerase used to amplify the 3' half of PRP24 ORF (Figure 13) may have 
inserted mutation(s) responsible for the lack of function of the epitope tagged Prp24p. 
The addition of 15 extra amino acids at the C-terminus of Prp24p may have affected 
the function of the fusion protein. Raghunathan et al. (1997), have inserted at the C- 
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Figure 13. Cloning strategy followed to fuse the FLAG epitope-encoding 
sequence downstream of the PRP24 ORF. 
The fusion protein is tagged at its C-terminus with 15 amino acids. 
B, BainHI; C, ClaI; H, Hindu!; K, KnpI; P, PstI; S, Sail; crossed S, lost Sail site; 
Sm, Sma!; X, XbaI; Xo, XhoI. 
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terminus of Prp24p three Hemagglutinin (HA) epitopes (27 amino acids) and found that 
although the fusion protein was functional, it caused a detrimental effect on cell growth 
and on the stability of the U6 snRNA (Raghunathan, personnal communication). These 
data suggest that Prp24p may not tolerate very well extra amino acids at its C-terminus. 
If the lack of function of the Prp24-FLAG fusion protein was due to the presence of the 
FLAG epitope, the chemical nature of the 15 amino acids added rather than their 
number was more likely to be reponsible for this dramatic effect. 
3.3 Production of Anti-Prp24 Antisera from Rabbits 
3.3.1 	Expression of the PRP24 gene in E.coli 
Four different expression systems were tested for the producion of high amounts 
of Prp24p in E. coil cells. For this purpose three plasmids (pATP24, pGEX24, 
pGAP24, pIP24) derived from pATH3, pGEX-2T, pUR288 and pQE-30 respectively 
were constructed and the cloning strategy followed is described in Figure 14 
Production of anthranilate synthase-Prp24 fusion protein with pATP24: the sequence 
analysis showed that the PRP24 ORF amplified by PCR from yeast genomic DNA and 
cloned into the pATH3 vector was identical to that contained in the plasmid YCpXba 
(Table 9). DH5aF' (pATP24) E. coli cells (Table 6) were induced for the production of 
the anthranilate-Prp24 fusion protein by addition of indoleacrylic acid (IAA) (section 
2.9.1). The production of the fusion protein (87 kD) was confirmed by Coomassie blue 
staining of proteins after fractionation on an SDS-PAGE gel (data not shown). In 
addition to the trpE-Prp24 protein, numerous unrelated polypeptides of similar size 
were concomitantly produced and interfered with the partial purification of the fusion 
protein (section 2.9.2), preventing its utilization to raise antibodies from rabbits. 
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Figure 14. Cloning strategy followed to construct pATP24, pGEX24, 
pGAP24 and pIP24 plasmids. 
For ATP24: the PRP24 ORF was amplified by PCR with the pfu polymerase 
using genomic yeast DNA prepared from the wild-type DJY84 strain (Table 7) 
as template. Oligodeoxynucleotides S8948 and S8949 (Table 8) were utilized 
as primers. The resulting PCR product possessed the entire PRP24 ORF 
lacking any flanking sequence and two restriction sites were engineered at 
each extremity (BamHI at the 5' end and XbaI at the 3' end). After BamHI and 
XbaI digestion the amplified DNA was cloned in frame between the BamHI 
and XbaI restriction sites of the trpE-expression vector (pATH3; Koerner et 
al., 1990). The PRP24 ORF was inserted in frame with the anthranylate 
synthase encoding gene. 
For pGEX24: the PRP24 ORF was isolated from pATP24 vector by BamI-H 
and Sail digestion and was ligated to the BamHI end of the BamII-SmaI 
opened-pGEM-2T vector. Then the Sail extremity of the PRP24 ORF was 
filled-in by the klenow enzyme and ligated to the Smal end of the vector. 
PRP24 ORF was cloned in frame with the 3' end of the GST encoding 
sequence in the pGEX-2T expression vector (Pharmacia). 
For pIP24: PRP24 ORF was isolated from pATP24 after digestion with 
BamHI and Sail and ligated to the BamHI/Sall-opened pQE-30 vector 
(Qiagen). The resulting pIP24 construct harbors a sequence encoding for 6 
repeats of histidine fused in frame with PRP24 encoding sequence. 
For pGAP24: the PRP24 ORF was isolated from pGEX24 by BamHI and 
XbaI digestion and was inserted between the BamHI and XbaI restriction sites 
of the expression vector pUR288 (RUther et al., 1983). The resulting pGAP24 
vector possesses the Prp24p encoding sequence fused in frame to the - 
galactosidase gene. 
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Production of the glutalhione-S-transftrase-Prp24 fusion protein with pGEX24: 
BMH71-18 (pGEX24) cells (Tables 6 and 9) were induced for the production of the 
GST-Prp24 fusion protein by addition of IPTG (section 2.9.1). After extraction and 
fractionation on an SDS-polyacrylamide gel, proteins were visualised by Coomassie 
blue staining (Figure 15, Panel A). A polypeptide of the expected size of the fusion 
protein (--76 kD) was produced only when IPTG was added in the culture. The best 
production of GST-Prp24 fusion protein was obtained after 4-6 h incubation in the 
presence of (0.2 mM-0.4 mlvi) IPTG (lanes 5, 6, 8, 9). Increasing the IPTG 
concentration (0.2 mM compared to 0.4 mM) in the culture had no effect on the 
production of the fusion protein which was limited. The induction of GST-Prp24p 
production reduced the growth rate of the cells decreasing overall protein production 
(compare lane 4 with 5, 6 and lane 7 with 8, 9), suggesting that GST-Prp24p was toxic 
in E. coli. This meant only small amounts of the fusion protein were produced. 
Production of the f3-galactosidase-Prp24 fusion protein with pGAP24: BMH71-18 
(pGAP24) cells were induced for the production of the -galactosidase-Prp24 fusion 
protein by addition of IPTG (the control culture had no IPTG). After 4 h of induction 
cells were collected, proteins extracted, resolved on a 8% SDS-polyacrylamide gel and 
detected by Coomassie blue staining (Figure 15, Panel B). The fusion protein was 
produced only in the presence of IPTG and resolved at the expected size of 166 kD 
(compare lanes 3 and 4). A protein of a size similar to 3-galactosidase was also 
detected, indicating that the fusion protein was partially unstable (lane 4). This partial 
degradation of the fusion protein has been mentioned by RUther et al. (1983) but the 
reasons for this proteolysis are not well understood. The fusion protein was not toxic in 
bacteria and no major contaminating polypeptides were detected by Coomassie blue 
staining. A large quantity of proteins was extracted from induced cells (section 2.5.2) 
and the 3-galactosidase-Prp24 fusion protein was partially purified by electroelution 
(section 2.9.2) and used to immunise rabbits against Prp24p. 
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Figure 15. Analysis of proteins in E. coli cell extracts by Coomassie blue 
staining. 
Fresh cultures (5 ml) of E. coli BMH71-18 (pGEX24) cells were grown to 
0D595=0.3-0.4 and the production of the GST-Prp24 fusion protein was 
induced by addition of 0.2 mM IPTG (lanes 2, 5, 8) or 0.4 mM IPTG (lanes 3, 
6, 9). Control lacking IPTG were included (lanes 1, 4, 7). Cells were collected 
after 3 h, 4 h or 6 h induction. Proteins were extracted (small scale method, 
section 2.5.2) and a 20 tl aliquot (undetermined protein concentration) was 
loaded and fractionated on a 6% SDS-polyacrylamide gel. Proteins were 
detected by Coomassie blue staining. The expected size of the fusion protein 
was 76 kD. M: molecular weight markers. NI; noninduced 
Competent BMH71-1 8 E. coil cells were transformed with pGAP24 (lanes 
3, 4) or with pUR288 vector (lane 1, 2). Fresh culture (5 ml) was grown to 
0D595=0.3-0.4, then IPTG was added to a final concentration of 1 mM IPTG 
(lanes 2 and 4) or was omitted (lanes 1 and 3). After 4 h induction, cells were 
collected and proteins extracted (section 2.5.2). 20 p.1 aliquot (undetermined 
protein concentration) was loaded on a 6% SDS-polyacrylamide gel. Proteins 
were detected by Coomassie blue staining. The expected size of the fusion 
protein was 166 kD and of the -galactosidase was 116 kD. M: molecular 
weight markers. NI: no IPTG added; I: IPTG added. 
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Production of the 6X Ii istidine-Prp24 fusion protein with pIP24: BMH7 1-18 (pIP24) 
cells were induced for the production of the 6X His-Prp24 fusion protein by addition of 
IPTG. After 4h induction (0.4 mlvi IPTG) cells were collected, proteins extracted and 
fractionated on an 8% SDS-polyacrylamide gel. The detection of the proteins by 
Coomassie blue staining indicated that the fusion protein was produced only in the 
presence of IPTG and possessed the expected size (50 kD) (data not shown). High 
yields of protein were produced and used to affinity purify the polyclonal anti-Prp24 
antibodies (section 2.9.5). 
3.3.2 	Detection of Prp24 protein by immunoblotting 
Anti-Prp24 antibodies were obtained from rabbits after six injections with the - 
galactosidase-Prp24 fusion protein. Two independant batches (1015 and 1016) of 
antiserum were obtained from the immunization of two rabbits, both were tested for 
their ability to recognize Prp24p in a total yeast protein extract by Western blotting 
(section 2.5.6) (Figure 16, Panel A). In extract prepared from cells overproducing 
Prp24p, several polypeptides were detected at around 50 kD which may have been 
Prp24p (lane 2). Batch 1015 had more cross-reacting bands than 1016. 
Proteins immunoprecipitated with anti-Prp24 antisera bound to PAS beads were 
detected by Western blotting (Figure 16; Panel B). Both batches of antibodies 
specifically precipitated Prp24p under nondenaturing conditions (section 2.8), however 
the protein was compressed by the heavy chain of the IgG (60 kD) and consequently 
possessed an apparent molecular weight of-45 kD (compare lane 1 with lanes 3 and 5). 
A protein a size similar to the major signal detected from a total yeast extract was 
- immunoprecipitated with both batches of antibodies covalently attached to an Affi-Gel 
HZ resin (section 2.9.6) (data not shown). No difference in the efficiency of 
immunoprecipitation of Prp24p was noticed between the two antisera tested, also both 
immunoprecipitated Prp24p with similar efficiency after protein denaturation (data not 
shown). 
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Figure 16. Detection by Western blotting of Prp24p with both batches of 
anti-Prp24 rabbits antisera. 
Yeast S150-213 (jBM24: CEN4, URA3, GAL]-PRP24; Tables 7 and 9) 
cells were grown in YMGlyLac medium (section 2.1.2.3) supplemented with 
tryptophan (Table 5) and galactose was added (20% (v/v) final) when cells 
reached the exponential phase. After 5 h galactose induction of PRP24 
expression, cells were harvested and proteins extracted (section 2.5.2). The 
protein content was determined by Bradford assay (section 2.5. 1) and 100 .tg 
of total proteins were loaded in each slot of a 8% SDS-polyacrylamide gel. 
Proteins were transferred to a PVDF membrane by Western blotting (section 
2.5.6), detected by Ponceau S staining and the membrane was cut into several 
bands each containing the same amount of protein. A band was incubated with 
the preimmune serum (1/1000 fold diluted in 5% BSA/1X PBS) (lane 1) or 
with the crude anti-Prp24 antiserum (1/1000 fold diluted in 5% BSA/1X PBS) 
(lane 2). 
Detection by Western blotting of immunoprecipitated proteins with anti-
Prp24 antibodies. A splicing extract (60 p1; 4 mg total proteins) prepared from 
S150-213 (pBM24) cells collected after 5 h galactose' induction of Prp24p 
production was mixed with an equal volume of 2X IQ buffer (section 2.8). The 
mixture was incubated with crude antibodies attached to PAS beads (final 
bleed, lanes 3, 5) or with preimmune serum (lanes 2, 4). Immunoprecipitation 
was carried out for 2h at 4 °C (section 2.8), after washes with buffer containing 
150 mM NaCl, immunoprecipitated proteins were recovered and loaded on a 
8% SDS-polyacrylamide gel. Alongside, 100 ig of total proteins (provided 
from the same protein extract) was loaded on the gel (lane 1), proteins were 
transferred to a PVDF membrane and detected by Western blotting with anti-
Prp24 serum batch 1016 (final bleed) 1/1000 diluted in 5% BSA/1X PBS. IP: 
inmiunoprecipitation. 
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Immunoprecipitation with a-Prp24 Abs 
3.3.3 Analysis of snRNAs co-immunoprecipitated with anti-Prp24 antiserum 
The snRNAs that are co-immunoprecipitated with anti-Prp24 antisera from a 
yeast splicing extract (SC261, Table 7) are shown in Figure 17. Both batches of antisera 
precipitated mainly U6 snRNA and only a very tiny fraction of U4 snRNA, while no 
Ui, U2 or U5 snRNAs were detected. Neither the incubation at 25°C for 25 min nor the 
induction of spliceosome formation affected the immunoprecipitation of snRNAs by 
either anti-Prp24 antiserum, demonstrating that both batches of antibodies detected 
Prp24p associated with the U6 snRNA before spliceosome formation. This was in 
agreement with the data of Shannon and Guthrie (1991) and Jandrositz and Guthrie 
(1995), showing that the immunoprecipitated Prp24p was only associated with the U6 
snRNA in the U6 snRNP particles (in a wild-type yeast background). 
3.4 Discussion 
It was shown that Prp24p was essential for yeast cell viability, in agreement 
with data reported subsequently by Vaidya et al. (1996). 
The production in E. coil of a -galactosidase-Prp24 fusion protein allowed the partial 
purification of sufficient amounts of protein to induce an immune response in rabbits. 
Two batches of polyclonal anti-Prp24 antisera were produced. Both antibodies 
recognized a polypeptide of an apparent molecular weigth of 50 kD in a yeast extract 
overproducing Prp24p. Much less cross-reacting proteins were detected with antiserum 
batch 1016. Both anti-Prp24 antibodies inmiunoprecipitated with an equal efficiency 
Prp24p (50 kD) under nondenaturing conditions (150 mM NaCl) or after protein 
denaturation. 
In our hands, anti-Prp24 antibodies co-immunoprecipitated mainly the U6 snRNA and 
traces of the U4 snRNA. This was demonstrated in a splicing extract prepared from 
wild-type yeast cells in a reaction containing ATP. Spliceosome formation was not 
required for Prp24p-U6 snRNA association. The same results were obtained when 
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Figure 17. Northern blotting analysis of snRNAs co-immunoprecipitated 
with anti-Prp24 antisera. 
A splicing extract (40 tl) prepared from the wild-type yeast SC261 strain 
(Table 7) was present in a splicing reaction mix (100 p.!), and incubated for 25 
min at 25°C (or left on ice) (section 2.6.2.1). Spliceosome formation was 
induced by addition to the sample of substrate RNA (1 p.M of actin p283, 
Table 9). No spliceosomes were formed when substrate RNA was omitted. 
After 25 min incubation, samples where quenched on ice and Prp24p was 
immunoprecipitated under nondenaturing conditions (section 2.8) with anti-
Prp24 antisera batches 1016 (final bleed) or with the preimmune serum. After 
five washes containing 150 mM NaCl, co-immunoprecipitated snRNAs were 
recovered (section 2.8) and transferred to a nylon membrane (section 2.4.4.3). 
The presence of Ui, U2, U4, U5 and U6 snRNAs was detected by 
hybridization with end-radiolabelled (section 2.4.3.10) oligodeoxynucleotides 
486A, G1803, 483A, 485A and Taq6A respectively (Table 8). Total yeast 
RNA was extracted from a 5 .t1 splicing extract (lane 1) (section 2.8). The 
membrane to which Ui snRNA and U2 snRNAs were transferred is not shown 
but no immunoprecipitation was detected. Identical results (not shown on this 
Figure) were obtained when anti-Prp24 antibodies batch 1015 (final bleed) 
was used. 
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affinity purified anti-Prp24 antibodies were used (see section 5.2.1). These results 
suggest that the polyclonal antibodies recognize Prp24p interacting with the U6 snRNA 
in the U6 snRNP particle. This is in agreement with data of Shannon and Guthrie 
(1991) and Jandrositz and Guthrie (1995). These authors demonstrated that Prp24p was 
associated with the U6 snRNA in the U6 snRNP particle only. Recently Prp24p has 
been proposed to be required for the recycling of the U41U6 snRNP after spliceosome 
disassembly, in an ATP-dependent manner (Raghunathan and Guthrie, 1998). These 
authors showed that in yeast cells producing a Prp24-3HA fusion protein, U6 snRNA 
and also U4 snRNA were associated with Prp24-3HA in an ATP-dependent manner 
(Raghunathan and Guthrie, 1998). Several explanations for the discrepancy between 
these published data and this work are proposed: 
Raghunathan and Guthrie (1998) have investigated the association of Prp24p with 
snRNAs at low salt concentrations (50 mlvi NaCl), while in this work more stringent 
conditions (150 mM NaCl). Therefore in the presence of 150 mlvi NaCl, the association 
between Prp24p and the U4/U6 duplex may have been disrupted. 
Although these authors demonstrated that the Prp24-3HA protein was functional, the 
addition of extra amino acids might have increased the affinity of Prp24p for the U4/U6 
duplex. 
The association of Prp24p with the U4/U6 snRNAs might have been disrupted by the 
binding of the polyclonal antibodies used, or the Prp24p epitope(s) was masked in the 
Prp24p-U4/U6 snRNP complex. 
The ability of both antisera to immunoprecipitate Prp24p UV-crosslinked to the 




The U6 snRNP RECONSTITUTION 
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INTRODUCTION 
SnRNPs have been reconstituted in vitro in both mammalian and yeast systems 
allowing the study of protein-protein, protein-RNA and RNA-RNA interactions 
occuring in snRNP particles and in the spliceosome (for examples see McPheeters et al, 
1989; Wersig et al., 1992; Sdgault et al., 1995; O'Keefe et al., 1996). 
The U6 snRNP reconstitution method (section 2.6.2.3) has been published by Fabrizio 
et al. in 1989. The principle of this technique consists of replacing, in a yeast splicing 
extract, the endogenous U6 snRNA by one produced by transcription in vitro. For this 
purpose a U6 knockout oligo (Table 8) complementary to the U6 snRNA sequence U 28-
U54 was added to the yeast cellular extract and allowed to anneal to the endogenous U6 
snRNA. The region of the U6 snRNA involved in the RNA-DNA interaction was 
consequently degraded by the RNase H which is present in the yeast cellular extract and 
is activated upon incubation at 30 0C. Due to the depletion of the endogenous U6 
snRINA, the splicing activity of the extract was abolished. The addition of U6 snRNA 
produced by transcription in vitro reconstitutes functional U6 snRNP particles and 
therefore restores the splicing activity of the yeast extract. 
Although this reconstitution technique appears to be relatively simple, numerous 
difficulties have been encounted which will be described and discussed in this chapter. 
4.1 	Preparation of a Heat Stable Yeast Splicing Extract and Test for 
Depletion of the Endogenous U6 SnRNA 
To deplete the U6 snRNA from the yeast cellular extract, it was necessary to 
incubate the reconstitution mixture at 30 °C for 30 min in order to activate the 
endogenous RNase H (section 2.6.2.3). Comparison of the splicing activity of both heat 
treated and untreated yeast extracts, in the absence of U6 knockout oligo, revealed that 
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the incubation at 30 °C was abolishing completely or partially the splicing activity of the 
extract. The splicing conditions reported by Fabrizio et al. (1989) were different from 
those described in section 2.6.2.1. Whereas Fabrizio et al. used a potassium phosphate 
buffer of pH 7.0 and 2 mM spermidine in their splicing reaction, potassium phosphate 
buffer pIE-I 7.5 was used and no spermidine was added in the reaction. These differences 
did not affect the heat stability of the extract, no improvement was obtained. The 
splicing extracts were prepared from the wild-type yeast strain S150-2B  (Table 7), 
extracts from a yeast strain containing mutations in protease encoding genes (SC26 1: 
prb 1-1132, prc 1-407, pep4-3; Table 7) were prepared; also the effect of the addition of 
protease inhibitors during the extract preparation was tested, no changes were noticed. 
The exclusive use of sterile solutions and material (centrifugation tubes, Pasteur 
pipettes, magnetic stirrers...) and the careful resuspension of yeast spheroplasts 
(spheroplasts were first resuspended in a small volume of the appropriate buffer until 
complete homogenisation, then more buffer was added), were the two determining 
precautions which permitted the preparation of heat stable splicing extracts. 
An accurate titration of the knockout oligo was essential to ensure complete digestion 
of the endogenous U6 snRNA and to avoid degradation of the transcribed U6 RNA by 
excess oligo. For most of the extracts tested, a final concentration of 110 nM-140 nM of 
U6 knockout oligo was sufficient to completely abolish the splicing activity of the 
extract. However when another knockout oligo was included to deplete either U2 or US 
snRNAs in addition to the U6 snRNA (sections 2.6.2.4 and 2.6.2.5), the stability of the 
added U6 RNA was compromised. Consequently the efficiency of the U6 snRNP 
reconstitution was reduced. The splicing activity of a yeast extract before and after U6 
snRNP reconstitution is shown in Figure 18 (Panel A). In addition to the radiolabelled 
splicing intermediates and products, the U6 RNA (32P-aATP) was also detected. The 
splicing activity recovered after U6 snRNP reconstitution varies from 50% of the 
initial level of activity of the extract (based on the comparison of the lariat-intron-exon 
2 and lariat-intron signals), or was -20% of the initial splicing activity (based on the 
comparison of the spliced RNA signal) (compare lanes 1 and 3). In this particular 
reconstituted yeast cellular extract, the spliced RNA was less stable than the lariat- 
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Figure 18. Analysis of the U6 RNA transcribed in vitro on denaturing geL 
U6 snRNP reconstitution and splicing reaction. The initial splicing activity 
of the yeast cellular extract is shown in lane 1, the extract has been 
preincubated at 30 °C for 30 min prior to the splicing reaction. The addition of 
140 nM of U6 knockout DNA oligo was sufficient to completely deplete the 
endogenous U6 snRNA and abolish the splicing activity of the extract (lane 2). 
U6 snRNPs were reconstituted with a radiolabelled U6 snRNA produced by 
transcription in vitro. In each reconstitution reaction 6 nM of U6 RNA was 
added (lanes 3-5). The recovery of the splicing activity was observed in lane 3. 
In addition to the endogenous U6 snRNA, U2 snRNA was depleted by the 
presence of 600 nM of U2 knockout oligo SRU2 (Table 8) (lane 4). The U5 
snRNA was also degraded in addition to the U6 snRNA with 700 nM of each 
U5 knockout oligos Rok8L and Rok8R (Table 8) (lane 5). A 10 p1 
reconstitution reaction was carried out with a splicing extract prepared from 
the yeast strain SC261 (Table 7; lanes 1-4) or from the yeast strain Rok8 
(provided by I. Dix, this lab) (Table 7; lane 5). After splicing reaction, RNAs 
were recovered and resolved on a 7% polyacrylamide/urealTBE gel. RNA 
signals were detected by autoradiography. IVS-E2: lariat-intron-exon 2; IVS: 
lariat-excised intron; pre-mIRNA: actin substrate RNA (p283, Table 9); 
mRNA: spliced RNA; El: exon 1; U6 RNA: U6 snRNA produced by 
transcription in vitro with the T7 RNA polymerase. 
U6 RNA was transcribed (10 p1 reaction) in vitro from the template 
pUC12U6 linearized with DraI (section 2.4.4.1) (lane 1) or from the pU6ribo 
template linearized with EcoRI (lane 2). Transcripts were resolved on a 6% 
polyacrylamide/ureaITBE gel and detected by autoradiography. A DNA ladder 
(pBR322 plasmid digested with MspI and radiolabelled with a- 32PdCTP) was 
run alongside with the U6 snRNA transcripts. U6 RNA: U6 snRNA produced 
by transcription in vitro with the T7 RNA polymerase and radiolabelled with 
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intron product. As expected no splicing activity was detected when the endogenous U2 
or U5 snRNA was depleted in addition to the U6 snRNA (lanes 4 and 5), however 
under these experimental conditions much less radiolabelled U6 RNA was recovered 
(compare the U6 RNA signal from lane 3 with lanes 4 and 5). The U6 RNA was 
apparently degraded in the extract. This U6 RNA instability was also noticed when an 
oligodeoxynucleotide, lacking any complementarity to any of the known snRNAs, was 
added to the reconstitution reaction with the U6 knockout oligo (data not shown). This 
suggested that the increased degradation of the U6 RNA was not dependent on the 
sequence of the second oligo added. 
Fabrizio et al. demonstrated that after 30 min incubation at 30 °C less than 1% of the 
initially added U6 knockout oligo remained in the extract, having probably been 
degraded by endogenous DNase activity. Therefore presumably, in the double knockout 
experiment the presence of a second oligo limited the DNase degradation of the U6 
knockout oligo. Consequently a larger fraction of the U6 knockout oligo remained in 
the extract and annealed to the U6 RNA which was then RNase H digested. Therefore 
when the endogenous U2 or U5 snRNAs were depleted in addition to the U6 snRNA, a 
lower quantity of U6 knockout oligo was added in the reconstitution reaction to 
compensate for the longer life span of the U6 knockout oligo in the extract whereas the 
incubation time was unchanged. 
4.2 Analysis of the U6 SnRNA Produced by Transcription In Vitro 
The length of the U6 RNA transcribed from pUC 1 2U6 or from pU6ribo (Table 
9) was analysed on a denaturing gel (Figure 18, Panel B). The U6 RNA transcribed 
from the pU6ribo template was 190 nucleotides long. It possesses at its 3' end a hairpin 
ribozyme which autocleaves and releases the ribozyme (77 nt) and the U6 RNA of the 
expected size (113 nt) (lane 2). The U6 RNA transcribed from pUC12U6 was longer 
than expected. According to the DNA . ladder, it was 130 nt in length and therefore 
possesses 17 extra nucleotides (lane 1). 
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The unexpected production of T7 transcripts containing extra nucleotides at their 3' end 
has been reported in the literature (Cazenave et al., 1994; Triana-Alonso et al., 1995). 
Triana-Alonso et al. suggested a reduction in the UTP concentration to circumvent this 
extension problem. A decrease in the concentration of UTP had no effect on the size of 
the U6 RNA transcribed. Likewise, various magnesium concentrations were tested, in 
combination with different nucleotide concentrations; the U6 RNA produced by 
transcription in vitro from pUC12U6 was still 130 nt long. In an attempt to disrupt any 
U6 RNA secondary structures which may have been responsible for this 3' end 
extension, DMSO was added in the transcription reaction at 5% (v/v) or 10% (v/v). No 
improvement was observed. No changes were detected when the reaction temperature 
was changed to 30°C or 40°C, or when different sources of T7 RNA polymerases were 
tested (Boehringer Mannheim, New England Biolabs, Pharmacia). A PCR product 
containing the U6 snRNA gene downstream of the T7 transcription promoter was 
produced using oligodeoxynucleotides S5760 and S5761 (Table 8). When this was used 
as a DNA template in the transcription reaction, the resulting U6 RNA was again 130 nt 
in length. Whatever the experimental conditions tested, the U6 RNA produced by 
transcription in vitro was always longer than expected. 
Cazenave and Uhlenbeck (1994) have shown that T7 RNA polymerase is capable of 
extending the 3' end of a transcript by RNA template-directed RNA synthesis. This 
occurs because the RNA made from the DNA template is able to form an intra or 
intermolecular primed-template. The same 3' end extention was indeed occuring when 
the U6 RNA was transcribed in vitro. I. Kelly (University of Cambridge) sequenced the 
17 extra nucleotides located at the 3' end of the U6 RNA. The sequence was 5'-
UAAAAAAACGGUUCAUC-3' (I. Kelly, personal communication), the underlined 
sequence is complementary to U6 snRNA nucleotides 78-90 confirming this RNA-
templated transcription activity. 
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4.3 U6 SnRNP Reconstitution with the U6 RNA Transcribed In Vitro 
The fact that the U6 RNA was longer than expected was a concern for its 
functionality and the success of the U6 snRNP reconstitution. The ability of the 130 nt-
U6 RNA to reconstitute snRNP particles was investigated and compared with that 
obtained when the 113 nt-U6 RNA was used (Figure 19). The splicing extract tested 
was heat stable, and the heat treatment seems to increase slightly the stability of the 
spliced RNA and the lariat-intron signals (compare lanes 1 and 2). The amount (130 
nM) of U6 knockout oligo added was sufficient to abolish the splicing activity of the 
extract (lane 3). After U6 snRNP reconstitution with the longer U6 RNA (130 nt), the 
initial splicing activity of the extract was recovered with an efficiency which varies 
from 60% (with 5 nM of U6 RNA, lane 4) to 100% (with 100 nM of U6 RNA, lane 7), 
with respect to the lariat-intron and lariat-intron-exon 2 signals. However slightly less 
than 100% of mRNA was recovered after U6 snRNP reconstitution with 50 nM or 100 
nM of U6 RNA (130 nt) (compare mRNA signal in lane 2 with lanes 6 and 7). For no 
obvious reason the spliced RNA was instable. When U6 snRNPs were reconstituted 
with the U6 RNA of 113 nt in length, a slightly lower if not similar reconstitution 
efficiency was detected. Therefore the extra 17 nucleotides present at the 3' end of the 
130 nt-U6 RNA do not affect its ability to reconstitute functional U6 snRNP particles. 
In order to detect the U6 RNA after reconstitution and splicing reaction, U6 snRNP 
particles were reconstituted with a radiolabelled 130 nt-U6 RNA or 113 nt-U6 RNA 
(Figure 20, Panel A). An RNA, of a size similar to the 113 nt-U6 RNA initially added 
in the reaction, was detected after U6 snRNP reconstitution and splicing (compare lanes 
1 and 2). When the 130 nt-U6 RNA was used, a shorter RNA (-113 nt in length) was 
detected, which was not initially added in the reaction (compare lanes 3 and 4). This 
shortened U6 RNA was also detected in the absence of substrate RNA, suggesting that 
no spliceosome formation was required for the 130 nt-U6 RNA to be shortened (data 
not shown). This result was unexpected. Was the 130 nt-U6 RNA (or at least a fraction 
of it) processed in the extract to an RNA of the expected size? Were both U6 RNA 
species functional? 
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Figure 19. The 130 nt-U6 RNA is functional. 
U6 snRNPs were reconstituted with the 130 nt-U6 RNA (lanes 4-7) or with the 
113 nt-U6 RNA (lanes 8-11). The splicing activity of the extract prepared 
from SC261 (Table 7) is shown in lane 1. Its ability to splice was not altered 
when the extract was preincubated at 30 °C for 30 min before splicing reaction 
(lane 2). The splicing activity of the yeast extract was abolished when 130 nM 
of U6 knockout oligo was added to deplete the endogenous U6 snRNA (lane 
3). Increasing amounts of U6 RNA were added to reconstitute U6 snRNPs. 
IVS-E2: lariat-intron-exon 2; IVS: lariat-excised intron; pre-mRNA: actin 
substrate RNA (p283, Table 9); mRNA: spliced RNA; El: exon 1. 
Reconstituted U6 snRNPS 
U6 RNA 	U6 RNA 
(130nt) (113 nt) 
cc 
— V) — II - 	— 




- 	I— El 
1 23 4 5 6 7 89 1011 
Figure 20. Analysis of the 130 nt-U6 RNA in a splicing extract. 
Splicing activity of an extract prepared from 5C26 1 cells (Table 7) assayed 
after U6 snRNP reconstitution. U6 snRNPs were reconstituted with a 
radiolabelled 113 nt-U6 RNA (30 nM) (lane 2) or with a radiolabelled 130 nt-
U6 RNA (100 nM) (lane 4). 10 jil of reconstitution and splicing reactions were 
performed. After splicing, RINAs were recovered and resolved on a 7% 
polyacrylamide/urealTBE gel. On the same gel 300 fmole of the 113 nt-U6 
RNA (lane 1) and 1 pmole of the 130 nt-U6 RNA were loaded alongside. IVS-
E2: lariat-intron-exon 2; IVS: lariat-excised intron; pre-mRNA: actin substrate 
RNA (p283, Table 9); mRNA: spliced RNA; El: exon 1; U6 RNA: U6 
snRNA produced by transcription in vitro with T7 RNA polymerase. 
Analysis of the U6 RNA in the reconstituted Ussip-containing snRNPs. U6 
snRNP were reconstituted (50 jt1 reaction) with 80 nM of 130 nt-U6 RNA or 
113 nt-U6 RNA. After reconstitution the U6 snRNA contained in U6 snRNP, 
U411J6 snRNP and in U41U6.U5 tri-snRNP particles was co-
immunoprecipitated with the crude anti-Ussi antisera under native conditions 
(lanes 6 and 7). As a control reconstituted snRNP particles were incubated 
with PAS beads only (lane 5). Immunoprecipitation and washes were carried 
out in 150 mM NaCl. After immunoprecipitation the RNAs were recovered, 
fractionated on a 6% polyacrylamide/urea/TBE gel, blotted (section 2.8) and 
the U6 snRNA was probed with a radiolabelled oligodeoxynucleotide Taq6A 
(Table 8; sections 2.4.3.10 and 2.4.3.11). Total RNAs were also recovered 
from 5 p.1 of splicing extract (lane 3) or from 5 p.1 of splicing extract lacking 
the endogenous U6 snRINA (lane 4). On the same gel 50 fmole of the initial 
stock of 130 nt-U6 RNA (lane 1) and 113 nt-U6 RNA (lane 2) were loaded 







130 nt-16 RNA 









1 	2 	3 	4 	5 	6 	7 
The length of the U6 RNA in reconstituted snRNP particles was investigated. For this 
purpose U6 snRNP particles were reconstituted with the 130 nt-U6 RNA or with the 
113 nt-U6 RNA. Then, U6 snRNP, the U4/U6 snRNP and to a lesser extent the 
U4/U6.U5 tri-snRNP were immunoprecipitated with the crude anti-Ussi antiserum and 
the co-immunoprecipitated U6 RNAs were recovered and analysed by Northern 
blotting (section 2.4.4.3) (Figure 20, Panel B). The RNase H degradation of the 
endogenous U6 snRNA was total (lane 4), and the co-immunoprecipitation of the U6 
RNA was antiserum specific (lane 5). Little size difference was observed between the 
transcribed 113 nt-U6 RNA used to reconstitute U6 snRNPs and the U6 RNA 
recovered from the Ussip-containing snRNP particles (compare lanes 2 and 7). After 
U6 snRNP reconstitution with the 130 nt-U6 RNA, only a shorter (-113 nt) U6 RNA 
was recovered in Ussip-containing snRNP particles (compare lane 1 and 6). This 
suggests that only the shortened 113 nt-U6 RNA was present in the yeast Ussip-
containing snRNPs. This could explain why no difference in the reconstitution 
efficiency was observed between the 113 nt-U6 RNA and the 130 nt-U6 RNA (see 
Figure 19). 
4.4 Production of Large Amounts of Radiolabelled U6 SnRNA by 
Transcription In Vitro 
Large amounts of highly radiolabelled U6 RNA were required to investigate U6 
RNA-protein interactions (section 2.6.2.3). Initially the transcription recipe described in 
section 2.4.4.1 using 32P-ctUTP to radiolabel the transcript was followed, and the 
plasmid pUC 1 2U6 (Table 9) linearised with DraI was used as template. The 
transcription efficiency obtained was very low while much larger quantities of US RNA 
were produced following the same recipe (data not shown). Thus the limitation of the 
transcription efficiency was specific for the U6 RNA. Several parameters (temperature, 
source of T7 RNA polymerase, addition of 5% (vlv) or 10% (v/v) DMSO, different 
concentrations of ribonucleotides, different transcription buffers) were modified in 
order to increase the production of radiolabelled U6 RNA; very little effect was 
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observed. The best transcription efficiency was obtained when U6 RNA was 
radiolabelled with 32P-aATP instead of 32P-aUTP (data not shown). Indeed labelling 
the U6 RNA with 32P-ctUTP limits the availability of the UTP in the reaction; since U6 
RNA contains a U at position 2, this may affect its transcription efficiency by causing 
high levels of abortive transcription. The first A in U6 RNA occurs at position 8, 
therefore limitating ATP in the reaction was probably less detrimental to the 
transcription efficiency of the full length U6 RNA. 
A U6 RNA transcription template harboring at its 5' end six extra nucleotides (5'-
GGGAGA-3') located between the T7 RNA polymerase consensus promoter sequence 
and the U6 snRNA encoding sequence was generated by PCR (section 2.4.3.8) (L. 
Verdone, this lab). Oligodeoxyribonucleotides Loryl and S5761 were employed as 
primers (Table 8) and the plasmid pUC12U6 was used as template DNA in the PCR 
reaction. The amplified DNA product was named PCU6. The addition of these extra 
nucleotides at the 5' end of the transcription template greatly improved the transcription 
efficiency which was much higher than that obtained when the pUC12U6 was used as 
template DNA (L. Verdone, personnal communication). Large amounts of U6 RNA 
transcribed from the PCU6 template and radiolabelled with either 32P-aATP, 32P-aCTP 
or 32P-aUTP were also obtained, whereas only a U6 RNA radiolabelled with 32P-xATP 
was produced in reasonable amounts from the pUC12U6 template (data not shown). 
Further analysis indicated that the U6 RNA harboring six extra nucleotides at its 5' end 
was able to reconstitute functional U6 snRNP particles (i.e. tested for their ability to 




In our hands the U6 RNA produced by transcription in vitro from pUC 1 2U6 
linearized with DraI was 130 nucleotides long instead of the expected 113 nucleotides. 
Seventeen extra nucleotides were added at the 3' end of the transcript, probably due to 
an RNA-template directed synthesis. Fabrizio et al. (1989) made no mention of this 3' 
end extension of the full length U6 transcript. The plasmid (J)UC 1 2U6) used for the 
run-off transcription was similar to the one used by Fabrizio et al., (1989): both 
plasmids contain the T7 promoter followed by an extra G, and they both were 
linearized with DraI the transcription of the full length U6 snRNA molecule. The only 
difference was the vector in which the T7-U6 RNA gene was cloned: pUC12U6 
plasmid was based on the vector pUC12, while Fabrizio et al. used the pUC18 vector. 
This difference was unlikely to be responsible for the transcription discrepancy. Also, 
the transcription conditions used by Fabrizio et al. (which were slightly different from 
those described in section 2.4.4.1) produced a 130 nt-RNA in our hands. This disparity 
remains obscure. 
Fabrizio et al. (1989) showed that a longer U6 RNA containing 8 extra nucleotides at 
the 3' end, produced by run-off transcription of their plasmid DNA template linearized 
with BamHI, gave a lower recovery of splicing activity. The functionality of the U6 
RNA seems more affected by the sequence of the added nucleotides at the 3' end rather 
than by their number. Indeed, the results reported in this chapter showed that the 
addition of 17 nucleotides at the 3' end of the U6 RNA did not affect its functionality; 
the 130 nt-U6 RNA restored splicing activity with the same efficiency than the 113 nt-
U6 RNA. 
Another U6 transcription template has been generated by PCR which contains six extra 
nucleotides at its 5' end. This DNA template was named PCU6 and it allowed the 
production of large amounts of U6 RNA radiolabelled with either 32P-aATP, 32P-aCTP 
or 32P-aUTP. The presence of the 5'-GGGAGA-3' sequence at the 5' end of U6 RNA 
did not affect its functionality. This U6 RNA was therefore utilised to investigate U6 
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RNA-protein interactions (chapters 5 and 6). In the UV-crosslinking experiments 
presented in the following chapters, for convenience we will name the U6 RNA 
transcribed from pUC12U6/DraI and radiolabelled with 32P-aATP: U6 RNA (32P-
ctATP) and the U6 RNA transcribed from PCU6 and radiolabelled with 32P-aUTP: U6 
RNA (32P-aUTP). 
The analysis of the splicing intermediates and products detected after U6 snRNP 
reconstitution and splicing reaction indicated that sometimes these RNA species were 
unstable. Optimization experiments of in vitro splicing showed that different pre-
mRNAs were spliced at different rates, and also the products and intermediates were 
degraded at different rates depending partly on the particular splicing extract (M. 
Lossky, 1988). In our hands, for the same splicing extract tested, the stability of the 
splicing signals varies from one reaction sample to another. This instability was not 
well understood and may occur randomly during the reaction and/or during the 
recovery of the RNAs after splicing. 
When the 130 nucleotides long U6 RNA was incubated in the extract, a shorter RNA of 
approximately the same length as native U6 snRNA (-113 nt) appeared. The analysis of 
the Ussip-associated snRNPs revealed that they contained only the shortened U6 RNA. 
The 130 nt-U6 RNA might have been processed in the yeast extract or it could have 
been protected from further degradation by the protein(s) interacting with the U6 RNA 
in the Uss 1-containing snRNPs. The length of U6 RNA in other snRNP particles and in 
the spliceosome has not been investigated; however since the presence of 17 extra 
nucleotides at the 3' end of U6 RNA did not affect its functionality, it would be highly 
probable that the shortened U6 RNA (-113 nt) was also contained in other snRNP 
particles and in the spliceosome. Also, it would have been interesting to investigate the 
length of the U6 RNA containing six extra nucleotides at its 5' end in snRNP particles. 
Interestingly, in man, mouse, frog, soya bean and fruitfly cells (Terns et al., 1992; Lund 
et al., 1992) the U6 snRNA undergoes 3' end posttranscriptional modifications. The U6 
snRNA is actually heterogeneous, and diverse RNA species have been distinguished: 
some U6 snRNAs possessed at their 3' end five oligouridylate residues and a 2'-3' 
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cyclic phosphate while other U6 snRNAs have a variable length of oligouridylate 
stretch. In Hela cells, the La and the hnRNP C proteins have been shown to interact 
only with the stretch of uridylates of the U6 snRNA. The 2'-3' cyclic phosphate end as 
been shown to be generated within the spliceosome as a consequence of pre-mRNA 
splicing. These data suggest that the U6 snRNA 3' end modification process is linked 
with the functionality of the U6 snRNA and/or the formation of snRNP particles (Terns 
et al., 1992; Tazi et al., 1993; Forné et al., 1995). In yeast cells no 3' end 
posttranscriptional modification of the U6 snRNA has been reported to date. The 
analysis on a native gel of the endogenous U6 snRNA in a yeast extract revealed that 
the U6 snRNA is heterogenous, three U6 snRNA species are sometimes detected in the 
U6 snRNP particles (M. Cooper, personnal communication). Could the shortening of 
the 130 nt-U6 RNA to a functional 113 nt-U6 RNA reflect a posttranscriptional U6 
snRNA modification? Does the shorter U6 RNA result from a 5' or 3' exonuclease 
activity or from an endonuclease cleavage? However, this shortening of the 130 nt-U6 
RNA may just be an artefact of the in vitro system used since the extra 17 nucleotides 
were added by the T7 RNA polymerase and until now there is no evidence for the 
transcription in vivo of a longer precursor U6 snRNA. 
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CHAPTER FIVE 




The mechanistic similarities between the splicing reactions catalyzed by group 
II introns and eukaryotic spliceosomes favour a possible common evolutionary origin 
of group II introns and spliceosomes (for review see Cech, 1985; Sharp, 1994). While 
autocatalytic group II RNAs are able to fold and splice themselves via an extensive 
structure encoded in the substrate RNA, the eukaryotic pre-mRNAs require for their 
maturation trans-acting elements (snRNAs and proteins) which interact with one 
another in a highly ordered fashion in a large complex known as the spliceosome. The 
spliceosome components as well as transiently associated splicing factors have been 
suggested to promote the correct folding of the substrate RNA into a splicing-
competent configuration and to influence the efficiency and fidelity of the splicing 
reaction. The study of protein-RNA interactions is therefore very important in order to 
understand the mechanism of spliceosome assembly and the splicing reaction. 
The U6 snRNA undergoes several conformational changes during snRNP interactions 
and spliceosome assembly. It can be found as a U6 snRNP particle or can be partially 
base-paired with the U4 snRNA in the U4/U6 snRNP. Once in the spliceosome, U6 
snRNA interacts with the pre-mRNA and the U2 snRNA; it is believed to be part of the 
catalytic centre. At each step of spliceosome assembly numerous well characterised 
RNA-RNA interactions occur; in contrast much less is known about RNA-protein 
contacts. The aim of this project is to detect and analyse any U6 snRINA-protein 
interactions. 
In order to study U6 5nRNA-protein interactions we have employed a commonly used 
UV-crosslinking technique. The chemistry of the UV crosslinking is partly understood. 
Irradiation with UV-light forms covalent linkage between nucleic acid bases and amino 
acid side-chains. Pyrimidine bases are more photoreactive than purines, and only eleven 
amino acids appear to be involved in the crosslinking reaction. The most reactive amino 
acids are cysteine, tyrosine, phenylalanine, histidine, arginine and lysine. The chemical 
reaction induced by short-wave UV-irradiation is specific: no RNA-RNA crosslinks 
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occur, nor do proteins become crosslinked to one another (Greenberg, 1979). Proteins 
and RNA molecules which are close enough one to the other (within one hydrogen 
bond length) could become crosslinked and can therefore be assumed to have been in 
direct contact. 
The procedure developed to study U6 snRNA-protein interactions and the results 
obtained are presented in this chapter. 
5.1 Proteins UV-Crosslinked to U6 SnRNA: The Technique 
In a yeast splicing extract U6 snRNPs were reconstituted with a U6 RNA 
transcribed in vitro and radiolabelled at a high specific activity (sections 2.4.4.1 and 
2.6.2.3). Typically a 50 i.l-100 tl reconstitution reaction was set-up and 32P- U6 RNA 
was added at a final concentration of 6 nM. U6 snRNPs were then reconstituted, and 
spliceosome formation was activated by adding in the reaction unlabelled substrate 
RNA (1 tM final concentration) transcribed in vitro (section 2.4.4.1); water was added 
instead of the precursor-mRINA when protein-RNA interaction studies were not focused 
in the spliceosome. 
After reconstitution and splicing (section 2.4.4.1), samples were quenched on ice then 
UV-irradiated (section 2.7) with the presence of 1 jil of nonspecific competitor E. coli 
tRNA solution (10 mg/ml). 
After UV irradiation, samples were transferred to a fresh Eppendorf tube and cooled on 
ice for 5 mm. Polyclonal antibodies (Table 10) were used for immunoprecipitation 
(section 2.8) either under nondenaturing conditions to isolate the entire snRNP 
particle(s) or the spliceosome, or proteins were denatured prior to immunoprecipitation 
to isolate only the protein of interest (section 2.8). For the denaturation of proteins prior 
to the immunoprecipitation, SDS, Triton X-100 and DTT were added at a final 
concentration of 2% (w/v), 1% (v/v) and 87 mM respectively and the tubes were boiled 
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for 2 mm. An equal volume of 2X IQ buffer was added to the denatured sample and the 
volume increased to 10 fold with 1X IQ buffer (section 2.8). This mixture was added to 
the antibodies bound to the PAS beads and the immunoprecipitation was carried out for 
2-3 hat 4°C. 
The protein complexes attached to the PAS beads were washed 5 times with NTN 
buffer (section 2.8), then the beads were resuspended in 30 p.! of RNase buffer [200 
mM NaCl, 20 mM Tris-Cl pH 7.5, 10 MM  MgCl2}. Samples were boiled for 1 min in 
order to destabilize any strong protein-RNA interactions, then ribonucleases Ti and A 
were added to a final concentration of 7 units/p.! and 330 mg/pA respectively. RNase A 
cleaves RNA molecules adjacent to pyrimidines while the RNase Ti cleaves 3' to G 
residues only. When a U6 RNA containing at a specific site a photosensitive 
radiolabelled 4-thioU was used, occasionally the sequence upstream from the labelled 
site introduced an RNase A or Ti cleavage point which would cleave the radiolabelled 
phosphate away from the 4-thiouridine. In this case only the RNase which did not 
cleave this site was used. RNase digestion was carried out for 40 min at 37 °C. Then 15 
p.1 of 3X SDS-!oading dye [94 mM Tris-Cl pH 6.8, 38% (v/v) glycerol, 7.5% (w/v) 
SDS, 300 mM DTT, 10 mg/ml BPB] were added per sample followed by 10 mm 
boiling. The supernate was split in two and each half was loaded on an SDS-PAGE gel 
of a different protein resolution ability. Finally, the gel was dried and the proteins UV-
crosslinked to the radiolabelled U6 RNA fragments were detected by autoradiography 
(section 2.2.2). 
Typically 3 and 10 day exposures were required to detect proteins UV-crosslinked to 
uniformly radiolabeiled U6 RNA and separated on a 15% and 6% SDS-PAGE gel 
respectively. When proteins were UV-crosslinked to a 4-thiouridine-containing U6 
RNA, an overnight exposure was sufficient to detect proteins. 
In order to monitor the success of the U6 snRNP reconstitution, splicing activity was 
assayed. After addition of the synthetic 32P-U6 RNA, a 9 p.1 reaction aliquot was 
transferred to a fresh Eppendorf tube and 1 p.1 of radiolabelled pre-mRNA (20 000 cpm) 
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was added. Following incubation at 25°C the RNAs species were recovered (section 
2.6.2.2), resolved on a polyacrylamide/ureaJTBE gel, and detected by autoradiography 
(section 2.2.2). Figure 21 summarises the method developed to detect U6 snRNA-
protein interactions. 
5.2 Studies of Prp24p, Ussip and Prp8p Contacts with the U6 SnRNA 
In order to detect protein-U6 RNA interactions the experimental protocol 
described above was followed (section 5.1) and anti-Prp24, anti-Uss 1 and anti-Prp8 
antisera (Table 10) were used to immunoprecipitate snRNP particles. 
Ussip (21 kD) is associated with the U6 snIRNA (Cooper et al., 1995). Crude anti-Ussi 
antibodies co-immunoprecipitate U6 snRNP, U4/1J6 snRNP and to a lesser extent 
U4/U6.U5 tri-snRNP (Cooper et al., 1995). Prp24p (45-50 kD) is a U6 snRNP 
associated protein which contacts the U6 snRNA directly (Ghetti et al., 1995; 
Jandrositz and Guthrie, 1995). The two batches (1015 and 1016) of anti-Prp24 antisera 
prepared in this work (Chapter 3) were tested for their ability to precipitate Prp24p UV-
crosslinked to the U6 RNA. Polyclonal anti-Prp24 antisera co-immunoprecipitate the 
U6 snRNP (Shannon and Guthrie, 1991; Jandrositz and Guthrie, 1995; section 3.3.3). 
Prp8p is a 280 kD U5 snRNP protein which also associates with the tri-snRNP (Lossky 
et al., 1987). Prp8p is required for the stability of the tri-snRNP and its association into 
the spliceosome (Brown et al., 1992). Prp8p remains in the spliceosome and interacts at 
least with the US snRNA and the pre-mRNA (Teigelkamp et al., 1995). The anti-Prp8 
antibodies (Table 10) used in these experiments are co-immunoprecipitating the US 
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Detection of the RNA by Autoradiography 
5.2.1 Preliminary characterisation of the different tools required to detect U6 
RNA-protein interactions 
5.2.1.1 Analysis of the two batches of crude anti-Prp24 antisera produced from 
rabbits 
Both batches (10 15 and 10 16) of anti-Prp24 antisera were tested for their ability 
to immunoprecipitate Prp24p UV-crosslinked to the radiolabelled U6 RNA (32P-aATP) 
(section 5.2) (Figure 22). In the absence of UV-irradiation, two rather diffuse signals 
(-15 kD and 20 kD) were detected with antiserum batch 1015 (lane 5); only the 20 kD 
band was observed with batch 1016 (lane 2). A weak signal at 15 kD was noticed with 
the preimmune serum of batch 1015 (lane 6) but no signal was detected with that of 
batch 1016 (lane 1). The 15 kD and the 20 kD signals were neither UV-crosslinking nor 
antibody specific thus they were not of interest. Following UV irradiation a protein of 
--45 kD contacted the U6 RNA and was immunoprecipitated with both antisera under 
nondenaturing conditions (lanes 3 and 7) or after protein denaturation (lanes 4 and 8), 
indicating that Prp24p was UV-crosslinked to the U6 RNA. When the crude antiserum 
batch 1015 was used to immunoprecipitate the denatured protein, in addition to Prp24p 
another nonspecific signal (-20 kD) was also detected. However only the UV-
crosslinked Prp24p was precipitated with antiserum batch 1016. Two other proteins 
(--16 kD and 25 kD) were also bound to the U6 RNA and co-immunoprecipitated with 
both batches of antisera under nondenaturing conditions (lanes 3 and 7). Under these 
particular experimental conditions (i.e. U6 RNA was radiolabelled with 32P-aATP), no 
proteins of a high molecular weight were UV-crosslinked to the U6 RNA, 
immunoprecipitated with anti-Prp24 antibodies and detected on a 6% SDS-
polyacrylamide gel (data not shown). 
The analysis of both anti-Prp24 antisera demonstrated that less background signal was 
detected with batch 1016 which was therefore more suitable to investigate U6 RNA-
protein contacts. 
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Figure 22. Proteins UV-crosslinked to the U6 RNA and 
immunoprecipitated with crude anti-Prp24 antisera. 
U6 snRNPs were reconstituted (50 .i1 reaction) with a U6 RNA transcribed in 
vitro using pUC12U6 linearized with Dral as template and 32P-aATP as 
source of radioactivity (section 2.4.4.1). Proteins were UV-crosslinked to the 
nucleic acids and then incubated with preimmune serum (lanes 1 and 6) or 
with the crude anti-Prp24 antiserum under nondenaturing conditions (lane 3 
and 7) or after protein denaturation (lanes 4 and 8). UV-irradiation was 
omitted in lanes 2 and 5. Immunoprecipitation and washes were carried out 
with 150 mM NaCl. Proteins were resolved on a 15% SDS-polyacrylamide gel 
and detected by autoradiography. 
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5.2.1.2 Characterisation of affinity purified anti-Prp24 and anti-Ussi antibodies 
The analysis by Western blotting of proteins detected from a total yeast extract 
with the crude anti-Prp24 or anti-Ussi antisera indicated that both lots of antibodies 
were reacting with Prp24 or Uss 1 respectively and also with numerous additional 
proteins, see Figure 23 (Panels A and B, lane 1). 
Nonspecific UV-crosslinking signals were detected when both batches of crude anti-
Prp24 antisera were used to immunoprecipitate the protein complexes, with batch 1016 
being better (Figure 22). Also when denatured proteins UV-crosslinked to U6 RNA 
were immunoprecipitated with the crude anti-Ussi antiserum, Ussip and two additional 
polypeptides (-45 kD and -190 kD) were detected (data not shown). To improve the 
specificity of detection of the proteins UV-crosslinked to the U6 RNA, anti-Prp24 and 
anti-Uss 1 antibodies were affinity purified from their respective crude serum (section 
2.9.5). Also the use of affinity purified anti-Ussi antibodies would indicate whether the 
additional polypeptides (45 kD and 190 kD) UV-crosslinked to the U6 RNA and 
immunoprecipitated after proteins denaturation were contaminating proteins or if they 
were sharing homology with Ussip. No background signal was detected when the 
crude anti-Prp8 antiserum was used in the immunoprecipitation step; therefore no 
affinity purification of these antibodies was required. 
In order to limit the cross reactivity with other unrelated polypeptides, anti-Prp24 
antibodies were affinity purified (section 2.9.5 ) against a fusion protein (6X His-Prp24) 
different from the one (3-galactosidase-Prp24p) used to raise polyclonal antibodies 
from rabbits (Table 10). Likewise anti-Ussi antibodies were affinity purified against a 
(TrpE-Ussl) fusion protein while they were raised against Ussip fused to the 13 -
galactosidase (Table 10). The proteins detected by Western blotting with the crude or 
the purified anti-Prp24 and anti-Ussi antibodies are shown in Figure 23. The affinity 
purification of both antisera greatly decreased the number of cross-reacting proteins 
(Panels A and B, compare lanes 2 and 3). In addition to Prp24p, one weaker signal (60 
kD) was detected from a yeast total extract with the affinity purified anti-Prp24 
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Figure 23. Characterisation of the affinity purified anti-Prp24 and anti-
Ussi antibodies. 
Detection by Western blotting of Prp24p and Ussip. Yeast S150-2B 
(pBM24:CEN4, URA3, GAL]-PRP24) cells (Tables 7 and 9) were grown in 
YMG1yLac medium (section 2.1.2.3) supplemented with tryptophan (Table 5) 
and galactose was added (20% (v/v) final) when cells reached the exponential 
phase. After 5h galactose-induction of PRP24 expression, cells were harvested 
and proteins extracted (section 2.5.2). The protein content was estimated by 
Bradford assay (section 2.5. 1) and proteins were loaded on a 10% SDS-
polyacrylamide gel. After resolution, proteins were transferred to a PVDF 
membrane by Western blotting (section 2.5.6), detected by Ponceau staining 
and the membrane was cut into several bands each containing an equal amount 
of proteins (100 pg). A band was incubated with the preimmune serum 1/1000 
fold diluted (lane 1) or with the crude anti-Prp24 antiserum batch 1016 
(1/1000 fold dilution) (lane 2) or with the affinity purified anti-PR-P24 
antibodies (1/1000 fold dilution) (lane 3). 
Yeast MCY4 (LEU2-GALJ-USSJ, pYEP24-USS1) cells (Tables 7 and 9) 
were grown in YPDA (section 2.1.2.3), cells were harvested at the exponential 
phase and proteins extracted (section 2.5.2). Proteins were resolved on a 15% 
SDS-polyacrylamide gel, transferred on a PVDF membrane which was cut 
into several bands (each containing 100 p.g of proteins). One band was 
incubated with the preimmune serum (1/1000 fold dilution) (lane 1), or with 
the crude anti-Ussi antiserum (1/1000 fold dilution) (lane 2) or with the 
affinity purified anti-Ussi antibodies (lane 3). 
Sn-RNAs associated with the affinity purified anti-Prp24 and anti-Ussi 
antibodies and with the crude anti-Prp8 antiserum. A yeast splicing extract (40 
p1) prepared from SC261 cells (Table 7) was added in a splicing reaction (100 
p1) and snRNAs were co-immunoprecipitated with the affinity purified anti-
Prp24 (lane 4) or anti-Ussi (lane 5) antibodies or with the crude anti-Prp8 
antiserum (lane 6). As controls, the mixture was incubated with PAS beads 
only (lane 2) or with the preiminune serum (lane 3). Immunoprecipitation and 
washes (section 2.8) were carried out under 150 mM NaCl. Co-
immunoprecipitated snRNAs were recovered, resolved on a 6% 
urea/polyacrylamide gel and tranferred on a nylon membrane (section 2.4.4.3). 
The presence of Ul, U2, U4, U5 and U6 snRNAs was detected by 
hybridization with end-radiolabelled (section 2.4.3.10) oligodeoxynucleotides 
486A, G1803, 483A, 485A and Taq6A respectively (Table 8). Total yeast 
RNA was extracted from 5 jtl of splicing extract (section 2.8) (lane 1). 
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antibodies. Also, in addition to Ussip, two other weaker signals (a doublet at 70-80 
kD) were detected with the affinity purified anti-Ussi antibodies. 
The ability of the affinity purified anti-Ussi and anti-Prp24 antisera to co-
immunoprecipitate snRNAs was tested (section 2.8) and compared with one another 
and with the snRNAs co-immunoprecipitated with anti-Prp8 antibodies (Figure 23; 
Panel C). Like the crude anti-Prp24 antiserum (see Figure 17), the affinity purified 
antibodies co-immunoprecipitated the U6 snRNA and very little of U4 snRNA (lane 4). 
The affinity purified anti-Uss 1 antibodies co-immunoprecipitated the U4 snRNA and 
the U6 snRNA, no U5 snRNA was detected (lane 5), whereas a small fraction of U5 
snRNAs was co-immunoprecipitated with the crude antiserum (Cooper et al., 1995, and 
see Figure 35). The U4 snRNA, the U6 snRNA and the two species of U5 snRNAs 
were co-immunoprecipitated with anti-Prp8 antibodies (lane 6). No Ui or U2 snRNAs 
were detected since no precursor mRNA was added in the reaction mix, therefore very 
little, if any, spliceosomes formed and were isolated with anti-Prp8 antibodies. 
5.2.1.3 Influence of the radiolabelled U6 RNA on the U6 RNA-protein contacts 
detected 
The DNA template (PCU6) containing 6 extra nucleotides at its 5' end (see 
section 4.4) was used to transcribe in vitro a U6 RNA radiolabelled with either 32P-
aATP, 32P-aCTP or 32P-aUTP. U6 snRNPs were reconstituted with each of these U6 
RNAs containing the same specific activity. Subsequently, RNA-protein contacts were 
investigated by UV-crosslinking and protein complexes were immunoprecipitated with 
anti-Prp24, anti-Ussi and anti-Prp8 antibodies. The signals detected with U6 RNA 
labelled with 32P-aATP are UV-irradiation dependent (Figure 24, lanes 1, 3, 5). The 
digestion with RNase A and Ti of U6 RNA produces fragments which contain more A 
than T or C residues, since neither of these enzymes cleaves after an A. Therefore, even 
if the UV-crosslinking dependency of the signals has not been investigated with U6 
32  a 	i i RNA labelled with 32  P-aCTP or with P- UTP, t s more likely that no signal would 
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Figure 24. Proteins UV-crosslinked to U6 RNA randomly radiolabellcd 
with different nucleotides. 
U6 RNA was transcribed from a DNA template amplified by PCR (PCU6) 
with oligodeoxynucleotides Loryl and S5761 (Table 8) used as primers. This 
U6 RNA was radiolabelled with either 32P-aATP, 32P-aCTP or 32P-aUTP 
with the same specific activity (section 2.4.4.1). U6 snlRNPs were 
reconstituted (100 l) with 5 nM of each of these U6 RNAs. Proteins were 
UV-crosslinked to the nucleic acids and co-immunoprecipitated with the 
affinity purified anti-Prp24 (lanes 4, 8, 11) or anti-Ussi (lanes 2, 7, 10) 
antibodies or with the crude anti-Prp8 antiserum (lanes 6, 9, 12). UV-
crosslinking was omitted in samples 1, 3 and 5. Protein complexes were 
washed with NTN buffer (section 2.8) containing 150 mM NaCl, half of the 
proteins were loaded on a 6% SDS-polyacrylamide gel and the other half were 
loaded on a 15% SDS-polyacrylamide gel. 
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have been observed in the absence of UV-irradiation. After U6 snRNP reconstitution 
and UV-crosslinking, the intensity of the bands varies according to the radioactive 
nucleotide used to label the U6 RNA. For each radioactive U6 RNA tested, proteins 
were most efficiently co-immunoprecipitated with anti-Prp24 antibodies. Weaker 
signals were obtained with the U6 RNA labelled with 32P-aATP (lanes 2, 4, 6) or with 
32P-aCTP (lanes 7-9) compared with 32P-aUTP, which gave by far the strongest LIV-
crosslinking signals (lanes 10-12). Also with 32P-aUTP, an additional 10 kD protein 
was UV-crosslinked and immunoprecipitated with all the antisera used. 
The use of 32P-aUTP to radiolabel the U6 RNA transcribed in vitro from PCU6 
template, gave the best detection of proteins UV-crosslinked to the RNA. Therefore U6 
RNA was radiolabelled only with 32P-cUTP while the U6 RNA transcribed from 
pUC12U6 linearized with Dral was radiolabelled with 32P-aATP. In order to 
distinguish between these two RNAs, we conventionally named the former U6 RNA 
(32P-aUTP) and the latter U6 RNA (32P-aATP). 
5.2.2 Proteins contacting the U6 RNA and isolated with anti-Prp24, anti-Ussi 
and anti-Prp8 antibodies 
Immunoprecipitated proteins detected after U6 snRNP reconstitution with the 
U6 RNA (32P-(xUTP) and UV-crosslinking are shown in Figure 25. Prp24p contacted 
the U6 RNA and was immunoprecipitated with the affinity purified anti-Prp24 
antibodies under nondenaturing conditions or after protein denaturation (15% gel; lanes 
3, 4). This binding was antiserum and UV-irradiation specific (lanes 1 and 2). A protein 
of -25 kD contacted the U6 RNA and was immunoprecipitated with the affinity 
purified anti -Uss 1 antibodies under nondenaturing conditions or after protein 
denaturation (15% gel; lanes 5 and 6), thus Ussip contacted the U6 RNA. Likewise a 
protein of> 210 kD was detected after UV-crosslinking and immunoprecipitation with 
anti-Prp8 antibodies under nondenaturing conditions or after protein denaturation (6% 
gel; lanes 7 and 8) indicating that Prp8p was also in close proximity to the U6 RNA. 
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Figure 25. Proteins UV-crosslinked to the randomly radiolabelled U6 
RNA (32P-aUTP). 
A U6 snRNP reconstitution reaction (100 t1) was prepared, proteins were 
immunoprecipitated with the affinity purified anti-Prp24 antibodies under 
nondenaturing conditions (lane 3) or after proteins denaturation (lane 4), or 
anti-Ussi antibodies under nondenaturing conditions (lane 5) or after protein 
denaturation (lane 6). UV-crosslinked proteins were also co-
immunoprecipitated with the crude anti-Prp8 antiserum under nondenaturing 
conditions (lane 7) or after protein denaturation (lane 8). Samples were 
incubated with the preimmune serum in lane 1 or were not UV-irradiated in 
lane 2. Precipitations and washes were carried out under 150 mM NaCl. Half 
of the protein complexes were resolved on a 6% SDS-polyacrylamide gel and 
the other half on a 15% SDS-polyacrylamide gel. The star symbol on the 6% 
SDS-PAGE highlight the protein bands. 
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On a 6% and 15% SDS-PAGE gels (Figure 25), five additional proteins (10 kD, 16 kD, 
25 kD, 70-75 kD and 90 kD; lane 3) were co-immunoprecipitated under nondenaturing 
conditions with anti-Prp24 antibodies. Six other polypeptides (10 kD, 16 kD, 45 kD, 
70-75 kD, 80 kD and 90 kD; lane 5) were UV-crosslinked to U6 RNA and co-
immunoprecipitated with anti-Ussi antibodies. At least eight other polypeptides (10 
kD, 16 kD, 25 kD, 43 kD, 65-70 kD, 70-75 kD and --85kD; one at >210 kD; lane 7) 
were detected with anti-Prp8 antiserum under nondenaturing conditions. 
Proteins of similar sizes were UV-crosslinked to the U6 RNA and co-
immunoprecipitated with the three different antisera tested. In particular, the 25 kD 
protein detected with anti-Prp24 and anti-Prp8 antibodies migrated to the same position 
as Ussip. In order to identify this polypeptide we followed Ussip in snRNP particles 
immunoprecipitated with the three lots of antibodies previously used. For this purpose, 
splicing extract was prepared from MCY4 (LEU2-GALJ-USSJ, pAEM13; Tables 7 and 
9) cells grown on glucose-containing medium. In this extract cells overproduce a Ga14-
Ussi fusion protein (Gussip) as only the source of Ussip. This fusion protein possesses 
a theoretical molecular weight of 37 kD and is functional since it complements the 
Ussip defect in vivo (A. Mayes, this lab; personal communication). The splicing 
activity and the U6 snRNP reconstitution efficiency of an extract containing only 
Guss 1 p  were tested (Figure 26; Panel A). The splicing activity of the extract prepared 
from MCY4 (pAEM13) was weaker than that detected in an extract prepared from 
wild-type SC261 cells (Table 7) (compare lane 1 versus 4). The spliced RNA and the 
lariat-intermediate detected in the former extract were longer that the one observed in 
the latter. Maybe in MCY4 (pAEM13) cells the pre-mRNAs were polyadenylated. No 
splicing activity was detected when the endogenous U6 snRNA was degraded (lanes 2 
and 5). Splicing activity was recovered in both extracts by addition of U6 RNA (32P - 
aUTP) (lanes 3 and 6); about 50 % of the initial activity (in respect to excised lariat-
intron, and lariat-intron-exon2 signals) was restored after U6 snRNP reconstitution. 
This demonstrated that the Gussi fusion protein was also functional in vitro and had no 
detrimental effect on the reconstitution of the U6 snRNP particles and the splicing 
activity of the extract. 
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Figure 26. Ussip contacts the U6 RNA in the U6 snRNP 9 the U41U6 
snRNP and in the tni-simNP. 
U6 snRNP reconstitution in extracts producing either Ussip or Gussip. 
The initial splicing activity of an extract prepared from SC26 1 cell (Lane 1) or 
from MCY4 (pAEM1 3) cells grown on YPDA (Tables 7 and 9) (lane 4) was 
tested after preincubation at 30 °C for 30 mm. The addition of 140 nM of U6 
knockout DNA oligo was sufficient to completely deplete the endogenous U6 
snRNA and abolish the splicing activity of the extracts (lanes 2 and 5). U6 
snRNPs were reconstituted (60 p.1 reaction) with 5 nM of randomly 
radiolabelled U6 RNA (32P-aUTP). An aliquot (9 p.1) was taken off and 1 p.1 of 
radiolabelled precursor mRNA (20 000 cpm) was added (lanes 3 and 6). After 
splicing, RNA species were extracted, loaded on a 7M urealpolyacrylamide 
gel and detected by autoradiography. IVS: excised lariat-intron; IVS-E2: 
lariat-intron-exon2; El: exoni; pre-mRNA: actin substrate RNA (P283, Table 
9); mRNA: spliced RNA; U6 RNA: RNA produced by transcription in vitro 
and radiolabelled with 32P-aUTP. 
Investigation of U6 RNA-protein contacts in U6 snRNP, U4/1J6 snRNP 
and U411J6.U5 tri-snRNP. U6 snRNPs (60 p.1 reaction) were reconstituted with 
5 nM of U6 RNA (32P-aUTP) after UV-crosslinking proteins were 
immunoprecipitated with affinity purified anti-Prp24 antibodies under 
nondenaturing conditions (lane 2) or with affinity purified anti-Ussi 
antibodies under nondenaturing conditions (lanes 4 and 6) or after protein 
denaturation (lanes 5 and 7). Proteins complexes were also 
immunoprecipitated with the crude anti-Prp8 antiserum under nondenaturing 
conditions (lanes 9 and 10). UV-irradiation was omitted in lanes 1, 3, 5 and 8. 
Protein complexes were washed with NTN buffer (section 2.8) containing 150 
mM NaCl, loaded and resolved on a 15% SDS-polyacrylamide gel. WT: 
splicing extract prepared from wild-type SC261 cells; Gal: splicing extract 
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U6 snRNPs were reconstituted with U6 RNA (32P-(xUTP) from a wild-type extract or 
from an extract containing the Gussi fusion protein. After UV-crosslinking proteins 
were immunoprecipitated with different antisera and resolved on a 15% SDS-PAGE 
(Figure 26, Panel B). Little difference was observed in the intensity of the signals 
between the two extracts tested (compare lanes 4/6, 5/7 and 9/10, and compare Figure 
25 lane 3 with Figure 26 lane 2). Therefore the weaker splicing activity of the extract 
containing Gussip did not affect the U6 RNA-protein contacts. The reconstitution 
efficiency of the U6 snRNP particles was probably similar in both extracts. In extract 
prepared from MCY4 (pAEM1 3) grown on YPDA (section 2.1.2.3), signals in the 20-
30 kD range were much reduced whereas a protein of a size (40 kD) similar to Guss I  
was observed which was not detected in a wild-type extract (compare lanes 4 and 6). 
This 40 kD polypeptide was also immunoprecipitated with anti-Ussi antibodies after 
protein denaturation (lane 7) demonstrating that Gussip contacted the U6 RNA. The 
fusion of the Ga14 to Ussip did not interfere with its interaction with the U6 RNA. Also 
in the extract containing the fusion protein, two additional proteins (16 kD and 45 kD) 
were UV-crosslinked to the U6 RNA and immunoprecipitated under nondenaturing 
conditions with anti-Ussi antibodies (lane 6). Similar signals were detected when 
protein extracted from SC261 cells were UV-crosslinked to the U6 RNA and 
immunoprecipitated with the same antibodies (lane 4) suggesting that, if these bands 
corresponded to identical polypeptides, their binding to the U6 molecule was extract 
independent. The 25 kD protein UV-crosslinked to the U6 RNA from a wild-type 
extract (Figure 25, 15 % gel; lane 3) and co-immunoprecipitated with anti-Prp24 
antibodies was not detected anymore in an extract containing the fusion Gussi protein, 
instead, a new protein (40 kD) was observed (Fig 26, lane 2). Therefore the 25 kD 
protein was indeed Ussip in close proximity to the U6 RNA in a Prp24p-containing 
protein complex. Likewise, the 25 kD protein UV-crosslinked to the U6 RNA and co-
immunoprecipitated with anti-Prp8 antibodies was shifted up to a band of -40 kD in an 
extract containing Gusslp (Figure 26, compare lanes 9 and 10); thus Usslp also 
contacted the U6 RNA in Prp8p-containing protein complex. 
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By using the same band shift principle it was attempted to identify the 45 kI) 
polypeptide co-immunoprecipitated with anti-Ussi antisera. As the Prp24 protein 
tagged with the FLAG-epitope was not functional (Chapter 3), YVDP24 
(prp24. :HIS3/PRP24) cells were transformed with the plasmid pGPRP24 (Table 9). 
This plasmid harbours the gene encoding Prp24p fused at its N-terminus with the Ga14 
DNA binding domain (A. Colley, this lab). The corresponding fusion protein 
(Gprp24p) possessed a theoretical molecular weight of 65-70 kD. Despite several trials, 
no sporulation of YVDP24 (pGPRP24) was obtained, therefore no functional 
complementation test was carried out for this fusion protein. Splicing extracts were 
prepared from YVDP24 (pGPRP24) and proteins were UV-crosslinked to the U6 RNA, 
denatured and immunoprecipitated with anti-Prp24 antibodies. Two protein signals (45 
kD, --65 kD) were detected (data not shown) with the 65 kD band being much weaker 
than Prp24p signal. This suggested that compared to the wild-type protein, much less of 
the fusion Gprp24p was incorporated into snRNP particles and/or UV-crosslinked to 
the U6 RNA. As the signal for the 45 kD protein co-immunoprecipitated with anti-Ussi 
antibodies was already weak (Figure 26, compare the 45 kD band in lanes 2 and 4), the 
inefficiency of the UV-crosslinking of the fusion Gprp24 protein prevented its use for a 
band shift assay. 
Protein-U6 RNA contacts reported in this section are summarised in Table 12. 
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U6 snRNP 
(affinity purified anti- 
Prp24 antisera) 
U6 snRNP + U41U6 
snRNP 
(affinity purified anti- 
Ussi antibodies) 








90 kD -.90 kD 
85 kD 
80 k 
70-75 kD 70-75 kD 70-75 kD 
65-7OkD 
45 k 45 	k 
(Prp24p) 
43 kD 
25 	k 25 	k 25 	k 
(Ussip) (Ussip) (Ussip) 
16 k 16 k 16 k 
10 k 10 k 10 k 
Protein molecular weights indicated in Table 12 were determined according to the 
molecular markers run alongside the reaction samples on the same protein gel. The size 
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values reported are not very precise and depend on the accuracy of the supplied protein 
ladder and the resolution ability of the protein gel used. 
5.3 	Discussion 
Western blotting analysis indicated that both affinity purified anti-Prp24 and 
anti-Ussi antibodies recognised specifically Prp24p and Ussip in a total protein extract 
prepared from yeast cells overproducing Prp24p or Ussip respectively. One additional 
polypeptides (65 kD) was detected with anti-Prp24 antisera; also two other proteins 
(-70-80 kD) were recognised by anti-Ussi antisera. These proteins were most likely 
cross-reacting polypeptides. The analysis by Northern blotting of the snRNAs co-
immunoprecipitated with the affinity purified antisera indicated that the purification of 
anti-Prp24 antibodies had not altered their ability to precipitate the U6 snRNA and 
traces of U4 snRNA. The affinity purified anti-Ussl antibodies co-immunoprecipitated 
the U4 snRNA and the U6 snRNA but unlike the crude antiserum, no U5 snRNA was 
recovered (see Figure 35 and Cooper et al., 1995). Probably the antibodies recognising 
Usslp in the tri-snRNP have not been selected during the purification procedure. The 
affinity purification of both lots of antibodies greatly improved their binding specificity 
since in the absence of UV-irradiation no proteins were detected after 
immunoprecipitation. When denatured proteins were immunoprecipitated with the 
affinity purified anti-Prp24 or anti-Ussi antibodies only Prp24 and Ussi respectively 
were detected by autoradiography. Thus the -P45 kD and the 190 kD polypeptides 
detected after protein denaturation and immunoprecipitation with the crude anti-Ussl 
antiserum were artefactually isolated with this antiserum. The 45 kD polypeptide could 
have been Prp24p remaining associated with the denatured Ussip since both proteins 
are present in the U6 snRNP particle co-immunoprecipitated with anti-Prp4 or with 
anti-Uss 1 antiserum. 
The strongest protein-U6 RNA UV-crosslinking signals were obtained when the U6 
RNA was radiolabelled with 32p-aUTP, while much weaker signals were detected when 
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the U6 RNA was radiolabelled with 32p-aATP or with 32p-aCTP. This difference was 
particularly striking for the 10 kD signal which was visible only when U6 RNA (32p-
(xUTP) was used. The relatively inefficient UV-crosslinking of proteins to the U6 RNA 
radiolabelled with 32p-aATP confirmed that purines were not the most photoreactive 
bases. Although cytidine was theoretically much more reactive than adenosine, proteins 
were as inefficiently UV-crosslinked to the U6 RNA (32p-aCTP) as to the U6 RNA 
(32p-aATP). The best UV-crosslinking results were obtained with the U6 (32p-aUTP) 
indicating that, in addition to being a photoreactive base, proteins were contacting the 
U6 RNA preferentially at uridine residues rather than at cytidine. In particular the 10 
kD polypeptide was more likely to bind the U6 RNA in a U-rich sequence. 
The study of the proteins UV-crosslinked to the U6 RNA confirmed that Prp24p was in 
close proximity to the U6 RNA in the U6 snRNP (Jandrositz and Guthrie, 1995; Ghetti 
et al., 1995; this study). Although we failed to confirm the identity of the 45 kD band 
UV-crosslinked to the U6 RNA and co-immunoprecipitated with anti-Ussi antibodies, 
as this antiserum co-immunoprecipitate the U6 snRNP and the U4/1J6 snRNP particles, 
it is highly probable that this protein was actually Prp24p. 
Ussip is an Sm-like U6 snRNP specific protein which shares significant homology 
with the yeast SmD3 core protein (Cooper et al., 1995). To date, the only known 
interaction between a core protein and snRNA is that between the 5' moiety of the Ui 
snRNA Sin site and the G protein. This contact was demonstrated by UV-crosslinking 
experiments in HeLa cells (Heinrichs et al., 1992). Ussip does not contain a good 
match to any of the characterised RNA binding motifs, making it hard to predict its 
direct binding with U6 snRNA. The UV-crosslinking experiments described in this 
work indicate that actually Ussip contacts the U6 RNA in the U6 snRNP, U4/1J6 
snRNP and in the tri-snRNP. Ussip is required for U6 snRNA stability (Cooper et al., 
1995); it may stabilises the U6 RNA molecule through its direct binding. 
Prp8p is exceptionally large (280 kD) and its size and sequence are highly conserved 
(Hodges et al, 1995), suggesting it has an important role to play. Although Prp8p 
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contains no obvious similarities to known RNA-binding motifs, it is known to bind at 
least three different RNAs: exoni of the pre-mRNA; the 3' splice site of the lariat 
intermediate (Teigelkamp et al., 1995, 1995b); U5 snRNA (Ian Dix et al., 1998). Now 
a fourth interaction has been demonstrated with U6 RNA; indeed we have shown that 
Prp8p contacts the U6 RNA in the U4/U6.U5 tri-snRNP. Prp8p may stabilise U6 
snRNA-RNA interaction(s) as has been proposed for the U5 snRNA and the 5' and 3' 
splice site contacts in the spliceosome (Beggs et al., 1995; Teigelkamp etal., 1995). 
In addition to Prp24p, Ussip and Prp8p, other unidentified polypeptides were in close 
proximity to the U6 RNA (see Table 12). Some of them contacted the U6 RNA in all 
snIRNP particles, while others seem to release from the U6 RNA (or to be more loosely 
associated with the U6 RNA) as snRNP particle assembly progressed and other proteins 
seem to contact the U6 RNA only in the tri-snRNP. From these observations and by 
assuming that proteins of similar size and precipitated with different antisera 
correspond to identical entities, we can speculate that a pool of protein (at least 10 kD, 
16 kD, Ussip, 70-75 kD) contacts the U6 RNA in the U6 snRNP and remain associated 
at least until in the tri-snRNP particle while other proteins move away from or contact 
the U6 snIRNA as snRNP assembly progresses. This gives us a first dynamic picture of 
the U6 RNA-protein interactions detected by UV-crosslinking. Therefore it would be 
very interesting to follow these contacts in the spliceosome and also to identify the 
unknown polypeptides detected so far. 
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CHAPTER SIX 




Prp24p, Ussip and SmX4p/Uss2p are associated with the U6 snRNA (Shannon 
and Guthrie, 1991; Jandrositz and Guthrie, 1995; Ghetti et al., 1995; Cooper et al., 
1995; Séraphin, 1995). Five ORFs (YJL124c, YBL026w, YER146w, YDR378c and 
YNL 147w) encoding putative U6 snRNP proteins which share homology with the core 
proteins have been identified (Séraphin, 1995; Fromont-Racine et al., 1997, see section 
1.4.3.2). Two additional ORFs (YJR022c and SMX1/YCR020Ca) encoding yeast 
proteins containing the Sin motifs but not much other similarity with the core proteins 
have been identified by computer sequence analysis (Séraphin, 1995; Fromont-Racine 
et al., 1997). An exhaustive two-hybrid screen showed that the protein encoded by 
YJR022w contacts Ussip and the putative U6 snRNP-specific Uss5, Uss6, Uss7 
proteins (Fromont-Racine et al., 1997; A. Mayes, 1998). Further screens using the Sm-
like U6 snRNP proteins as baits have generated an entire network of protein-protein 
interactions suggesting that all these polypeptides are interacting (directly or indirectly) 
with each other (A. Mayes, 1998). 
The deletion in haploid yeast cells of the ORFs encoding the Sm-like proteins is 
associated with a lethal or a temperature-sensitive phenotype, correlated (for most of 
them) to a detrimental effect on the level of U6 snRNA in the cells (A. Mayes, 1998). 
Immunoprecipitation and Northern blotting analysis showed that the Sm-like proteins 
are associated with the U6 snRNA. Taken together these data suggest that these 
polypeptides constitute a set of U6 snRNP specific proteins. 
The direct binding of the Sm-like proteins to the U6 snRNA was investigated by UV-
crosslinking and the results are presented in this chapter. 
A description of the yeast strains used in this chapter is reported in Table 13. 
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Table 13. Description of the yeast strains used in this chapter. 
These strains have been constructed by A. Mayes (this Lab; 1998). They are 
all haploids and contain a deleted ORF encoding an Sm-like U6 snRNP-
associated protein. The missing protein is supplied in trans by a corresponding 
fusion protein. The sequence encoding the fusion polypeptide is provided by a 
plasmid contained in the yeast strain (Table 7). Only the AEMY28 strain does 
not harbour a deleted ORF. Instead, the sequence encoding the HA-epitope has 
been inserted onto the yeast genome upstream of the YJL124c ORF. 
Name 	ORF deleted 	Plasmid 	Particular characteristics 
complementing 
the ORF deletion 
AEMY42 YNL147w pAEM59 Overproduce LexA-Uss5p (34 kD) 
YNL147w pAEM62 Overproduce HA-Uss5p (13 kD) 
AEMY44 YDR378c pAEM34 Overproduce LexA-Uss4p (36 kD) 
YDR378c pAEM61 Overproduce HA-Uss4p (17 kD) 
AEMY31 YLR438c pAEM64 Overproduce HA-Uss2p (20 lcD) 
AEMY29 	YER146w 	pAEM70 	Overproduce Ga14-HA-Uss7p (35 
kD) 
AEMY28 	No ORF 	Insertion of the Produce HA-Spb8p (22-23 lcD) 
deletion sequence coding 
for the HA epitope 
upstream the 
YJL124cORF 
AEMY46 	YBL026w 	pAEM68 	Overproduce Uss6-HAp (13 kD) 
LMA4-2A 	YJR022w 	pAEM71 	Overproduce Ga14-HA-Uss3p (38 
kD) 
6.1 Investigation of U6 RNA-Uss5p Contacts 
The deletion of the YNL147c ORF in haploid cells is associated with a 
temperature-sensitive phenotype at 37 0C, and a diminution of the level of U6 snRNA is 
observed at the restrictive temperature. Immunoprecipitation and Northern blotting 
analysis showed that Uss5p is associated with the U6 snRNA and with the U4 snIRNA 
probably indirectly via its interaction with the U6 snRNA (A. Mayes, 1998). 
Uss5p is a 12 kD protein. Its direct binding with the U6 RNA was investigated in two 
ways (Figure 27). 
Splicing extracts were prepared from AEMY42 yeast cells (Table 13) overproducing 
a LexA-Uss5 fusion protein. The LexA is located at the N-terminus of Uss5p and the 
fusion protein possesses a theoretical molecular weight of 34 kD, permitting its 
identification by size, compared to results with untagged protein. 
Splicing extracts were prepared from AEMY43 cells (Table 13) overproducing an 
HA epitope-tagged Uss5 protein. The HA epitope is located at the N-terminus of Uss5p 
and the fusion protein possesses a calculated molecular weight of —13 kD (A. Mayes, 
1998). This permits its identification by immunoprecipitation with anti-HA antibodies 
rather than by the very small size difference. 
U6 snRNPs were reconstituted with U6 RNA (32P-aUTP) in splicing extract containing 
LexA-Uss5p or in an extract prepared from wild-type SC261 yeast cells. After UV-
crosslinking, proteins were immunoprecipitated under nondenaturing conditions with 
anti-Prp24 (Figure 27; lanes 3 and 4) or anti-Ussl antibodies (Figure 27; lanes 5 and 6) 
or with anti-Prp8 antiserum (Figure 27; lanes 7 and 8). The --16 kD signal detected in a 
wild-type extract was much weaker in an extract containing the LexA-Uss5 fusion 
protein, also, an additional band at 30-40 kD was detected (compare lane 3 versus 4, 
lane 5 versus 6, lane 7 versus 8). This band shift was observed with the protein 
complexes co-immunoprecipitated with either anti-Prp24, anti-Ussi or with anti-Prp8 
antibodies. Thus LexA-Uss5p contacts the U6 RNA in the U6 snRNP, in the tri-snRNP 
and probably in the U4/U6 snIRNP. U6 snRNPs were reconstituted in a splicing extract 
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Figure 27. Analysis of U6 RNA-Uss5p contacts. 
U6 snRNPs were reconstituted (50 .xl) with a randomly radiolabelled U6 RNA 
(32P-aUTP) (5 nM) in splicing extract prepared from: SC261 cells; AEMY42 
cells overproducing the LexA-UssS fusion protein; AEMY43 cells 
overproducing the HA-Uss5 fusion protein. After UV-crosslinking, proteins 
were immunoprecipitated under nondenaturing conditions with the affinity 
purified anti-Prp24 antibodies (lane 1, 3, 4); anti-Ussi antibodies (lanes 5 and 
6); with anti-Prp8 antiserum (lanes 7 and 8) or with monoclonal anti-HA 
antibodies (lanes 9 and 10). Proteins were denatured then immunoprecipitated 
with anti-HA antibodies (lane 11). As controls, proteins were incubated with 
the preimmune serum in sample 2 and UV-crosslinking was omitted in sample 
1. Protein complexes were washed (150 mM NaCl) then resolved on a 15% 
SDS-polyacrylamide gel. WT: proteins extracted from SC261 cells; Lex: 
extracts prepared from cells overproducing the LexA-UssS fusion protein; HA: 







containing the HA-Uss5 fusion protein. After UV-crosslinking, proteins were 
immunoprecipitated with anti-HA antibodies under nondenaturing conditions (Figure 
27; lane 10). At least five polypeptides (10 kD, 17 kD, 25 kD, 40 kD and 50-60 kD) 
contacted the U6 RNA in a protein complex associated with HA-Uss5p. Only one 
protein (17 kD) was detected when the polypeptides were denatured before 
immunoprecipitation (lane 11), indicating that HA-Uss5p was also in close proximity to 
the U6 RNA. This fusion protein appears to contact the U6 RNA in a protein complex 
very similar (with respect to their molecular weight) to those co-immunoprecipitated 
with anti-Prp24, anti-Ussi and anti-Prp8 antisera. 
Splicing extracts prepared from cells overproducing either LexA-Uss5p or HA-Uss5p 
were functional before and after U6 snRNP reconstitution (data not shown). Thus the 
formation of snRNPs and spliceosomes was not affected by the overproduction of these 
fusion proteins. In extract containing LexA-Uss5p, apart from the 30-40 kD signal 
reflecting the UV-crosslinking of LexA-Uss5p to the U6 RNA, the other U6 RNA-
crosslinked proteins detected with anti-Prp24, anti-Uss 1 and anti-Prp8 antibodies were 
identical (with respect to their size) to the proteins immunoprecipitated with the same 
antibodies in extract prepared from wild-type cells. It is therefore unlikely that the 
binding of LexA-Uss5p to the U6 RNA is an artefact of the overproduction of this 
protein in the cells. Both LexA-UssS and the HA-Uss5 fusion proteins bind to the U6 
RNA, this contact is unlikely to be an artefact of the extra amino acids added at the N-
terminus of Uss5p. These data suggest that the Uss5 protein is in close proximity to the 
U6 RNA in the U6 snRNP, the U4/U6.U5 tri-snRNP and maybe in the U4/U6 snRNP. 
The persistence of a fraction of the 16 kD signal in extracts overproducing the LexA-
UssS protein (and not in extracts producing the untagged Uss5p) suggests that in 
addition to Uss5p, other protein(s) that co-migrate with Uss5p on a 15% SDS-
polyacrylamide gel may contact the U6 RNA. 
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6.2 Investigation of U6 RNA-Uss4p Interactions 
YDR378c encodes a 14 kD protein which shares homology with the core SmF 
protein (Fromont-Racine et al., 1997). The deletion of the YDR378c ORF in haploid 
cells is associated with a temperature-sensitive phenotype at 37 °C correlated with a 
decrease in the stability of the U6 snRNA. Immunoprecipitation and Northern blotting 
analysis showed that Uss4p is associated with the U6 snRNA and with the U4 snRNA, 
probably through its interaction with the U6 snRNA (A. Mayes, 1998). 
Two splicing extracts were prepared. One was made from AEMY44 (Table 13) cells 
overproducing a LexA-Uss4 fusion protein which possesses a molecular weight of 36 
kD. The second extract was made from AEMY45 (Table 13) cells which overproduce 
an HA epitope-tagged Uss4 fusion protein of 17 kD. 
The U6 RNA-Uss4p contacts were investigated by UV-crosslinking (Figure 28). The 
detected signals are UV and antisera specific (lanes 1, 2). In extracts overproducing the 
LexA-Uss4 fusion protein, a signal at -35 kD was noticed while a very weak signal 
remained at -16 kD. This 35 kD protein was not detected when U6 snlRNPs were 
reconstituted in an extract prepared from the wild-type SC26 1 cells (compare lanes 3 
and 4, 5 and 6, 7 and 8). This difference was observed in the protein complexes co-
immunoprecipitated with the three varieties of antibodies tested, indicating that LexA-
Uss4p contacts the U6 RNA in the U6 snRNP, the U4/U6.U5 tri-snRNP and maybe in 
the U41LJ6 snRNP. In extracts prepared from cells overproducing HA-Uss4p, several 
proteins (10 kD, 18 kD, 25 kD, 45 kD, 60 kD and other signals of undefined higher 
molecular weights) were co-immunoprecipitated with anti-HA antibodies (Figure 28, 
lane 10). Only the -18 kD signal remained, after immunoprecipitation of denatured 
proteins (lane 11). Thus HA-Uss4p is in close proximity to the U6 RNA in a complex 
of proteins very similar (with respect to their apparent molecular weight) to those 
precipitated with anti-Prp24, anti-Ussi or with the anti-Prp8 antibodies. 
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Figure 28. Analysis of U6 RNA-Uss4p contacts. 
U6 snRNPs were reconstituted (50 p1) with 5 nM of randomly radiolabelled 
U6 RNA (32P-(xUTP) in a splicing extract prepared from: SC261 cells; 
AEMY44 cells overproducing the LexA-Uss4 fusion protein; AEMY45 cells 
overproducing the HA-Uss4 fusion protein. After UV-crosslinking, proteins 
were immunoprecipitated under nondenaturing conditions with the affinity-
purified anti-Prp24 (lane 1, 3, 4) or anti-Ussi antibodies (lanes 5 and 6) or 
with anti-Prp8 antiserum (lanes 7 and 8) or with monoclonal anti-HA 
antibodies (lanes 9 and 10). Proteins were denatured then immunoprecipitated 
with anti-HA antibodies (lane 11). As controls, proteins were incubated with 
preimmune serum in sample 2 and UV-crosslinking was omitted in sample 1. 
Protein complexes were washed (150 mM NaCl) then resolved on a 15% SDS-
polyacrylamide gel. WI: proteins extracted from SC261 cells; Lex: extracts 
prepared from cells overproducing the LexA-Uss4 fusion protein; HA: extracts 
prepared from cells overproducing the HA-Uss4 fusion protein. 
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These data demonstrate that LexA-Uss4p and HA-Uss4p bind to the U6 RNA. For the 
same reasons as were indicated for the binding of Uss5p to the U6 RNA, the interaction 
of the LexA-Uss4p and the HA-Uss4p fusion proteins with the U6 RNA probably 
indicates that Uss4p itself contacts the U6 RNA. 
6.3 Analysis of U6 RNA Contacts with Spb8p, Uss6p, Uss2p, Uss7p and 
Uss3p 
The deletion of the YJL 1 24c ORF in cells is associated with a temperature-
sensitive phenotype at 37 °C which is not linked with the instability of any spliceosomal 
snRNAs. Immunoprecipitation and Northern blotting analysis showed that the encoded 
Spb8 protein is only weakly associated with the U6 snRNA (not above 50 mM NaCl) 
(A. Mayes, 1998). 
The deletions of YBLO26w, YLR438c and YER146w ORFs are associated with a lethal 
phenotype. Temperature-sensitive or galactose-inducible alleles of these genes have 
been generated (A. Mayes, this lab), and an arrest of growth was observed in cells 
shifted to the nonpermissive temperature or to glucose-containing medium. This effect 
was correlated with a decrease in the levels of U6 and US L snRNAs in AEMY30 
(YBL026wt.:HIS3; pAEM55) cells (Tables 7 and 9) or in AEMY31 
(YLR438cLx::H183; pAEM64) cells grown respectively at the nonpermissive 
temperature or in glucose-containing medium (A. Mayes, 1998). The level of the 
spliceosomal snRNAs remained unchanged in AEMY29 (YER146wA:: TRP1; 
pAEM70) cells grown at nonpermissive temperature. Immunoprecipitation and 
Northern blotting analysis showed that all three proteins were associated with the U6 
snRNA and with the U4 snRNA, probably through their interaction with the U6 
snIRNA. Uss6p was also associated with a tiny amount of U5 snRNA (A. Mayes, 1998). 
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Deletion of the YJR022w ORF was lethal and no conditional allele was available. 
Immunoprecipitation data indicate that the corresponding protein is associated with the 
U6 snRNA and the U4 snRNA, probably through its association with the former. 
6.3.1 Investigation of U6 RNA contacts with Spb8p and Uss6p 
AEMY28 cells (Table 14) produce an HA-tagged Spb8 protein with molecular 
weight 22-23 kD (A. Mayes, 1998). AEMY46 (Table 13) cells grown overproduce an 
HA-tagged Uss6 protein of a size (-43 kD) (A. Mayes, 1998). As little size difference 
exists between the wild-type and the fusion proteins, in splicing extracts prepared from 
either AEMY28 or AEMY46 cells, HA-Sbp8p or Uss6-HAp will be identified by 
immunoprecipitation with anti-HA antibodies only. 
U6 snRNPs were reconstituted with U6 RNA (32P-aUTP) in splicing extracts prepared 
from AEMY28. Subsequently proteins were UV-crosslinked to the nucleic acids and 
immunoprecipitated with anti-HA antibodies under nondenaturing conditions or after 
protein denaturation (Figure 29, lanes 1-3). In an extract producing the HA-Spb8 fusion 
protein, two bands (-16 kD and a large signal at 25-27 kD) were detected after UV-
crosslinking (lane 2). Additional signal(s) of undetermined size(s) were visible at the 
top of the SDS-polyacrylamide gel (lane 2). Only a band at -P27 kD was detected when 
denatured proteins were immunoprecipitated with anti-HA antibodies (lane 3). HA-
Spb8p contacts the U6 RNA in a protein complex quite different (with respect to their 
molecular weights) than those co-immunoprecipitated with anti-Prp24, anti-Ussi or 
with anti-Prp8 antibodies. The expression of HA-YJL124c is under the control of the 
endogenous promoter, therefore as much HA-Spb8p is produced in AEMY28 cells as 
Spb8p is produced in wild-type yeast cells. The binding of HA-Spb8p cannot be an 
artefact due to overproduction. The interaction of HA-Uss5p and HA-Uss4p with the 
U6 RNA was not linked to the presence of the HA epitope, thus it is unlikely that the 
HA epitope has promoted the binding of HA-Spb8p to the U6 RNA. The UV- 
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Figure 29. Analysis of U6 RNA-Spb8p and -Uss6p contacts. 
U6 snRNPs were reconstituted (50 p.!) with a randomly radiolabelled U6 RNA 
(32P-aUTP) (5 nM) in a splicing extract prepared from AEMY28 cells 
producing an HA-Spb8 fusion protein (lanes 1, 2, 3); or from AEMY46 cells 
overproducing the Uss6-HA fusion protein (lanes 4, 5, 6). After UV-
crosslinking, proteins were immunoprecipitated under nondenaturing 
conditions with anti-HA antibodies (lanes 2 and 5), or proteins were denatured 
before immunoprecipitation with anti-HA antibodies (lanes 3 and 6). Samples 
were not UV-irradiated in lanes 1 and 4. Protein complexes were washed (150 
mM NaCl) then resolved on a 15% SDS-polyacrylamide gel. 
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crosslinking data presented here suggest that HA-Spb8p and probably also the Spb8 
protein contact directly the U6 RNA. 
U6 snRNPs were reconstituted in an extract prepared from cells overproducing the 
Uss6-HA protein. After UV-crosslinking, proteins were immunoprecipitated with anti-
HA antibodies (Figure 29, lanes 4-6). Radioactive signals were detected in the absence 
of UV-irradiation (lane 4). They probably correspond to fragments of undigested U6 
RNA interacting with proteins cross-reacting with the anti-HA antibodies, or these 
RNA fragments may interact with the PAS beads despite the washes (150 MM NaC1). 
Few proteins contacting the U6 RNA were associated with the Uss6-HA fusion protein 
(lane 5); only two signals (14 kD and 26 kD) were observed. The 14 kD band was 
detected when denatured proteins were immunoprecipitated with anti-HA antibodies 
(lane 6), suggesting that Uss6-HAp binds, although weakly, to the U6 RNA. 
6.3.2 Investigation of the U6 RNA-Uss7p, -Uss2p and -Uss3p contacts 
Splicing extracts were prepared from AEMY3 1 (Table 13) cells overproducing 
an HA epitope-tagged Uss2 protein of 20 kD. AEMY29 (Table 13) cells overproducing 
a Ga14-HA-Uss7 fusion protein of 35 kD. LMA4-2A (Table 13) cells overproducing a 
Ga14-HA-Uss3 fusion protein of 38 kD. Since there is only a small size difference 
between HA-Uss2p and Uss2p, the former can only be identified using anti-HA 
antibodies. The greater size difference (15 kD-22 kD) between Uss7p or Uss3p and 
their respective Ga14-14A-fusion proteins allowed their identification by size, since no 
polypeptide of 35 kD or 38 kD contacts the U6 RNA in protein complexes isolated with 
anti-Ussi, anti-Prp24 or anti-Prp8 antibodies (see Figure 25). These fusion proteins can 
also be identified using anti-HA antibodies. 
In extracts containing either Ga14-HA-Uss7p or HA-Uss2p, after U6 snRNP 
reconstitution and UV-crosslinking, no denatured proteins were immunoprecipitated 
with the anti-HA antibodies (Figure 30; lanes 3 and 6). No signal the size of the Ga14- 
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Figure 30. Analysis of U6 RNA-Uss7p, -Uss2p and -Uss3p contacts. 
U6 snRNPs were reconstituted (50 jil) with a randomly radiolabelled U6 RNA 
(32P-ctUTP) (5 nM) in a splicing extract prepared from AEMY29 cells 
producing an Ga14-HA-Uss7 fusion protein (lanes 1-3); from AEMY3 1 cells 
overproducing the HA-Uss2 fusion protein (lanes 4-6); from LMA4-2A cells 
overproducing the Ga14-HA-Uss3 fusion protein (lanes 7-9). After UV-
crosslinking, proteins were immunoprecipitated under nondenaturing 
conditions with anti-HA (lanes 2, 5 and 8) or with anti-Prp24 antibodies (lanes 
1 and 7). Proteins were denatured then immunoprecipitated with anti-HA 
antibodies (lanes 3, 6 and 9). Samples were not UV-irradiated in lane 4. 









HA-Uss7 protein (35 kD) was detected in the protein complexes isolated with anti-
Prp24 (lane 1) or with anti-HA antibodies (lane 2). The 10 kD band was not affected by 
the replacement in the cells of Uss2p or Uss7p by their respectively fusion proteins of a 
higher molecular weight. Thus under the experimental conditions tested, neither HA-
Uss2p nor Ga14-HA-Uss7p bind to the U6 RNA. 
In extract overproducing the Gal4-HA-Uss3 protein, after U6 snRNP reconstitution and 
UV-crosslinking, a very faint signal the size of the fusion protein (38 kD) was detected 
when proteins were co-immunoprecipitated with anti-Prp24 or with anti-anti-HA 
antibodies (Figure 30, lanes 7 and 8). An overexposure of the autorad was necessary to 
visualize this signal. A very weak signal the size of Gal4-HA-Uss3p was detected when 
after UV-crosslinking denatured proteins were immunoprecipitated with anti-HA 
antibodies (lane 9). Therefore presumably, Ga14-HA-Uss3p and probably also Uss3p 
contacts the U6 RNA but crosslinks very weakly. 
6.4 Investigation of the Binding Specificity of the Proteins to the U6 RNA 
6.4.1 The binding specificity of Spb8p 
In a splicing extract prepared from AEMY28 cells which produce the HA-Spb8 
fusion protein, U6 snRNPs were reconstituted with 5 nM of U6 RNA (32P-aUTP). 
Increasing amounts of unlabelled U6 or U2 RNAs were added in the reconstitution 
reaction as competitor RNAs. After UV-crosslinking, the proteins were denatured and 
immunoprecipitated with anti-HA antibodies (Figure 31, Panel A). Radioactive signals 
(between 18 kD and 25 kD) were detected in the absence of UV-irradiation, and also in 
UV-crosslinked samples that contain no or very little (0.5 nM) competitor RNAs (lanes 
2 and 6). These signals were probably fragments of radioactive U6 RNA which strongly 
associate with proteins cross-reacting with the anti-HA antibodies. Alternatively, these 
RNA fragments may have been attached to the PAS beads despite the washes. The 
addition of unlabelled U2 or U6 RNAs (1 nM-50 nM) competes for their binding and 
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Figure 31. Analysis of the binding specificity of the proteins to the U6 
KNA, 
In an extract prepared from AEMY28 cells producing the HA-Sb8 fusion 
protein, U6 snRNPs were reconstituted with 5 nM of U6 RNA ( 2P-aUTP) 
(lanes 1-9). Different amounts of unlabelled U2 RNA (lanes 3-5) or U6 RNA 
(lanes 6-9) were added at the same time in the reconstitution reaction (50 p.1). 
Samples were UV-irradiated, proteins denatured and immunoprecipitated with 
anti-HA antibodies. Sample 1 was not submitted to UV-crosslinking. 
In splicing extracts prepared from AEMY43 cells overproducing the HA-
Uss5 fusion protein, the endogenous U6 snRNA was depleted by RNase H 
degradation. 5nM of radiolabelled (32P-aUTP) U6 RNA (lanes 1-3); or 5 nM 
of radiolabelled U2 RNA (lanes 4, 5) was added. 5 nM of radiolabelled 
truncated actin RNA was added in an extract lacking the endogenous U6 
snRNA (lanes 6, 7). Samples were UV-irradiated (except for sample 1), then 
proteins were immunoprecipitated under nondenaturing conditions with anti-
HA antibodies (lanes 1, 2, 4, 6) or with the affinity-purified anti-Prp24 (lanes 
3, 5, 7) antibodies. Protein complexes were washed with 150 mM NaCl and 
resolved on a 15% SDS-PAGE gel. 
The endogenous U6 snRNA was depleted in a splicing extract prepared 
from SC261 wild-type cells. Then 5nM of radiolabelled (32P-(xUTP) U6 RNA 
(lanes 1-3); 5nM of radiolabelled U2 RNA (lanes 4, 5); 5nM of radiolabelled 
actin RNA harboring Exoni and a short intron sequence finishing after the 
branchpoint (lanes 6, 7) was added. Samples were UV-irradiated (except for 
sample 1), then proteins were inmiunoprecipitated under nondenaturing 
conditions or after proteins denaturation with the affinity-purifed anti-Ussi 
antibodies. Protein complexes were washed with 150 mM NaC1 and resolved 
on a 15% SDS-PAGE gel. 
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no RNA fragments were detected any more (Figure 3 1A; lanes 3-5 and lanes 7-9). The 
addition of increasing amounts of unlabelled U6 RNA (0.5 nM-50 nM) in the U6 
snRNP reconstitution reaction, affected slightly the binding of Spb8p to the 
radiolabelled U6 RNA (lanes 6-9). Only a three fold reduction of the UV-crosslinking 
signal was observed when a ten fold excess of unlabelled U6 RNA was present in the 
reaction (lane 9). This indicates that the level of reconstituted U6 snRNPs was not 
saturated in the presence of 5 nM of U6 RNA (32P-aUTP). Therefore, the addition of 
unlabelled U6 RNA initially increases the number of reconstituted U6 snRNPs, prior to 
competing with the radiolabelled U6 RNA for its association with proteins. This result 
was predictable since it was shown (Figure 19) that only —60 % of the initial splicing 
activity of the extract was recovered following U6 snRNP reconstitution with 5 nM of 
U6 RNA. Larger amounts of U6 RNA (50 nM-100 nM) were required for a complete 
recovery of splicing. In this experiment the amount of reconstituted U6 snRNPs was 
limited, and therefore the ability of the unlabelled U6 RNA to compete for the binding 
of Spb8p with the radiolabelled U6 RNA cannot be investigated. Consequently no 
comparison with the binding of Spb8p with the U2 snRNA in the absence of the 
endogenous U6 snRNA can be made. These experiments were inconclusive. 
6.4.2 The binding specificity of Uss5p and Prp24p 
A splicing extract was prepared from AEMY43 cells which overproduce an HA-
UssS fusion protein of 18 kD. In this extract, U6 snRNP particles were reconstituted 
either with a radiolabelled U6 RNA or with a radiolabelled U2 RNA. U6 snRNPs were 
also reconstituted with a nonfunctional radiolabelled actin substrate (produced by run-
off transcription of p283 linearised with ClaI, Table 9). This actin RNA is truncated 
and possesses exoni and a short intron sequence finishing just after the branchpoint. 
Subsequently, proteins were UV-crosslinked to the RNAs and immunoprecipitated with 
anti-HA or anti-Prp24 antibodies under nondenaturing conditions (Figure 31, Panel B). 
When the radiolabelled U6 RNA was added, HA-Uss5p as well as three other 
polypeptides (10 kD, 25 kD, —50 kD), were co-immunoprecipitated with anti-HA 
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antibodies (lane 2). In addition to Prp24p, other polypeptides (10 kD, 25 kD, a weak 16 
kD band and a rather diffuse signal at 18 kD) were UV-crosslinked to the U6 RNA and 
co-immunoprecipitated with anti-Prp24 antibodies (lane 3). When instead a 
radiolabelled U2 RNA was added in the reaction, a 25 kD protein and a weak 50 kD 
signal were detected after immunoprecipitation with anti-HA antibodies (lane 4). Only 
a faint 50 kD signal was detected after inimunoprecipitation with anti-Prp24 antibodies 
(lane 5). When a truncated radiolabelled actin RNA was added in an extract lacking the 
endogenous U6 snRNA, two bands (25 kD and >50 kD) and a rather diffuse 18 kD 
signal were detected after UV-irradiation and immunoprecipitation with anti-HA 
antibodies (lane 6). Two proteins (50 kD and >50 kD) were co-immunoprecipitated 
with anti-Prp24 antibodies after UV-crosslinking (lane 7). The 18 kD signal might 
reflect a weak binding of HA-Uss5p to the actin RNA or the interaction of a 
polypeptide of a similar size. Even if HA-Uss5p binds to the actin RNA it shows a 
much greater preference for the U6 RNA. 
Among the proteins (10 kD, 25 kD and 50 kD) associated with HA-Uss5p and UV-
crosslinked to the U6 RNA, the 10 kD protein bound neither the U2 RNA nor the actin 
RNA, while the 25 kD polypeptide contacted all the different RNAs tested. The faint 50 
kD signal detected after UV-crosslinking with the U2 or actin RNAs and 
immunoprecipitated with anti-HA and anti-Prp24 antibodies, suggests that either 
Prp24p interacts very weakly with these RNAs or a polypeptide of a size similar to 
Prp24p binds to the U2 and/or actin RNAs. Prp24p possesses three RNA binding 
domains (Shannon and Guthrie, 1991) and may therefore contact other RNAs in the 
absence of U6 snRNA. Even if Prp24p contacts the U2 or actin RNAs, it shows a much 
greater preference for the U6 RNA. 
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6.4.3 Specificity of the binding of Ussip 
Splicing extracts prepared from wild-type SC261 cells (Table 7) were depleted 
from their endogenous U6 snRNA. Equal amounts of either radiolabelled U6 or U2 
RNAs, or a truncated actin RNA were then added. Proteins were UV-crosslinked to the 
nucleic acids and immunoprecipitated with anti-Ussi antibodies (Figure 31, Panel Q. 
Ussip and other proteins (10 kD, 16 kD, 50 kD (this signal probably corresponds to the 
binding of Prp24p to the U6 RNA, see chapter 5)) were UV-crosslinked to the 
radiolabelled U6 RNA and co-immunoprecipitated with anti-Ussi antibodies (lane 2). 
When a radiolabelled U2 RNA was added in the extract lacking the endogenous U6 
snRNA, after UV-crosslinking, two faint signals were detected at 25 kD and at 50 kD 
(lane 4). The same proteins and a third one of >50 kD were UV-crosslinked to the 
radiolabelled actin RNA (lane 6). None of these polypeptides was detected when 
denatured proteins were immunoprecipitated with anti-Ussi antibodies (lanes 5 and 7). 
Anti-Ussi antibodies precipitate the denatured Ussip less efficiently (compare lanes 2 
and 3). Thus we cannot rule out that despite the loss of signal, the 25 kD band UV -
crosslinked to the radiolabelled U2 or actin RNAs and co-immunoprecipitated with 
anti-Ussi antiserum, was Ussip very weakly associated with these RNAs. 
Alternatively, this 25 kD band may reflect the binding of another protein. Even if 
Ussip contacted the U2 and actin RNAs, it shows a clear preference for the U6 RNA. If 
another polypeptide of -25 kD contacted the U2 and actin RNAs, a potential candidate 
would be Sbp8p, since it possesses a size (20 kID) similar to Ussip (21 kD) and does 
not show much specificity for the binding to the U6 RNA (see Figure 31A). As 
discussed in the previous section (9.4.2), the 50 kD band might correspond to Prp24p 
weakly associated with the U2 or actin RNAs or to an other polypeptide. 
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6.5 	Discussion 
The investigation of U6 RNA-protein interactions with the Sm-like U6 snRNP 
proteins identified the 16 kD signal. Two proteins: Uss4p (14 kD) and Uss5p (12 kD) 
contacted the U6 RNA and migrated close together as a 16 kD crosslinked signal on a 
15% SDS-polyacrylamide gel. These polypeptides possessed a molecular weight higher 
than calculated. The covalent binding of an RNA molecule to these small proteins 
probably affects their mobility so that Uss4p and Uss5p appear much bigger. Both 
Uss4p and Uss5p contact the U6 RNA in the U6 snRNP, the U4/U6.U5 tri-snRNP and 
probably in the U4/1J6 snRNP, through their direct contact with the U6 RNA. This 
result is in good agreement with the association of both I-IA epitope-tagged proteins 
with the U6 and the U4 snRNAs in yeast cells (A. Mayes, 1998). No association 
between Uss4p or Uss5p and the U5 snRNA has been observed in yeast (A. Mayes, 
1998). This could reflect a detrimental effect of the HA epitope on the association of 
these proteins with the tri-snRNP, or the HA epitope may be masked in the tri-snRNP. 
Uss4p and Uss5p are required for the stability of the U6 snRNA (A. Mayes, 1998). 
They stabilise this molecule probably through their direct contact. 
The 10 kD band was not detected any more when RNase digestion was followed by 
proteinase K treatment (40 min incubation at 37 °C, data not shown). This signal may 
correspond to a fragment of U6 RNA protected from complete RNase degradation by 
UV-crosslinked protein(s). The degradation of the proteins by proteinase K would 
therefore made it susceptible to total RNase digestion. The proteinase K sensitivity of 
the 10 kD band may also indicate that very small protein(s) were UV-crosslinked to the 
U6 RNA. Among the U6 snRNP-associated proteins, Uss6p (11 kD), Uss2p (10 kD) 
and Uss7p (10 kD) could potentially contact the U6 RNA. UV-crosslinking analyses 
have shown that the HA epitope-tagged Uss6 protein contacts the U6 RNA, but the 
signal was quite faint and clearly needs to be repeated for confirmation. Western 
blotting analysis indicated that among all the HA epitope-tagged Sm-like proteins 
produced in yeast cells, Uss6p was least abundant (A. Mayes, personnal 
communication). Uss6-HAp was probably unstable and/or the expression of the 
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encoding gene was inefficient, which correlates with the observation that the expression 
of YBL026w-H4 in AEMY46 cells (Table 14) is associated with a temperature-sensitive 
phenotype at 37 °C (A. Mayes, 1998). Thus a detrimental effect of the HA epitope on 
the function of the protein, or the low abundance of Uss6-HAp in cells, might be 
responsible for the weak UV-crosslinking of Uss6-HAp to the U6 RNA. 
No direct binding between HA-Uss2p and the U6 RNA has been detected under the 
experimental conditions tested. However, this fusion protein was associated with 
polypeptides UV-crosslinked to the U6 RNA and co-immunoprecipitated with anti-HA 
antibodies. The detection of HA-Uss2p (20 kD) on an SDS-PAGE gel would have 
been prevented by the presence of other protein(s) (i.e. Ussip) migrating to a similar 
position on the gel. If several proteins UV-crosslinked to the U6 RNA co-migrated with 
Uss2p, in an extract containing only HA-Uss2p, the detection of the loss of the 
untagged Uss2p signal would have been prevented by the presence of the other 
protein(s). Anti-HA antibodies precipitate denatured proteins with a low efficiency. 
Consequently, the failure to detect any denatured protein UV-crosslinked to the U6 
RNA using these antibodies, does not absolutely indicate a lack of binding. For all 
these reasons we cannot declare that HA-Uss2p does not contact the U6 RNA. 
No direct binding of Ga14-HA-Uss7p was detected when after UV-crosslinking 
denatured proteins were immunoprecipitated with anti-HA antibodies. Also no signal 
the size of the Ga14-HA-Uss7 fusion protein (35 kD) was detected when anti-Prp24 
antibodies were used to isolate the UV-crosslinked proteins. This suggests that this 
fusion protein did not contact the U6 RNA. The overexpression of the Ga14-HA-
YER146w ORF complements the lethal phenotype associated with the deletion of 
YER146w, however, cells show a temperature-sensitive phenotype at 37 °C (A. Mayes, 
1998). Thus the addition of extra amino acids at the N-terminus of Uss7p might affect 
its function and maybe also its binding with the U6 RNA. 
In extracts overexproducing the Ga14-HA-Uss3 fusion protein a very weak UV -
crosslinking signal was detected when denatured proteins were immunoprecipitated 
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with anti-HA antibodies. Only a faint band the size of Uss3p (38 kD) was detected 
(after overexposure of the autorad) in protein complexes co-immunoprecipitated with 
anti-Prp24 or anti-HA antibodies. Thus if the Ga14-HA-Uss3 protein contacted the U6 
RNA, this interaction was very weak. This suggests that the presence of additional 
amino acids at the N-terminus of Uss3p affects its function and/or this protein is loosely 
associated with the U6 RNA. 
The HA-Spb8 protein was UV-crosslinked to the U6 RNA. Although the experiments 
investigating its binding specificity with the U6 RNA were inconclusive, Spb8p binds 
to the U2 RNA in the absence of the endogenous U6 snIRNA. The size difference (--3 
kD) between the wild-type Spb8 and the fusion protein prevented the investigation of 
its binding in the snRNPs. The expression of HA-YJL124c was under the control of the 
endogenous promoter therefore HA-Spb8p was not overproduced in the cells. Thus the 
level of production of HA-Spb8p was probably not responsible for its binding to the U2 
RNA. Spb8p has been identified by computer analysis as an Sm-like protein (Fromont-
Racine et al., 1997). There is only little evidence to suggest that Spb8p is a U6 snRNP-
specific protein. From all the Sm-like U6 snRNP proteins tested, Spb8p is the only one 
showing a weak interaction with the U6 snRNA (it binds at 50 MM NaCl only while the 
others bind at 150 mM NaCl; A. Mayes, 1998). Also the absence of Spb8p in yeast 
cells does not affect the stability of the spliceosomal snRNAs (A. Mayes, 1998). Very 
recently a mutation in the YJLJ24c gene (also named SPB8) has been isolated as a 
suppressor of a poly(A)-binding protein (PAB]) gene deletion (Boeck et al., 1998). In 
the spb8-2 strain stabilisation of the cap structure is observed, suggesting that Spb8p is 
involved in the degradation of the mRNAs in the cell (Boeck et al., 1998). Taken 
together these data suggest that either Spb8p is not a U6 snRNP specific protein, or it 
possesses a double function and it is also required for the degradation of the mRNAs. 
This second hypothesis implies that Spb8p is present in the nucleus of the cell to 
associate with the U6 snRNP, and also in the cytoplasm to contribute to the degradation 
of mRNAs. Thus, additional factor(s) might be required to either maintain Spb8p in the 
cytoplasm or for its nuclear import. In a splicing extract, nuclear and cytoplasmic 
components are mixed together, therefore the lack of membrane separating the nuclear 
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and the cytoplasmic components, or the loss of factor(s) during the preparation of the 
splicing extract may promote its binding to any RNA molecule. 
The investigation of the binding specificity of Uss5p, Uss ip and Prp24p shows that all 
three polypeptides possess a clear preference for the U6 RNA. Very little, if any, 
interaction was detected between these proteins and the U2 or actin RNAs. 
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CHAPTER SEVEN 
Effect of U6 snRNA Mutations on Protein Interactions 
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INTRODUCTION 
SnRNPs and spliceosomes assembly can be affected by U6 snRNA point 
mutations. In particular, the U6 snRNA C48A and G60C mutations block the in vitro 
splicing reaction prior to step I, while the A5 1U and A59U mutations block in vitro 
splicing at step II (Fabrizio et al., 1989, 1990 and this work). In vivo, all these 
mutations are associated with a lethal phenotype (Madhani and Guthrie, 1992; 
McPheeters, 1996). The effect of these mutations on protein contacts was analysed in 
vitro by UV-crosslinking. Hopefully this will bring greater insight on the implication of 
these U6 snRNA nucleotides on protein interactions and/or it will give a preliminary 
map of the binding sites (s) of the polypeptides onto the U6 snRNA. 
U6 snRNPs reconstituted with a truncated U6 RNA (U6 RNA!FokI) lacking the last 18 
nucleotides possess a reduced splicing activity (Fabrizio et al., 1989 and this work). 
The implication of the U6 snRNA 3' tail on protein contacts was investigated by UV-
crosslinking of proteins to the shorter U6 RNAIFokI. 
The U6 snRNA mutations and truncation studied in this work are shown below on the 
free U6 snRNA structure proposed by Fortner et al. (1994): 
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7.1 U6 SnRNA Site Directed Mutagenesis and Testing U6 SnRNA Mutants 
Functionality 
For the production of C48A, A59U and G60C mutant U6 RNAs, the wild-type 
U6 snRNA-encoding gene from the phagemid pUCU6f1 (Table 9) was used as 
mutagenic template DNA (section 2.4.3.12). The mutagenic oligodeoxynucleotides 
T1849, T1851 and T1850 (Table 8) were employed for the synthesis of respectively 
C48A, A59U and G60C mutated U6 snRNA genes. Plasmids harbouring the mutated 
U6 snRNA genes were screened by sequencing (section 2.4.3.13). The plasmid DNA 
(pU6A5 1 U) containing the gene encoding the A5 1 U mutant U6 snRNA was a gift from 
I. Kelly (University of Cambridge). The U6 snRNAlFokI truncation was produced by 
run-off transcription ofpUCl2U6 plasmid template linearised with FokI. 
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The functionality of U6 snRNPs reconstituted with the mutated or truncated U6 RNAs 
was assayed by in vitro splicing reaction (Figure 32). When U6 snRNPs were 
reconstituted with the wild-type U6 RNA, nearly all the initial splicing activity of the 
extract was recovered on the basis of lariat-intron-exon 2 and lariat-intron signals, 
while only 30% of the initial spliced RNA was detected (compare lanes 1 and 3). The 
mRNA was probably unstable. As expected, no splicing activity was detected with U6 
RNA mutants C48A and G60C (lanes 4 and 7). The U6 RNA A51U mutation 
completely blocked the second trans-esterification step (Step II) of the splicing reaction 
(lane 5), whereas inhibition was less with the A59U mutation (a small fraction of lariat-
intron and spliced RNA was detected) (lane 6). Only 50% of the splicing activity 
detected with the wild-type U6 RNA was recovered with the truncated U6 RNA 
(compare lanes 3 and 8). 
7.2 Proteins Contacting the Mutated and Truncated U6 SnRNAs 
U6 snRNPs were reconstituted with the wild-type or the mutated/truncated U6 
RNA randomly radiolabelled with 32P-aATP. After UV-crosslinking, proteins were 
immunoprecipitated with crude anti-Prp24 antibodies, then resolved on a 15 % SDS-
PAGE gel (Figure 33). For an unknown reason, a diffuse signal was observed instead of 
a 16 kD protein UV-crosslinked to the wild-type U6 RNA (compare Figure 25, lane 3 
and Figure 33, lane 3). The C48A U6 RNA mutation and the Fok! truncation 
dramatically reduced the binding of Prp24p (with a more substantial reduction with U6 
RNA/FokI truncation), while Ussip was not detected anymore (Figure 33, lanes 4 and 
8). The lack of the Ussip binding might either reflect loss of protein-U6 RNA contact 
or be a consequence of loss of Prp24p interaction. Other U6 RNA mutations tested did 
not affect protein-U6 RNA contacts (Figure 33, compare lane 3 with lanes 5-7). No 
polypeptides were detected on a 6% gel (data not shown). 
The profile of proteins UV-crosslinked to the wild-type, mutated or truncated U6 RNA 
(32P-aATP) and immunoprecipitated with the crude anti-Ussi and anti-Prp8 antibodies 
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Figure 32. Splicing activity of U6 snRNPs reconstituted with wild-type, 
mutated or truncated U6 RNA. 
U6 snRNPs were reconstituted with wild-type, mutated or truncated U6 
snRNA (lanes 3-8) in a 100 p1 reaction. An aliquot (9 jtl) was taken off and 1 
jtl substrate RNA (20 000 cpm) was added to assay for the splicing activity. 
Splicing reaction only was carried out (with preincubation step at 30 °C for 30 
mm) in lane 1; endogenous U6 snRNA was degraded by RNase H in the 
presence of 140 nM of U6 knockout oligo and no U6 RNA was added (lane 2). 
After splicing, RNAs were recovered and resolved on a 7% 
polyacrylamide/urea gel. IVS-E2: lariat-intron exon 2; IVS: lariat excised 
intron; pre-mRNA: actin substrate RNA p283 (Table 9); E1-E2: spliced RNA; 
U6 RNA: U6 snRNA transcribed with the T7 RNA polymerase and randomly 
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Figure 33. Analysis of the effect of U6 snRNA mutation and truncation on 
protein-U6 RNA interactions. 
U6 snRNPs were reconstituted with 5 nM of randomly radiolabelled wild-
type, mutated or truncated U6 RNA (32P-ctATP) in a 100 j.il reaction. Samples 
were UV-irradiated and protein complexes co-immunoprecipitated with the 
crude anti-Prp24 antibodies (batch 1016). Reaction sample was not UV-
irradiated in lane 2 and preimmune serum was incubated with proteins in lane 
1. Immunoprecipitated protein complexes were washed with NTN buffer 
containing 150 mM NaCl, after RNase treatment half of the precipitated 
proteins were loaded on a 15% SD S-PAGE and the other half was loaded on a 
6% SDS-PAGE (this gel was not shown as no signal was detected). 
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is shown in Figure 34. The comparison of proteins UV-crosslinked to the wild-type and 
to the mutated/truncated U6 RNAs suggested that, with the exception of the 90 kD 
polypeptide (6% gel, lane 6), proteins immunoprecipitated with anti-Ussi antibodies 
were less efficiently UV-crosslinked to C48A mutant U6 RNA. In particular the 45 kD 
polypeptide (which probably reflects the binding of Prp24p to the U6 RNA; see chapter 
5) was hardly detectable (compare lanes 4 and 6). With the exception of the 45 kD and 
90 kD bands, the diminishion of the intensity of the protein signals was proportional to 
that of Ussip. Therefore, the reduction of the UV-crosslinking efficiency might just be 
a consequence of a weaker Ussip interaction. The C48A U6 RNA mutation weakly 
affected proteins UV-crosslinked and immunoprecipitated with anti-Prp8 antibodies; 
only signals detected on the 15% gel were reduced (compare lanes 5 and 7). 
The AS 1U U6 RNA mutation had no obvious effect on proteins UV-crosslinked and 
immunoprecipitated with anti-Ussi or with anti-Prp8 antibodies (Figure 34, compare 
lane 4 with 8 and lane 5 with 9). 
The A59U U6 RNA mutation partially affected the binding of proteins contacting the 
U6 RNA and immunoprecipitated with anti-Ussi or with anti-Prp8 antibodies, in that 
protein signals were reduced (Figure 34, compare lane 4 with 10 and lane 5 with 11). 
The G60C U6 RNA mutation prevented the direct interaction of the 70-80 kD protein 
(Figure 34, 15% gel, compare lane 4 with 12) and the binding of Prp8p detected after 
immunoprecipitation with the crude anti-Ussi antiserum (6% gel, compare lane 4 with 
12). No proteins co-immunoprecipitated with anti-Prp8 antibodies were detected on the 
15% gel, only a weak Prp8p band was observed on the 6% gel (lane 13). The lack of 
proteins UV-crosslinked to the G60C mutant U6 RNA and co-immunoprecipitated with 
anti-Prp8 antibodies might be a consequence of the loss of Prp8p interaction. 
For the U6 FokI truncation, with the exception of the -90 kD signal, hardly any 
proteins were UV-crosslinked and co-immunoprecipitated with anti-Ussi antibodies 
(Figure 34, lane 14). No effect was noticed for the proteins immunoprecipitated with 
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Figure 34. Proteins UV-crosslinked to the mutated and truncated U6 
RNA. 
U6 snRNPs were reconstituted with 5 nM of randomly radiolabelled wild- 
32 type, mutated or truncated U6 RNA ( P-aATP) in a 100 pi reaction. A 9 j.il 
aliquot was assayed for splicing activity (Figure 32), and with the remaining 
91 iii, proteins were UV-crosslinked and immunoprecipitated with either the 
crude anti-Uss 1 antiserum or with the crude anti-Prp8 antiserum. As controls, 
a reaction sample was not UV-irradiated (lane 1); samples were incubated with 
PAS beads (lane 2) or with preimmune serum (lane 3). Immunoprecipitated 
protein complexes were washed with 150 mM NaCl, after RNase treatment 
half of the precipitated proteins was loaded on a 15% SDS-PAGE gel, the 
remaining half was loaded on a 6% SDS-PAGE gel. 
1: proteins immunoprecipitated with anti-Uss 1 antibodies; 8: proteins 
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anti-Prp8 antibodies and resolved on the 6% gel, whereas only two weak signals (28 kD 
and --'60 kD) remain on the 15% gel (lane 15). 
On the basis of these LTV-crosslinking experiments, it was unclear whether the absence 
of protein signal reflected the loss of protein-U6 RNA interaction and/or a detrimental 
effect on snRNP formation/stability. The effect of U6 RNA mutations and truncation on 
snRNP formation was therefore further investigated as follows. After U6 snRNP 
reconstitution, the crude anti-Ussi or anti-Prp8 antisera were used to 
immunoprecipitate the snRNP particles. U6 snRNPs, U4/U6 snRNPs and to a lesser 
extend U4/U6.U5 tri-snRNPs were co-immunoprecipitated with the crude anti-Ussi 
antiserum; essentially US snRNPs and tri-snRNPs were co-immunoprecipitated with 
the crude anti-Prp8 antibodies (no substrate RNA was added in the reconstitution 
reaction). The co-immunoprecipitated U4, U5 and U6 snRNAs were recovered and 
detected by snRNA blotting (section 2.4.4.3) (Figure 35, Panels A and B). 
The precipitation of snRNAs was antibody specific (Figure 35, Panels A and B, lane 1) 
and the depletion of the endogenous U6 snRNA by RNase H degradation was total 
(lane 4). By comparison with the sample containing wild-type U6 RNA, in the absence 
of endogenous U6 snRNA, lower amounts of U4 snRNA and similar amounts of U5 
snRNA were co-immunoprecipitated with anti-Ussi and anti-Prp8 antibodies (compare 
lanes 3 and 4). Ussip and Prp8p interactions with U4 snRNA and US snRNA suggest 
that these snRNAs remain associated with each Other upon degradation of U6 snRNA. 
SnRNAs detected after U6 snRNP reconstitution and immunoprecipitation with anti-
Ussi antibodies are shown in Figure 35 (Panel A). The comparison of U4 snRNA and 
U6 RNA immunoprecipitated after U6 snRNP reconstitution with wild-type or 
mutatedJtruncated U6 RNA indicated that slightly less C48A U6 RNA but as much U4 
snRINA were co-immunoprecipitated (compare lanes 3 and 5). A similar variation in the 
amount of wild-type and C48A U6 RNA was detected in the immunoprecipitation 
supemate (data not shown), suggesting that this difference was probably due to the fact 
that only one probe annealed to C48A U6 RNA while two hybridized to the wild-type 
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Figure 35. Study by snRNA blotting of snRNP formation. 
A reconstitution reaction (50 t1) was carried out with 10 nM of unlabelled 
wild-type, mutated or truncated U6 RNA (transcribed from pUC 1 2U6 (Table 
9) linearized with DraI or FokI). The endogenous U6 snRNA was degraded by 
RNase H degradation in sample 4. SnRNAs were co-immunoprecipitated with 
the crude anti-Ussi (Panel A) or anti-Prp8 (Panel B) antisera. As controls, 
samples were incubated with preimmune serum (Panel B, lane 1) or with PAS 
beads only (Panel A, lane 1). The inmiunoprecipitated protein-RNA 
complexes were washed with 150 mM NaCl, snRNAs were recovered, 
resolved on a 6% polyacrylamide/urea gel and transferred by snRINA blotting 
onto a membrane. U4, U5 and U6 snRNAs were detected by hybridization 
(section 2.4.4.3) with end-labelled oligodeoxynucleotides (Table 8) 483A, 
485A, Taq6A and V5578 respectively. Two oligodeoxynucleotides (Taq6A 
and V5578) were used to detect U6 snRNA since the former do not anneal to 
C48A and AS 1U mutant U6 RNAs and the second do not anneal to the 
truncated U6 RNA. Mutant U6 RNAs recognized by only one probe are 
indicated by an asterisk. Total yeast snRNAs were prepared from 5 tl of 
splicing extract treated with proteinase K, extracted with phenol/chloroform 
and precipitated with ethanol. The RNA pellet was resuspended in 2 p.1 of 
water, an equal volume of 100% formamide loading dye was added, after 
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U6 RNA. No effect was detected with A51U, A59U and G60C U6 RNA mutations 
(compare lane 3 with respectively lanes 6, 7, and 8). Less U6 RNA and U4 snRNA 
were immunoprecipitated with anti-Ussi antibodies after U6 snIRNP reconstitution with 
the truncated U6 RNA (compare lane 3 with 9). Little difference was observed between 
the amount of wild-type and truncated U6 RNAs detected in the immunoprecipitation 
supernate (data not shown). The lack of the last 18 nucleotides was detrimental to the 
formation of U6 snRNP, U41U6 snRNP and maybe tri-snRNP. Alternatively the 
removal of the last 18 nucleotides affects the association of Uss 1 p  with snRNP 
particles. 
The snRNAs co-immunoprecipitated with anti-Prp8 antibodies after U6 snRNP 
reconstitution are shown in Figure 35 (Panel B). Comparison of U4 snRNA and U6 
RNA immunoprecipitated after U6 snRNP reconstitution with wild-type U6 RNA or 
with mutated/truncated U6 RNA suggested that less C48A mutant U6 RNA was 
imrnunoprecipitated (compare lane 3 with 5). A similar variation was detected in the 
immunoprecipitation supernate, indicating that this difference was presumably due to 
the difference in the homology of the probes used to detect the U6 RNAs. The C48A 
U6 RNA mutation did not affect tri-snRNP formation. The A5 1 U U6 RNA mutation 
did not have a detrimental effect on tri-snIRNP formation (compare lane 3 with 6). Less 
U4, U5 and U6 snRNAs were recovered after immunoprecipitation of snRNP 
containing the A59U mutant U6 RNA (lane 7), an unfortunate RNase degradation was 
responsible for this nonspecific decrease of snRNA signals. This experiment has been 
reproduced several times and snIRNP particles formation was not affected by A59U U6 
RNA mutation. A smaller amount of U4 snRNA and G60C mutant U6 RNA was 
immunoprecipitated with anti-Prp8 antibodies after U6 snRNP reconstitution (compare 
lane 3 with 8). However, a similar quantity of the G60C and wild-type U6 RNA was 
added to the reaction (data not shown) suggesting that this mutation was detrimental to 
tri-snRNP formation and/or Prp8p association with the tri-snRNP. A reduced amount of 
U4 snRNA and truncated U6 RNA was immunoprecipitated (compare lane 3 with 9). 
The snRNA analysis of the immunoprecipitate supernate (data not shown) indicated 
that the low recovery of truncated U6 RNA was not only due to the difference of 
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Table 15. Effects of U6 snRNA mutations and truncation on U6 snRNA-
protein interactions. 
After immunoprecipitation the recovery of mutated/truncated U6 RNAs was 
compared to that of wild-type and indicated as follows: +1- for very low; ++ 
for weaker; +++ for as good as wild-type U6 RNA. 
IP with crude 	a- 
Prp24 	Abs 	(U6 
snRNP) 
IP with crude a-Ussl 
Abs (U6 snRNP, 1J4/U6 
snRNP, U411J6.U5 snRNP) 
U6 
IP with crude a-Prp8 
Abs (t15 snRNP, U41U6.U5 
snRNP) 
U6 
U6 snRNA Effect on Effect on 	snR Effect on 	snR 
mutants UV-crossllnking UV-crossllnking 	NA UV-crosslinking 	NA 
Co- Co- 
IP IF 
C48A Much reduced Prp24p All signals reduced No significant effect 
signal with Prp24p nearly 	++ 
Loss of Uss I  contact undetectable 
A5JU No significant effect No significant effect 	++± No significant effect 	+±+ 
A59U No significant effect No significant effect 	-H--F No significant effect 	+++ 
Loss of signal at 	43 
kD 
G60C No significant effect Loss of a band at No 	proteins 	on 	a 
70-80 kD and Prp8p 	+++ 15% SDS-PAGE gel 
signals Only ly a weak Prp8p 
signal 	remains 	on 
6% SDS-PAGE gel 
FokI Much reduced Prp24p 11 	signals Signals detected on . 
truncation 
- 
signal dramatically 	+1- 15% 	gel 	(only):+1- 
Loss of Uss I  contact reduced, only a —90 dramatically reduced 
kD band remain 
homology of the probes used to detect the shorter and the wild-type U6 RNAs. 
Therefore, the removal of the last 18 nucleotides of U6 RNA affects tri-snRNP 
formation/stability and/or Prp8p association with this particle. 
The effects of U6 snRNA mutations and truncation are summarised in Table 15. 
7.3 	Discussion 
This work showed that U6 and/or U4/U6 snRNP and U4/1J6.U5 tri-snRNP 
formation, assayed by immunoprecipitation of snRNPs and snRNA blotting, was not 
affected by AS 1U and A59U U6 snRNA mutations. These mutations did not interfere 
with protein-U6 RNA contacts detected before spliceosome formation (no substrate 
RNA was added) as demonstrated by UV-crosslinking and immunoprecipitation. 
Substitution of A to U, C or G, at U6 snRNA position 51 or 59, blocks the second step 
of the splicing reaction (Fabrizio et al., 1991). Therefore, as the results presented in this 
chapter suggest, snRNPs and spliceosome assembly occur as in the wild-type situation. 
These data also indicate that, before spliceosome formation, U6 snRNA nucleotides 
A51 and A59 nucleotides are not essential for the direct binding of proteins co-
immunoprecipitated with anti-Ussi, anti-Prp24 or anti-Prp8 antibodies. 
More dramatic effects were observed with the C48A U6 RNA mutation. It affects: 
- U6, U4/U6 snRNP and U4/U6.U5 tri-snRNP formation (very mild effect). 
- The binding of proteins (Prp24p and Ussip) to the U6 snRNA in the U6 snRNP and 
immunoprecipitated with the anti-Prp24 antiserum. 
- The UV-crosslinking of proteins (Prp24p and Ussip) to U6 snRNA in the U6 snRNP 
and/or in the U4/U6 snRNP and immunoprecipitated with the anti-Ussi antiserum. 
Despite the reduced binding of Prp24p to C48A mutant U6 RNA, Prp24 fulfilled its 
function since U4/U6 snRNPs and tri-snRNPs form (Fabrizio et al., 1990; and this 
work), thus two hypotheses are suggested: 
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- Although the binding of Prp24p to U6 snRNA was dramatically reduced, the 
remaining contact was sufficient to drive U4/U6 snRNPs formation. 
- Prp24p-U6 RNA UV-crosslinking did not reflect a functional interaction therefore the 
reduction of the radioactive signal did not correlate with an alteration of Prp24p's 
function. 
The binding of some proteins (in particular Prp24p) to U6 RNA was affected by the 
C48A mutation (this study). Despite these detrimental effects, U4 snRNA, C48A U6 
RNA and U5 snRNA seem to interact with each other to form U4/U6 snRNP and 
U4/U6.U5 tri-snRNP which were immunoprecipitated with anti-Ussi and anti-Prp8 
antisera. These particles were similar to those containing the wild-type U6 RNA (in 
respect to snRNP containing the wild-type U6 RNA and immunoprecipitated with anti-
Uss 1 and anti-Prp8 antisera) (this study). Fabrizio et al. (1990) reported that in vitro, no 
active spliceosome form with the C48A U6 RNA mutant. Presumably, the tri-snRNPs 
containing the mutated U6 RNA were unable to associate with the prespliceosome, or 
further progression toward active spliceosome was blocked. The C48A U6 RNA 
mutation is located in the highly conserved sequence A 47CAGA51 which interacts with 
the pre-mRNA 5' splice site (Lesser et al., 1993; Kandels-Lewis et al., 1993). This 
sequence has been proposed to start base-pairing with the 5' splice site before 
disruption of U6 snRNA base-pairing with the U4 snRNA (Konforti et al., 1994). The 
interaction between this U6 snRNA sequence and the 5' splice site may also be required 
to disrupt U4/U6 snRNAs interaction (Li et al., 1996). Thus, the C48A mutation may 
destabilize the U6 snRNA-5' splice site base-pairing and prevent U4/1J6 snRNP 
dissociation, blocking spliceosome maturation. Kandels-Lewis et al. (1993) reported 
that the splicing defect associated with C48A mutation was suppressed by a 
complementary mutation in the intron at position 5 (G5C). This complementation never 
restored splicing activity to a wild-type level, suggesting that the U6 snRNA C48A 
mutation affects the interaction of other factor(s) with the U6 snRNA. Prp24p is 
suspected to disturb the U4/U6 snRNA stem II and facilitate the action of other splicing 
factor(s) required for U4/U6 snRNP dissociation prior to the first step of splicing 
(Ghetti et al., 1995). Vaidya et al. (1996) have reported a genetic interaction between 
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Prp24p and Prp2 ip (a component of the U2 snRNP) suggesting that Prp24p is 
associated with the immature spliceosome. The results presented in this work suggest 
that the C48A U6 .RNA mutation destabilizes Prp24p binding to the U6 snRNA in the 
U6 snRNP. Taking these data together one can speculate that C48A U6 snRNA 
mutation destabilizes (U6 snRNA-5 'splice site) and (U6 snRNA-Prp24p) interactions. 
Consequently, U4 snRNA remains in the spliceosome and blocks spliceosome 
activation. 
U6 and U4/U6 snRNPs formed with G60C mutant U6 RNA (with respect to snRNPs 
immunoprecipitated with anti-Uss 1 antiserum), also protein contacts were only slightly 
affected (this study). This mutation prevented the detection of proteins UV-crosslinked 
to the G60C U6 RNA and immunoprecipitated with anti-Prp8 antiserum, suggesting 
that the G60C substitution had a detrimental effect on tri-snRNP formation and/or 
Prp8p association with this particle. 
The U6 snRNA 3' terminal domain (nucleotides 81-112) is poorly conserved in 
sequence but is strictly conserved in size (between 29 nt and 32 nt in all species). 
Unexpectedly, alterations in the length of this domain were associated in vivo with mild 
phenotypes (Madhani et al., 1990) and in vitro did not dramatically affect the splicing 
reaction (Fabrizio et al. 1989 and this work). Further 3' end truncations of the U6 
snRNA (LJ6/BclI: lacks the last 22 nucleotides, U61EcoNI: lacks the last 32 nucleotides) 
do not restore splicing activity of the extract after U6 snRNPs reconstitution (Fabrizio 
et al., 1989). Probably, the removal of the last 18 nucleotides is the maximum 
truncation allowed to maintain U6 snRNA's function. On a nondenaturing gel, U4/U6 
snRNPs formed with the FokI truncated U6 RNA possess a similar mobility to particles 
containing the wild-type U6 RNA (Fabrizio et al., 1989). Also, presumably, tri-snRNPs 
and spliceosomes have formed since splicing occurs. UV-crosslinking and 
immunoprecipitation experiments have shown that this truncation affected proteins 
contacting the U6 snRNA in the U6 snRNP and in the U4/U6 snRNP particles (this 
study). In particular Prp24p and Ussip binding was dramatically reduced. In the tn-
snRNP Prp8p signal remained unchanged whereas Ussip contact was not detected 
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anymore. These results suggest that either Ussip and Prp24p were UV-crosslinked to 
the 3' tail of the U6 RNA or that the 3' end was required for Uss ip and Prp24p to 
contact the U6 RNA elsewhere. Alternatively, other protein(s) may interact with the last 
18 nucleotides of U6 RNA and help Ussip and Prp24p to bind U6 snRNA elsewhere. 
Fortner et al. (1990) observed that in their yeast extract the U6 snRNA was degraded by 
a 3' nuclease activity producing a 90 nt and a 60 nt U6 snRNA forms (the nuclease was 
probably paused by the U6 snRNA 3' stem loop (nt 61-87), suggesting that the 3' tail 
was not strongly protected from nuclease degradation by protein(s). This region is more 
likely to be free or weakly associated with proteins. According to the U6 snIRNA 
secondary structure proposed by Fortner et al. (1990), the last 18 nucleotides are not 
involved in any RNA-RNA interactions in U6 snRNP or U4/U6 snRNP. Therefore, 
presumably by being free, the U6 snRNA 3' tail may act as a flexible arm and guide 
and/or stabilize protein(s) onto the U6 snRNA. 
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CHAPTER EIGHT 
Analysis by Site Specific UV-Crosslinking of Proteins Contacting 
the U6 snRNA 
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INTRODUCTION 
In order to map the binding site of proteins to the U6 RNA, a single 
photoactivatable reagent (4-thiouridine) was incorporated into a specific position of the 
U6 snRNA. Protein-U6 snRNA contacts were subsequently investigated by UV-
crosslinking. 
4-Thiouridine (4-thioU) is a uridine analog in which the keto oxygen at position 4 of 
the pyrimidine ring is replaced by a sulphur atom (Figure 36). 
S 
H 	4 '___ 
51 3 	
51 
R = nbosyl 
Figure 36. Structure of the 4-thiouridine 
Due to the replacement of the 0 by a S, the C-S bond is twice the length of the C-0 
bond (0.8 A instead of 0.4 A). In the case of a Watson-Crick [A-S 4U] base-pair the 
NH ... 0 bond (2.9 A) is replaced by an NH ... S bridge of 3.4 A, corresponding to a 15-
20% increase in bond length. Despite these structural variations, it has been shown that 
low substitution levels appear to have minor effects on polynucleotide conformation 
and stability (Favre, 1990). The incorporation of a single 4-thioU in the U6 snRNA 
molecule did not interfere with its functionality (this chapter). The 4-thioU possesses 
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base-pairing properties similar to those of unmodified uridine and is very efficiently 
photoactivatable by wavelengths above 320 nm which keep undesirable side reactions 
at a minimum. RNAs containing 4-thiouridine have been widely used to study RNA-
RNA and RNA-protein interactions since this photoactivatable base possesses a high 
photoreactivity with both amino acids and nucleotides (Sontheimer, 1994). 
For two main reasons the binding of proteins to the U6 snRNA nucleotide U 54 has been 
investigated: 
- U54 is situated after the invariant U6 snRNA sequence A 47CAGAGA53 located in a 
region suspected to be part of the catalytic centre of the spliceo some (Madhani et al., 
1992, 1994; Lesser et al., 1993) 
- Following the method described in section 2.4.4.5, the site of incorporation of the 
photoactivatable chemical must be at an UpG position. Since a G residue follows U 54 , 
the incorporation of a 4-thioU will not necessitate mutation of the U6 snRNA sequence. 
8.1 Production of a U6 RNA Containing a Radiolabelled 4-Thiouridine at 
Position U54 
The method described in section 2.4.4.5 was followed and both transcription 
DNA templates used to produce the 5' and the 3' halves of the U6 snRNA were 
amplified by Polymerase Chain Reaction (section 2.4.3.8). 
The PCR programme applied was: 
Denaturation step: 	94°C 	1 mm 
Annealing step: 	50°C 	1 mm 
Amplification step: 70 °C 	2 mm 
N° of cycles: 	35 
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For the amplification of the 5' half transcription template, oligodeoxynucleotides S5760 
and W3464 were used as 5' and 3' primers respectively and pUC12U6 was utilized as 
the DNA template. For the amplification of the 3' half transcription template, 
oligodeoxynucleotides W3463 and S5761 were used as 5' and 3' primers respectively 
and pU6 was utilized as the DNA template. Two U6 snRNA 3' halves were produced 
by transcription in vitro, one contains at its 5' extremity a 4-thiouridine whereas the 
other (as a control) possesses a uridine. These 3' U6 snRNA moieties were 5' end 
radio labelled and ligated with the 5' U6 RNA half by using oligodeoxynucleotide 
W3462 as a bridging oligo (Table 8, section 2.4.4.5). The ligation product was resolved 
on a 8% polyacrylamide-urea gel, detected by autoradiography (section 2.2.2) (data not 
shown) and gel purifed. 
U6 snRNPs were reconstituted with U6 RNA containing a 32P-U or a 32P-4-thioU at 
position 54, and their ability to support splicing was assayed (Figure 37). Eighty to 
ninety percent of the initial splicing activity was recovered (on the basis of lariat-intron-
exon 2 and lariat-intron signals (compare lane 1 with lanes 3 and 4)), indicating that 
both U6 RNA molecules are functional and that the quantity (unknown) of U6 RNA 
added allows U6 snRNPs reconstitution with a high efficiency. A slightly lower 
splicing activity was detected with U6 RNA containing the 4-thioU, however the 
comparison of the U6 RNA signals indicated that slightly less 4-thioU-containing U6 
RNA was added in the reaction. 
Attempts to incorporate a radiolabelled 4-thioU or U at U6 snRNA positions U38, 59  and 
U80 failed; three main problems were encounted: 
- the transcription efficiency of the 3' U6 RNA halves (initiated by UpG or 4-thioUpG) 
was very low and often not enough RNA was produced, even when different 
transcription conditions were tested. For an unknown reason there was a high level of 
abortive transcription. 
- the 5' end radiolabelling of the 3' RNA halves was inefficient, which may reflect an 
inefficient initiation of the transcription with UpG or with 4-thioUpG. 
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Figure 37. U6 snRNP reconstitution with U6 snRNA containing a 	or 
a 32P-4thioU at position U54 
A splicing extract (prepared from the yeast strain SC261) was preincubated for 
30 min at 30°C before testing its splicing activity (lane 1). No splicing activity 
was left when endogenous U6 snRNA was degraded by RNase H in the 
presence of 140 nM U6 knockout DNA oligo (lane 2). U6 snRNP particles 
were reconstituted with a U6 RNA containing a 32P-uridine (lane 3) or a 
photoactivatable 32P-4-thiouridine (lane 4) at position U 54 . From a 100 p.1 
reconstitution reaction (prepared to UV-crosslink proteins to U6 snIRNA; 
Figure 38), an aliquot (9 p.1) was taken to which 1 p.1 of radiolabelled substrate 
RNA (20 000 cpm) was added. After splicing, RNAs were recovered and 
resolved on a 7% polyacrylamide/urea gel. IVS-E2: lariat-intron-exon 2; IVS: 
excised lariat-intron; pre-mRNA: actin substrate RNA (p283, Table 9); E1-E2: 
messenger RNA; El: exon 1; U6 RNA: U6 snRNA produced by transcription 
in vitro with the T7 RNA polymerase. The amount of U6 RNA added to the 
reaction was unknown, approximately 200 cps (on the Geiger counter) of U6 
RNA was added per 100 p.fl reconstitution reaction. 
- IVS-E2 






- the ligation of the 5' and the 3' RNA halves was limited, probably because non-
templated nucleotides were added by the T7 RNA polymerase at the 3' end of the 
transcripts. This would consequently reduce the RNA ligation efficiency since a perfect 
match with the RNA extremities and the bridging oligodeoxynucleotide is required. 
This 3' end tailing cannot be circumvented, and the best solution would have been to 
chemically synthesise the 5' half U6 RNA or to generate by RNase H cleavage an RNA 
with the correct 3' end (Yu and Steitz, 1997; Lapham et al., 1997). 
8.2 Study of Proteins Interacting with the U6 SnRNA at Position U 54 
Proteins UV-crosslinked to U6 RNA at position U 54 and immunoprecipitated 
with the crude anti-Ussi or anti-Prp8 antibodies are shown in Figure 38. The UV-
crosslinking signals detected were specific for the presence of the photoactivatable 4-
thioU (compare lanes 1-4 and lanes 5-8). A protein of ---25 kD was immunoprecipitated 
with anti-Uss 1 antibodies under nondenaturing conditions or when proteins were 
denatured prior to immunoprecipitation, thus Ussip contacts U6 snRNA at position U 54 
(lanes 5, 6). At least seven additional polypeptides were inimunoprecipitated with the 
anti-Ussi antibodies and detected on the 6% and 15% gels. They possessed apparent 
molecular weights of 28 kD, 40 kD, 60 kD, --86 kD, 150-170 kD, 190 kD and >200 kD. 
A protein of >200 kD was immunoprecipitated with anti-Prp8 antibodies under 
nondenaturing conditions or when proteins were denatured before immunoprecipitation, 
suggesting that Prp8p contacts U6 RNA at position U 54 (lanes 7, 8). The >200 kD 
signal detected after UV-crosslinking and immunoprecipitation with anti-Ussi 
antibodies probably reflects the binding of Prp8p to the U6 RNA in the small fraction 
of tri-snlRNPs co-immunoprecipitated with anti-Ussi antibodies. At least seven 
additional polypeptides were detected on the 6% and 15% gels after co-
immunoprecipitation with anti-Prp8 antibodies. They possessed apparent molecular 
sizes of 16 kD, 25 kD, 28 lcD, 40 kD, --60 kD and two signals at >220 kD. The 25 kD 
protein could well be Ussip since it was shown previously (Figure 26) that it contacts 
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Figure 38. Proteins UV-crosslinked to the U6 snRNA at position U 54 . 
U6 snRNP reconstitution reaction (100 p1) was carried out (no substrate RNA 
was present). The concentration of U6 RNA was unknown, 200 cps (on the 
Geiger counter) of U6 RNA was added per reconstitution reaction. U6 snRNPs 
were reconstituted with U6 snRNA containing a 32P-U (lanes 1-4) or 
containing a long wavelength photoactivatable 32P-4-thioU (lanes 5-8) at 
position U54. In lanes 1, 2, 5 and 6, protein complexes were 
immunoprecipitated with the crude anti-Ussi antiserum under nondenaturing 
conditions (lanes 1 and 5) or after denaturation of proteins (lanes 2 and 6). In 
lanes 3, 4, 7 and 8, protein complexes were immunoprecipitated with anti-Prp8 
antiserum under nondenaturing conditions (lanes 3 and 7) or after denaturation 
of proteins (lanes 4 and 8). Half of the immunoprecipitated proteins was 
resolved on a 15% SDS-PAGE gel and the other half on a 6% SDS-PAGE gel. 
Proteins were detected by autoradiography after an overnight exposure. 
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Table 16. Proteins UV-crosslinked to U6 snRNA at position U54 . 
The intensity of the protein signals was indicated as follows: ++++, very 
strong; +++, strong; ++, medium; +, weak; +1-, very weak. 
the U6 snRNA in the tri-snRNP. The proteins interacting with the U6 RNA at position 
U54 are indicated in Table 16. 
Protein co-immunoprecipitated with Proteins co-immunoprecipitated with 
Anti-Ussi antisera Anti-Prp8 antisera 
15% gel 	 6% gel 15% gel 	 6% gel 
(kD) (kD) (kD) (kD) 
86 	 >200 '7Prp8p Prp8p 
6O >2OO 
19O' 




+1- 25 	/Usslp 
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8.3 	Discussion 
Prp8p and Uss ip contact the U6 RNA at position U 54 in addition to numerous 
uncharacterized proteins. The site specific UV-crosslinking method was extremely 
efficient; for a shorter UV exposure time (5 min instead of 25 mm) and with only a 
single photoactivatable nucleotide, many more proteins were UV-crosslinked to U 54 
than were UV-crosslinked to the randomly radiolabelled U6 RNA. Also, the intensity 
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of the signals was a lot higher since only an overnight exposure of the hypersensitive 
film was necessary compared to 5-15 days needed to detect proteins contacting the 
randomly radiolabelled U6 RNA. Unexpectedly numerous protein-U6 RNA 
interactions were detected at position U 54 suggesting that snRNP particles were 
"breathing" leading to dymanic protein-RNA associations. 
A substantial variation in the intensity of the protein signals was noticed which may 
reflect a difference in the LTV-crosslinking efficiency between the various polypeptides 
present in the vicinity of the U6 RNA. In particular, the Ussip signal was weak, 
suggesting that although it contacts the U6 RNA at position U 54 it may not be the main 
site of interaction. 
Unfortunately technical problems prevented to map the binding site of the proteins at 
different positions of the U6 RNA. At the time when the experiments were carried out, 
another technique allowing insertion of a 4-thiouridine at specific positions of the RNA 
molecule was published (Yu and Steitz, 1997). This new method permitted the 
introduction of a 4-thiouridine at any site of the RNA independently of its sequence. 
Also RNA molecules lacking non-templated additional nucleotides were generated by 
site-specific RiNase H cleavage directed by 2'-O-methyl-specific cleavage (Yu and 
Steitz, 1997). The use of this technique may circumvent the problems encounted in this 
work. One obvious limitation of this method would be the cost since the synthesis of 
2' -0-methyl-containing oligodeoxyribonucleotides is very expensive. 
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CHAPTER NINE 




The splicing reaction is catalyzed by the spliceosome, which is formed by an 
ordered interaction of snRNPs and numerous proteins with short conserved sequences 
of the substrate pre-mRNA (the 5' and 3' splice sites and the branched point). There is 
considerable evidence that the U6 snRNA is part of the catalytic centre of this large 
ribonucleoprotein complex (Fabrizio et al., 1990; Madhani et al., 1992, 1994; 
McPheeters, 1996; Sawa et al., 1991; Sontheimer et al., 1993; Wassarman et al., 1992). 
Therefore the investigation of U6 RNA-protein interactions occuring in the spliceosome 
is of great interest and may allow the identification of protein(s) required for splicing. 
To date only two splicing factors have been reported to interact with U6 snRNA in the 
spliceosome, Prpl6p and Slt22p: 
- Prpl6p (120 kD), an RNA-dependent ATPase required for the second catalytic step of 
the splicing reaction (Schwer et al., 1991), has been shown to genetically interact with 
the U6 snRNA nucleotides 40-46 and also with U2-U6 snRNAs helix I in the 
spliceosome (Madhani et al., 1994b; McPheeters, 1996). 
- S1t22p (246 kD) is an RNA-dependent ATPase and a putative RNA helicase that 
interacts genetically with a region of U2 snRNA involved in potential U211J6 helix II. 
S1t22p possesses an ATPase activity that is stimulated by the presence of U2/U6 
snRNAs (Xu et al., 1996), suggesting that U2/U6 hybrid might be a natural binding 
substrate for this protein. 
The method described in section 5.1 was applied to study U6 RNA-protein interactions 
occuring in the spliceosome. Spliceosome complexes were indirectly isolated by 
immunoprecipitation with anti-Prp2, anti-poly(A) binding protein (PAB) and anti-Prp8 
antibodies: 
- Prp2p is a 100 kD protein (Lee et al., 1986) required for promotion of the first step of 
the splicing reaction (Lin et al., 1987). It is a putative RNA helicase which possesses an 
RNA-stimulated ATPase activity (Kim et al., 1992). Prp2p interacts transiently with the 
spliceosome prior to and during step I of splicing (King et al., 1990), consequently, the 
co-inimunoprecipitation of the spliceosome with anti-Prp2 antibodies is inefficient. A 
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dominant negative mutant p2pLAT  has been engineered (Plumpton et al., 1994). This 
mutant protein contains a single amino acid change within the conserved SAT motif 
that is potentially required for RNA unwinding. p2pLAT  becomes stalled in the 
spliceosome complex and blocks the splicing reaction before step I (Plumpton et al., 
1994). As this mutated protein is efficiently precipitated with anti-Prp2 antibodies, the 
spliceosome, poised before step I, can be co-immunoprecipitated with these antibodies. 
- The poly(A) binding protein is present in the cytoplasm, with a molecular size of 70 
kD, and is also found in the nucleus as two proteolytic forms (53 kD and 13 kD) of the 
cytoplasmic protein. The 70 kD and 53 kD forms possess the ability to bind poly(A) 
RNAs with high affinity (Sachs et al., 1986). In the in vitro system described in section 
5. 1, spliceo some formation will be induced by the addition of unlabelled pre-mRNA 
containing a poly(A) tail, thus PABp will interact with this substrate RNA, and 
spliceosomes will be co-immunoprecipitated using anti-PAB antibodies (Whittaker and 
Beggs, 1990). 
- Under nondenaturing conditions, anti-Prp8 antibodies co-immunoprecipitate the US 
snRNP, the U4/U6.U5 tri-snRNP and the spliceosome (Brown, 1992) and will be 
utilized to isolate these complexes. 
9.1 Proteins Contacting the U6 SnRNA in the Spliceosome 
In order to study protein-U6 snRNA contacts occuring in the spliceosome in 
vitro, spliceosome formation was induced by adding unlabelled substrate RNA 
(RP5 1 A; 1 M final concentration) following U6 snRNP reconstitution. This substrate 
possesses a 100 nt-long poly(A) tail and was produced by run-off transcription of the 
RP51A plasmid linearized with BamHI (Table 9). As a negative control, a mutant 
RP51A lacking the 5' splice site (RP51A-5'0) and unable to form spliceosomes was 
added in independent reconstitution reactions. This substrate was produced by run-off 
transcription of the RP51A-5'0 plasmid linearized with BamHI (Table 9). As an 
additional control, substrate was ommitted to test for the specificity of binding of 
PABp. 
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Proteins UV-crosslinked to the U6 RNA (32P-aATP) and immunoprecipitated with 
anti-PAB or anti-Prp8 antisera are shown in Figure 39. Five UV-crosslinked proteins 
were precipitated with anti-Prp8 antibodies (16 kD, 23 kD, 25 kD, 40 kD and -P60 kD) 
in the absence of substrate RNA or when no spliceosome form (lanes 6 and 7). When 
the formation of functional spliceosomes was induced by the addition of unlabelled 
substrate RNA, the signal at 40 kD was much stronger, and a novel polypeptide (30 kD) 
was detected (compare lane 5 with lanes 6 and 7). Other protein signals (16 kD, 23 kD, 
25 kD and 60 kD) remain unchanged indicating that these proteins contact the U6 RNA 
at least in the tri-snRNP, however their presence in the spliceosome is uncertain. The 
intensity of the 40 kD band was greatly increased in a spliceosome-dependent fashion. 
It may be that the same signal detected, in the absence of substrate or when a 
nonfunctional RP51A-5'0 was added, reflects a basal level of spliceosomes formed 
with endogenous pre-mRNA. Alternatively this 40 kD signal may correspond to a 
different protein interacting with the U6 snIRNA in the tri-snRNP, or to a polypeptide 
which binds weakly to the U6 RNA in the tri-snRNP and more tighly when 
spliceosomes form. The immunoprecipitation of spliceosomes with anti-PAB antiserum 
shows that at least five proteins are in close proximity to the U6 RNA (lane 8). They 
possess apparent molecular weigths of 23 kD (weak signal), 25 kD, 30 kD, 40 kD and 
-70 kD. The 70 kD polypeptide was detected independently of spliceosome formation 
and remain UV-crosslinked to the U6 RNA and associated with the anti-PAB antiserum 
after denaturation (data not shown). Thus, this signal reflects the binding of the PAB 
protein to the U6 RNA. 
The mixture of a splicing extract prepared from yeast cells S150-213 overproducing 
pppLAT with an extract prepared from wild-type yeast cells (SC261) resulted in the 
accumulation of spliceosomes stalled prior to the first step (i.e. complex I on a native 
gel; section 2.6.2.2) (Plumpton et al., 1994). Titration experiments showed that the best 
complex I accumulation was obtained by mixing 2 volumes of Prp2p' T-containing 
splicing extract with 3 volumes of wild-type yeast extract (data not shown). Splicing 
extracts were then mixed to such a ratio and U6 snRNPs were reconstituted with 
randomly radiolabelled U6 RNA (32P-aATP). Proteins were UV-crosslinked to U6 
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Figure 39. Proteins UV-crosslinked to uniformly radiolabelled U6 RNA 
(32p-(xATP) and immunoprecipitated with anti-PAB and anti-Prp8 
antibodies. 
In a splicing extract (50 tl) prepared from wild-type SC261 cells (Table 7), 
U6 snRNPs were reconstituted (section 2.6.2.3) with 6 nM of randomly 
radiolabelled U6 RNA (32P-aATP). Unlabelled wild-type substrate RP5 1A (1 
p.M of final concentration) was then added (lanes 1-5 and lane 8) to induce 
spliceosome formation. As controls, substrate was omitted (lanes 6 and 9) or 
an unlabelled mutant RP51A-5'0 pre-mRNA (1 jiM) lacking the 5' splice site 
and unable to form spliceosomes was added (lanes 7 and 10). Samples were 
UV-irradiated then proteins were incubated with anti-prp8 (lanes 5-7) or anti-
PAB (lanes 8-10) antisera. As a control, UV-crosslinking was omitted in 
samples 2 and 4, or proteins were incubated with preimmune serum (lanes 1 
and 3). After washes (150 mM NaC1), proteins were resolved on a 15% SDS-
PAGE gel. Two different exposure times of the hypersensitive film are shown 
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RNA in stalled spliceosomes and immunoprecipitated with anti-Prp2 antibodies (Figure 
40, Panel A). At least three polypeptides (30 kD, 40 kD and 45 kD) were specifically 
UV-crosslinked to U6 RNA in the spliceosome before step I and detected on a 15% 
SDS-polyacrylamide gel (lane 1). The investigation of protein-pre-mRNA contacts 
using anti-Prp2 antibodies indicated that the proteins UV-crosslinked to the U6 RNA 
did not bind to the substrate. Instead, a polypeptide of 15 kD was in close proximity to 
the substrate before step I of splicing (lane 3). 
High molecular weight proteins UV-crosslinked to the U6 RNA and co-
immunoprecipitated with anti-Prp2 antibodies are shown in Figure 40 (Panel B). Six 
proteins of an apparent molecular size of >200 kD, -450 kD, 110 kD, a doublet at 90-
100 kD, 80 kD were UV-crosslinked to U6 RNA before step I and co-
immunoprecipiated with anti-Prp2 antiserum (lane 3). The >200 kD polypeptide may 
reflect the binding of Prp8p (280 kD) or Slt22p (246 kD) to the U6 RNA in the 
spliceosome stalled before step I. No denatured protein was immunoprecipitated with 
anti-Prp2 antibodies, indicating that under the experimental conditions tested the 
mutant p2LAT  does not interact directly with U6 RNA (lane 5). 
9.2 	Discussion 
Two proteins (30 kD and 40 kD) specifically interact with the U6 RNA in 
spliceosomes isolated with all three different antibodies (anti-PAB, -Prp2, -Prp8). Their 
immunoprecipitation with stalled spliceosomes indicates that they contact U6 RNA at 
least before step I of splicing. Two additional proteins (23 kD and 25 kD) contacting 
the U6 RNA in the spliceosome were immunoprecipitated with anti-PAB and anti-Prp8 
antisera but were not UV-crosslinked to U6 RNA in spliceosomes stalled before step I 
and/or irnmunoprecipitated with anti-Prp2 antisera. This suggests that these two 
polypeptides bind U6 RNA after the first splicing reaction and/or that compared to anti-
Prp2 antibodies, anti-PAB and anti-Prp8 antisera immunoprecipitate spliceosomes more 
efficiently. These two proteins may contact U6 RNA already in the tri-snRNP since two 
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Figure 40. Proteins UV-crosslinked to U6 RNA and immunoprecipitated 
with anti-Prp2 antibodies. 
A splicing extract (30 .il) prepared from wild-type SC261 cells (Table 7) 
was mixed with a splicing extract (20 pd) prepared from S150-2B 
(pBMPRP2LAT) cells (Tables 7 and 9) overproducing the mutant prp2LAT 
protein. After depletion of the endogenous U6 snRNA, U6 snRNPs were 
reconstituted with 6 nM of randomly radiolabelled U6 RNA (32P-aATP) 
(section 2.6.2.3). Wild-type unlabelled substrate RP51A (1 iM final 
concentration) was added to the reaction samples to induce spliceosome 
formation. Following U6 snRNP reconstitution and splicing, samples were 
UV-irradiated and proteins were immunoprecipitated under nondenaturing 
conditions with anti-Prp2 antisera (lane 1). As a control samples were not UV-
irradiated in lane 2. In splicing extract (50 tl) prepared from SC261 cells, a 
highly radiolabelled substrate RP51A (32P-aUTP) (section 2.6.2.1) was added 
and splicing reaction was carried out. After UV-irradiation, protein samples 
were immunoprecipitated with anti-Prp2 antibodies (lane 3). As controls 
sample was not UV-crosslinked (lanes 2 and 4) or proteins were incubated 
with preimmune serum (lane 5). After washes (150 mM NaC1), proteins were 
resolved on a 15% SDS-PAGE gel. 
A splicing extract (30 p1) prepared from wild-type SC261 cells (Table 7) 
was mixed with a splicing extract (20 p1) prepared from S150-213 
 (pBMPRP2 IA)  cells (Tables 7 and 9) overproducing the mutant Prp2 LAT  
protein. After depletion of the endogenous U6 snRNA, U6 snRNPs were 
reconstituted with 6 nM of randomly radiolabelled U6 RNA (32P-aATP) 
(section 2.6.2.3). Wild-type unlabelled substrate RP51A (1 pM final 
concentration) was added to the reaction samples to induce spliceosome 
formation. Following U6 snRNP reconstitution and splicing, samples were 
UV-irradiated. Proteins were immunoprecipitated under nondenaturing 
conditions (lane 3) or after denaturation (lane 5) with anti-Prp2 antisera. As 
controls, samples were not UV-irradiated (lane 1), or protein complexes were 
incubated with the preimmune serum (lane 2). In splicing extract (50 
prepared from SC261 cells, a highly radiolabelled substrate RP51A (3  P 
aUTP) (section 2.6.2.1) was addded and splicing reaction was carried out. 
After UV-irradiation, protein were denatured and immunoprecipitated with 
anti-Prp2 antibodies (lane 4). Proteins were washed (150 mM NaC1), then 























proteins of a similar molecular size (23 kD and 25 kD) were immunoprecipitated with 
anti-Prp8 antisera in the absence of substrate RNA or when a defective RP5 1 A-5'0 pre-
mRNA was added in the reaction. It would be interesting to identify the 23 kD and the 
25 kD proteins since they possess a molecular weight similar to Ussip (21 kD). 
In metazoans, splicing and cleavage/polyadenylation can be mutually stimulating in 
vivo and in vitro (Niwa et al., 1990; Niwa and Berget, 1991). The presence of 
functional signal for cleavage and polyadenylation can stimulate the removal of the 
most 3' intron in a pre-mRNA. This involves an interaction between splicing and the 3' 
end formation machineries (Gunderson et al., 1997; for review see Colgan and Manley, 
1997). Although in yeast similar links have not been reported, the binding of PABp to 
the U6 RNA may reflect an interaction between the polyadenylation and the splicing 
machineries, however this contact might be an artefact due to the in vitro system used. 
The investigation of the binding of high molecular weight proteins to the U6 RNA in 
spliceosomes co-immunoprecipitated with anti-Prp2 antibodies, suggests that p2LAT 
does not directly contact the U6 RNA. This lack of binding may reflect a detrimental 
effect of the mutation in the putative RNA unwinding motif of Prp2p. Other 
polypeptides of an apparent molecular weight of 110 kD, —150 kD, 90-100 kD and 80 
kD were also UV-crosslinked to the U6 RNA and co-immunoprecipitated with anti-
Prp2 antibodies under nondenaturing conditions. The UV-crosslinking of these proteins 
to the U6 RNA was difficult to reproduce suggesting that their covalent binding to the 
U6 RNA in the spliceosome was inefficient and/or the immunoprecipitation of the 
spliceosomes with anti-Prp2 antibodies was not proficient enough. 
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9.3 Attempts to Investigate of the Presence of Ussip in the Spliceosome 
Proteins interacting with Ussip are being studied by A. Mayes in the laboratory 
with the yeast two-hybrid approach (Fromont-Racine et al., 1997; A. Mayes et al., 
1997, 1998). Two hybrid screens were carried out using the Ga14-Ussl fusion protein 
as a bait. Among many interacting proteins detected, some U2 snRNP-associated 
proteins, suggesting that Ussip might be present in the prespliceosome and/or in the 
spliceosome (A. Mayes, 1997). The UV-crosslinking analysis of proteins interacting 
with U6 RNA in the spliceosome using anti-Prp8 or anti-PAB antisera allowed us to 
detect four polypeptides (23 kD, 25 kD, 30 kD and 40 kD). As the 23 kD and the 25 kD 
proteins possesses a molecular weight similar to Ussip (21 kD), the presence of this 
splicing factor in the spliceosome was investigated following several experimental 
strategies: 
Immunoprecipitation of stalled splicesomes. Splicing extracts containing spliceosome 
complexes stalled before step I were immunoprecipitated with anti-Prp2 antiserum. 
Proteins were progressively eluted from the complex by gradually increasing the salt 
concentration of the washing buffer (NTN containing 300 mM-1000 mM NaCl, section 
2.8), and precipitated with acetone. Proteins were resolved on an SDS-polyacrylamide 
gel, and the presence of Ussip, Prp2p and Prp8p was assayed by Western blotting 
analysis using the respective antibodies. Only a very weak signal was detected with 
anti-Prp2 antiserum. The detection of proteins by silver staining indicated that actually 
few polypeptides had been recovered (data not shown). 
Gel fractionation and elution of splicing complexes. After incubation of a Prp2lT 
containing splicing extract with a radiolabelled substrate (section 2.4.4.1), splicing 
complexes (stalled before step I) were resolved on a native gel system (section 2.6.2.2). 
Complexes were detected by autoradiography and gel slides containing complex I 
(immature spliceosome containing p2LAT)  or complex III (prespliceosome) were cut 
out. Gel slices were transferred to dialysis tubes and proteins electoeluted (section 
2.9.2). Proteins were either precipitated with acetone or concentrated with a Centricon 
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centrifugal concentrator (Amicon) according to the manufacturers' instructions. 
Proteins were resolved on an SDS-PAGE gel and the presence of Ussip in the splicing 
complexes was investigated by Western blotting using anti-Ussl antisera. A faint 
Ussip signal was observed in complex III whereas a much stronger band was detected 
in complex I (data not shown). Despite of the several attempts, we have been unable to 
repeat this experiment. The native gel system used (section 2.6.2.2) was unreliable and 
good resolution was difficult to reproduce. Resolution was largely dependent on the 
quality of the total yeast RNA in the Q buffer required to resolve the spliceosome 
complex on the native gel system used (section 2.6.2.2). For an unknown reason the 
best resolution was obtained when total yeast RNA was prepared from temperature-
sensitive splicing mutants grown under non-permissive temperature conditions. 





Nine proteins are associated with the yeast U6 snRNA: Ussip (Cooper et al., 
1995), Uss2p (Séraphin, 1995), Prp24p (Shannon and Guthrie, 1991; Jandrositz and 
Guthrie, 1995), Spb8p, Uss3p, Uss4p, Uss5p, Uss6p and Uss7p (Fromont-Racine et al., 
1997; Mayes et al., 1998). Chemical footprinting analysis of the U6 snRNA in the U6 
snRNP indicated that only the central domain (in particular nucleotides A40-C43, G50 
and G60) and the lower part of the 3' stem-loop (in particular nucleotides G81-A83) of 
the U6 snRNA are in contact with proteins (Jandrositz and Guthrie, 1995). Further 
investigations demonstrated that Prp24p contacts the central domain (nucleotides A40-
C43) of the U6 snRNA (Jandrositz and Guthrie, 1995; Ghetti et al., 1995). 
The work presented here has extended our knowledge on U6 snRNA-protein 
interactions. Among the U6 snRNP-associated proteins tested Prp24p, Ussip, Uss3p, 
Uss4p, Uss5p, Uss6p and Spb8p bind directly to the U6 snRNA. UV-crosslinking 
analysis demonstrated that at least Ussip, Uss4p and Uss5p interact with the U6 
snRNA in the U6 snRNP, the U4/U6 snRNP and in the tri-snRNP. Also two additional 
proteins (10 kD and 70-75 kD), as yet unidentified, contact the U6 snRNA in these 
particles, while other polypeptides (-40 kD, -85 kD, >210 kD and Prp8p) interact with 
the U6 snRNA in the tri-snRNP only. 
Very little difference, if any, was observed between the proteins bound to the U6 
snRNA in the U6 snRNP and in the U4/U6 snRNP. Two explanations are proposed: 
1- Prp24p is a U6 snRNP-associated protein which functions at different steps during 
snRNP assembly. It promotes the annealing of the U6 snRNA and the U4 snRNA to 
form the U4/U6 snRNP. During this step, Prp24p interacts transiently with these 
snRNAs in a Prp24p-U4/U6 snRNAs intermediate complex. In this complex Prp24p 
contacts the U41U6 snRNAs stem II region, which shows a partial 
distortion/unwinding. From this observation it has been proposed that Prp24p has to 
leave this intermediate complex to allow complete U4/U6 snRNAs association. Prp24p 
may also be involved in the destabilisation of U4/U6 snRNAs as they interact with the 
spliceosome (Shannon and Guthrie, 1991; Jandrositz and Guthrie, 1995; Ghetti et al., 
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1995). Recently Prp24p was shown to recycle, in an ATP-dependent manner, the 
U41U6 snRNP from U4 and U6 snRNPs released after splicing (Raghunathan and 
Guthrie, 1998). Although the interaction of Prp24p in the Prp24p-U4-U6 snRNAs 
complex is transient, the UV-irradiation may have fixed Prp24p with these snRNAs. 
Consequently, even if the anti-Prp24 antibodies used in this work associate with only 
traces of U4 snRNA and probably very little of U4/U6 snRNP, following TJV-
crosslinking, anti-Prp24 antibodies may also precipitate the Prp24p-U4-U6 snRNAs 
complex and the associated proteins. Thus little difference would have been observed 
between the proteins contacting the U6 snRNA and isolated with the anti-Prp24 or with 
anti-Ussi antibodies, since both antibodies co-immunoprecipitate the U6 and the 
U4/U6 snRNPs. 
2- Despite the transient association of Prp24p with U4/U6 snRNAs, following UV-
crosslinking, anti-Prp24 antibodies co-immunoprecipitate mainly the U6 snRNP 
particle. Thus the little difference observed between proteins contacting the U6 snIRNA 
in the U6 snRNP and in the U4/1J6 snRNP indicates that these polypeptides are in close 
proximity to the U6 snRNA in these two particles. The U6 snRNA undergoes dramatic 
conformational changes in order to interact with the U4 snRNA in the U4/U6 snRNP. 
Despite these changes the U6 snRNP associated proteins remain in contact with the U6 
snRNA. This suggests that either they accomodate the U6 snRNA conformational 
changes, or they contact the 3' tail of the U6 snIRNA since it is the only region of this 
molecule which remains single stranded in the U6 snRNP and in the U4/1J6 snRNP. 
Interestingly, the removal of the last 18 nucleotides of the U6 snRNA dramatically 
affects the binding of proteins to the U6 snRNA in the U6 snRNP and in the U4/U6 
snIRNP. This suggests that proteins contact the 3' tail of the U6 snRNA or they require 
this 3' tail to contact the U6 snRNA elsewhere. 
Among the U6 snRNP-specific proteins, Ussip, Uss4p and Uss5p bind to the U6 
snRNA in the U6 snRNP, the U4/U6 snRNP and in the U41U6.U5 tri-snRNP, 
suggesting an important role for them to play. Several hypotheses can be proposed: 
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- U6 snRNA undergoes dramatic conformational changes during snRNP assembly and 
spliceosome formation. Ussip, Uss4p and Uss5p may function as chaperones and 
stabilize the U6 snRNA and/or facilitate its conformational changes. 
- In yeast, the U6 snRNA is in large excess over the U4 snRNA for no obvious reasons, 
thus only a fraction of the former associates with the latter to produce the U41tJ6 
snRNP. It is unknown whether all the U6 snRNA is involved in splicing or if this 
molecule is required for other cellular function(s). The binding of Ussip, Uss4p and 
Uss5p to the U6 snRNA may commit this molecule to splicing and may also be 
required for the recognition of the U6 snRNA by the other components of the splicing 
machinery. 
- Ussip, Uss4p and Uss5p share homology with the cannonical Sm proteins. The Sm 
proteins are required for the hypermethylation of the (7-mG) cap structure of the Ui, 
U2, U4 and U5 snRNAs and also for their nuclear import thus participating at snRNP 
biogenesis. Although it is unknown whether the yeast U6 snRNA leaves the nucleus, 
the Sm-like U6 snRNP-specific proteins might be involved in the transport of the U6 
snRNA either from the cytoplasm to the nucleus or within the nucleus from one 
compartment to an other where snRNP biogenesis and/or snRNP assembly occurs. 
In addition to Ussip, Uss4p, Uss5p, a 10 kD and a 70-75 kD proteins, at least five 
additional proteins (43 kD, 65-80 kD, 85 kD, >>210 kD and Prp8p) contact the U6 
snRINA in the tri-snRNP only. The conformation of the U4, U6 and the U5 snRNAs in 
the tri-snRNP is unknown, however twice as many proteins contact the U6 snRNA in 
this particle, suggesting that its conformation has changed. It is possible that the U4/1J6 
snRNA stems I and II have been partially opened-up or distorted, or that the 5' U6 
snRNA hairpin structure has been unwound. These conformational changes may have 
permitted the contact of other proteins with the U6 snRNA. Interestingly, among the 
proteins bind the U6 snRNA in the tri-snRNP, Prp8p was detected which has been 
hypothesised to stabilize RNA-RNA interactions between the US snRNA and the pre-
mRNA (Beggs et al., 1995; Teigelkamp et al., 1995, 1995b; Dix et al., 1998). The 
>>210 kD protein possesses a size similar to Slt22p (246 kD) which is a U5 snIRNP and 
tri-snRNP associated splicing factor. S1t22p is a member of the DEXH-box protein 
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family and shows in vitro ATPase activity, preferentially stimulated by annealed U2/U6 
snRNAs (Xu et al., 1996). One can speculate that in the tri-snRNP, S1t22p unwinds 
intra- or intermolecular RNA-RNA interactions involving the U6 snRNA and the U4 
snRNA. Another tri-snRNP associated protein and member of the DEAD-box protein 
family of putative RNA helicases, Prp28p (66 kD), was proposed to unwind the U41EJ6 
snRNAs probably with the help of another factor (maybe Prp24p) (Shannon and 
Guthrie, 1991; Strauss and Guthrie, 1994). Interestingly a protein of a size (>65 kD) 
similar to Prp28p binds to the U6 snRNA specifically in the tri-snRNP, indicating that 
this polypeptide could potentially be Prp28p. Therefore one can speculate that in the tn -
snRNP the structure of the U6 snRNA is altered, probably by the action of RNA 
helicases, and that this modified structure is stabilized by the binding of Prp8p, Ussip, 
Uss4p and Uss5p. These U6 snRNA conformational changes may be necessary to 
prime the association of the tri-snRNP with the prespliceosome. 
Future Work. 
Ussip, Uss4p and Uss5p bind to the U6 snRNA in the U6 snRNP, U4/U6 
snRNP and in the tri-snRNP. It would be of great interest to determine whether these 
polypeptides contact the U6 snRNA in the spliceosome. The investigation by UV -
crosslinking at 254 nm of protein-U6 snRNA contacts in the spliceosome indicated that 
not many proteins (30 kD, 40 kD) bind to the randomly radiolabelled U6 RNA. In the 
spliceosome the U6 snRNA is involved in numerous intra- or intermolecular helix 
structures which might limit the efficiency of protein-U6 snRNA UV-crosslinking. This 
low efficiency can be partially overcome by using a U6 RNA containing 4-thiouridine. 
As shown in this work, the UV-crosslinking at 365 nm of proteins to a U6 RNA 
containing a single radiolabelled 4-thiounidine was highly efficient. Therefore a 
randomly radiolabelled U6 RNA could be transcribed in vitro in a reaction containing a 
mixture of uridine and 4-thiouridine as well as other nucleotides and components 
required for transcription. Subsequently, U6 snRNPs would be reconstituted and 
spliceosomes would form by addition of unlabelled pre-mRNA. Following UV- 
214 
crosslinking at 365 nm, spliceosomes would be co-immunoprecipitated or isolated by 
gel filtration. After RNase digestion, proteins would be resolved on an SDS-PAGE gel 
and detected by autoradiography. To investigate the presence of Ussip, Uss4p and 
Uss5p, splicing extracts containing as only source of these proteins an HA-fusion 
would be utilized. After isolation of the spliceosomes and UV-irradiation, proteins 
would be denatured and immunoprecipitated with anti-HA antibodies. Following 
resolution of the proteins on an SDS-PAGE gel, those UV-crosslinked to the 
radiolabelled U6 snRNA would be detected by autoradiography. 
Preliminary experiments to map the binding of the proteins to the U6 snRNA showed 
that several polypeptides (in particular Ussip and Prp8p) contact the U6 snRNA at 
position U54 . It would be of great interest to thoroughly map the binding site of the 
proteins to the U6 snRNA in the different snRNPs. A photoactivatable 4-thiouridine 
could be inserted at specific positions of the U6 snRNA following the method described 
in Figure 41. This method possesses several advantages over that used in this work 
(Chapter 8 and section 2.4.4.5). Indeed, the 4-thiouridine can be incorporated at any 
position in the molecule and it does not require the use of 4-thioUpG which is no longer 
commercially available. As the 5' RNA moiety is generated by RNase H cleavage of 
the full length U6 RNA, its 3' end does no harbour any non-templated extra 
nucleotides. Thus, in theory, the ligation efficiency of the 5' and the 3' RNA halves 
should be higher than that obtained with the method applied in this work. 
The binding of Spb8p, Uss3p and Uss6p to the U6 snRNA requires further 
investigations. Ga14-HA fusion of Spb8p and Uss6p could be generated and the binding 
of these proteins to the U6 snRNA analysed in the snRNPs. As the Ga14-HA-Uss3p 
binds weakly to the U6 snRNA, another fusion of this protein could be generated and 
used to investigate the binding of Uss3p to the U6 snilNA. This might determine 
whether the fusion of the Ga14-HA to Uss3p has a detrimental effect on its binding to 
the U6 RNA. 
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Figure 41. Site specific incorporation of a 32P-4 thiouridine. 
This protocol is adapted from that described by Yu and Steitz (1997). Full 
length U6 snRNA transcribed in vitro with the T7 RNA polymerase is 
annealed with a (2' -0-Methyl-RNA-DNA-2 '-0-Methyl RNA) chimera oligo. 
This chimera oligo is complementary to a sequence of the U6 snRNA and 
directs its cleavage by RNase H. RNase H cleaves RNA only in an RNA:DNA 
heteroduplex, whereas RNA base-paired with a 2'-O-Methyl-RNA is protected 
from cleavage. Depending on the source of RNase H used, the nbonucleotide 
base-paired with the first deoxyribonucleotide from the 5' end of the chimera 
oligo cuts either at its 5' site (RNase H purchased from Boehringer) or at its 3' 
site (RNase H purchased from Pharmacia). A (*P4sUp),  derived from (4supu) 
by phosphorylation with (y- 32P-ATP) (Laphma et al., 1997) followed by 
digestion with RNase A, is ligated at the 3' extremity of the 5' half of the U6 
RNA. The 3' phosphate of the ligated product is removed by Calf intestinal 
alkaline phosphatase treatment to produce a 3'-OH group. Subsequently the 
two halves of the U6 RNA are aligned by complementarity with a bridging 
oligodeoxyribonucleotide and ligated with the T4 DNA ligase. The resulting 
U6 RNA contains at a specific site a radiolabelled 4-thiouridine. Open boxes 
represent the RNA moities. Underlined letters of the chimera oligo represent 
the 2'-O-Methyl RNA, bold letters represent the deoxyribonucleotide and the 
RNase H cleavage positions are shown as arrows. 
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I- 
Site specifically radiolabelled U6 RNA containing a 4-thioU 
In summary, this work describes the first characterisation of the protein contacts made 
with the U6 snRNA in the snRNP particles and in the spliceosome. Some of these 
polypeptides appear to accomodate the conformational changes of the U6 snRNA and 
remain in close proximity to this molecule in the U6, U41U6 snRNP and in the tn-
snRNP, whereas other proteins contact the U6 snRNA only in one type of snRNP. 
From these observations one can speculate that some of the polypeptides are most 
likely to maintain the stability of the U6 snRNA while other promote its conformational 
changes. Interestingly, the U6 snIRNP-associated proteins (at least Ussip, Uss4p and 
Uss5p) bind to the U6 snRNA in the U6 snRNP, the U4/U6 snRNP and in the tn-
snRNP. They possess significant homology with the cannonical Sm proteins, in 
particular they share the Sm motif. It would be of particular interest to investigate 
whether by analogy with the core proteins, the U6 snRNP-associated Sm-like proteins 
are involved in the biogenesis of the U6 snRNP. Do they contact the U6 snRNA in the 
spliceosome? Are they required for splicing? The U6 snRNA does not contain any 
cannonical Sm binding site, therefore the mapping of the binding site of the Sm-like 




Abovich, N., Legrain, P. and Rosbash, M. (1990) Mol. Cell. Biol., 10, 6417-6425. 
Abovich, N., Liao, X.L. and Rosbash, M. (1994) Genes Dev., 8, 843-854. 
Abovich, N. and Rosbash, M. (1997) Cell, 89, 403-4 12. 
Aebi, M., Hornig, H., Padgett, R.A., Reiser, J. and Weissmann, C. (1986) Cell, 47, 555-
565. 
Aebi, M., Hornig, H, and Weismann, C. (1987) Cell, 50,237-246. 
Achsel, T., Teigelkamp, S. Mundt,C., Cronshagen, U., Göthel, S.F., Marahiel, M.A. 
and LUhrmann, R. (1997) RNA '97, the second annual meeting of the RNA society. 
Ansari, A. and Schwer, B. (1995) EMBO J., 14,4001-4009. 
Anthony, J.G., Weidenhammer, E.M. and Woolford, J.L.JR. (1997) RNA, 3,143-1152. 
Arenas, J.E. and Abelson, J.N. (1993) Proc. Natl. Acad Sci. USA, 90, 677 1-6775. 
Arenas, J.E. and Abelson, J.N. (1998) Proc. Natl. Acad. Sd. USA, 94, 11798-11802. 
Arenas, J. and Hurwitz, J. (1987) Biol. Chem., 25, 4274-4279. 
Ares, M. and Weiner, B. (1995) Prog. Nucleic Acid Res. Mol. Biol., 50, 131-159. 
Arning, S., GrUter, P., Bilbe, G. and Kramer, A. (1996) RNA, 2, 794-8 10. 
Ast, G. and Weiner, A.M. (1996) Science, 272, 88 1-884. 
Ast, G. and Weiner, A.M. (1997) RNA, 3, 3 71-3 8 1. 
Ayadi, L., Miller, M. and Banroques, J. (1997) RNA, 3,197-209. 
Bach, M., Winkelmann, G. and LUhrmann, R. (1989) Proc. Nati. Acad: Sci. USA, 86, 
6038-6042. 
Banroques, J., Abelson, J. (1989) Mol. Cell. Biol., 9, 3710-3719. 
Barabino, S.M., Blencowe, B.J., Ryder, U., Sproat, B.S. and Lamond, A.I. (1990) Cell, 
63, 293-302. 
Been, M.D. and Perrotta, A.T. (199 1) Science, 252, 434-437. 
217 
Beggs, J.D., Van den Berg, J., Ooyen, A. and Weissmann, C. (1980) Nature, 283, 835-
840. 
Beggs, J.D. and M. Plumpton (1992) Nucleic Acids and Mol. Biol., 6, 187-202. 
Beggs, J.D. (1993) Mol. Biol. Reports, 18, 99-103. 
Beggs, J.D. (1995) Pre-mRNA processing, A. Lamond (ed), Springer-Verlag Berlin 
Heidelberg. pp79-95. 
Beggs, J.D, Teigelkamp, S. and Newman, A.J. (1995) J Cell Science, 19, 101-105. 
Behrens, S-E., Tyc, K., Kastner, B., Reichelt, J. and Luhrmann, R. (1993) Mol. Cell. 
Biol., 13, 307-319. 
Bennett, M., Michaud, S., Kingston, J. and Reed, R. (1992) Genes Dev., 6, 1986-2000. 
Bennett, M. Reed, R. (1993) Science, 262, 105-108. 
Berglund, J.A., Chua, K., Abovich, N., Reed, R. and Rosbash, M. (1997) Cell, 89, 781-
787. 
Bimey, E., Kumar, S. and Kramer, A.R. (1993) Nucleic Acids Res., 21, 5803-5816. 
Blanton, S., Srinivasan, A. and Rymond, B. (1992) Mol. Cell. Biol., 12, 3939-3947. 
Blencowe, B.J., Sproat, and Ryder, U. (1989) Cell, 59, 531-539. 
Boelens, W.C., Scherly, D., Jansen, E.J.R., Kolen, K., Mattaj, I.W. and Van Venrooij, 
W.J. (199 1) Nucleic Acids Res., 19, 4611-4618. 
Boelens, W.C., Palacios, I. and Mattaj, I.W. (1995) RNA, 1, 273-283. 
Boeck, R., Lapeyre, B., Brown, C.E. and Sachs, A.B. (1998) Mol. Cell. Biol., in press. 
Bordonné, R., Banroques, J., Abelson, J. and Guthrie, C. (1990) Genes Dev., 4, 1185-
1195. 
Branlant, C., Krol, A., Ebel, J.P., Lazar, E., Haendler, B. and Jacob, M. (1982) EMBO 
J., 1, 1259-1265. 
Breathnach, R. and Chambon, P. (198 1) Annu. Rev. Biochem., 50, 349-384. 
Breathnach, R., Manel, J.L. and Chambon, P. (1977) Nature, 270, 314-319. 
Bringmann, P., Renter, R., Rinke, J., Appel, B., Bald, R. and LUhrmann, R. (1984) J. 
Biol. Chem., 258, 2745-2747. 
218 
Brosi, R., Hauri, H-P. and Kramer, A. (1993)1 Biol. Chem., 268, 17640-17646. 
Brosi, R., Groning, K., Behrens, S-E., LUhrmann, R. and Kramer, A. (1993b) Science, 
262, 102-105. 
Brow, D.A. and Guthrie, C. (1988) Nature, 334, 213-218. 
Brown, J.D. and Beggs, J.D. (1992) EMBO J., 11,3721-3729. 
Brys, A. and Schwer, B. (1996) RNA, 2, 707-717. 
Burke, J.M. and RajBhandary, U.L. (1982) Cell, 31, 509-520. 
Camasses, A., Bragado-Nilsson, E., Martin, R., Séraphin, B. and Bordonné, R. (1998) 
Mol. Cell. Biol., 18,1956-1966. 
Cazenave, C. and Uhienbeck, C.O. (1994) Proc. Nati. Acad. Sci. USA, 91, 6972-6976. 
Cech, T.R. (1985) Cell, 43, 713-716. 
Cech, T.R. (1993) The RNA world, Cold Spring Harbor Laboratory Press, p239-269. 
Champion-Arnaud, P. and Reed, R. (1994) Genes Dev., 8, 1974-1983. 
Champion-Arnaud, P., Gonzani, 0., Palandjian, L. and Reed, R. (1995) Mol. Cell. 
Biol., 15, 5750-5756. 
Chanfreau, G., Elela, S.A., Ares, M.Jr. and Guthrie, C. (1997) Genes Dev., 11, 2741-
2751. 
Chapman, K.B. and Boeke, J.D. (1991) Cell, 65,483-492. 
Chapon, C. and Legrain, P. (1992) EMBO J., 11,3279-3288. 
Chen, H.R., Jan, S.P., Tsao, T.Y., Sheu, Y.J., Banroques, and Cheng, S.C. (1998) Mol. 
Cell Biol. ;18, 2196-2204. 
Cheng, S-C. and Abelson, J. (1987) Genes Dev., 1, 1014-1027. 
Chiara, M.D., Champion-Arnaud, P., Buvoli, M., Nadal-Ginard, B. and Reed, R. (1993) 
Proc. Nati. Acad. Sci. USA, 91, 6403-6407. 
Chiara, M.D., Champion-Arnaud, P., Buvoli, M., Nadal-Ginard, B., and Reed, R. 
(1994) Proc. Natl. Acad. Sci. USA, 91, 6403-6407. 
Christopher, D.A. and Hallick, R.B. (1989) Nucleic Acids Res., 17, 7591-7608. 
219 
Chu, F., Maley, G.F., West, D.K., Belfort, M. and Maley, F. (1986) Cell, 45, 157-166. 
Chu, J-l. and Elkon, K.B. (199 1) Gene, 97, 311-312. 
Church, G.M. and Gilbert, G. (1984) Proc. Nati. Acad. Sci. USA, 81, 1991-1995. 
Ciliberto, G., Dathan, N., Frank, R., Philipson, L. and Mattaj, I.W. (1986) EMBO J., 5, 
2931-2937. 
Colgan, D.F. and Manley, J.L. (1997) Genes Dev., 11, 2755-2766. 
Colot, H.V., Stutz, F. and Rosbash, M. (1996) Genes Dev., 10, 1699-1708. 
Company, M., Arenas, J. and Abelson, J. (199 1) Nature, 349, 487-493. 
Cooper, M. (1995) Ph.D. Thesis, University of Edinburgh. 
Cooper, M, Johnston, L.H. and Beggs, J.D. (1995) EMBO J., 14, 2066-2075. 
Copertino, D.W. and Hallick, R.B. (1991) EMBO J., 10, 433-442. 
Copertino, D.W.,Christopher, D.A. and Hallick, R.B. (1991b) Nucleic Acids Res., 19, 
6491-6497. 
Copertino, D.W., Shigeoka, S. and Hallick, R.B. (1992) EMBO J., 11, 5041-5050. 
Copertino, D.W. and Hallick, R.B. (1993) TIBS, 18,467-471. 
Crispino, J.D., Blencowe, B.J. and Sharp, P.A. (1994) Science, 265, 1866-1869. 
Dahlberg, J.E. and Lund, E. (1988) Birnstiel, M.L., Verlag-Springer, pp  38-70. 
Dalbadie-McFarland and Abelson (1990) Proc. Nat!. Acad. Sci. USA, 87, 4236- 
Dalrymple, M.A., Petersen-Bjorn, S.; Friesen, J.D. and Beggs, J.D. (1989) Cell, 58, 
811-812. 
Das, G., Henning, D. and Reddy, R. (1987) J Biol. Chem., 262, 1187-1193. 
Datta, B. and Weiner, A.M. (199 1) Nature, 352, 821-824. 
Datta, B. and Weiner, A.M. (1993) Mol. Cell. Biol., 13, 5377-5382. 
Davies, R.W, Waring, R.B., Ray, J.A., Brown, T.A. and Scazzocchio, C. (1982) 
Nature, 300, 719-724. 
220 
Decatur, W.A., Einvik, C., Johansen, S. and Vogt, V.M. (1995) EMBO J, 14, 4558-
4568. 
Dix, I., O'Keefe, R., Russel, C., Newman, A. and Beggs, J.D. (1998) RNA, In press. 
Eperon, I.C., Ireland, D.C., Smith, R.A., Mayeda, A. and Kramer, A.R. (1993) EMBO 
J., 12, 3606-3617. 
Fabrizio, P., McPheeters, D.S. and Abelson, J. (1989) Genes Dev., 3, 2137-2150. 
Fabrizio, P. and Abelson, J. (1990) Science, 250, 404-409. 
Fabrizio, P. and Abelson, J. (1992) Nucleic Acids Res., 20, 3659-3664. 
Fabrizio, P., Esser, S., Kastner, B. and Lührmann, R. (1994) Science, 264, 261-264. 
Fabrizio, P., Laggerbauer, B., Lauber, J., Lane, W.S. and LUhrmann, R. (1997) EMBO 
J., 16, 4092-4106. 
Favre, A. (1990) Morrison, H (ed.) Bioorganic Photochemistry, Chap. 5, 379-425. 
Feinberg, A.P. and Vogelstein, B. (1983) Anal. Biochem., 132, 6-13. 
Feinberg, A.P. and Vogelstein, B. (1984) Addendum. Anal. Biochem., 137, 266-267. 
Fetzer, S., Lauber, J., Will, C.L and LUhrmann, R. (1997) RNA, 3,334-3 55. 
Field, D.J and Friesen, J.D. (1996) Genes Dev., 10, 489-501. 
Fisher, D.E, Conner, G.E., Reeves, W.H., Wisniewoiski, R. and Blobel, G. (1985) Cell, 
42, 751-758. 
Fisher, U., Wittman-Liebold, B., Lang, K., Kiefhaber, T. and Schmid, F.X. (1989) 
Nature, 337, 476-478. 
Fisher, U. and Lührmann, R. (1990) Science, 249, 786-790. 
Fleckner, J., Zhang, M., Valcarcel, J. and Green, M.R. (1997) Genes Dev., 15, 1864-
1872. 
Foreman, P.K. and Davis, R. (1994) Gene, 144, 63-68. 
Forné, T., Rossi, F., Labourier, E., Antoine, E., Cathala, G., Brunel, C. and Tazi, J. 
(1995)1 Biol. Chem., 270, 16476-16481. 
Fortner, D.M., Troy, R.G. and Brow, D.A. (1994) Genes Dev., 8,221-233. 
221 
Fouser, L. A. and Friesen, J.D. (1986) Cell, 45, 81-93. 
Frank, D.N., Patterson, B. and Guthrie, C. (1992) Mol. Cell. Biol., 12, 5 197-5205. 
Frank, D.N., Roiha, H. and Guthrie, C. (1994) Mol. Cell. Biol., 14, 2180-2190. 
Frendeway, D. and Keller, W. (1985) Cell, 42, 3 55-367. 
Fresco, L.D. and Buratowski, S. (1996) RNA, 2, 584-596. 
Fromont-Racine, M., Rain, J-C. and Legrain, P. (1997) Nature Genetics, 16, 277-282. 
Fu, X-D. and Maniatis, T. (1990) Nature, 343, 437-441. 
Fu, X-D. (1995) RNA, 1, 663-680. 
Fuller-Pace, F.V. and Lane, D. (1992) In Eckstein, F. and Lilley, D.M.J. (eds), Nucleic 
acids and Molecular Biology Volume 6. Springer-Verlag Berlin Heidelberg. pp. 159-
173. 
Fury, M. and Zieve, G.W. (1996) Experimental Cell Research, 228, 160-163. 
Galisson, F. and Legrain, P. (1993) Nucleic Acids Res., 21, 1555-1562. 
Garcia-Blanco, M.A., Anderson, G.J., Beggs, J.D. and Sharp, P.A. (1990) Proc. Natl. 
Acad. Sci. USA, 87,3082-3086. 
Ge, H. and Manley, J.L (1990) Cell, 62, 25-34. 
Gee, S., Wald Krauss, S., Miller, E., Aoyagi, K., Arenas, J. and Conboy, J.G. (1998) 
Proc. Natl.Acad. Sci. USA, 94, 11803-11807. 
Ghetti, A., Company, M. and Abelson, J. (1995) RNA, 1, 132-145. 
Gietz, R. D. and Sugino, A. (1988) Gene, 74, 527-535. 
Gietz, R. D., St Jean, A., Woods, R.A. and Schiesti, R.H. (1992) Nucleic Acids Res., 21, 
1425. 
Goldschmidt-Clermont, M. (1991) Cell, 65,135-143. 
Gott, J.M., Shub, D.A and Belfort, M. (1986) Cell, 47, 81-87. 
Gottschalk. A., Tang, J., Puig, 0., Salgado, J., Neubauer, G., Colot, H.V., Mann, M., 
Séraphin, B., Rosbash, M., LUhrmann, R. and Fabrizio, P. (1998) RNA, 4, 374-393. 
Gozani, 0., Patton, J.G. and Reed, R. (1994) EMBO J., 13,3356-3367. 
222 
Gozani 3O., Feld, R. and Reed, R. (1996) Genes Dev., 10, 233-243. 
Greenberg, J.R. (1979) Nuci. Acids Res., 6, 715-732. 
Gunderson, S.I., Vagner, S., Polycarpou-Schwarz, M. and Mattaj, I.W. (1997) Genes 
Dev., 11, 761-773. 
Guthrie, C. and Patterson, B. (1988) Annu. Rev. Genet., 22, 387-419. 
Hall, I.J. (199 1) Nucleic Acids Res., 19, 3795-3798. 
Hall, R. S. and Padgett, R.A. (1994) 1 Mol.Biol., 239, 3 57-365. 
Hall, S.L and Pradgett, R.A. (1996) Science, 271, 1716-1718. 
Hallick, R.B., Hong, L., Drager, R.G., Favreau, M.R., Monfort, A., Orsat, B., 
Spielmann, A. and Stutz, E. (1993) Nucleic Acids Res., 21, 3537-3544. 
Haltiner-Jones, M. and Guthrie, C. (1990) EMBO J., 9,2555-2561. 
Hamm, J., Datzynkiewicz, E., Tahara, S.M. and Mattaj, I.W. (1990) Cell, 62, 569-577. 
Hanahan, D. (1983)1 Mol. Biol., 166, 557-580. 
Harrison, S. (1991) Nature, 353, 715-719. 
Hashimoto, C. and Steitz, J.A. (11984) Nucleic Acids Res., 12, 3283-3293. 
Heinrichs, V., Bach, M., Winkelmann, G. and Luhrmann, R. (1990) Science, 247, 69-
72. 
Heiririchs, V., Hack!, W. and LUhrmann, R. (1992)1. Mol. Biol., 227, 15-28. 
Hermann, H., Fabrizio, P., Raker, V.A., Foulaki, K., Hornig, H., Brahms, H. and 
LUhrmann, R. (1995) EMBOJ., 14, 2076-2088. 
Hernandez, N. and Keller, W. (1983) Cell, 35, 89-99. 
Hernandez, N. and Weiner, A.M. (1986) Cell, 47, 249-258. 
Hetzer, M., Wurzer, G., Schweyen, R.J and Manfred, W.M. (1997) Nature, 386, 417-
420. 
Hieter, P. and Sikorski, R.S. (1989) Genetics, 122, 19-27. 
223 
Hilleren, P.J., Kao, H-Y. and Siliciano, P.G. (1995) Mol. Cell. Biol., 15, 6341-6350. 
Hodges, P.E. and Beggs, J.D. (1994) Current Biology, 4,264-267. 
Hodges, P.E., Jackson, S.P., Brown, J.D. and Beggs, J.D. (1995) Yeast, 11, 337-342. 
Hong, L. and Hallick, R.B. (1994) Genes & Dev., 8,1589-1599. 
Hong, W., Bennett, M., Xiao, Y., Feld Kramer, R., Wang, C. and Reed, R. (1997) 
Nucleic Acids Res., 25, 354-361. 
Horowitz, D.S. and Abelson, J. (1993a) Mol. Cell. Biol., 13, 2959-2970. 
Horowitz, D. S. and Abelson, J. (1993b) Genes Dev., 7, 320-329. 
Horowitz, D. S. and Kramer, A. (1997) Genes Dev., 11, 139-15 1. 
Hu, J., Xu, Y., Schappert, K., Harrington, T., Wang, A., Braga, R., Mogridge, J. and 
Friesen, J.D. (1994) Nucleic Acids Res., 22, 1724-1734. 
Igel, H., Wells, S., Perriman, R. and Ares, M. Jr. (1998) RNA, 4, 1-10. 
Iggo, R.D., Jamieson, D.J., MacNeill, S.A., Southgate, J., McPheat, J. and Lane, D.P. 
(199 1) Mol. Cell. Biol., 11, 1326- 
Izaurralde, E. and Adam, S. (1998) RNA, 4, 35 1-364. 
Jackson, S.P., Lossky, M. and Beggs, J.D. (1988) Mol. Cell. Biol., 8, 1067-1075. 
Jacquier, A. and Rosbash, M. (1986) Proc. Natl. Acad. Sci. USA., 83, 583 5-5839. 
Jacquier, A. (1990) Trends Biochem. Sci., 15, 351-354. 
Jacquier, A. and Jacquesson-Breuleux, N. (1991) .J Mol. Biol., 219, 415-428. 
Jamison, S.F., Crow, A. and Garcia-Blanco, M.A. (1992) Mol. Cell. Biol., 12, 4279-
4287. 
Jandrositz, A. and Guthrie, C. (1995) EMBO J., 14, 820-832. 
Jarmolowski, A. and Mattaj, I.W. (1993) EMBO J., 12, 223-232. 
Jarrell, K.A., Dietrich, R. C. and Perlamn, P. S. (198 8) Mol. Cell. Biol., 8, 2361-2366. 
Jeifreys, A.J. and Flavell, R. A. (1977) Cell, 12, 1097-1108. 
224 
Jenkins, K.P, Hong, L. and Hallick, R.B. (1995) RNA, 1, 624-633. 
Johansen, S., Elde, M., Vader, A., Haugen, P., Haugh, K and Haugh, F. (1997) 
Molecular Microbiology, 24, 737-745. 
Johnston, M. and Davis, R.W. (1984) Mol. Cell. Biol., 4,1440-1448. 
Jones, M.H. and Guthrie, C. (1990) EMBO J., 9,2555-2561. 
Jones, M.H., Frank, D.N. and Guthrie, C. (1995) Proc. Natl. Acad. Sci. USA, 92, 9687-
9691. 
Kambach, C. and Mattaj, I.W. (1992)1 Cell. Biol., 118,11-21. 
Kandel-Lewis, S. and Séraphin, B. (1993) Science, 262, 2035-2039. 
Kao, H-Y. and Siliciano, P.G. (1992) Nucleic Acids Res., 20, 4009-4013. 
Kao, H-Y. and Siliciano, P. G. (1996) Mol. Cell. Biol., 16, 960-967. 
Kao, H-Y. and Rymond, B. (1996) Mol. Cell. Biol., 16, 960-967. 
Keller, E.B. and Noon, W.A. (1985) Nucleic Acids Res., 13, 4971-498 1. 
Kenan, D.J., Query, C.C. and Keene, J.D. (199 1) Trends Biochem. Sc., 16, 214-220. 
Kidd, D.D. and Ruano, G. (1994) PCR 2: A practical approach. IRL Press, p.9. 
Kim, S.H., Smith, J., Claude, A. and Lin, R.J. (1992) EMBOJ., 11, 2319-2326. 
Kim, S-H. and Lin, R-J. (1996) Mol. Cell. Biol., 16, 6810-6819. 
Kim, C.H., Ryan, D.E., Marciniec, T. and Abelson, J. (1997) EMBO J., 16, 2119-2129. 
King, D.S. and Beggs, J.D (1990) Nucleic Acids Res., 18, 6559-6564. 
Kiss, T., Jakab, G., Antal, M., Pálfi, Z., Hegyi, H., Kis, M. and Solymosy, F. (1988) 
Nucleic Acids Res., 16, 5407-5426. 
Kleinschmidt, A.N. and Pederson, T. (1987) Mol. Cell. Biol., 7, 3131-3137. 
Kleinschmidt, AX, Patton, J.R. and Pederson, T. (1989) Nucleic Acids Res., 17, 4817- 
4828. 
Koch, J.L., Boulanger, S.C., Dibhajj, S.D, Hebbar, S.K and Perlman, P.S. (1992) Mol. 
Cell. Biol., 12,1950-1958. 
225 
Koerner, T.J., Hill, J.E., Myers, A.M. and Tzagoloff, A. (1990) Methods in Enz., 194, 
477-490. 
Kohtz, J.D., Jamison, S.F., Will, C.L., Zuo, P., Luhrmann, R. and Garcia-Blanco, M.A. 
(1994) Nature, 368, 119-124. 
Kolossova, I. and Padgett, R.A. (1997) RNA, 3, 227-233. 
Konarska, M.M., Grabowski, P.J., Padgett, R.A. and Sharp, P.A. (1985) Nature, 313, 
552-557. 
Konarska, M.M. and Sharp, P.A. (1986) Cell, 46, 845-855. 
Konarska, M.M. and Sharp, P.A. (1987) Cell, 49, 763-774. 
Konforti, B.B. and Konarska, M.M. (1994) Genes Dev., 8, 1962-1973. 
Kramer, A.R., Maniatis, T., Ruskin, B. and Green, M.R. (1984) Cell, 36, 993-1005. 
Kramer, A.R., Conway, G.C. and Kozak, D. (1990) Cell, 62, 35-42. 
Kramer, A., Legrain, P., Mulhauser, F., Groning, K., Brosi, R. and Bilbe, G. (1994) 
Nucleic Acids Res., 22, 5223-5228. 
Kramer, A. (1995) In Lamond, A.I. (ed.), Pre-mRNA Processing, R.G. Landes 
Company, Springer-Verlag, pp. 35-64. 
Kunkel, TA., Roberts, JD. and Zamour, RA. (1987) Methods in Enz., 154, 367-382. 
Laemmli, U.K. (1970) Nature, 277, 680-685. 
Laggerbauer, B., Lauber, J. and LUhrmann, R. (1996) Nucleic Acids Res., 24, 868-875. 
Lamb, J.R.; Tugendreich, S. and Heiter, P. (1995) Trends Biochem. Sci., 20, 257-259. 
Lambowitz, A. M. and Belfort, M. (1993) Annu. Rev. Biochem., 62, 587-622. 
Lambright, D.G., Sondek, J., Bohm, A., Skiba, N.P., Hamm, H.E., Sigler, P.B. (1996) 
Nature, 376, 311-319. 
Lamm, G.M., Blencowe, B.J. and Sproat, B.S. (1991) Nucleic Acids Res., 19, 3193-
3198. 
Lamond, A.I., Konarska, M.M. and Sharp, P.A. (1987) Genes Dev., 1, 532-543. 
Lamond, A.I., Konarska, M.M. and Grabowski, P.A. (1988) Proc. Natl. Acad. Sci. 
USA, 85, 411-415. 
226 
Lapham, J, Yu, Y-T., Shu, M-D., Steitz, J.A. and Crothers, D.M. (1997) RNA, 3, 950-
951. 
Last, R.L., Maddock, J.R. and Woolford, J.L. (1987) Genetics, 117, 619-631. 
Lauber, J., Fabrizio, P., Teigelkamp, S., Lane, W.S., Hartmann, E. and LUhrmarin, R. 
(1996) EMBO J., 15, 4001-4015. 
Lauber, J., Plessel, G., Prehn, S., Will, C.L., Fabrizio, P., Gronig, K., Lane, W.S. and 
LUhrmann, R. (1997) RNA, 3, 926-941. 
Lazowska, J., Claisse, M., Gargouri, A., Zotylak, Z., Spyridakis, A. and Slonimski, P.P. 
(1989)1 Mo!. Biol., 205, 275-290. 
Legrain, P., Séraphin, B. and Rosbash, M. (1988) Mol. Cell. Biol., 8, 3755-3760. 
Legrain, P., Chapon, C. and Galisson, F. (1993) Genes Dev., 7, 1390-1399. 
Legrain, P., Chapon, C. (1993b) Science, 262, 108-110. 
Lehmeier, T., Raker, V., Hermann, H. and Lülirmann, R. (1994) Proc. Nat!. Acad. Sci. 
USA, 91, 12317-1232 1. 
Lesser, C.F. and Guthrie, C. (1993) Science, 262, 1982-1988. 
Lewis, J.D., Izaurralde, E., Jarmolowski, A., McGuigan, C. and Mattaj, I.W. (1996a) 
Genes Dev., 10, 1683-1698. 
Lewis, J.D., Görlich, D. and Mattaj, I.W. (1996b) Nucleic Acids Res., 24, 3332-3336. 
Li, Z. and Brow, D.A. (1993) Nucleic Acids Res., 21, 4645-4646. 
Liautard, J.P., Sri-Widada, J., Brunel, C. and Jeanteur, P. (1982) 1. Mo!. Biol., 162, 
623-643. 
Liao, X.C., Colot, H.V., Wang, Y. and Rosbash, M. (1992) Nucleic Acids Res., 20, 
4237-4245. 
Liao, X.C., Tang, J. and Rosbash, M. (1993) Genes Dev., 7, 419-428. 
Lin, R.-J., Newman, A.J., Cheng, 5.-C. and Abelson, J. (1985) 1 Biol. Chem., 260, 
14780-14792. 
Lin, R.-J., Lustig, A.J. and Abelson, J. (1987) Genes Dev., 1, 7-18. 
Lin, J. and Rossi, J.J. (1996) RNA, 2, 83 5-848. 
227 
Lockhart, S.R. and Rymond, B. (1994) Mo!. Cell. Biol., 14, 3623-3633. 
Lossky, M., Anderson, G.J., Jackson, S. and Beggs, J.D. (1987) Cell, 51, 1019-1026. 
Lithrmann, R., Kastner. B. and Bach, M. (1990) Biochim. Biophys. Acta., 1087, 265-
292. 
Lund, E. and Dahlberg, J.E. (1992) Science, 255, 327-330. 
Maddock, J.R., Roy, J., and Woolford, J.L. Jr. (1996) Nucleic Acids Res., 6, 1037-1044. 
Madhani, H.D., Bordonné, R. and Guthrie, C. (1990) Genes Dev., 4, 2264-2277. 
Madhani, H.D. and Guthrie, C. (1992) Cell, 71, 803-817. 
Madhani, H.D. and Guthrie, C. (1994a) Genes Dev., 8, 1071-1086. 
Madhani, H.D. and Guthrie, C. (1994b) Genetics, 137, 677-687. 
Madhani, H.D. and Guthrie, C. (1994c) Annu. Rev. Genet., 28, 1-26. 
Madore, S.J., Wieden, E.D. and Pederson, T. (1984a)J Cell. Biol., 98, 188-192. 
Madore, S.J., Wieden, E.D., Kunkel, G.R. and Pederson, T. (1984b) .1 Cell. Biol, 99, 
1140-1144. 
Maier, U.G., Rensing, S.A., Igloi, G.L. and Maez, M. (1995) Mo!. Gen. Genet., 246, 
128-131. 
Manley, J.L., Tacke, R. (1996) Genes Dev., 10, 1569-1579. 
Mattaj, I.W. and De Robertis, E.M. (1985) Cell, 40,111-118. 
Mattaj, I.W. (1986) Cell, 46, 905-911. 
Mattaj, I.W., Habets, W.J., van Venrooij, W.J. (1986) EMBO J., 5, 997-1002. 
Mattaj, I.W. (1988) (Bimstiel M.L ed), Berlin, Springer-Verlag. 
Mayes, A. E., Fromont-Racine, M., Legrain, P. and Beggs, J.D. (1997) RNA'97, The 
second annual meeting of the RNA society (Banff Centre). 
Mayes, A. E., Legrain, P. and Beggs, J.D. (1998) In preparation. 
McAllister, G., Roby, S.A., Amara, S.G. and Lerner, M.R. (1989) EMBO J., 8, 1177-
1181. 
228 
McLean, M.R. and Rymond, B.C. (1998) Mol. Cell. Biol. ;18, 353-360. 
McPheeters, D. S. (1996) RNA, 2, 1110-1123. 
McPheeters, D.S., Fabrizio, P. and Abelson, J. (1989) Genes Dev., 3, 2124-2136. 
McPheeters, D.S. and Abelson, J. (1992) Cell, 71, 819-83 1. 
Mermound, J.E., Calvio, C. and Lamond, A.I. (1994) Adv. Prot. Phosphatases, 8, 99-
118. 
Messing, J., Gronenbom, B., Muller-Hill, B. and Hofschneider, P.H. (1977) Proc. Natl. 
Acad. Sci. USA, 74, 3642-3646. 
Michaud, S. and Reed, R. (1991) Genes Dev., 5,2534-2546. 
Michel, F., Hanna, M., Green, R., Bartel, D.P. and Szostak, J.W. (1989) Nature, 342, 
391-395. 
Michel, F., Umesono, K and Ozeki, H. (1989b) Gene, 82, 5-30. 
Michel, F. and Westhof, E. (1990)1 Mol. Biol., 216, 585-6 10. 
Milligan, J.F. and Uhlenberck, O.C. (1989) Methods in Enz., 180, 5 1-62. 
Montzka Wassarman, K. and Steitz, J.A. (1992) Mol. Cell. Biol., 12, 1276-1285. 
Moore, M.J., Query, C. and Sharp, P.A. (1993) The RNA world, Cold Spring Harbor 
Laboratory Press, Chapter 13, pp  303-357. 
Mount, S.M. (1982) Nucleic Acids Res., 10, 459-472. 
Mueller, M.W., Allmaier, M., Eskes, R. and Schweyen, R.J. (1993) Nature, 366, 174-
176. 
Nakagawa, T. and Ogawa, H. (1997) Genes Cells, 2, 65-79. 
Neer, E.J., Schmidt, C.J., Nambudripad, R., Smith, T.F. (1994) Nature, 371, 297-300. 
Neer, E.J. (1995) Cell, 80, 249-257. 
Nelissen, R.L.H., Heinrichs, V., Habets, W.J., Simons, F., LUhrmann, R. and Van 
Venrooij, W.J. (1991) Nucleic Acid Res., 19, 449-454. 
Nelissen, R.L.H., Will, C.L., Van Venrooij, W.J. and LUhrmann, R. (1994) EMBO J., 
13,4113-4125. 
229 
Neubauer, G., Gottschalk, A., fabrizio, P., Séraphin, B., Lührmann, R. and Mann, M. 
(1997) Proc. Nat!. Acad. Sd. USA, 94, 385-390. 
Neuman de Vegvar, H.E. and Dahlberg, J.E. (1986) Cell, 47, 259-266. 
Neuman de Vegvar, H.E. and Dahlberg, J.E. (1990) Mo!. Cell. Biol., 10, 3365-3375. 
Newman, A.J., Lin, R.-J., Cheng, S.-C., and Abelson, J. (1985) Cell, 42, 335-344. 
Newman, A.J. and Norman, C. (199 1) Cell, 65, 115-123. 
Newman, A.J. and Norman, C. (1992) Cell, 68, 743-754. 
Newman, A.J.(1994) Curr. Biol., 4, 462-464. 
Newman, A.J., Teigelkamp, S. and Beggs, J.D. (1995) RNA, 1, 968-980. 
Newman, A.J. (1997) EMBO J., 16, 5797-5800. 
Nilsen, T.W. (1994) Cell, 78, 1-4. 
Niwa, M., Rose, S.D. and Berget, S.M. (1990) Genes Dev., 4, 1552-1559. 
Niwa, M. and Berget, S.M. (199 1) Genes Dev., 5, 2086-2095. 
Noble, S.M. and Guthrie, C. (1996a) Genetics, 143, 67-80. 
Noble, S.M. and Guthrie, C. (1996b) EMBO J., 15, 4368-4379. 
O'Day, C.L., Dalbadie-McFarland, G. and Abelson, J. (1996) 1 Biol. Chem., 271, 
33261-33267. 
Ogawa, H.; Johzuka, K.; Nakagawa, T.; Leem, S.H. and Hagihara, A.H. (1995) Adv 
Biophys, 31, 67-76. 
O'Keefe, R.T., Norman, C. and Newman, A.J. (1996) Cell, 86, 679-689. 
O'Keefe, R.T. and Newman, A.J. (1998) EMBO 1., 17, 565-574. 
Ordway, R.W., Pallanck, L. and Ganetzky, B. (1995) Trends Biochem. Sci., 19, 530-
531. 
Padgett, R.A., Garbowski, P.J., Konarska, M.M., Seiler, S. and Sharp, P.A. (1986) 
Annu. Rev. Biochem., 55, 1119-1150. 
Pante N., Jarmolowski A., Izaurralde E., Sauder U., Baschong W. and Mattaj I.W. 
(1997) RNA, 3,498-513. 
230 
Pante N., Jarmolowski A., Izaurralde E., Sauder U., Baschong W. and Mattaj I.W. 
(1997) RNA, 3, 498-513. 
Parker, R., Siliciano, P.G. and Guthrie, C. (1987) Cell, 49, 229-239. 
Parker, R. and Siliciano, P.G. (1993) Nature, 361, 660-662. 
Parkes V. and Johnston, L.H. (1992) Nucleic Acids Res., 21, 5617-5623. 
Patterson, B. and Guthrie, C. (1987) Cell, 49, 613-624. 
Patterson, B. and Guthrie, C. (1991) Cell, 64, 181-197. 
Patton J. R. (1991) Mol. Cell. Biol. 11, 5998-6006. 
Patton, J.R. (1993) Biochem. J, 290, 595-600. 
Patton, J.R. (1994) Biochemistry, 33, 10423-10427. 
Patton, J.R., Jacobson, M.R. and Pederson, T. (1994) Proc. Natl. Acad. Sci. USA., 91, 
3324-3328. 
Petersen-Bjøm,S.A., Soltyk, J.D., Beggs, J.D. and Friesen, J.D. (1989) Mol. Cell. Biol., 
9, 3698-3709. 
Pikielny, C.W. and Rosbash, M. (1986) Cell, 45, 869-877. 
Pikielny, C.W., Rymond, B.C. and Rosbash, M. (1986) Nature, 324, 341-345. 
Plessel, G., Fisher, U. and Luhrmann, R. (1994) Mol. Cell. Biol., 14, 4160-4172. 
Plessel, G., Lührmann, R. and Kastner, B. (1997) J. Mol. Biol., 265, 87-94. 
Plumpton, M. McGarvey, M. and Beggs, J.D. (1994) EMBO J., 13, 879-887. 
Potashkin, J. and Frendewey, D. (1990) EMBO J., 9, 525-534. 
Query, C.C., Bentley, R.C. and Keene, J.D. (1989) Cell, 57, 89-101. 
Raghunathan, P. and Guthrie, C. (1997) RNA '97: the second annual meeting of the 
RNA society. 
Raghunathan, P. and Guthrie, C. (1998) Science, 279, 857-879. 
Raker, V.A., Plessel, G. and LUhrmaim, R. (1996) EMBO J., 15, 2256-2269. 
231 
Ramamurthy, L., Ingledue, T.C., Pilch, D.R., Kay, B.K. and Marluff, W.F. (1996) 
Nucleic Acids Res., 24, 4525-4534. 
Reddy, R. and Busch, H. Small nuclear RNAs, Birnstiel ML (ed), Berlin, Springer-
Verlag, 1988, pp 1-37. 
Reed, R. and Maniatis, T. (1985) Cell, 41, 95-105. 
Reed, R. (1996) Curr. Opin. Genet. Dev., 6, 215-220. 
Reyes, J.L., Kois, P., Konforti, B.B. and Konarska, M.M. (1996) RNA, 2, 213 -225. 
Rinke, J., Appel, B., Digweed, M. and Lübrmann, R. (1985) J. Mol. Biol., 185, 721-
731. 
Romac, J.J-M., Graff, D.H. and Keene, J.D. (1994) Mol. Cell. Biol., 14, 4662-4670. 
Roscigno, R.F. and Garcia-Blanco, M.A. (1995) RNA, 1, 692-706. 
Roy, J., Zheng, B., Rymond, B.C. and Woolford, J.L. (1995a) Mo!. Cell. Biol., 15, 445- 
455. 
Roy, J., Kim, K.; Maddock, J.R.; Antony, J.G. and Woolford, J.L. (1995b) RNA, 4, 
375-390. 
Ruby, S.W., Chang, T-H. and Abelson, J. (1993) Genes. Dev., 7, 1909-19 
Ruby, S.W. (1997)J. Biol. Chem., 272, 17333-17341. 
Ruther, U. and Muller-Hill, B. (1983) EMBO J., 2, 1791-1794. 
Ruskin, B. and Green, M.R. (1985a) Nature, 317, 732-734. 
Ruskin, B. and Green, M.R. (1985b) Science, 229,135-229. 
Ruskin, B., Zamore, P.D. and Green, M.R. (198 8) Cell, 52, 207-219. 
Rymond, B. (1993) Proc. Nat!. Acad. Sci. USA, 90, 848-852. 
Rymond, B., Rokeach, L.A. and Hoch S.O. (1993) Nucleic Acids Res., 21, 3501-3505. 
Sachs, A., Bond, M.W. and Kornberg, R.D. (1986) Cell, 45, 827-835. 
Sauterer, R.A., Goyal, A. and Zieve, G.W. (1990) 1 Biol. Chem., 265,1048-1058. 
Sawa, H. and Shimura, Y. (199 1) Nucleic Acids Res., 19, 6819-6821. 
232 
Sawa, H. and Abelson, J. (1992) Proc. Nat!. Acad. Sci. USA, 89,11269-11273. 
Sawa, H. and Shimura, Y. (1992) Genes Dev., 6, 244-254. 
Scherly, D., Boelens, W., Van Venrooij, W.J., Dathan, N.A., Hamm, J. and Matta, I.W. 
(1989) EMBO J., 8,4163-4170. 
Scherly, D., Boelens, W., Dathan, N.A., Van Venrooij, W.J. and Mattaj, I.W. (1990) 
Nature, 345, 502-506. 
Schmid, S.R., Linder, P. (1992) Mol. Microbiol., 6, 283292. 
Schwer, B. and Guthrie, C. (199 1) Nature, 349, 494-499. 
Schwer, B. and Guthrie, C. (1992a) Mol. Cell. Biol., 12, 3540-3547. 
Schwer, B. and Guthrie, C. (1992b) EMBO J., 11, 5033-5039. 
Schwer, B. and Shuman, S. (1996) RNA, 2, 574-583. 
Schwer, B. and Gross, C.H. (1998) EMBO J., 17,2086-2094. 
Ségault, V., Will, C.L, Sproat, B.S and LUhrmann, R. (1995) EMBOJ., 16, 4010-4021. 
Sellem, C.H. and Belcour, L. (1994) Nucleic Acids Res., 22, 1135-1137. 
Séraphin, B., Kretzner, L. and Rosbash, M. (1988) EMBO J., 7,2533-2538. 
Séraphin, B. and Rosbash, M. (1989) Cell, 59, 349-358. 
Séraphin, B., Abovich, N. and Rosbash, M. (1991)Nucleic Acids Res., 19,3857-3860. 
Séraphin, B. (1995) EMBO J., 14, 2089-2098. 
Siemester, G., Buchholz, C. and Hachtel, W. (1990) Mol. Gen. Gene,'., 220, 425-432. 
Siliciano, P.G., Jones, M.H. and Guthrie, C. (1987a) Science, 237, 1484-1487. 
Siliciano, P.G., Brow, D.A., Roiha, H. and Guthrie, C. (1987b) Cell, 50, 585-592. 
Siliciano, P.G. and Guthrie, C. (1988) Genes Dev., 2, 1258-1267. 
Sillekens, P.T.G., Beijer, R.C., Habets, W.J. and Van Venrooij, W.J. (1988) Nucleic 
Acids Res., 16, 8307-8321. 
Simon, MI; Strathmann, M.P. and Gautam, N. (199 1) Science, 252, 802-808. 
233 
Singh, R., Valcarcel, J. and Green, M.R. (1995) Science, 268, 1173-1176. 
Shannon, K.W. and Guthrie, C. (199 1) Genes Dev., 5, 773-785. 
Sharp, P.A (1994) Cell, 77, 805-815. 
Sharp, P.A. and Burhe, C.B. (1997) Cell, 91, 875-879. 
Shuster, E.O. and Guthrie, C. (1988) Cell, 55, 41-48. 
Smith, V. and Barrell, B. (199 1) EMBO J., 10, 2627-2634. 
Sondek, J., Bohm, N.H., Lambright, D.G., Hamm, H.E. and Sigler, P.B. (1996) Nature, 
379, 369-374. 
Sontheimer, E.J. and Steitz, J.A. (1993) Science, 262, 1989-1996. 
Sontheimer, E.J. (1994) Mo!. Biol. Reports, 20, 3 5-44. 
Staknis, D. and Reed, R. (1994) Mo!. Cell. Biol., 14, 2994-3005. 
Steitz, J.A. (1992) Science, 257, 888-889. 
Strauss, E.J. and Guthrie, C. (1991) Genes Dev., 5, 629-641. 
Strauss, E.J. and Guthrie, C. (1994) Nucleic Acids Res., 22, 3187-3193. 
Sun, J.S. and Manley, J.L. (1995) Genes Dev., 9, 843-854. 
Sun, J. S. and Manley, J.L. (1997) RNA, 3, 514-526. 
Takahashi, N.; Hayano, T. and Suzuki, M. (1989) Nature, 337, 473-475. 
Tang, J. and Rosbash, M. (1996) RNA, 2,1058-1070. 
Tang, J., Abovich, N. and Rosbash, M. (1996b) Mo!. Cell. Biol., 16, 2787-2795. 
Tang, J., Abovich, N., Fleming, M.L., Séraphin, B and Rosbash, M. (1997) EMBO J., 
16, 4082-4091. 
Tarn T. and Ohshima Y. (1989) Nature, 337, 87-90 
Tarn, W.Y., Lee, K.R. and Cheng, S.C. (1993) Proc NatlAcadSci USA, 15; 10821-
10825. 
Tarn, W-Y. and Steitz, J.A. (1994a) Genes Dev., 8, 2704-2717. 
234 
Tarn, W-Y., Hsu, C.H., Huang, K.T., Chen, H.R., Kao, H.Y., Lee, K.R. and Cheng S.C. 
(1994b) EMBO J., 13, 2421-243 1. 
Tarn, W-Y., Yario, T.A. and Steitz J.A. (1995) RNA, 1, 644-656. 
Tarn, W-Y. and Steitz, J.A. (1996a) Cell, 84, 801-811. 
Tam, W-Y. and Steitz, J.A. (1996b) Science, 273, 1824-1832. 
Tarn, W-Y. and Steitz, J.A. (1997) TIBS, 22,132-137. 
Tazi, J., Fornd, T., Jeanteur, P., Cathala, G. and Brunel, C. (1993) Mol. Cell. Biol., 13, 
1641-1650. 
Tazi, J., Kornstadt, U., Rossi, F., Jeanteur, P., Catala, G., Brunel, C. and Ltthrmann, R. 
(1993b) Nature, 363, 283-286. 
Teigelkamp, S., McGarvey, M., Plumpton, M. and Beggs, J.D. (1994) EMBO J., 13, 
888-897. 
Teigelkamp, S., Newman, A.J. and Beggs, J.D. (1995) EMBO J., 14, 2602-2612. 
Teigelkamp, S., Whittaker, E and Beggs, J.D. (1 995b) Nucleic Acids Res., 23, 320-326. 
RNA 1997 Nov;3(1 1):1313-1326 
Teigelkamp, S., Mundt, C., Achsel, T., Will, C.L. and Lührmann, R. (1997) RNA, 3, 
1313-1326. 
Teigelkamp, S., Achsel, T., Mundt, C., Göthel, S-F., Cronshagen, U., Lane, W.S., 
Marahiel, M. and LUhrmann, R. (1998) RNA, 4,127-141. 
Terns, M.P., Lund, E. and Dahlberg, J.E. (1992) Mol. Cell. Biol., 12, 3032-3040. 
Tilghman, S.M, Tiemeier, D.C., Seidman, J.G., Peterlin, B.M., Sullivan, M., Maizel, 
J.V. and Leder, P. (1978) Proc. Natl. Acad. Sci. USA, 75, 1485-1489. 
Tollervey, D. and Mattaj, I.W. (1987) EMBO J., 6,469-476. 
Triana-Alonso, F.J., Dabrowski, M., Wadzack, J. and Nierhaus, K.H. (1995) 1 Biol. 
Chemistry, 11, 6298-6307. 
Umen, J.G. and Guthrie, C. (1995) RNA, 1, 584-597. 
Umen, J.G. and Guthrie, C. (1996) Genetics, 143, 723-739. 
235 
Vaidya, V.C., Seshadri, V. and Vijayraghavan, U. (1996) Mol. Gen. Genet., 250, 267-
276. 
Van Dam, A. (1989) EMBO J., 8,3853-3860. 
Van Dyck, L., Jonniau, J.L., deMelo, B.T., Kleine, K. and Goffeau, A. (1994) Yeast, 
10, 1663-1673. 
Vankan, P., McGuigan, C. and Mattaj, I.W. (1992) EMBOJ., 11, 335-343. 
Vijayraghavan, U., Company, M. and Abelson, J. (1986) Genes Dev., 3, 1206-1216. 
Vijayraghavan, U., Parker, R., Tamm, J., Limura, Y., Rossi, J., Abelson, J. and Guthrie, 
C. (1986b)EMBOJ., 5, 1683-1695. 
Vijayraghavan, U. and Abelson, J. (1990) Mol. Cell. Biol., 10, 324-332. 
Wagner, J.D.O., Company, M. and Abelson, J. (1997) RNA '97: the second annual 
meeting of the RNA society. 
Wagner, J.D.O., Jankowsky, E. Company, M., Pyle, A.M. and Abelson, J. (1998) 
EMBOJ., 17,2926-2937. 
Wall, M.A., Coleman, D.E., Lee, E., Iniguez-Lluli, J.A., Posner, B.A., Gilman, A.G. 
and Sprang, S.R. (1995) Cell, 83, 1047-1058. 
Wang, Y.; Wagner, J.D.O and Guthrie, C. (1998) Curr. Biol., 8,441-451. 
Wassarman, D.A. and Steitz, J.O. (1992) Science, 257, 1918-1925. 
Weidenhammer, E.M., Ruiz-Noriega, M. and Woolford, J.L.JR. (1997) Mol. Cell. Biol., 
17, 3580-3588. 
Wells, S.E. and Ares, M.JR. (1994) Mol. Cell. Biol., 14, 6337-6349. 
Wells, S.E., Neville, M., Haynes, M., Wang, J., Igel, H. and Ares, M.J. (1996) Genes 
Dev., 10, 220-232. 
Wersig, C. and Bindereif, A. (1992) Mol. Cell. Biol., 12, 1460-1468. 
Whittaker, E., Lossky, M. and Beggs, J.D. (1990) Proc Natl. Acad. Sd. USA, 87, 2216- 
2219. 
Whittaker, E. and Beggs, J.D. (1991) Nucleic Acids Res., 19,5483-5489. 
Will, C.L., Behrens, S-E. and Luhrmann, R. (1993) Mol. Biol. Reports, 18,121-126. 
236 
Will, C.L. and Lübrmann, R. (1997) Curr. Opin. Cell Biol., 9,320-328. 
Wolff, T. and Bindereif, A. (1993) Genes Dev., 7, 1377-1389. 
Wooley, J.C., Zukerberg, L.R. and Chung, S-Y. (1983) Proc. Nat! Acad Sd. USA., 80, 
5208-5212. 
Woppmann, A., Patschinsky, T., Bringmaim, P., Godt, F. and Ltthrmann, R. (1990) 
Nucleic Acids Res., 18, 4427-4438. 
Woppmann, A., Will, C.L., Kornstädt, U., Zuo, P., Manley, J.L. and Lührmann, R. 
(1993) Nucleic Acids Res., 21, 2815-2822. 
Wu, J. and Manley, J.L. (1989) Genes Dev., 3,1553-1561. 
Wu, J.Y. and Maniatis, T. (1993) Cell, 75,1061-1070. 
Wu, Q. and Kramer, A.R. (1997) RNA, 3, 586-601. 
Wyatt, J.R., Sontheimer, E.J. and Steitz, J.A. (1992) Genes Dev., 6, 2542-2553. 
Xiao, S-H. and Manley, J.L. (1997) Genes Dev., 11, 334-344. 
Xie, J., Beickman, K., Otte, E. and Rymond, B.C. (1998) EMBO J., 17, 2938-2946. 
Xu, Y., Petersen-Bjorn, S. and Friesen, J.D. (1990) Mo!. Cell. Biol., 3,1217-1225. 
Xu, Y., Nouraini, S., Field, D., Tang, S-J. and Friesen, J.D. (1996) Nature, 381, 709-
713. 
Yean, S-H., and Lin, R-J. (1991) Mo!. Cell. Biol., 11, 5571-5577. 
Yisraeli, J.K and Melton, D.A (1 898) Methods in Enz., 180, 42-49. 
Yu, Y-T. and Steitz, J.O. (1997) RNA, 3, 807-810. 
Zahier, A.M., Lane, W.S., Stolk, I.A. and Roth, M.B. (1992) Genes Dev., 6, 837-847. 
Zamore, P.D. and Green, M.R. (1989) Proc. Nat!. Acad. Sci. USA, 86, 9243-9247. 
Zamore, P.D., Patton, J.G. and Green, M.R. (1992) Nature, 355, 609-614. 
Zerby, D.B. and Patton, J.R. (1996) Nucleic Acids Res., 24, 3583-3589. 
Zhang, M., Zamore, P.D., Carmo-Fonseca, M., Lamond, A.I. and Green, M.R. (1992) 
Proc. Mad. Acad. Sci. USA, 89, 8769-8773. 
237 
Zhang, W-J. and Wu, J.Y. (1996) Mol. Cell. Biol., 16, 5400-5408. 
Zhang, X. and Schwer, B. (1997) Nucleic Acids Res., 25, 2146-2152. 
Zhou, C., Yang, Y. and Jong, A. Y. (1990) Biotechniques, 2, 172-173. 
Zhuang, Y. and Weiner, A.M. (1986) Cell, 46, 827-83 5. 
Zieve, G.W., Sauterer, R.A. and Feeney, R.J. (1988)1 Mo!. Biol., 199, 2259-2267. 
Zillmann, M,, Zapp., M.L. and Berget, S.M. (1988) Mo!. Cell. Rio!., 8, 814-82 1. 
Zuo, P. and Maniatis, T. (1996) Genes Dcv., 10, 1356-1368. 
238 
ANNEX I 
Sequence of the. 3.5 Kb- XbaI fragment contained in YCpXba plasmid (Table 9) 
(Shannon et al., 1991). 
This sequence was communicated by A. Ghetti from J. Abelson's laboratory 
(California), it is now available in the Saccharomyces cerevisiae genome database of 
the yeast chromosome XIII; PRP24 ORF can be found under the accession number 
YMR268c. 
The nucleotides indicated in bold characters belong to PRP24 ORF; the 
oligodeoxynucleotides used in this work are indicated by arrows. 
1 TCTAGATGTG GATGAATTGA ACATTCCAAA CGAAATATCC CGGAATATCT 
51 TAGTTAPJCT GGACAGCTTA TTCGAAGGGT TGCATGATAA AATAGCCAA 
101 GAGAACGAAT TCGATGTAAG GCAAGATAAG CATTCTAATA ATATAAGGGC 
151 GAATCAGATA GACGACGAGC CCATGCAGGC CAATCGACGA ATTAATACA 
201 CATATCATGA CTTGGTTTCA AGAGGTTGTG AAATGAACGA GGATATGACG 
251 GATATCTACA TGAAATCATT AGAGCTATAT AACGATATCC CAGAAAAGTA 
301 TAAAAAGAGA APJTTCAGAC TGCCCAAACA AATTCTAAAA AAGTATCACC 
351 AGCCAAAAAA GACCAGTTCA TACTTAAAGG AGCTATTAAG TAAAACAAGA 
401 GAAGATTTCA TACCTGTGGA AAGTTATTG AAGGATAAAC GGTTGACATC 
451 AAAGGACAAA TCCAAGCTAC AACGCTTAA TCGTGAAGAG ACGGAAGATG 
501 CTCTAAACAA AAGAACATTT TTTCAGGTAA AGGGCTACTT AGAGGATGAG 
551 AATGAGATCT CTGATTACGA GTTGGACGAC TGCCTCATAG AACTGCCTAA 
601 TGGGAACATA TGAATGAGAA AATCTTTTTT TTACCTTTTT CCATTAAGAA 
651 ATATTCATCT CCTTTTAAGA TCAACATATG TAACAATAAA TATACTCTTT 
701 TAPAGATGTT CTTTTAATTT ACTTACTGAA ATTTAATATT AATAAAGTT 
751 CGAkkACAA.A GACTAAATAC AAAAATAAAA AGATCATAAA TTCAAACTTT 
801 TAAGAATGTC TTTTACGGAT ACATATTTAC ATATTAGACT ATGATAI&TCA 
851 TATATGCTCC TTTCTATCTC TTCTTGCTGA ACTTTCTTCC TTTTTATGTT 
239 
901 TTTTTGACTT TTTGGATTTT TTATGCTTCG ATTTATCACC TTCATCGCTG 
951 CTATGCTTAC TTTTCTTTCC TTTTTTACTC TCCTTCTTGC TTTTCTTCTT 
1001 CTTCTTCTTC TTACTCTCAC TGTCGTTACT AGTCTTTTTA TCTTTTTTCA 
1051 ATTTTTTTCT CTTGACCTTG TTATCATCTT CATCACGCCT TCTTCTCTTC 
1101 TTCCCTTTAC TCGAACTTGC ACTAGATACA ACAGCTGG CTTCCTCCTT 
1151 TTTACCAAGA TTAGTAATGG TTCCTTTCAG CCCTTCTCCC TTTACAAACC 
1201 ACCTGTATAG AGGTGAGCTA CTTTTCGATA CAGCAGTAGC ACTGCCTCA 
1251 TTTTGAGTA1 ATTTAATACT GCCATTATTC GAATCAGTGC TTACATCCAG 
1301 GTTCTTCAGA TGTCCATCAP ATAGCCTTTC CCACCATGCT TCGCCATCAT 
1351 TCCCGCCAGG AGCATTACCC AATCCCTTCT TATCTCTCTT GTGCTTTACC 
1401 AGTATGGGTC TTTTCAAACC ACCTTCTCTA AACGCTTCTC CTTCTTTCCA 
1451 ACCATATGAT ATCAGATATT CTTTGCTATC CATGTCCGAT TTATTCTGAT 
1501 AATATTTCCG CTTGTATCAT TCATTTTCT ATGTACATCA TGACAATGAA 
1551 TTGTAGAGTG CATCATGTC TTTTTTAAAG TCATCGCTAA APAATTTTCA 
1601 GGCGGGAACT TATTCAAAAT GGCAGATTTA CTACAACATT GAAAACCCTT 
1651 TATATTTATT ATATGAGAAT CATTAGCGAT AAACAAGCCC ACATATTCAC 
1701 TTCATAATCT GTGATAATGG AGTATGGACA TCACGCTAGA CCAGATTCAA 
/ 	 S8948 
1751 AACGACCATT GGATGAAGGA TCACCAGCAG CCGCAGGATT AACTTCTAAG 
1801 AAGGCGAACG AAGCTTTAAC AAGAAATAGA GAATTAACAA CTGTATTAGT 
P5118 
1851 CAAAAATTTG CCTAAGAGCT ATAATCAAAA CAAAGTCTAT AAGTACTTCA 
1901 AACATTGTGG GCCCATTATA CACGTTGATG TTGCGGATTC GCTGAAGAAG 
1951 AACTTTCGTT TTGCACGTAT TGAATTTGCC AGGTATGATG GAGCCCTCGC 
2001 TGCAATAACC AACACACA AAGTTGTAGG TCAGAATGAA ATTATAGTAT 
2051 CTCATTTAAC AGAATGCACA TTATGGATGA CGAATTTCCC CCCAAGTTAT 
2101 ACTCAAAG.AA ATATTAGAGA TCTATTGCAA GATATTAACG TTGTTGCACT 
240 
2151 CAGTATACGG CTTCCCAGTT TACGATTCAA TACAAGCAGA AGGTTCGCTT 
N6089 
2201 ACATCGATGT TACTTCTAAA GAGGATGCAA GATATTGTGT AGAAAAATTG 
2251 AATGGACTCA .A.AATAGAAGG TTATACTTTA GTTACTAAAG TTTCCAATCC 
2301 GCTGGAAA.AG TCGACGGA CCGATTCTGC CACACTAGAG GGGCGAGAGA 
2351 TTATGATACG AAACCTAAGT ACAGAATTGC TCGACGAAA CCTTCTGAGG 
2401 GAATCTTTTG AGGGATTTGG TTCCATTGAA AAAATCAACA TACCTGCTGG 
2451 ACAGAAAGAG CACAGTTTCA ATAACTGTTG TGCATTTATG GTTTTTGAAA 
2501 ATAAAGATTC TGCTGAA.AGG GCACTTCAAA TGAATAGAAG TTTGTTAGGT 
2551 AATAGGGAAA TTTCCGTTTC CTTGGCTGAT AAAAAACCAT TCTTAGAA.AG 
2601 AAACGAAGTC AAAAGACTTC TCGCATCGCG TAACAGCAAA GAACTAGAA.A 
2651 CACTAATATG CTTATTTCCA CTTTCAGATA AGGTGTCACC AAGCTTAATC 
JMB11 
2701 TGCCAATTTC TTCAGGAAGA AATACACATC AATGAAAAAG ATATTAGGAA 
2751 AATACTTCTC GTTAGCGACT TCAATGGCGC CATTATTATA TTTAGAGATA 
4 
P5117 
2801 GTAAGTTTGC AGCAAAA.ATG CTAATGATAC TAAATGGATC TCAATTTCAG 
2851 GGAA.AGGTGA TACGTTCAGG TACTATTAAT GACATGAAAA GATATTATAA 
2901 CAATCAACAG AATCACAGCA TGAAACACGT CAA.ACCTAGT TGTATAAACA 
P4852 
2951 TGATGGAAA AGGACCA1AT CTTCAAGTAA AGAAAAAT TCCTGACAAA 
3001 CAAGAGCAGA TGTCCAACGA CGATTTTCGC AAGATGTTTC TAGTGAGTA 
S8949 
N6088 
3051 GACTAACCGA ACCGGAGAAA GACGA1CTTC TAATAGGATG TCATTTTAGC 
3101 AGTGAATATA ACCCAAGTT TCTTTCCAAA CGTTCACATA CATCAAGCAG 
3151 CCA1CATTCG AGAGAGCAGA GATTACGTAA TTATATACAA GGAACCTTTA 
3201 TCTAAACATT TTCTTCGAAG GTATTATTTT CATATTAAAC GTAATACCAT 
3251 TTTTGCACCT CAGGCGGTAT TTGAGAAGGG GGTTTAACAC TATCTTCA1G 
3301 TGTGACACCA TTACCAGCCC TTTCTGTATT AGGCAGGTTG TCATACTTCT 
3351 CCTGGAGTGA TCCTGAAATG AGGTTTTTCC ACGAATTGTG ACATTTCTTT 
3401 ATAGTTTGGA TGGTTTTATT GGAATTTTGA TACTGTTCAT GAAAGGCGAA 
241 
JMB 10 
3451 ACTATTTAAT GGCTTCCCTG CTGGAACTTT ATACTTTCTA AACCACTCCC 
3501 TAGTCGTA 
242 
